data_2la8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2la8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.8 155.65 27.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 9.4 mttt -149.39 129.72 13.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.069 0.462 . . . . 0.0 110.708 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.495 ' CE1' ' CG2' ' A' ' 81' ' ' VAL . 28.1 p90 -138.49 169.58 17.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.688 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.58 135.88 49.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.158 0.504 . . . . 0.0 111.382 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 43' ' ' LYS . 19.2 t -114.42 107.06 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.157 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 1.5 p30 -111.74 127.27 55.74 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.016 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.568 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -151.68 157.8 42.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.55 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.33 118.33 14.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 110.696 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.6 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -101.14 129.13 47.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.812 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 3.5 mmtp -119.61 68.61 0.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.166 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.9 77.33 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.422 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 48.95 100.78 0.01 OUTLIER Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.329 -0.462 . . . . 0.0 114.167 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.464 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -159.4 -101.58 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 22.3 mt-10 -69.22 -5.41 22.57 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.53 ' HG ' ' HE2' ' A' ' 10' ' ' LYS . 2.7 mt -45.5 -30.32 1.39 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.963 0.411 . . . . 0.0 109.906 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 24.81 63.05 0.05 OUTLIER Glycine 0 C--N 1.331 0.284 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 178.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.474 HD21 ' CD2' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -145.85 92.02 2.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.108 0.48 . . . . 0.0 110.098 178.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 30' ' ' ALA . 1.5 t -63.42 120.73 12.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.175 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -100.0 158.07 16.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.585 -179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.41 163.33 51.28 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.348 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.33 117.56 5.22 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.492 2.128 . . . . 0.0 112.77 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.9 162.61 29.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -79.66 -37.26 36.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.99 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 pt -94.34 -6.03 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.888 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.27 -122.65 1.08 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.619 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -138.99 106.23 5.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.727 0.298 . . . . 0.0 110.924 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -66.82 121.04 14.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.246 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.0 mt -62.85 104.59 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.561 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -72.1 -25.5 61.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -172.54 -178.02 1.87 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.386 0.612 . . . . 0.0 111.38 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.428 ' HA ' ' HZ3' ' A' ' 105' ' ' TRP . 0.2 OUTLIER -164.36 136.73 4.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.553 178.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.593 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 3.1 pt -96.0 100.32 10.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.303 0.573 . . . . 0.0 110.334 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -63.6 153.24 36.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.86 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.8 -16.15 61.46 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.703 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.2 mp0 -77.77 -50.08 13.09 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.712 0.291 . . . . 0.0 110.727 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -135.07 139.69 32.68 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.766 0.317 . . . . 0.0 110.829 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.15 -50.27 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.693 2.262 . . . . 0.0 113.05 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.7 mp0 -59.56 -49.25 78.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 110.838 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.476 HG13 ' HB3' ' A' ' 37' ' ' TYR . 4.2 mt -56.04 -48.22 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.92 -30.3 70.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.511 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 m -99.16 3.37 46.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.367 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -125.32 -71.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.4 mt -71.13 156.24 39.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.466 0.65 . . . . 0.0 112.498 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -153.95 -175.78 5.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.857 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -92.83 117.55 30.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.888 0.375 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.35 17.53 4.38 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.896 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -115.32 167.35 10.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.783 0.291 . . . . 0.0 110.82 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.5 mp -137.01 120.61 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.453 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 9.8 mt -74.21 100.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.07 0.462 . . . . 0.0 110.567 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.2 p -95.71 -3.71 45.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.245 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -144.52 143.96 31.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.984 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.452 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 32.0 t80 -150.1 111.74 4.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.954 0.407 . . . . 0.0 111.369 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.68 46.17 26.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.132 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.95 24.26 76.55 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.391 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -126.68 104.47 8.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.693 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.3 117.28 3.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.223 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mt -92.8 17.67 10.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.968 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -87.21 127.72 35.15 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.891 0.376 . . . . 0.0 111.226 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.4 -23.84 28.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.791 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.24 153.81 66.25 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.998 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.01 -172.57 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.578 2.186 . . . . 0.0 112.244 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.429 ' CE1' ' HB2' ' A' ' 67' ' ' TYR . 55.0 t80 -91.95 -29.18 16.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.713 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -53.96 -43.43 69.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.58 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 p -65.28 -46.22 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.423 ' HA ' HD21 ' A' ' 69' ' ' LEU . 89.4 m -60.21 -49.62 76.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.661 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 16.1 t80 -58.52 -31.97 68.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.599 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.01 -50.85 20.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.213 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.452 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.46 -37.02 82.29 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.473 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.453 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 5.0 m-85 -67.49 -34.02 76.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.419 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 34.9 mtmt -82.18 -29.76 31.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.28 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.85 15.93 61.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.637 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.482 ' O ' ' HD3' ' A' ' 10' ' ' LYS . . . -78.12 138.14 38.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.709 0.29 . . . . 0.0 110.591 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 2.2 p30 -169.52 100.07 0.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.989 0.424 . . . . 0.0 110.785 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.17 78.32 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.961 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.36 114.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.962 0.411 . . . . 0.0 110.27 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.6 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -124.82 107.85 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.614 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.7 t -102.71 109.81 21.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.303 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.418 ' CE ' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -116.63 123.77 48.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.57 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tt0 -86.66 106.24 17.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 110.307 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.495 ' CG2' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -95.95 142.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.626 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.403 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 94.2 m -108.78 120.81 43.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -103.9 91.43 3.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 C--N 1.343 0.249 0 C-N-CA 122.45 2.1 . . . . 0.0 112.325 179.861 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.515 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 17.1 mm-40 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.508 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.0 t80 -79.44 96.1 5.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.593 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 54.3 m95 -99.3 139.83 34.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.095 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.416 HG11 ' CD1' ' A' ' 67' ' ' TYR . 10.8 m . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.125 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.736 0.303 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.15 162.21 22.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.912 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.9 mttp -154.43 129.64 9.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.816 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.523 ' CE1' HG22 ' A' ' 81' ' ' VAL . 12.7 p90 -137.71 169.73 17.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.882 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.46 135.82 49.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.002 0.429 . . . . 0.0 111.069 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 81' ' ' VAL . 11.3 t -117.07 107.27 21.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.574 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 6.8 p-10 -108.56 127.15 53.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.805 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.96 155.05 40.27 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.955 0.407 . . . . 0.0 110.481 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.94 119.04 11.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.246 0.546 . . . . 0.0 110.459 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.67 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -101.89 149.79 23.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.092 -178.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 16.7 mmtt -138.55 68.94 1.38 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.182 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.09 27.16 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.425 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.483 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 96.18 116.9 3.25 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.099 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -169.75 -99.09 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 111.533 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.667 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 26.6 mt-10 -69.37 -4.77 19.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.529 ' CD1' ' HE2' ' A' ' 10' ' ' LYS . 4.2 mt -44.16 -37.96 3.43 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.832 0.348 . . . . 0.0 110.33 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 33.37 55.43 0.58 Allowed Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.802 -0.635 . . . . 0.0 114.146 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.429 ' CD1' ' CD2' ' A' ' 20' ' ' LEU . 1.1 pp -138.33 91.94 2.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.822 0.344 . . . . 0.0 110.365 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -63.07 110.37 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.577 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.429 ' CD2' ' CD1' ' A' ' 18' ' ' LEU . 3.3 mt -91.62 161.11 15.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.736 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 7.0 m -142.94 152.2 58.13 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.68 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.69 135.87 70.14 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.661 2.241 . . . . 0.0 112.706 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.3 162.68 36.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.141 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -81.56 -19.76 41.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.272 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.8 pt -115.34 -4.61 11.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.753 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.79 -123.39 1.15 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.166 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 21' ' ' SER . 0.9 OUTLIER -140.68 106.05 5.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.774 0.321 . . . . 0.0 111.265 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.4 m -70.82 128.61 36.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.598 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.6 mt -71.65 104.92 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.712 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.34 66.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.174 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.51 164.34 38.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.87 128.79 11.71 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.262 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.575 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 11.5 pt -104.78 100.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.347 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -72.16 159.98 33.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.086 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.56 64.72 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.125 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -81.54 -41.67 21.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.941 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.667 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -139.29 136.28 17.86 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.197 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.9 -44.46 5.4 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.622 2.214 . . . . 0.0 113.137 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 43' ' ' LYS . 3.9 mm-40 -64.86 -52.88 54.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.66 0.267 . . . . 0.0 110.943 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 5.2 mt -54.54 -48.02 70.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.052 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -63.46 -30.21 71.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.552 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 m -97.01 3.24 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.268 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -131.62 -73.46 0.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.397 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.8 mt -72.34 149.28 44.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.077 0.465 . . . . 0.0 111.363 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.64 160.09 42.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.538 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -59.22 105.0 0.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.97 37.27 0.62 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.596 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.65 139.3 47.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.784 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.5 mt -110.99 117.26 54.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.977 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.446 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 15.2 mt -77.42 100.22 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.995 0.426 . . . . 0.0 110.539 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.1 p -94.63 0.33 55.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.207 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -148.53 142.05 25.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.029 179.258 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.431 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 36.3 t80 -145.68 108.43 4.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.86 0.362 . . . . 0.0 111.061 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 51.88 53.95 11.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.949 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.43 69.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.371 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -123.33 103.25 8.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.802 0.334 . . . . 0.0 110.604 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.28 113.32 1.52 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.332 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.425 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 15.1 mt -88.61 9.93 22.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -68.42 145.91 53.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.879 0.371 . . . . 0.0 111.085 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.96 26.11 47.47 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.633 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.6 mt -116.73 148.12 41.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.686 0.279 . . . . 0.0 110.849 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.64 -167.38 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.551 2.167 . . . . 0.0 112.227 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.9 t80 -97.77 -26.56 14.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.767 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -57.43 -47.93 80.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.968 0.413 . . . . 0.0 110.273 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.6 m -63.8 -47.03 92.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.087 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.402 ' HA ' HD23 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -59.27 -53.8 54.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.699 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 21.8 t80 -56.02 -31.14 62.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.692 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.33 -51.08 18.76 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.431 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.74 -34.76 76.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.851 0.358 . . . . 0.0 110.356 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.446 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 5.8 m-85 -69.06 -34.0 74.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.445 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 7.4 mtpt -81.31 -32.83 32.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.358 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.41 -26.47 57.09 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.51 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.472 ' CB ' ' HD2' ' A' ' 10' ' ' LYS . . . -45.13 139.52 3.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.881 0.372 . . . . 0.0 111.412 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -167.11 99.6 0.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.72 80.12 0.84 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.819 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.19 112.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 110.158 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.67 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -124.42 107.96 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.752 -178.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 t -98.5 114.43 26.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.45 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.82 122.21 42.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.666 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -83.31 102.93 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.609 HG23 HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -95.26 142.45 13.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.739 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.402 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 53.2 m -108.86 126.06 52.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.014 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -108.71 96.37 19.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.236 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 82' ' ' THR . 41.5 Cg_exo . . . . . 0 C--N 1.345 0.394 0 C-N-CA 122.564 2.176 . . . . 0.0 112.202 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.47 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 6.9 mm-40 . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.086 0.47 . . . . 0.0 111.852 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.525 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.6 t80 -83.18 96.09 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.575 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 27.7 m95 -103.39 126.52 50.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.046 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.457 ' CG1' ' CD1' ' A' ' 67' ' ' TYR . 8.6 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.079 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.822 0.344 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.27 157.13 38.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.699 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 4.5 mttt -151.43 129.68 11.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.973 0.416 . . . . 0.0 110.992 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.52 ' CE1' HG22 ' A' ' 81' ' ' VAL . 26.9 p90 -138.13 170.71 15.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.694 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.56 135.95 48.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.01 0.433 . . . . 0.0 111.349 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 43' ' ' LYS . 13.3 t -116.77 107.04 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.604 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 38.9 t0 -110.29 127.22 54.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.908 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.565 HD11 HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -148.92 157.57 43.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.57 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.02 110.05 5.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.962 0.41 . . . . 0.0 110.889 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.672 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -95.18 150.91 19.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.324 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 20.5 mmtt -138.45 69.28 1.38 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.5 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.4 22.25 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.253 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.29 113.97 1.38 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.411 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -162.28 -94.23 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.963 0.411 . . . . 0.0 111.351 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 15.1 mt-10 -69.15 -5.07 20.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.979 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.454 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 2.7 mt -45.09 -40.7 7.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.138 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.474 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 34.24 53.08 0.73 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 114.485 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.424 ' CD2' HD21 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -136.88 92.88 2.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.035 0.445 . . . . 0.0 110.232 178.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 30' ' ' ALA . 6.0 t -63.92 122.33 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.05 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -100.98 169.33 9.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.438 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.22 167.72 13.82 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.358 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.43 121.63 6.92 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.489 2.126 . . . . 0.0 112.59 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.67 162.52 31.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.03 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.32 -32.84 43.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 pt -99.81 -7.09 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.867 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.27 -123.57 1.12 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.243 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -140.55 106.2 5.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.93 0.395 . . . . 0.0 111.195 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.6 m -66.63 132.08 47.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.548 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 32' ' ' LEU . 43.3 mt -68.58 104.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.903 0.382 . . . . 0.0 110.583 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -68.19 -23.38 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.223 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.436 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 5.5 m-20 -171.83 174.38 4.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.995 0.426 . . . . 0.0 111.13 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.405 ' CD1' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -152.05 127.28 9.85 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.535 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.543 HG23 ' CZ2' ' A' ' 105' ' ' TRP . 6.0 pt -101.32 100.59 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.212 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -65.91 173.85 2.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.822 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.44 18.93 72.16 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.608 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -111.25 -46.28 3.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.767 0.318 . . . . 0.0 110.289 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -142.75 139.61 17.36 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.368 179.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.5 -49.36 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 113.085 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 43' ' ' LYS . 30.4 mm-40 -61.12 -51.48 68.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 6.1 mt -54.17 -50.89 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.056 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.41 -30.21 69.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.562 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 m -96.92 2.48 51.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.255 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.56 -73.58 0.58 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.867 0.365 . . . . 0.0 111.759 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.0 mt -72.16 149.52 44.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.006 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -147.4 -175.8 4.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.487 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -87.16 115.04 24.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.09 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.23 31.84 1.78 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.705 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.53 162.63 25.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.649 0.261 . . . . 0.0 110.748 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -133.18 119.21 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.062 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 5.7 mt -74.5 100.49 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 110.51 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -93.94 -4.53 49.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.154 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 80' ' ' GLU . 2.0 mttt -144.56 144.29 31.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CD2' ' CE1' ' A' ' 70' ' ' PHE . 51.3 t80 -149.01 110.89 4.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.917 0.389 . . . . 0.0 111.194 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.83 46.05 23.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.75 21.46 76.51 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.47 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -123.62 107.32 11.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.779 0.323 . . . . 0.0 110.758 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.55 118.57 4.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.318 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.407 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 12.4 mt -92.6 16.93 11.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.32 144.76 42.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.965 0.412 . . . . 0.0 111.195 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.19 20.53 58.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.695 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.0 mt -115.4 137.73 23.26 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.54 0.21 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.45 -160.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.421 2.081 . . . . 0.0 112.1 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -103.32 -24.96 13.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -56.01 -47.81 77.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.562 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.8 m -67.44 -45.63 85.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.817 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 15.8 m -56.56 -48.4 77.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.665 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 22.0 t80 -64.75 -30.89 71.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.747 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.45 -50.9 41.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.125 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.448 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -68.73 -35.33 76.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.938 0.399 . . . . 0.0 110.444 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.496 ' CE1' ' CD2' ' A' ' 53' ' ' PHE . 6.3 m-85 -70.31 -27.38 64.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.299 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.447 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 1.5 mtmp? -84.12 -41.68 16.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.14 -22.46 76.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.845 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' CB ' HG13 ' A' ' 77' ' ' VAL . . . -43.26 127.12 4.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.876 0.37 . . . . 0.0 111.698 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -156.05 104.21 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.87 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.44 85.39 1.76 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.271 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.36 115.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 110.357 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.672 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -129.84 107.81 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.648 -179.023 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -99.92 112.86 25.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.314 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.4 124.48 47.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.434 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tt0 -86.87 104.53 16.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.928 0.394 . . . . 0.0 110.047 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.52 HG22 ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -95.17 143.05 12.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.522 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.404 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 98.0 m -108.42 120.17 41.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.638 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -103.5 92.52 4.12 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.505 2.137 . . . . 0.0 112.222 179.77 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.515 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 10.9 mm-40 . . . . . 0 N--CA 1.456 -0.138 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.523 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 2.6 t80 -86.82 96.46 10.21 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.056 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.543 ' CZ2' HG23 ' A' ' 33' ' ' ILE . 18.1 m95 -103.34 139.32 38.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.575 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.413 HG12 ' CE1' ' A' ' 67' ' ' TYR . 11.4 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.111 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.4 mt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.695 0.283 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -77.54 157.54 30.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.985 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 10.2 mttt -154.87 129.71 9.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.666 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.546 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 28.0 p90 -138.44 171.85 13.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.194 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.57 135.99 48.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.96 0.409 . . . . 0.0 111.256 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 3.5 t -120.19 107.71 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.827 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 11.9 p30 -108.5 127.18 53.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.718 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -145.56 154.49 42.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.931 0.395 . . . . 0.0 110.553 179.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.2 111.92 4.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.059 0.457 . . . . 0.0 110.691 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.622 ' HB2' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -97.4 148.47 23.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.675 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.429 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 21.5 mmtt -138.12 69.29 1.39 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.278 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.71 27.69 9.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.184 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.66 111.52 0.56 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.439 ' CG ' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.64 -96.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 111.263 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' A' ' 36' ' ' GLN . 3.6 mt-10 -67.31 -5.73 15.53 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.032 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.484 ' HG ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -46.1 -43.46 14.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.768 0.318 . . . . 0.0 110.445 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 33.46 61.82 0.43 Allowed Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 114.611 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.484 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -141.96 104.19 4.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.933 0.397 . . . . 0.0 110.375 178.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 t -71.55 119.39 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.148 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.418 ' CD2' HD13 ' A' ' 50' ' ' ILE . 76.4 mt -108.86 169.17 8.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.551 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -148.16 167.79 12.53 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.529 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.56 135.89 32.09 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.502 2.135 . . . . 0.0 112.747 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.49 162.53 36.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.07 -21.53 46.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.226 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.5 pt -114.81 5.38 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.713 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.95 -123.74 1.41 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.129 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 21' ' ' SER . 1.9 p -140.47 109.05 5.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.922 0.392 . . . . 0.0 111.155 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -72.04 136.9 46.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.58 104.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.625 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.83 66.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.474 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 3.4 m-20 -161.3 168.37 24.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.28 126.76 10.07 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.244 0.545 . . . . 0.0 111.967 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.71 ' O ' ' HG3' ' A' ' 36' ' ' GLN . 5.3 pt -96.4 100.72 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.224 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -73.67 136.67 43.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.037 0.446 . . . . 0.0 111.368 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.65 32.98 4.59 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.71 ' HG3' ' O ' ' A' ' 33' ' ' ILE . 1.1 pp0? -122.72 -21.9 5.5 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -161.19 143.86 9.34 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.106 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.04 -48.42 2.76 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.483 2.122 . . . . 0.0 112.915 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 43' ' ' LYS . 52.6 mm-40 -67.62 -53.26 29.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 110.838 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.3 mt -54.7 -40.38 51.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.414 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.97 -30.66 65.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.806 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -98.17 3.64 49.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.163 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -128.34 -72.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.959 0.409 . . . . 0.0 111.571 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -59.0 149.42 27.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.669 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -153.94 146.81 24.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.58 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -59.54 112.43 1.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.67 38.16 0.93 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.585 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.49 155.01 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 110.821 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -124.62 119.42 56.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.983 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 6.3 mt -74.57 100.52 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.104 0.478 . . . . 0.0 110.338 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 p -97.36 26.81 4.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.924 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' CB ' ' HB2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -172.71 144.36 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.091 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 69' ' ' LEU . 64.3 t80 -151.54 108.5 3.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 111.066 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 53.22 52.55 13.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.792 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.93 20.91 71.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.428 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -122.56 103.94 9.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.839 0.352 . . . . 0.0 110.766 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.43 115.58 2.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.276 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.402 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 13.7 mt -87.64 7.85 27.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -67.74 146.13 54.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.841 0.353 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.73 23.66 55.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.666 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.9 mt -116.84 149.13 43.49 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.653 0.263 . . . . 0.0 110.896 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.38 -169.22 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.553 2.169 . . . . 0.0 112.299 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 67' ' ' TYR . 11.3 t80 -96.97 -26.43 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.785 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -57.08 -46.33 82.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.414 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 t -68.4 -47.03 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.763 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 88.3 m -56.54 -53.74 54.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 6.2 t80 -60.95 -30.98 70.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.671 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.05 36.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.125 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -69.55 -33.4 72.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.235 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 5.6 m-85 -72.15 -27.26 62.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.299 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -85.22 -37.74 19.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.701 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.52 -19.39 68.72 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.056 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HB1' ' HG3' ' A' ' 10' ' ' LYS . . . -44.18 131.28 6.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.711 0.291 . . . . 0.0 111.676 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -157.2 102.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.2 82.8 1.3 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.307 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.29 115.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.882 0.373 . . . . 0.0 110.509 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -128.78 107.95 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.964 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -98.89 116.02 30.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.195 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.54 128.43 52.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.303 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -88.77 105.46 17.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 0.0 110.252 179.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.501 ' CG2' ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -95.14 142.86 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.249 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.9 m -108.51 119.61 40.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.608 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.99 89.89 1.76 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.044 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 C--N 1.345 0.357 0 C-N-CA 122.445 2.096 . . . . 0.0 112.075 179.712 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.515 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 15.2 mm100 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 121.096 0.474 . . . . 0.0 112.167 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 1.1 t80 -84.74 96.23 9.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.053 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.549 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 18.7 m95 -105.94 135.37 47.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.183 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.43 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 16.0 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.707 0.289 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -79.81 159.46 26.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.88 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 11.0 mttt -146.18 129.43 16.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.682 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.502 ' CE1' HG22 ' A' ' 81' ' ' VAL . 12.6 p90 -137.07 169.25 18.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.055 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.57 135.92 49.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.316 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.552 HG23 HG23 ' A' ' 81' ' ' VAL . 17.0 t -115.56 107.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.471 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 12.4 t0 -112.69 127.28 56.08 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.586 HD13 HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -153.63 157.84 40.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 110.735 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.67 123.62 20.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.118 0.485 . . . . 0.0 111.005 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.597 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -108.02 128.37 54.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.297 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.443 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 4.1 mmtp -118.36 68.52 0.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.892 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.76 78.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.262 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.414 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 46.91 99.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.276 -0.42 . . . . 0.0 114.018 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.443 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 6.3 ptpt -157.06 -99.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 16.6 mt-10 -69.15 -5.3 21.57 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.523 ' HG ' ' HE2' ' A' ' 10' ' ' LYS . 3.0 mt -45.48 -30.61 1.46 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.063 0.458 . . . . 0.0 109.803 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.544 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 24.79 62.41 0.05 OUTLIER Glycine 0 CA--C 1.519 0.314 0 N-CA-C 115.453 0.941 . . . . 0.0 115.453 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.452 HD21 ' CD2' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -146.33 91.83 2.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.175 0.512 . . . . 0.0 110.252 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 t -60.17 115.22 3.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.413 ' CD2' HD12 ' A' ' 50' ' ' ILE . 62.7 mt -97.37 163.75 12.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.313 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.43 166.85 19.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.488 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.47 130.05 16.69 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.351 2.034 . . . . 0.0 112.682 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.01 162.4 35.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -26.59 37.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.299 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 pt -106.84 -7.04 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.826 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.64 -125.14 1.24 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.854 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.2 p -140.61 106.07 5.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.906 0.384 . . . . 0.0 111.162 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.8 m -66.03 134.44 52.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.458 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.8 mt -75.88 104.88 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.559 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.43 -26.77 63.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.989 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.449 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.3 OUTLIER -161.01 169.8 21.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.046 0.451 . . . . 0.0 111.221 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.25 124.68 6.98 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.267 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.547 HG23 ' CZ2' ' A' ' 105' ' ' TRP . 5.1 pt -96.43 100.49 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.194 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -68.9 153.59 43.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.981 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.37 -23.02 36.78 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.787 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.575 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.9 mp0 -67.63 -46.74 71.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.77 0.319 . . . . 0.0 110.811 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -138.24 141.82 33.17 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.477 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.19 -49.04 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.522 2.148 . . . . 0.0 112.96 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 26.9 mm-40 -62.3 -50.95 69.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.338 . . . . 0.0 110.962 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.4 mt -54.47 -50.1 60.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.243 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -60.96 -30.48 70.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.565 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -97.98 3.41 49.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.149 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.46 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -128.79 -72.99 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.918 0.389 . . . . 0.0 111.625 -178.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.403 HD22 HG21 ' A' ' 81' ' ' VAL . 87.3 mt -75.8 145.76 40.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.744 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.67 163.53 38.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.473 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -59.41 110.88 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.92 0.39 . . . . 0.0 110.991 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.67 46.89 0.55 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.682 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.03 139.43 28.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 110.711 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.47 117.59 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.23 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.429 HD11 ' CZ ' ' A' ' 70' ' ' PHE . 5.0 mt -76.85 100.69 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 0.0 110.601 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.7 p -98.18 16.0 22.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.164 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 7.2 mttt -162.42 132.68 4.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.003 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 58.3 t80 -136.78 108.76 7.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 111.067 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 55.27 52.93 10.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.851 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.62 17.51 66.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.358 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -121.01 103.4 9.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 110.634 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.49 120.38 7.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.436 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 9.5 mt -92.82 18.11 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.807 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -73.77 142.83 46.22 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.948 0.404 . . . . 0.0 111.312 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.77 18.22 52.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.753 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.9 mt -109.69 137.85 20.49 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.701 0.251 . . . . 0.0 110.826 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.72 -159.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.302 2.001 . . . . 0.0 112.148 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -106.0 -23.7 12.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.016 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -54.98 -48.8 72.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.3 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.47 -44.36 83.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.823 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.412 ' HA ' HD23 ' A' ' 69' ' ' LEU . 1.5 m -55.95 -54.05 49.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.729 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.548 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 5.1 t80 -62.13 -30.97 71.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.926 0.393 . . . . 0.0 110.437 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.63 -51.13 37.72 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.484 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.37 -42.27 83.72 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.361 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.429 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 11.4 m-85 -63.33 -31.13 72.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 25.9 mtmt -83.03 -31.95 27.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.037 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.407 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -88.83 11.04 70.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.734 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 10' ' ' LYS . . . -76.8 136.93 38.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.663 0.268 . . . . 0.0 110.484 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 2.2 p30 -168.13 100.72 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.144 0.497 . . . . 0.0 110.886 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.91 77.68 0.74 Allowed Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.919 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.08 115.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.141 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.597 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -124.22 107.66 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.727 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 t -99.5 115.15 28.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.46 120.89 35.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -81.83 111.24 17.87 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.552 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -102.69 142.28 17.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.95 -178.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.7 m -109.06 118.39 36.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.289 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.96 97.23 20.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.139 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo . . . . . 0 C--N 1.345 0.343 0 C-N-CA 122.55 2.166 . . . . 0.0 112.383 179.742 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.4 mm-40 . . . . . 0 C--O 1.232 0.132 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.548 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.5 t80 -85.03 96.18 9.32 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.547 ' CZ2' HG23 ' A' ' 33' ' ' ILE . 20.0 m95 -104.14 132.05 50.8 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.197 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.41 HG13 ' CE1' ' A' ' 67' ' ' TYR . 20.4 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.131 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.844 0.354 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.88 154.07 23.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.636 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -147.75 129.65 15.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.042 0.448 . . . . 0.0 110.929 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.521 ' CE2' HG23 ' A' ' 6' ' ' VAL . 29.6 p90 -138.23 172.09 13.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.666 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.01 136.02 49.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 111.813 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 43' ' ' LYS . 15.9 t -116.3 107.28 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.124 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.574 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.6 p30 -114.44 127.4 55.81 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.779 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.518 HD13 HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -155.28 160.95 41.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.753 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.49 127.63 33.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.609 ' HB2' HG21 ' A' ' 77' ' ' VAL . 4.2 tmtt? -112.5 136.97 51.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.26 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HB2' ' HG2' ' A' ' 14' ' ' LYS . 13.2 mmtt -131.07 68.92 1.48 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.59 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 34.56 82.94 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.387 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.33 57.66 8.99 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.632 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HG2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -98.48 -138.41 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.862 0.363 . . . . 0.0 111.198 -179.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.0 mt-10 -69.19 -4.54 18.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.529 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 0.3 OUTLIER -44.68 -44.2 8.91 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.286 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 23.86 68.05 0.03 OUTLIER Glycine 0 CA--C 1.518 0.25 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.592 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.47 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -133.1 92.91 3.09 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.049 0.452 . . . . 0.0 109.895 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.8 t -56.48 113.73 1.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.179 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.26 166.82 11.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.259 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.2 m -143.32 157.49 59.72 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.92 127.0 16.86 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.427 2.085 . . . . 0.0 112.574 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.7 162.59 34.75 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.823 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -81.35 -26.58 35.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.392 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 25' ' ' ILE . 2.9 pt -106.57 -8.41 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.895 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.74 -125.05 1.18 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.125 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -140.6 105.96 5.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.916 0.389 . . . . 0.0 111.189 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.401 ' OG1' HG12 ' A' ' 49' ' ' ILE . 85.0 m -67.33 126.91 30.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.516 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 mt -69.02 104.91 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.797 0.332 . . . . 0.0 110.685 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.15 -29.0 67.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.419 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 15.3 m-20 -163.88 167.25 20.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.73 132.74 16.19 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.349 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.564 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 4.3 pt -99.03 100.62 10.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.623 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -70.52 166.19 21.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.931 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.73 -0.39 88.28 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.009 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.523 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.32 -44.19 7.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.77 0.319 . . . . 0.0 110.453 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -139.59 139.6 22.74 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.998 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.53 -48.83 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.544 2.163 . . . . 0.0 112.834 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 43' ' ' LYS . 75.6 mm-40 -59.58 -51.23 70.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.654 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 6.2 mt -57.98 -44.54 87.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.972 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.87 -30.34 71.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.059 0.457 . . . . 0.0 110.218 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 m -99.96 3.41 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.074 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.535 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -126.32 -74.6 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.43 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.9 mt -76.41 151.88 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.582 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.86 -175.88 5.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.391 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -80.98 109.41 15.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.726 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.35 27.29 2.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.689 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.2 139.28 53.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 110.681 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.401 HG12 ' OG1' ' A' ' 28' ' ' THR . 2.0 mt -112.31 117.65 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.16 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.442 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 5.9 mt -75.6 100.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.398 . . . . 0.0 110.683 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.3 p -97.76 6.33 48.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.376 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -152.67 139.38 18.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.931 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.475 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 28.8 t80 -149.08 111.76 4.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.012 0.434 . . . . 0.0 111.217 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 55.62 48.9 17.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.71 23.03 68.69 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.321 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -125.4 98.03 5.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.889 0.376 . . . . 0.0 110.473 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.87 120.27 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.369 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mt -92.37 19.87 6.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.977 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -77.02 143.28 39.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.919 0.39 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.33 24.51 61.43 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.732 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.4 mt -116.21 144.42 32.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.576 0.227 . . . . 0.0 110.906 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.84 -170.62 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.466 2.111 . . . . 0.0 111.902 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -93.43 -26.4 17.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.972 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -43.42 88.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 0.0 110.528 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.22 -47.13 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.998 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.4 m -58.59 -53.81 54.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 110.567 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.541 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 73.2 t80 -61.32 -30.7 70.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.679 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.03 -51.25 41.08 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.475 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.44 -41.11 85.27 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.259 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.442 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 5.7 m-85 -61.64 -35.23 77.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 2.3 mtpt -78.36 -34.06 48.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.065 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.404 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -83.92 8.67 65.57 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.601 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.419 ' CB ' ' HD2' ' A' ' 10' ' ' LYS . . . -74.84 137.76 42.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.768 0.318 . . . . 0.0 110.558 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 72' ' ' GLY . 4.8 p30 -176.41 85.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.078 0.466 . . . . 0.0 110.746 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.2 71.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.183 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.43 96.5 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.011 0.434 . . . . 0.0 110.711 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.609 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -101.12 150.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.373 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.2 t -140.68 117.93 11.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.484 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.0 124.77 38.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -88.25 105.2 17.39 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.494 HG21 ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -95.12 142.76 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.15 -178.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 m -108.57 118.98 38.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.414 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -102.82 94.04 4.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.201 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 C--N 1.344 0.308 0 C-N-CA 122.475 2.117 . . . . 0.0 112.107 179.763 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.517 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 7.2 mm-40 . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.541 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.0 t80 -81.03 96.05 7.01 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.564 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 47.3 m95 -99.21 143.6 29.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.51 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.48 HG12 ' CE1' ' A' ' 67' ' ' TYR . 20.4 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.24 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.766 0.317 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.77 159.04 30.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.864 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -153.68 129.57 10.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.502 ' CE1' HG22 ' A' ' 81' ' ' VAL . 28.9 p90 -138.17 170.7 15.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.748 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.58 135.78 49.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.977 0.417 . . . . 0.0 111.366 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.501 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 14.3 t -116.6 106.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.213 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.554 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 9.0 p-10 -113.82 127.07 55.85 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.085 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -154.05 156.26 37.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 110.742 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.18 117.32 8.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.067 0.46 . . . . 0.0 111.151 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.642 ' HB2' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -101.47 142.0 33.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.132 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -126.95 69.49 1.27 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.533 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.73 21.49 5.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.34 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.85 113.01 1.45 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.777 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.07 -93.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.893 0.378 . . . . 0.0 110.925 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 25.0 mt-10 -69.44 -4.96 20.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.674 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.465 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 0.7 OUTLIER -44.97 -31.6 1.34 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.114 0.483 . . . . 0.0 109.94 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.522 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 28.39 61.82 0.12 Allowed Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.514 -0.766 . . . . 0.0 114.618 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.437 HD21 HD23 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -142.48 91.96 2.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.898 0.38 . . . . 0.0 110.273 178.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -67.92 109.33 3.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.424 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.433 ' CD2' HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -84.5 163.18 19.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.773 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.71 160.01 68.14 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.031 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.33 120.66 7.13 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.518 2.145 . . . . 0.0 112.759 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.61 162.7 33.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.002 0.429 . . . . 0.0 111.192 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.8 -39.43 30.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.315 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 pt -90.24 -12.99 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.863 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.95 -125.23 1.13 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.256 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -140.46 106.08 5.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.916 0.389 . . . . 0.0 110.851 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 94.5 m -63.7 134.68 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.766 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.3 mt -74.41 104.54 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.916 0.389 . . . . 0.0 110.141 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.29 -33.76 61.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.705 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 19' ' ' SER . 4.1 m-20 -162.24 174.01 13.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.278 0.561 . . . . 0.0 111.495 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.468 ' HA ' ' HZ3' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -157.83 136.62 11.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.93 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.589 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 4.2 pt -95.63 99.98 10.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 109.673 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -66.91 147.5 53.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.012 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.24 -17.63 56.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.768 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.441 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 2.2 mp0 -76.31 -48.45 20.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.733 0.302 . . . . 0.0 110.938 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -134.98 139.74 32.98 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.844 0.354 . . . . 0.0 110.692 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.99 -48.62 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.789 2.326 . . . . 0.0 113.112 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 43' ' ' LYS . 16.3 mm-40 -62.54 -48.42 79.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.0 mt -58.11 -42.71 83.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -30.25 70.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.386 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -99.85 3.55 44.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.351 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.496 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -123.36 -70.51 0.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.07 156.99 38.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.398 0.618 . . . . 0.0 112.409 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -153.94 -175.85 5.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.978 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.2 mtp-105 -91.87 99.79 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.47 39.28 0.21 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.586 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 28' ' ' THR . 0.5 OUTLIER -131.61 174.62 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.6 mt -145.82 118.53 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 7.1 mt -73.93 100.23 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.142 0.496 . . . . 0.0 110.402 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 p -98.73 2.43 47.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.054 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.7 mttt -150.27 139.55 21.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.816 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 41.8 t80 -147.18 113.09 5.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.932 0.396 . . . . 0.0 111.264 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 55.54 48.07 19.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.18 21.7 72.13 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.413 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -127.33 104.95 8.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.371 . . . . 0.0 110.669 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.26 125.42 20.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.251 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.52 27.45 3.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.802 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -82.83 142.42 31.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.04 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.7 21.81 65.5 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.661 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.8 mt -117.29 136.26 23.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.501 0.191 . . . . 0.0 110.811 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.4 -161.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.419 2.079 . . . . 0.0 112.065 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -98.83 -26.66 14.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.026 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -57.41 -46.02 83.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.7 t -64.1 -51.93 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.973 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 90.5 m -56.91 -50.2 73.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 29.3 t80 -59.43 -31.12 69.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.991 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.76 -50.85 26.35 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.462 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.76 -32.48 72.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 110.523 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.438 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 4.7 m-85 -73.82 -28.55 61.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.269 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.432 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 21.6 mtmt -83.44 -36.68 24.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.802 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.81 -18.0 68.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.102 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' ' HG3' ' A' ' 10' ' ' LYS . . . -46.44 130.81 11.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.894 0.378 . . . . 0.0 111.588 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -160.9 102.74 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.736 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.99 85.44 1.64 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.165 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.08 109.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.552 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.642 HG22 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -122.91 107.82 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.515 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.6 t -100.72 112.0 24.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.295 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.54 123.44 43.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.444 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -86.8 104.51 16.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.502 HG22 ' CE1' ' A' ' 4' ' ' PHE . 0.7 OUTLIER -95.09 142.54 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.588 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.6 m -108.94 123.45 49.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.369 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -104.24 92.93 5.08 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.159 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 C--N 1.345 0.354 0 C-N-CA 122.622 2.214 . . . . 0.0 112.235 179.87 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.501 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 5.6 mm-40 . . . . . 0 CA--C 1.523 -0.072 0 CA-C-O 121.074 0.464 . . . . 0.0 111.98 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.519 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.1 t80 -83.3 96.44 8.49 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.589 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 38.4 m95 -102.96 138.75 39.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.696 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.427 HG12 ' CD1' ' A' ' 67' ' ' TYR . 15.7 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.08 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.753 0.311 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -78.31 157.62 29.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 5.9 mttp -149.57 129.61 13.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.509 ' CE2' HG21 ' A' ' 6' ' ' VAL . 24.6 p90 -137.74 169.6 17.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.616 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.56 135.78 49.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.081 0.467 . . . . 0.0 111.142 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 43' ' ' LYS . 12.4 t -115.8 107.16 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.506 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.0 p30 -110.06 127.19 54.7 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.796 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.566 HD13 HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -148.68 155.37 40.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 110.61 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.51 113.86 6.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.94 0.4 . . . . 0.0 110.823 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.632 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -98.87 140.52 32.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.545 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 6.1 mmtp -127.55 69.34 1.31 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.304 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.18 23.43 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.275 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.27 113.62 1.17 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.612 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -161.78 -94.15 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.639 ' O ' ' HB3' ' A' ' 36' ' ' GLN . 24.0 mt-10 -69.24 -5.66 24.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.732 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' HG ' ' CD2' ' A' ' 18' ' ' LEU . 1.7 tp -45.53 -31.44 1.81 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.008 0.432 . . . . 0.0 109.843 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.547 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 23.24 59.59 0.04 OUTLIER Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.154 -0.93 . . . . 0.0 114.953 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.456 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 2.8 pp -138.79 99.34 3.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.073 0.464 . . . . 0.0 110.303 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -68.98 115.86 8.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.598 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' CD2' HD12 ' A' ' 50' ' ' ILE . 62.2 mt -98.81 161.79 13.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.023 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.79 166.32 28.19 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.425 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.01 98.56 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.711 2.274 . . . . 0.0 113.439 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -107.72 162.83 13.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.916 0.389 . . . . 0.0 111.358 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.76 -42.31 61.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.391 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 pt -92.68 -7.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.874 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.31 -130.22 1.93 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.858 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 p -140.64 106.39 5.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.904 0.383 . . . . 0.0 111.357 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.452 ' OG1' HG12 ' A' ' 49' ' ' ILE . 69.0 m -69.52 133.21 47.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.628 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.8 mt -69.08 104.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.282 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.67 -24.41 61.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.963 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.411 ' HB2' ' NE2' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -162.48 163.73 27.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.749 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.31 124.82 10.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.313 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.568 HG21 ' CZ2' ' A' ' 105' ' ' TRP . 6.0 pt -96.45 100.53 10.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.256 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.28 154.25 42.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.025 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.5 -21.68 43.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.754 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.639 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 6.0 mp0 -68.93 -48.55 63.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.678 0.275 . . . . 0.0 110.829 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -138.08 139.29 25.4 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.55 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.54 -43.72 3.81 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.628 2.218 . . . . 0.0 112.871 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' LYS . 19.0 mp0 -65.3 -51.72 58.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.966 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.8 mt -55.62 -49.36 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.964 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -61.34 -30.22 70.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.2 m -96.76 1.84 51.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.072 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -127.89 -74.16 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 0.0 111.504 -179.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.4 mt -73.53 148.31 43.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.418 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -153.17 158.61 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.635 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -58.89 98.27 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.982 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.91 44.81 0.13 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.604 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.4 146.57 30.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.935 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.452 HG12 ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -116.21 117.78 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.472 HD12 ' CD2' ' A' ' 20' ' ' LEU . 6.2 mt -74.7 100.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.005 0.431 . . . . 0.0 110.136 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 p -97.7 8.17 45.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.051 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 3.9 mttt -154.11 141.17 19.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.817 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.459 ' CD1' ' CD1' ' A' ' 69' ' ' LEU . 57.2 t80 -146.51 109.05 4.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.91 0.386 . . . . 0.0 111.229 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.21 49.65 16.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.56 18.79 74.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -124.34 105.9 9.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.661 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.52 124.99 20.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.293 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 mt -95.97 24.5 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -85.63 125.06 32.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.282 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.75 -20.6 40.99 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.853 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.07 149.46 69.91 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.684 0.278 . . . . 0.0 111.084 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.84 -167.51 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.625 2.216 . . . . 0.0 112.213 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -96.12 -24.45 16.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.82 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -58.99 -46.49 88.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.984 0.421 . . . . 0.0 110.013 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.95 -43.4 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.735 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 83.5 m -59.13 -53.64 56.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.568 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.541 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 8.6 t80 -59.64 -31.01 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.636 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.93 -51.1 35.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.339 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -69.78 -34.06 73.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.385 . . . . 0.0 110.184 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.452 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 4.0 m-85 -70.55 -27.68 64.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.031 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -85.18 -39.9 17.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.43 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.37 -21.77 74.63 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.914 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.488 ' CB ' HG11 ' A' ' 77' ' ' VAL . . . -42.95 129.44 4.38 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.74 0.305 . . . . 0.0 111.546 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -157.65 102.84 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.017 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.04 83.42 1.37 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.225 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.16 113.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.426 . . . . 0.0 110.395 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.632 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -125.25 107.78 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.724 -179.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.9 t -98.91 114.76 27.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.228 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.19 122.4 40.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.473 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 1.9 tt0 -85.27 104.53 15.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -95.24 142.55 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.774 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.401 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 92.1 m -108.82 119.54 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.674 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -103.87 93.3 5.14 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo . . . . . 0 C--N 1.345 0.384 0 C-N-CA 122.493 2.129 . . . . 0.0 112.281 179.835 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.491 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 3.8 mm100 . . . . . 0 C--O 1.231 0.112 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.541 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.2 t80 -84.48 96.34 9.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.209 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.568 ' CZ2' HG21 ' A' ' 33' ' ' ILE . 23.5 m95 -104.62 131.14 52.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.215 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.409 HG11 ' CD1' ' A' ' 67' ' ' TYR . 16.1 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.12 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.816 0.341 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.58 157.94 19.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.99 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HG2' HG21 ' A' ' 82' ' ' THR . 16.1 mttt -153.49 129.54 10.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.816 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.513 ' CE1' HG23 ' A' ' 81' ' ' VAL . 26.1 p90 -136.78 171.23 14.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.451 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.76 135.5 49.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.081 0.467 . . . . 0.0 111.144 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 43' ' ' LYS . 12.9 t -114.32 107.27 22.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.928 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.68 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.3 p30 -115.83 127.48 55.08 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.795 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.511 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -153.62 160.91 42.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.637 179.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 128.05 34.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.109 0.48 . . . . 0.0 110.784 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.554 ' HB2' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -114.92 127.89 55.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.319 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.423 ' HB2' ' HD2' ' A' ' 14' ' ' LYS . 6.5 mmtt -121.69 69.13 0.92 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.038 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 43.75 89.91 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.413 ' N ' ' NZ ' ' A' ' 10' ' ' LYS . . . 39.05 96.46 0.01 OUTLIER Glycine 0 C--N 1.337 0.597 0 CA-C-N 116.082 -0.508 . . . . 0.0 114.202 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.5 -106.27 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -69.15 -5.67 23.85 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.435 ' HG ' ' CE ' ' A' ' 10' ' ' LYS . 4.5 mt -45.83 -33.44 3.14 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.551 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 24.83 62.97 0.05 OUTLIER Glycine 0 C--N 1.333 0.407 0 CA-C-N 114.979 -1.01 . . . . 0.0 115.159 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.427 ' CD1' ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -141.13 91.71 2.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.934 0.397 . . . . 0.0 110.173 178.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 31' ' ' ASP . 2.1 t -60.38 113.16 2.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.778 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.436 HD22 ' CD1' ' A' ' 50' ' ' ILE . 16.8 mt -94.28 160.84 14.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.514 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.48 167.58 21.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.268 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.03 120.52 5.04 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.437 2.091 . . . . 0.0 112.799 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.08 162.62 30.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.209 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -77.55 -33.09 54.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.1 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 pt -100.25 -4.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.913 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.17 -126.48 1.47 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.067 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.2 p -140.51 106.16 5.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.946 0.403 . . . . 0.0 111.162 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.7 m -68.74 131.26 44.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.719 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.9 mt -72.03 105.06 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.607 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.27 -24.16 59.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.303 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -157.33 165.67 35.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.014 0.435 . . . . 0.0 111.283 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.66 125.83 7.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.294 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.565 HG21 ' CZ2' ' A' ' 105' ' ' TRP . 5.4 pt -97.15 100.55 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.652 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -68.31 154.36 41.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.978 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.36 -20.92 47.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.806 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.565 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.1 mp0 -71.73 -49.75 36.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.688 0.28 . . . . 0.0 110.887 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -136.95 139.7 29.46 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.867 0.365 . . . . 0.0 110.731 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.97 -48.15 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.653 2.236 . . . . 0.0 112.726 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -60.01 -50.4 73.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.701 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 37' ' ' TYR . 6.3 mt -56.85 -47.26 83.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.17 -30.41 71.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.548 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -97.03 1.83 50.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.07 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.545 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.32 -73.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.916 0.388 . . . . 0.0 111.458 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.6 mt -75.22 153.28 38.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.522 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.14 -175.83 5.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.572 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -86.82 87.46 7.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.87 0.367 . . . . 0.0 111.014 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.9 43.11 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.697 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.56 156.82 45.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 110.666 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -124.53 117.74 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.359 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.459 HD11 ' CZ ' ' A' ' 70' ' ' PHE . 6.2 mt -74.59 100.46 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.031 0.443 . . . . 0.0 110.474 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.0 p -93.46 -4.44 51.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.359 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.42 144.93 31.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.097 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.453 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 41.9 t80 -151.31 108.8 3.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 53.3 52.91 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.31 24.09 67.08 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.332 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -123.91 98.18 5.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.661 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.67 114.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.377 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.5 11.95 15.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.999 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.73 142.98 42.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.862 0.363 . . . . 0.0 111.113 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.1 24.23 64.87 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.775 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.07 141.26 31.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.526 0.203 . . . . 0.0 110.766 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.58 -160.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.518 2.145 . . . . 0.0 112.24 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -104.7 -24.54 12.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -55.87 -49.11 74.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 0.0 110.387 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.2 m -67.13 -45.85 85.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.778 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 91.0 m -55.57 -52.86 62.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.022 0.439 . . . . 0.0 110.81 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 26.7 t80 -62.17 -30.88 71.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.739 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.32 -51.37 45.42 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.453 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -65.96 -44.06 86.09 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.668 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.459 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 12.5 m-85 -61.44 -32.41 72.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.133 0.492 . . . . 0.0 109.905 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 6.4 mtpt -80.39 -34.28 36.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.958 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -87.88 10.85 68.7 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.435 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 10' ' ' LYS . . . -73.26 135.22 44.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.58 0.229 . . . . 0.0 110.544 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 72' ' ' GLY . 4.1 p30 -172.97 92.93 0.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 111.013 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.58 76.24 0.19 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.259 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.02 98.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.023 0.44 . . . . 0.0 110.698 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.68 ' O ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -101.95 152.85 5.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.468 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 t -140.48 119.63 12.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.516 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.12 122.82 30.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.5 106.99 17.89 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.513 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -97.0 143.02 13.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.719 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.424 HG21 ' HG2' ' A' ' 3' ' ' LYS . 45.3 m -108.48 119.39 39.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.527 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -103.91 89.33 2.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.112 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--N 1.344 0.292 0 C-N-CA 122.581 2.187 . . . . 0.0 112.319 179.859 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.479 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.0 mm-40 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 121.167 0.508 . . . . 0.0 112.204 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.52 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 2.1 t80 -84.54 96.4 9.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.565 ' CZ2' HG21 ' A' ' 33' ' ' ILE . 28.7 m95 -102.88 137.28 41.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.512 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 67' ' ' TYR . 6.4 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.095 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.738 0.304 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 157.9 31.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.8 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -151.93 129.58 11.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.513 ' CE1' HG23 ' A' ' 81' ' ' VAL . 27.6 p90 -138.54 171.82 13.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.813 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.68 135.94 49.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.955 0.407 . . . . 0.0 111.582 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' A' ' 43' ' ' LYS . 12.6 t -117.43 107.15 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.381 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.2 p30 -113.47 127.13 55.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.922 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -152.36 156.39 39.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.393 . . . . 0.0 110.735 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.35 119.66 12.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.506 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -100.96 137.5 39.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.388 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -126.62 69.1 1.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.703 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 33.75 91.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.174 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.6 96.26 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.324 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 33.5 ttmt -156.75 -114.1 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.755 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 9.3 mt-10 -70.88 -5.56 31.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.458 ' HG ' ' HE3' ' A' ' 10' ' ' LYS . 1.6 mt -45.43 -34.2 3.0 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.591 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 19.47 64.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 114.8 -1.091 . . . . 0.0 115.454 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.436 HD21 HD13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -143.46 91.73 2.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.145 0.498 . . . . 0.0 110.107 178.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -59.29 114.58 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.942 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -91.79 163.04 14.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.39 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.14 162.47 53.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.352 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.14 120.54 7.25 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.512 2.142 . . . . 0.0 112.723 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.25 162.46 31.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.721 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -82.65 -29.27 30.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.097 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.2 pt -103.49 -6.37 9.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.918 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.66 -125.57 1.29 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.249 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -140.59 106.1 5.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.954 0.407 . . . . 0.0 111.07 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.6 m -68.14 127.71 33.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.389 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.0 mt -70.69 104.92 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.851 0.358 . . . . 0.0 110.622 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.27 -25.64 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.047 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.18 166.97 31.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.043 0.449 . . . . 0.0 111.238 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.46 126.88 7.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.006 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.591 ' CG1' ' HA3' ' A' ' 17' ' ' GLY . 4.1 pt -96.46 100.58 11.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.64 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -72.7 139.67 47.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.842 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.69 -27.91 8.07 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.601 ' OE1' ' HA ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -67.21 -60.81 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.759 0.314 . . . . 0.0 110.712 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -123.77 136.75 27.72 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.129 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.98 -49.12 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.62 2.213 . . . . 0.0 112.903 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -56.82 -49.2 76.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.884 0.373 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.5 HG13 ' HB3' ' A' ' 37' ' ' TYR . 5.3 mt -57.49 -47.01 85.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.77 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.21 -30.39 71.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.606 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -97.2 1.6 49.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.226 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.548 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.56 -73.67 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 111.388 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.92 145.3 42.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.546 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.36 164.94 36.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.572 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -59.9 108.18 0.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.953 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.24 40.78 0.61 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.603 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -138.17 134.02 34.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.834 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.9 mt -106.36 117.39 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.908 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.428 ' CG1' HG12 ' A' ' 81' ' ' VAL . 5.8 mt -75.68 100.47 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 p -102.16 24.52 10.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 7.1 mttt -169.13 133.76 1.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.178 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.489 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 56.9 t80 -141.25 109.22 5.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.238 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 54.98 53.56 10.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.65 16.96 66.38 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -122.52 101.06 7.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.822 0.344 . . . . 0.0 110.608 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.98 123.41 14.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.344 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.439 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 3.8 mt -94.96 23.04 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.789 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.82 122.05 33.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.333 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.78 15.08 38.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.048 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.41 159.46 65.44 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.9 0.35 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.92 -171.77 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.765 2.31 . . . . 0.0 112.44 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -92.91 -33.46 14.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.486 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -48.63 -46.24 39.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.994 0.426 . . . . 0.0 110.649 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.9 m -65.46 -39.0 83.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.783 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 42.2 m -63.86 -53.74 45.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.737 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 26.8 t80 -57.6 -30.78 65.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.01 -51.1 42.8 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.489 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.4 -40.84 81.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.522 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.412 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 16.5 m-85 -64.24 -30.95 71.98 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.437 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -79.64 -33.52 41.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.026 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -90.55 15.53 60.02 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.668 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.92 133.7 38.03 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 72' ' ' GLY . 2.7 p30 -167.8 89.24 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 111.202 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.92 86.14 0.77 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.58 109.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.075 0.464 . . . . 0.0 110.783 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.57 HG23 HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -122.61 107.77 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.639 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.6 t -99.96 113.99 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.983 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.03 124.53 44.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.638 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -86.93 104.93 16.72 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.513 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -95.13 142.53 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.772 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.9 m -108.86 121.45 45.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.529 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -104.19 92.85 4.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.099 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--N 1.344 0.327 0 C-N-CA 122.528 2.152 . . . . 0.0 112.227 179.891 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.3 mm-40 . . . . . 0 CA--C 1.523 -0.087 0 CA-C-O 121.303 0.573 . . . . 0.0 112.37 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 4.8 t80 -84.88 96.42 9.32 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.211 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.565 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 18.7 m95 -104.59 136.5 44.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.114 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 67' ' ' TYR . 30.1 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.069 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.801 0.334 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -78.85 158.76 28.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.707 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -150.97 129.54 12.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.506 ' CE1' ' CG2' ' A' ' 81' ' ' VAL . 9.3 p90 -136.93 170.87 15.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.743 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.57 135.92 49.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.103 0.478 . . . . 0.0 111.253 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.684 HG21 HG22 ' A' ' 81' ' ' VAL . 14.8 t -116.42 107.01 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.432 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.1 p30 -110.4 127.05 54.9 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.792 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.603 HD11 HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -149.05 153.56 38.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 0.0 110.591 178.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.27 117.43 8.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.066 0.46 . . . . 0.0 110.827 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.634 ' HB2' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -101.93 128.6 48.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.598 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 7.7 mmtt -119.24 68.56 0.81 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.118 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.02 78.9 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.196 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.99 99.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.463 -0.398 . . . . 0.0 113.822 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.446 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 5.6 ptpt -155.79 -103.92 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 36' ' ' GLN . 7.1 mt-10 -69.13 -5.57 23.17 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.548 ' HG ' ' HE2' ' A' ' 10' ' ' LYS . 3.8 mt -45.54 -33.7 2.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.601 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.582 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 26.38 61.98 0.08 OUTLIER Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.024 -0.989 . . . . 0.0 115.201 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -142.82 91.87 2.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.046 0.451 . . . . 0.0 110.003 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 t -62.29 117.75 6.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.773 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.453 HD22 ' CD1' ' A' ' 50' ' ' ILE . 16.2 mt -97.7 167.65 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.462 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 66.1 m -141.62 156.56 66.34 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.441 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.21 118.63 5.72 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.476 2.117 . . . . 0.0 112.429 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.85 162.75 26.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -24.69 41.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.448 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 pt -108.71 -9.68 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.941 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 171.41 -122.18 0.94 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.143 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 21' ' ' SER . 8.7 m -140.55 106.46 5.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.812 0.339 . . . . 0.0 111.4 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.2 m -68.89 125.96 28.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.9 mt -67.81 104.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.628 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.49 -29.0 65.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.967 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 6.8 m-20 -161.89 170.69 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.061 0.458 . . . . 0.0 111.023 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.28 127.37 9.05 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.429 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.582 ' CG1' ' HA3' ' A' ' 17' ' ' GLY . 5.3 pt -96.74 100.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.165 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.05 153.2 43.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.047 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.11 -22.34 41.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.751 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 1.5 mp0 -69.94 -45.28 67.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.825 0.345 . . . . 0.0 110.862 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -141.12 139.73 19.79 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.646 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.46 -49.3 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.629 2.22 . . . . 0.0 112.977 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.2 -50.74 72.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 5.4 mt -55.87 -52.15 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.01 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -59.15 -30.23 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.583 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.2 m -96.46 0.68 50.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.24 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.98 -73.79 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 111.538 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.2 mt -72.87 145.31 46.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.564 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -149.59 159.78 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.621 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -60.94 109.32 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.072 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.46 -17.39 4.76 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.985 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.61 148.62 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.991 0.424 . . . . 0.0 111.13 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.57 117.78 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.599 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.453 ' CD1' HD22 ' A' ' 20' ' ' LEU . 5.1 mt -74.53 100.38 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 111.162 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 p -102.39 20.84 16.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.1 mttt -167.33 126.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.998 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CD1' ' CD1' ' A' ' 69' ' ' LEU . 44.0 t80 -132.23 109.58 10.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.19 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 50.52 62.96 2.42 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.021 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.74 20.59 48.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.464 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -125.31 98.04 5.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.699 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.71 121.49 8.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.387 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 9.1 mt -93.11 19.48 7.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.813 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.85 143.72 39.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.934 0.397 . . . . 0.0 111.176 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.89 26.61 48.32 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.704 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.8 mt -118.77 143.58 33.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.635 0.255 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.26 -164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.548 2.165 . . . . 0.0 112.035 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -110.58 -22.79 11.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.176 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -58.36 -50.99 71.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 110.687 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -65.52 -41.44 90.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.94 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.426 ' HA ' HD23 ' A' ' 69' ' ' LEU . 81.4 m -60.47 -52.3 65.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 25.9 t80 -60.34 -30.68 69.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.292 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.46 -51.03 39.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.247 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.457 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.69 -40.72 84.34 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.148 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.41 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 5.4 m-85 -61.16 -33.25 73.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 26.0 mtmt -83.41 -30.9 26.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.184 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.401 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -90.48 12.35 68.6 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.612 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.499 ' O ' ' HD3' ' A' ' 10' ' ' LYS . . . -75.59 138.78 41.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.637 0.256 . . . . 0.0 110.379 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 2.6 p30 -169.77 99.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.179 0.514 . . . . 0.0 111.101 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.44 76.35 0.53 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.044 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.82 108.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.938 0.399 . . . . 0.0 110.17 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.634 HG22 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -117.13 107.74 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.753 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.0 t -100.01 114.77 28.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.316 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.8 122.16 40.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.679 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 2.7 tt0 -84.17 102.38 12.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.684 HG22 HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -95.07 142.95 12.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.731 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 54.4 m -108.36 121.97 46.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.4 97.45 22.79 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 82' ' ' THR . 36.6 Cg_exo . . . . . 0 C--N 1.343 0.252 0 C-N-CA 122.533 2.156 . . . . 0.0 112.197 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.52 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 8.5 mm100 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.243 0.544 . . . . 0.0 112.259 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.8 t80 -85.99 96.3 9.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.094 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.57 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 13.3 m95 -105.36 136.17 45.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.237 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.435 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.3 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.122 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.8 0.333 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.79 158.8 22.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -152.73 129.65 11.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 110.867 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.518 ' CE1' HG23 ' A' ' 81' ' ' VAL . 28.0 p90 -137.91 171.18 14.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.784 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.61 135.91 49.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.957 0.408 . . . . 0.0 111.414 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.54 HG23 ' HB3' ' A' ' 43' ' ' LYS . 12.0 t -117.63 107.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.452 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 8.6 p-10 -111.02 127.26 55.48 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.972 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.04 153.68 39.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 110.758 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.19 114.87 6.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.058 0.456 . . . . 0.0 110.51 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.596 ' HB2' HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -98.03 145.34 26.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.882 -179.288 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 48.5 mmtt -132.66 69.23 1.48 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.183 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.25 21.89 4.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.493 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.65 115.05 1.52 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.69 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 7.9 ptpt -163.79 -94.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.3 mm-40 -69.21 -4.91 19.57 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.906 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.506 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 0.3 OUTLIER -44.95 -38.59 4.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.228 0.537 . . . . 0.0 109.643 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.561 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 33.64 59.06 0.56 Allowed Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.171 -0.922 . . . . 0.0 115.362 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.497 ' CD1' HD13 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -143.06 91.49 2.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.124 0.462 . . . . 0.0 110.059 177.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 30' ' ' ALA . 1.6 t -63.32 120.85 12.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.638 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.497 HD13 ' CD1' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -96.13 167.82 10.98 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.579 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -142.57 163.13 40.75 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.269 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 21' ' ' SER . 57.6 Cg_endo -71.71 126.11 11.74 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.269 1.979 . . . . 0.0 112.734 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.48 162.74 34.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.076 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.33 -32.71 37.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.4 pt -99.64 -6.94 9.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.87 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.21 -127.49 1.58 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.865 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 75.0 m -140.72 106.41 5.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.855 0.359 . . . . 0.0 111.644 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.7 m -63.64 133.42 53.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.289 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.8 mt -71.65 104.77 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.879 0.371 . . . . 0.0 110.422 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -68.51 -32.93 73.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.164 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.447 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -156.91 174.71 15.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.05 0.452 . . . . 0.0 111.457 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.74 128.98 7.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.508 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.588 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 6.2 pt -101.12 100.46 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.088 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -70.58 153.76 42.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.012 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.81 -21.92 43.36 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.682 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.575 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 6.4 mp0 -69.87 -52.57 23.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.672 0.272 . . . . 0.0 110.8 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -133.27 139.33 33.8 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.669 179.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.58 -48.23 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.662 2.241 . . . . 0.0 113.109 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -61.12 -49.32 77.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.761 0.315 . . . . 0.0 110.964 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.506 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.3 mt -57.91 -49.93 79.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -60.34 -30.33 69.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.976 0.417 . . . . 0.0 110.452 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -95.3 -1.43 51.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.129 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.54 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -123.93 -73.19 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.462 -178.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.8 mt -73.25 147.8 44.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.631 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.03 157.78 43.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.65 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.7 mtp-105 -59.73 96.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.073 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.81 43.38 0.17 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.722 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.18 140.13 35.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.72 0.295 . . . . 0.0 110.686 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.0 mt -107.52 117.54 53.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.091 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.431 ' CG1' HG12 ' A' ' 81' ' ' VAL . 8.8 mt -75.14 100.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.956 0.408 . . . . 0.0 110.461 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 p -101.79 23.43 11.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 4.5 mttt -170.21 137.01 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.982 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.455 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 35.9 t80 -144.82 115.6 7.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 0.0 111.272 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 53.35 54.42 10.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.75 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.7 22.5 64.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.353 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -128.44 103.16 6.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.935 0.397 . . . . 0.0 110.7 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.42 123.52 13.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.399 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 9.3 mt -93.7 22.11 5.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.584 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -77.81 119.58 21.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.888 0.375 . . . . 0.0 111.225 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -16.83 57.21 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.708 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 72.1 mt -76.23 135.6 69.55 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.589 0.194 . . . . 0.0 111.041 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -57.69 -160.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.412 2.074 . . . . 0.0 112.213 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 37.4 t80 -101.24 -25.6 13.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.89 -47.69 84.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.792 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.9 m -67.58 -46.81 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.414 ' HA ' HD21 ' A' ' 69' ' ' LEU . 19.0 m -59.62 -50.08 75.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 110.767 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.517 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 50.0 t80 -59.31 -33.3 70.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.982 0.42 . . . . 0.0 110.338 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.61 -50.98 39.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.172 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.455 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.83 -34.92 76.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 110.367 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.426 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 3.8 m-85 -69.52 -27.83 65.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.049 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.433 ' HD3' ' CZ ' ' A' ' 67' ' ' TYR . 19.8 mtmt -85.06 -41.55 15.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.911 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.3 -20.47 77.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.233 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.463 ' HB3' ' HG3' ' A' ' 10' ' ' LYS . . . -42.97 132.88 3.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 111.64 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -162.96 102.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.783 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.39 81.75 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.129 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.81 109.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.905 0.384 . . . . 0.0 110.553 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.596 HG23 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -121.46 107.69 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.751 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -98.88 114.76 27.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.404 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.16 123.59 43.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.378 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -87.05 104.69 16.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.964 0.411 . . . . 0.0 109.997 178.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.518 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -95.17 142.68 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.655 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.8 m -108.77 123.84 49.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.339 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 -104.61 92.68 5.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.225 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 C--N 1.345 0.367 0 C-N-CA 122.535 2.157 . . . . 0.0 112.133 179.804 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.529 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 27.2 mm-40 . . . . . 0 C--O 1.232 0.136 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.517 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.7 t80 -86.58 96.21 10.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.338 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.588 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 7.7 m95 -106.16 132.58 52.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.055 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.455 ' CG1' ' CD1' ' A' ' 67' ' ' TYR . 20.3 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.057 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.791 0.329 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.06 159.3 16.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -151.15 129.62 12.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.513 ' CE1' HG21 ' A' ' 81' ' ' VAL . 30.7 p90 -137.76 172.17 13.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.109 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.71 135.95 49.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 111.544 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 43' ' ' LYS . 15.7 t -117.05 107.25 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.265 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 5.7 p-10 -113.13 127.2 56.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.884 0.373 . . . . 0.0 111.139 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.576 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.86 156.24 40.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.38 178.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.47 117.6 12.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.9 0.381 . . . . 0.0 110.638 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.599 ' HB2' HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -100.03 128.39 46.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.538 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.435 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 10.7 mmtt -120.9 68.75 0.88 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.219 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.42 79.73 0.07 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.427 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 44.79 98.63 0.01 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 114.231 0.452 . . . . 0.0 114.231 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 7.5 ptpt -155.85 -102.37 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 1.8 mm-40 -69.23 -5.42 22.68 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.532 ' HG ' ' HE2' ' A' ' 10' ' ' LYS . 3.3 mt -45.53 -30.11 1.36 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.996 0.427 . . . . 0.0 110.17 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.528 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 26.76 62.64 0.08 OUTLIER Glycine 0 C--N 1.332 0.337 0 N-CA-C 115.149 0.82 . . . . 0.0 115.149 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.483 HD21 HD12 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -146.18 92.28 2.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.006 0.431 . . . . 0.0 110.331 178.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.3 t -66.8 116.69 7.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.277 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -92.87 162.74 13.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.199 0.523 . . . . 0.0 111.961 -179.055 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -139.17 148.11 55.95 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.35 124.84 17.24 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.634 2.223 . . . . 0.0 112.816 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.37 162.57 35.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.979 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.57 -38.89 28.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.086 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pt -91.33 -9.24 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.959 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.87 -123.2 1.07 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.452 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -140.51 106.19 5.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.771 0.32 . . . . 0.0 110.939 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.405 ' N ' HG23 ' A' ' 49' ' ' ILE . 86.5 m -67.07 119.37 11.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.532 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.51 104.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.52 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.58 66.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.342 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -165.63 178.72 6.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.342 0.591 . . . . 0.0 111.336 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.442 ' HA ' ' HZ3' ' A' ' 105' ' ' TRP . 0.2 OUTLIER -163.9 136.1 4.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.747 178.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.635 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 5.5 pt -95.9 100.32 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.244 0.545 . . . . 0.0 110.572 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -65.07 154.04 39.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.869 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.04 -27.46 16.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.522 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 3.5 mp0 -65.76 -49.56 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 110.461 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -133.98 140.21 35.64 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.475 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.31 -49.28 0.95 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.644 2.229 . . . . 0.0 113.169 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 43' ' ' LYS . 13.5 mm-40 -60.94 -50.48 73.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 111.036 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.483 HD12 HD21 ' A' ' 18' ' ' LEU . 3.3 mt -55.98 -51.2 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.257 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -59.37 -30.14 68.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.028 0.442 . . . . 0.0 110.632 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -99.42 3.45 45.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.425 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -122.94 -70.18 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.0 mt -70.9 153.72 42.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.266 0.555 . . . . 0.0 112.259 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.94 137.34 15.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.26 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.7 mtp-105 -48.18 114.07 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 111.435 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.93 7.1 6.16 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.18 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -106.61 163.96 12.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.913 0.357 . . . . 0.0 111.099 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.405 HG23 ' N ' ' A' ' 28' ' ' THR . 1.2 mp -131.48 120.14 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.027 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.447 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 6.9 mt -74.61 100.28 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.496 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.7 p -93.55 -9.58 37.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.238 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -139.18 145.97 39.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.455 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 31.1 t80 -152.55 112.54 3.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.865 0.364 . . . . 0.0 111.109 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 56.81 42.86 25.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.851 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.22 22.74 77.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.427 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -121.82 108.15 13.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.343 . . . . 0.0 110.75 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.66 107.95 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.308 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 mt -80.72 0.65 33.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.54 145.2 52.8 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.932 0.396 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.66 19.13 66.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.736 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.0 mt -120.15 141.51 31.81 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.575 0.226 . . . . 0.0 110.924 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.92 -158.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.507 2.138 . . . . 0.0 112.259 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -105.39 -23.91 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.929 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -56.32 -49.0 75.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 110.544 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.0 m -67.02 -45.36 87.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.996 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.0 m -56.97 -49.7 74.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.701 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.504 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 25.3 t80 -63.74 -31.01 72.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.835 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.99 33.09 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.455 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -65.83 -42.21 90.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.814 0.34 . . . . 0.0 110.519 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 5.7 m-85 -63.74 -32.62 74.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.919 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.44 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -82.65 -30.37 29.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.324 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.12 17.26 58.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.542 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 10' ' ' LYS . . . -79.23 136.21 37.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.764 0.316 . . . . 0.0 110.626 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -170.12 98.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.126 0.489 . . . . 0.0 110.728 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.56 77.25 0.52 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.887 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.54 110.39 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.857 0.36 . . . . 0.0 110.412 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.599 HG23 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -119.41 107.96 22.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.629 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.8 t -105.49 106.25 16.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.303 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.417 ' CE ' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -113.27 127.79 56.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.938 -178.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -89.06 107.62 19.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.919 0.39 . . . . 0.0 109.985 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.513 HG21 ' CE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -98.23 143.05 13.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.875 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.9 m -108.49 124.49 50.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.188 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -105.64 93.57 7.44 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.372 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.345 0.353 0 C-N-CA 122.555 2.17 . . . . 0.0 112.199 179.753 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.486 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 4.5 mm100 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 121.053 0.454 . . . . 0.0 111.952 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.504 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 3.3 t80 -79.4 95.9 5.88 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.635 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 53.2 m95 -100.86 145.61 28.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.036 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 67' ' ' TYR . 8.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.22 160.53 19.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.949 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -155.37 129.61 8.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.706 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.556 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 33.0 p90 -136.26 173.29 11.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.272 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.65 137.61 46.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 111.258 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' A' ' 4' ' ' PHE . 6.9 t -122.76 107.28 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.84 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 25.7 t0 -110.14 127.18 54.76 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.78 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.54 159.17 44.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.674 179.044 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.38 114.24 9.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.608 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -95.39 140.83 29.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.347 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 3.8 mmtp -132.57 69.27 1.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.36 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.36 22.09 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.336 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.92 114.27 0.96 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.536 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.401 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -162.08 -96.42 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.959 0.409 . . . . 0.0 111.367 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 16.7 mt-10 -68.23 -4.39 13.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.122 0.569 . . . . 0.0 112.156 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.534 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 2.8 mm? -44.48 -32.71 1.47 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.136 0.493 . . . . 0.0 110.03 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 32.93 51.24 0.47 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.333 -0.849 . . . . 0.0 114.65 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.463 ' CD1' HD13 ' A' ' 20' ' ' LEU . 1.3 pp -141.27 91.62 2.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.019 0.438 . . . . 0.0 110.323 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 30' ' ' ALA . 6.0 t -68.63 119.52 13.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.812 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 18' ' ' LEU . 5.5 mp -94.23 167.89 11.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.52 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -143.88 164.69 28.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.074 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.56 128.68 15.62 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.347 2.032 . . . . 0.0 112.672 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.02 162.66 34.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.039 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.04 -16.74 45.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.52 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 pt -118.1 -7.14 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.787 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 169.75 -124.98 1.2 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.839 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 21' ' ' SER . 21.0 m -140.81 106.16 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.905 0.383 . . . . 0.0 111.413 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.3 m -65.79 128.89 37.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.212 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -68.8 104.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.953 0.406 . . . . 0.0 110.534 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -67.42 -31.45 71.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.11 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.6 172.25 16.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 111.268 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.5 125.36 7.8 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.335 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.584 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 9.0 pt -97.09 100.49 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.967 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.88 160.4 31.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.93 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.16 3.39 88.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.93 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.91 -41.88 8.58 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.897 0.38 . . . . 0.0 110.734 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -143.5 140.95 18.1 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.428 179.177 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.09 -48.75 0.42 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.61 2.207 . . . . 0.0 113.241 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.7 mp0 -62.85 -45.58 91.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 111.065 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.9 mt -61.48 -49.84 82.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.962 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.23 -30.15 68.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.722 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -94.53 -12.87 26.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.234 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.556 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -111.75 -75.08 0.62 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.844 -178.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.8 mt -70.54 151.6 44.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.858 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -153.11 172.91 16.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.458 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -73.57 113.31 10.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.81 0.338 . . . . 0.0 111.052 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.98 27.34 2.99 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.812 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.09 136.45 54.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.731 0.301 . . . . 0.0 110.91 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mt -105.96 118.09 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.425 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 2.9 mt -75.24 100.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 p -104.42 27.8 7.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.181 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.1 mttt -172.76 138.3 0.82 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.166 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CD1' ' CD1' ' A' ' 69' ' ' LEU . 25.7 t80 -150.07 112.28 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.393 . . . . 0.0 111.237 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 55.66 51.0 13.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.69 21.51 65.15 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.367 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -124.03 101.27 7.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.575 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.4 120.93 6.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.369 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.6 mt -92.36 18.78 7.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.07 126.12 32.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.974 0.416 . . . . 0.0 111.429 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -19.67 43.5 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.069 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.6 mt -81.2 140.63 49.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.542 0.211 . . . . 0.0 111.171 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.51 -157.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.633 2.222 . . . . 0.0 112.16 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -104.45 -23.56 13.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.021 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -56.69 -49.06 76.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.06 0.457 . . . . 0.0 110.377 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -71.46 -45.44 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.856 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.4 ' HA ' HD23 ' A' ' 69' ' ' LEU . 91.2 m -55.0 -51.98 64.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.757 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 13.8 t80 -66.74 -30.65 70.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.656 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.73 -51.06 60.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.233 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.484 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.12 -41.44 86.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.856 0.36 . . . . 0.0 110.192 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.499 ' O ' ' HE2' ' A' ' 10' ' ' LYS . 3.4 m-85 -62.58 -33.7 75.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.672 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 13.0 mtmt -79.73 -35.73 38.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.373 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.71 7.66 72.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.566 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.443 ' HB3' ' HG3' ' A' ' 10' ' ' LYS . . . -71.4 141.44 50.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 0.0 110.808 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -175.25 99.17 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.681 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.42 74.68 0.51 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.819 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.26 120.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 110.081 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -132.0 107.91 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.84 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -99.75 111.88 24.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.473 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.93 128.81 55.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.397 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.87 104.74 17.29 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.526 HG22 ' CE1' ' A' ' 4' ' ' PHE . 1.7 m -95.05 143.16 12.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.781 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 62.0 m -108.22 127.91 54.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.205 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.11 95.44 15.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 82' ' ' THR . 52.7 Cg_exo . . . . . 0 C--N 1.343 0.265 0 C-N-CA 122.496 2.13 . . . . 0.0 112.147 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.533 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 5.2 mm100 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 121.119 0.485 . . . . 0.0 112.153 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.53 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -86.83 96.28 10.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.584 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 14.7 m95 -104.22 138.64 40.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 111.783 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.45 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 18.6 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.113 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.748 0.309 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.23 158.23 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.804 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -151.62 129.67 11.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.746 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.546 ' CE2' HG23 ' A' ' 6' ' ' VAL . 30.1 p90 -138.29 170.87 15.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.69 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.62 136.02 48.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.043 0.449 . . . . 0.0 111.431 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.546 HG23 ' CE2' ' A' ' 4' ' ' PHE . 19.6 t -114.93 106.93 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.681 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 15.4 p-10 -110.65 127.01 55.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.894 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.573 HD13 HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -149.87 159.27 44.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.377 . . . . 0.0 110.39 178.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.67 113.62 11.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.998 0.428 . . . . 0.0 110.941 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.628 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -97.66 151.63 19.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.431 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 8.0 mmtt -138.34 69.43 1.38 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.637 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.55 23.2 5.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.282 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.7 113.64 1.45 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.558 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.4 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -161.88 -96.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 0.0 110.985 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 19.4 mt-10 -69.41 -5.56 24.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.659 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.509 HD22 ' CD2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.6 -36.02 4.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.267 0.556 . . . . 0.0 109.583 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 25.32 62.6 0.06 OUTLIER Glycine 0 CA--C 1.52 0.352 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.509 ' CD2' HD22 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -138.56 91.69 2.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.166 0.508 . . . . 0.0 109.992 177.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -59.51 112.35 1.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.824 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 7.0 mt -96.21 168.3 10.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.613 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -146.6 158.33 46.66 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.335 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.35 125.07 13.37 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.475 2.117 . . . . 0.0 112.488 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.71 162.52 31.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.002 0.429 . . . . 0.0 111.105 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -81.63 -18.01 46.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.425 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 pt -117.8 -4.61 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.706 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.83 -123.51 1.14 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.183 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 1.3 m -140.76 106.47 5.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.825 0.345 . . . . 0.0 111.575 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 97.0 m -69.64 137.56 52.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.5 mt -79.46 104.92 8.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.865 0.364 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.59 -28.08 63.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.967 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -160.54 169.36 23.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 111.205 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.42 127.24 9.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.349 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.539 HG22 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -98.19 100.47 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.296 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.53 154.37 42.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.024 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.05 -20.72 47.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.903 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.58 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 11.9 mp0 -70.74 -48.03 56.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.71 142.2 33.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.787 0.327 . . . . 0.0 110.703 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.56 -48.85 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.545 2.163 . . . . 0.0 112.901 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' LYS . 23.1 mm-40 -61.41 -50.14 74.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 111.027 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.1 mt -56.44 -51.45 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.142 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -59.89 -30.31 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.819 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -97.79 1.98 48.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.427 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -125.6 -72.23 0.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.779 0.323 . . . . 0.0 111.552 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.1 mt -77.51 152.91 33.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.089 0.471 . . . . 0.0 111.61 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -150.35 -175.91 5.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.503 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -81.62 95.0 7.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.048 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.34 43.09 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.799 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.78 145.38 40.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 110.877 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.55 118.13 57.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.426 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 6.4 mt -74.62 100.46 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 110.83 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -100.45 26.5 6.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.724 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -172.61 136.16 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.905 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.449 ' CD1' ' CD1' ' A' ' 69' ' ' LEU . 61.3 t80 -142.62 109.98 5.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.219 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.57 48.71 19.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.914 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.78 76.98 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.396 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -124.71 105.61 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 0.0 110.712 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.92 121.81 10.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.316 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 11.4 mt -92.72 16.87 11.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.965 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.39 141.46 52.17 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.868 0.366 . . . . 0.0 111.081 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.79 29.65 55.12 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.667 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.8 mt -115.36 135.32 22.56 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.5 0.19 . . . . 0.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.69 -169.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.404 2.069 . . . . 0.0 112.167 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -98.39 -26.38 14.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.038 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -58.53 -46.84 85.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.032 0.444 . . . . 0.0 110.584 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.3 t -66.45 -48.97 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.897 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.5 -53.75 54.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.769 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 104' ' ' TYR . 38.3 t80 -58.07 -31.25 66.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.81 -51.04 24.52 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.449 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.99 -32.71 72.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 110.26 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.426 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 4.8 m-85 -72.42 -29.01 63.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.04 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.44 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 7.2 mtpt -85.15 -35.88 21.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.581 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.12 -22.7 65.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.874 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HB3' ' HG3' ' A' ' 10' ' ' LYS . . . -42.98 128.14 4.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.563 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -155.25 103.26 2.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 110.945 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.04 86.62 1.88 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.265 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.27 114.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 110.622 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.628 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -128.51 107.78 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.227 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 4.3 t -102.64 108.45 19.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.488 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.53 125.31 52.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.522 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -86.47 112.04 21.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.874 0.369 . . . . 0.0 110.216 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.494 HG21 ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -101.28 142.39 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.616 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.2 m -108.85 124.61 50.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.392 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -107.07 90.34 5.36 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.104 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--N 1.344 0.293 0 C-N-CA 122.656 2.238 . . . . 0.0 112.502 179.866 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.508 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 18.1 mm-40 . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 121.093 0.473 . . . . 0.0 112.243 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 1.8 t80 -84.8 96.13 9.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.539 ' CH2' HG22 ' A' ' 33' ' ' ILE . 25.6 m95 -102.55 132.21 48.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.316 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.455 ' CG1' ' CD1' ' A' ' 67' ' ' TYR . 11.4 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.178 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.797 0.332 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.01 162.44 14.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -155.77 129.62 8.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.503 ' CE1' ' CG2' ' A' ' 81' ' ' VAL . 30.0 p90 -140.04 175.38 9.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.785 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.49 139.27 47.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.159 0.504 . . . . 0.0 111.84 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.52 HG21 ' HB3' ' A' ' 43' ' ' LYS . 17.5 t -120.91 107.02 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.239 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 25.8 p-10 -112.24 127.24 55.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.568 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.06 156.14 42.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.008 0.432 . . . . 0.0 110.47 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.06 114.82 9.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.014 0.435 . . . . 0.0 110.539 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.517 ' HG2' HD23 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -96.4 145.01 26.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.739 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.418 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 23.8 mmtt -134.99 69.32 1.45 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.32 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.43 26.58 9.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.182 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.01 112.98 0.51 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.304 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -157.11 -94.46 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.027 0.442 . . . . 0.0 111.296 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 15.3 mt-10 -68.25 -4.45 14.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.154 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.517 HD23 ' HG2' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -44.58 -30.12 0.85 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.548 0.213 . . . . 0.0 110.552 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 19.47 53.22 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 114.62 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.444 ' CD2' ' CD1' ' A' ' 16' ' ' LEU . 2.0 pp -135.57 103.15 5.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.945 0.402 . . . . 0.0 110.066 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 103' ' ' GLN . 1.2 t -69.06 122.08 17.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.138 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mt -105.0 159.75 15.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.63 167.72 20.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.479 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.74 135.15 21.2 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.556 2.171 . . . . 0.0 112.585 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.4 162.64 38.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.088 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -32.89 38.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.154 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 pt -99.12 -7.95 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.82 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.78 -122.81 1.04 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.416 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 m -140.52 106.45 5.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.75 0.309 . . . . 0.0 111.246 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.6 m -66.95 127.33 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.399 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.7 mt -68.93 104.75 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.683 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.1 -23.38 62.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.945 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -171.68 172.45 4.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.825 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.442 ' HA ' ' HZ3' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -163.48 131.76 3.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.986 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.679 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -95.53 144.14 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.597 -179.112 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -94.0 169.39 10.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.937 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.87 21.38 71.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.764 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -111.77 -33.51 6.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 110.891 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -156.25 144.91 14.69 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.15 -47.91 4.12 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.469 2.112 . . . . 0.0 112.779 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 43' ' ' LYS . 14.2 mp0 -65.77 -52.27 52.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.221 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 2.6 mt -54.91 -40.95 55.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.558 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -71.23 -30.09 65.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.153 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.56 3.71 32.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.062 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.52 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -127.47 -73.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.459 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -60.12 148.88 34.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.884 -178.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -153.85 -175.71 5.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.539 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -92.93 116.8 29.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.51 -14.86 8.13 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.074 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -85.87 158.8 19.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 111.267 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.4 121.84 51.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.736 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.429 HD11 ' CZ ' ' A' ' 70' ' ' PHE . 14.6 mt -74.26 100.63 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.034 0.445 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 p -102.4 26.88 7.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.906 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 2.8 mttt -172.7 135.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.982 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.456 ' CD2' ' CD1' ' A' ' 69' ' ' LEU . 68.0 t80 -139.34 120.83 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.93 0.395 . . . . 0.0 111.37 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.63 39.88 22.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.985 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.17 17.52 78.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.498 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -124.23 106.5 10.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 0.0 110.714 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.62 124.57 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.431 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 10.4 mt -94.91 23.34 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.81 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.95 144.28 38.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.091 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.89 24.01 57.29 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.695 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.46 139.03 24.89 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.539 0.209 . . . . 0.0 110.803 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.95 -161.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.408 2.072 . . . . 0.0 112.17 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -106.73 -24.27 12.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -56.8 -50.65 71.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.063 0.459 . . . . 0.0 110.599 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.21 -47.45 92.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.067 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.401 ' HA ' HD21 ' A' ' 69' ' ' LEU . 63.5 m -57.5 -53.79 54.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 110.895 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.518 ' CZ ' ' CE2' ' A' ' 104' ' ' TYR . 18.6 t80 -57.37 -31.0 65.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.715 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.23 -51.11 18.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.233 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.456 ' CD1' ' CD2' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.31 -32.29 72.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 110.331 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.429 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 5.5 m-85 -73.1 -31.32 64.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.976 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.432 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -85.11 -29.87 24.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.577 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.27 -22.45 44.5 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.855 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 10' ' ' LYS . . . -43.46 131.52 4.92 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.809 0.338 . . . . 0.0 111.519 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -157.06 101.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.05 85.27 1.49 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.623 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 110.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.824 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -124.6 108.0 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.685 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -99.25 111.29 23.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.479 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.23 124.03 46.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -88.31 107.29 18.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 110.289 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.503 ' CG2' ' CE1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -95.29 142.94 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.422 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 92.8 m -108.45 128.4 54.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.079 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -110.54 93.43 16.37 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.208 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 82' ' ' THR . 38.8 Cg_exo . . . . . 0 C--N 1.344 0.293 0 C-N-CA 122.584 2.189 . . . . 0.0 112.218 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.496 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 29.3 mm-40 . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.906 0.384 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.518 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -80.88 96.0 6.89 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.679 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 54.7 m95 -100.71 138.05 38.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.698 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' A' ' 67' ' ' TYR . 34.4 m . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.211 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.794 0.331 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.09 162.51 5.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.824 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.9 mttt -156.19 129.52 8.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.61 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.517 ' CE2' HG21 ' A' ' 6' ' ' VAL . 35.0 p90 -136.92 173.94 11.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.791 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.8 135.87 49.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.955 0.407 . . . . 0.0 111.389 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.517 HG21 ' CE2' ' A' ' 4' ' ' PHE . 12.6 t -117.58 107.34 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.142 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -109.98 127.94 55.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.07 0.462 . . . . 0.0 110.9 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.538 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -159.52 153.07 22.61 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.928 179.318 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.94 127.14 31.67 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.529 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.451 ' HB2' ' CG2' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -103.79 136.58 43.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.79 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -115.45 69.6 0.73 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.94 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.93 27.61 0.74 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.398 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.77 73.07 1.13 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.281 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.585 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 29.6 ttmt -120.26 -102.82 0.41 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.571 0.224 . . . . 0.0 111.023 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.585 ' N ' ' HG2' ' A' ' 14' ' ' LYS . 7.7 mt-10 -70.95 -6.35 37.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.507 ' HG ' ' CD2' ' A' ' 18' ' ' LEU . 7.7 tp -46.16 -39.13 9.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 12.33 62.99 0.01 OUTLIER Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.434 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.507 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -127.88 91.77 3.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.135 0.493 . . . . 0.0 109.798 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.8 119.35 4.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.844 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.3 mt -107.39 165.26 11.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.542 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.19 167.68 13.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.361 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -75.2 135.81 19.19 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.494 2.129 . . . . 0.0 112.82 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.64 162.56 38.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.013 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.45 -28.85 41.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.183 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 pt -103.82 -2.01 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.919 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.8 -124.9 1.33 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.135 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.9 p -140.22 106.39 5.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.822 0.344 . . . . 0.0 111.078 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 84.8 m -65.45 128.85 37.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.69 104.74 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.618 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.11 -27.58 67.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.588 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -171.66 179.94 2.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.779 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.86 134.92 3.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.003 178.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.652 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 2.8 pt -95.99 119.39 43.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.79 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -72.22 175.24 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.308 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.41 -51.58 4.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.635 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -46.26 -74.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.672 0.272 . . . . 0.0 110.723 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -117.74 131.4 24.13 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.691 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.64 -42.74 8.68 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.457 2.105 . . . . 0.0 112.502 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.97 -48.45 81.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 37' ' ' TYR . 6.0 mt -59.43 -42.33 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.567 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.27 -30.12 69.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.679 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -99.67 3.36 45.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.505 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.513 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -125.08 -71.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.819 -179.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -72.17 150.33 43.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.248 0.547 . . . . 0.0 112.156 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -153.84 149.6 27.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.248 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 -55.64 107.97 0.39 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.186 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.24 41.0 0.42 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.624 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -142.06 164.07 31.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.573 0.225 . . . . 0.0 110.619 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.6 mp -133.32 120.29 38.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.238 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.461 ' CG1' HG13 ' A' ' 81' ' ' VAL . 6.1 mt -74.59 100.65 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.045 0.45 . . . . 0.0 110.471 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 p -99.84 18.63 17.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.948 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -162.27 142.52 9.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.138 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 60.2 t80 -151.67 109.85 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.911 0.386 . . . . 0.0 111.1 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 51.94 55.31 9.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.01 23.35 65.79 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.358 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.91 99.72 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.804 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.46 120.57 7.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.285 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -92.81 16.97 11.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.45 127.34 32.04 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.827 0.346 . . . . 0.0 111.142 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.65 -23.26 31.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.777 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.5 mt -79.6 148.34 69.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 111.096 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.21 -168.37 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.499 2.132 . . . . 0.0 112.205 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -87.76 -28.45 21.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.618 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.73 -42.33 83.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.406 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -66.2 -53.94 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.744 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 89.4 m -56.07 -53.82 52.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.056 0.455 . . . . 0.0 110.781 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 28.3 t80 -56.89 -30.88 64.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.18 -51.16 22.48 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.49 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.88 -37.18 81.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.351 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.445 ' CE1' ' HG2' ' A' ' 79' ' ' MET . 10.1 m-85 -68.34 -32.04 71.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.955 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 2.9 mtpt -81.34 -34.4 31.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.17 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.36 -23.77 55.87 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.458 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.432 ' HB3' ' HG3' ' A' ' 10' ' ' LYS . . . -45.99 138.92 4.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.658 0.266 . . . . 0.0 111.301 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -170.87 97.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.038 0.447 . . . . 0.0 111.571 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.46 96.36 2.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.93 87.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.128 0.489 . . . . 0.0 110.442 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 10' ' ' LYS . 3.5 t -114.4 130.72 68.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.147 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.7 t -122.82 139.62 53.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.445 ' HG2' ' CE1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -142.66 129.23 20.25 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.825 0.345 . . . . 0.0 111.675 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -91.21 108.12 19.66 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.515 ' CG2' ' CE1' ' A' ' 4' ' ' PHE . 1.9 m -95.16 142.64 13.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.837 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 45.3 m -108.65 125.33 51.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.196 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -107.68 97.63 21.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.097 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--N 1.345 0.346 0 C-N-CA 122.532 2.155 . . . . 0.0 112.286 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 17.9 mm-40 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.96 0.409 . . . . 0.0 112.083 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.6 t80 -76.81 95.98 4.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.652 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 68.4 m95 -101.71 138.14 39.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.352 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.42 HG21 HD22 ' A' ' 16' ' ' LEU . 16.0 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.196 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.796 0.331 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.14 155.43 18.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 8.9 mttp -144.86 129.57 18.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.848 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.515 ' CE1' HG23 ' A' ' 81' ' ' VAL . 26.5 p90 -137.03 171.49 14.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.818 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.72 136.03 48.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.057 0.456 . . . . 0.0 111.394 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 43' ' ' LYS . 16.0 t -116.26 107.33 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.551 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 12.3 t0 -110.66 127.21 55.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.027 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.581 HD12 HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -149.53 157.72 43.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 110.481 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.31 110.21 5.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.987 0.422 . . . . 0.0 111.037 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.654 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -94.56 144.39 25.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.093 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 6.6 mmtp -130.05 69.33 1.44 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.436 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.5 20.92 6.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.274 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.31 114.56 1.88 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.459 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -164.56 -94.29 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 111.444 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 29.1 mt-10 -69.2 -4.49 17.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.126 0.57 . . . . 0.0 112.359 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 2.5 mt -44.65 -32.13 1.38 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.47 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 30.34 59.61 0.22 Allowed Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 115.13 177.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.451 HD23 ' CD2' ' A' ' 16' ' ' LEU . 1.3 pp -148.11 91.83 1.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.034 0.445 . . . . 0.0 110.202 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 30' ' ' ALA . 3.0 t -65.75 117.28 7.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.549 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.449 HD11 HD13 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -88.0 170.35 11.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.603 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.81 159.39 56.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.11 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.76 111.52 2.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.427 2.085 . . . . 0.0 112.727 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.24 162.51 23.54 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.718 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -83.46 -29.06 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.349 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 pt -102.09 -8.66 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.763 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.43 -123.81 1.06 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.136 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.53 105.86 5.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.906 0.384 . . . . 0.0 111.046 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.415 ' OG1' HG12 ' A' ' 49' ' ' ILE . 92.3 m -68.64 128.95 38.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.179 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.8 mt -70.25 104.8 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.858 0.361 . . . . 0.0 110.639 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -69.86 -30.66 68.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.959 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.441 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.8 OUTLIER -158.34 173.65 16.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.413 . . . . 0.0 111.299 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.8 126.89 7.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.397 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.568 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 6.6 pt -96.9 100.38 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.972 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -69.16 155.4 40.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.075 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.0 -14.66 64.72 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.859 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 4.1 mp0 -76.83 -47.61 20.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.711 0.291 . . . . 0.0 110.717 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.4 138.96 23.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.653 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.22 -51.02 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.662 2.241 . . . . 0.0 113.012 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -58.54 -48.78 79.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.769 0.318 . . . . 0.0 111.044 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.488 HG13 ' HB3' ' A' ' 37' ' ' TYR . 4.6 mt -57.32 -50.44 76.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.133 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.39 -30.26 68.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.562 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -97.48 0.65 47.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.173 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.522 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.21 -73.74 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.838 0.351 . . . . 0.0 111.697 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.1 mt -73.29 157.29 37.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.045 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -153.94 -175.9 5.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.221 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -90.56 104.96 17.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 111.127 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.49 -8.7 3.72 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.21 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.18 160.43 15.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 111.182 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.415 HG12 ' OG1' ' A' ' 28' ' ' THR . 1.0 OUTLIER -126.9 119.69 53.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.431 ' CG1' HG12 ' A' ' 81' ' ' VAL . 4.3 mt -74.57 100.6 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 110.997 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.7 p -101.07 22.6 12.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.735 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.2 mttt -167.54 136.54 2.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.887 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 56.7 t80 -142.73 111.02 6.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.93 0.395 . . . . 0.0 111.265 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 54.17 46.84 24.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.26 22.15 78.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.431 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -126.16 106.41 9.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 110.737 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.68 121.49 9.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.324 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 7.9 mt -94.36 21.37 7.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.752 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -78.4 143.34 36.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.955 0.407 . . . . 0.0 111.097 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.23 24.02 60.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.792 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.6 mt -116.42 138.54 24.45 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.56 0.219 . . . . 0.0 110.841 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.36 -159.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.466 2.111 . . . . 0.0 112.182 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 67' ' ' TYR . 30.4 t80 -103.06 -24.44 13.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.984 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -57.73 -48.79 78.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.46 . . . . 0.0 110.515 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -63.96 -46.92 92.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.084 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 m -58.8 -51.86 68.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.85 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.514 ' CZ ' ' CE2' ' A' ' 104' ' ' TYR . 10.8 t80 -58.55 -31.22 67.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.23 -51.08 22.7 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.483 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -69.06 -32.24 71.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 110.268 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.415 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 8.9 m-85 -73.76 -28.69 61.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.283 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 29.2 mtmt -85.02 -38.99 18.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.7 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.16 -22.27 74.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.855 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' CB ' HG11 ' A' ' 77' ' ' VAL . . . -44.16 127.87 5.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.832 0.348 . . . . 0.0 111.691 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -159.45 104.02 1.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.089 0.471 . . . . 0.0 110.756 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.96 84.35 1.64 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.072 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 114.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 0.0 110.366 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -127.38 107.61 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.406 -179.165 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 t -99.57 114.96 28.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.062 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.83 123.49 41.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.574 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -85.84 105.78 16.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.189 179.107 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.515 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -96.61 142.68 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.893 -179.079 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.401 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 91.7 m -108.85 117.78 35.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.603 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -104.53 93.78 6.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.04 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--N 1.344 0.317 0 C-N-CA 122.512 2.141 . . . . 0.0 112.337 179.861 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.533 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 5.1 mm100 . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.122 0.487 . . . . 0.0 112.224 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.514 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -86.87 96.03 10.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.568 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 8.5 m95 -104.67 134.54 47.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.254 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.435 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.7 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.139 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.61 156.34 29.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.772 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -150.93 129.58 12.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.513 ' CE2' HG23 ' A' ' 6' ' ' VAL . 28.8 p90 -137.66 170.14 16.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.68 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.65 135.87 49.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.057 0.456 . . . . 0.0 111.305 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 43' ' ' LYS . 11.5 t -116.37 107.01 21.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.289 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 1.6 p30 -110.44 127.28 55.04 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.053 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.564 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.1 156.35 42.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.95 0.405 . . . . 0.0 110.663 178.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 113.45 7.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.026 0.441 . . . . 0.0 110.586 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.609 ' HB2' HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -96.33 151.26 19.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.434 0.635 . . . . 0.0 111.896 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 20.2 mmtt -138.0 69.27 1.39 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.246 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 53.84 24.06 4.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.3 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.43 113.94 1.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.551 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -159.28 -97.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.765 0.317 . . . . 0.0 111.312 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.0 mm-40 -69.14 -5.78 24.5 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.161 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HG ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -45.23 -33.97 2.59 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.885 0.374 . . . . 0.0 110.497 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.403 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 26.17 62.22 0.07 OUTLIER Glycine 0 CA--C 1.522 0.483 0 N-CA-C 115.379 0.912 . . . . 0.0 115.379 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -139.62 91.81 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.023 0.439 . . . . 0.0 110.244 177.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 t -61.74 114.28 3.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.023 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -93.78 161.59 14.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.36 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 p -136.3 164.77 40.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.577 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.56 122.0 8.48 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.773 2.316 . . . . 0.0 112.841 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.14 162.44 34.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -80.09 -36.83 34.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.115 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 pt -94.93 -7.65 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.02 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.76 -125.18 1.27 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.366 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -140.69 106.28 5.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.882 0.372 . . . . 0.0 111.522 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.471 ' OG1' HG12 ' A' ' 49' ' ' ILE . 98.7 m -69.76 128.37 36.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.197 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.6 mt -64.41 104.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.855 0.359 . . . . 0.0 110.446 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.96 -26.84 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.49 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 1.8 m-20 -159.47 163.96 34.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.739 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.68 129.14 9.9 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.113 0.482 . . . . 0.0 111.971 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.621 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 3.0 pt -96.17 108.92 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.083 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -82.38 128.61 34.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.079 0.466 . . . . 0.0 111.294 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.2 30.37 3.17 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.814 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.614 ' HG3' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -117.49 -29.89 5.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.708 0.29 . . . . 0.0 111.279 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -151.31 143.11 15.86 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.79 -47.18 2.83 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.453 2.102 . . . . 0.0 112.894 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 43' ' ' LYS . 7.2 mm-40 -66.02 -51.53 57.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.2 mt -55.47 -46.6 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.229 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.65 -30.37 71.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.991 0.424 . . . . 0.0 110.524 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -97.46 3.52 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.229 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.534 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -128.71 -72.67 0.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.944 0.402 . . . . 0.0 111.821 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.8 mt -73.7 149.11 42.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.119 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -153.96 155.8 36.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.357 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -57.81 104.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.151 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.03 45.2 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.899 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -144.77 145.05 31.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.366 . . . . 0.0 110.888 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.471 HG12 ' OG1' ' A' ' 28' ' ' THR . 0.9 OUTLIER -112.58 117.57 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.351 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.451 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 7.0 mt -74.89 100.23 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.264 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.9 p -93.68 -3.93 51.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.278 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -144.89 147.28 32.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.454 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 22.8 t80 -153.32 114.05 4.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.884 0.373 . . . . 0.0 111.323 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.42 46.36 25.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.002 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.54 24.73 76.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.353 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -124.98 102.98 7.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 110.654 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.97 114.95 1.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.457 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -91.12 15.78 11.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.59 125.36 35.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.72 15.62 51.94 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.373 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.64 159.74 66.43 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.976 0.388 . . . . 0.0 111.131 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.3 -171.7 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.695 2.264 . . . . 0.0 112.524 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 12.4 t80 -94.05 -32.11 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.594 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.72 -46.6 50.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.999 0.428 . . . . 0.0 110.449 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 m -64.26 -41.05 91.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.86 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 17.1 m -62.77 -51.77 65.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.919 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 37.2 t80 -58.49 -30.96 67.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.713 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.67 -50.96 31.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.454 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -70.07 -31.49 69.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.411 . . . . 0.0 110.239 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.455 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 3.4 m-85 -72.86 -27.61 62.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.138 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.442 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 1.8 mtpt -85.2 -43.84 13.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.794 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.28 -23.41 78.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.016 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.471 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -42.16 128.89 3.73 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 111.735 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -157.32 103.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.09 83.6 1.44 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.267 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.08 114.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.469 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.609 HG23 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -128.31 107.83 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.687 -179.056 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 t -100.35 111.98 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.501 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.9 124.02 49.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.323 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -87.13 104.66 16.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.066 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.503 HG22 ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -94.94 142.52 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.421 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 83.9 m -108.92 119.95 41.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.636 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -102.77 91.33 2.77 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo . . . . . 0 C--N 1.345 0.379 0 C-N-CA 122.531 2.154 . . . . 0.0 112.544 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.533 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 26.5 mm100 . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 5.7 t80 -86.85 96.47 10.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.243 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.621 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 9.0 m95 -106.48 137.16 44.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.414 HG12 ' CE1' ' A' ' 67' ' ' TYR . 27.5 m . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.207 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.858 0.361 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.66 156.07 25.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -150.74 129.59 12.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.962 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.514 ' CE1' HG22 ' A' ' 81' ' ' VAL . 25.5 p90 -136.85 171.58 14.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.801 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.62 135.65 49.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.031 0.443 . . . . 0.0 111.223 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 43' ' ' LYS . 12.3 t -116.11 107.28 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.361 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 14.5 p-10 -110.0 127.23 54.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD11 HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -149.36 158.6 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.527 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.02 113.32 8.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.103 0.478 . . . . 0.0 110.913 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.644 ' HB2' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -97.51 145.59 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.425 -179.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.406 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 12.4 mmtt -131.46 69.43 1.47 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.225 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.14 23.19 5.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.3 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.12 113.48 1.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.59 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 6.6 ptpt -161.5 -94.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 9.5 mt-10 -69.47 -5.9 26.95 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.669 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.492 ' HG ' HD23 ' A' ' 18' ' ' LEU . 2.1 tp -45.8 -34.36 3.67 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.515 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 22.74 62.16 0.03 OUTLIER Glycine 0 C--N 1.331 0.262 0 CA-C-N 114.933 -1.031 . . . . 0.0 115.008 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.492 HD23 ' HG ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -139.43 91.7 2.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 110.097 178.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.0 t -61.59 118.94 7.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.021 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -100.25 159.12 15.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.359 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 56.0 m -130.41 156.71 79.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.629 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.91 111.4 2.18 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.531 2.154 . . . . 0.0 112.474 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.85 162.57 21.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.064 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.09 -31.66 44.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.189 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 pt -101.12 -8.3 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.969 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 170.26 -121.19 0.9 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.484 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' SER . 3.0 m -140.47 106.48 5.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 111.224 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 97.5 m -69.69 119.96 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.561 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.35 104.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.741 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.72 -29.58 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.445 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.5 OUTLIER -158.67 171.45 20.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.064 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.31 128.2 5.26 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.454 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.62 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 2.4 pt -96.47 100.69 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.274 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -69.79 145.32 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.085 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.13 -25.34 23.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.915 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.553 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 1.8 mp0 -66.71 -47.52 72.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.722 0.296 . . . . 0.0 110.858 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -136.65 140.21 31.44 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.68 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.43 -50.15 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.635 2.223 . . . . 0.0 112.924 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -59.37 -49.71 76.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 110.997 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 37' ' ' TYR . 5.2 mt -55.85 -53.01 42.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -58.43 -30.17 66.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.6 m -97.17 0.99 49.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.338 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.552 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.37 -73.41 0.62 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 0.0 111.566 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.3 mt -72.81 155.59 39.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.908 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.5 -175.77 5.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.474 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -90.57 98.0 11.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.035 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.43 -18.53 1.68 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.046 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.79 162.44 21.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 111.236 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -128.9 120.36 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.419 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 5.9 mt -74.48 100.22 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 110.644 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 p -94.71 -7.4 40.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.43 147.95 38.77 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 69' ' ' LEU . 26.8 t80 -152.58 110.38 3.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 0.0 111.256 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 54.14 47.44 23.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.858 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.35 24.81 73.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.231 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -123.88 102.41 7.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 0.0 110.584 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.11 114.01 1.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.427 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.3 mt -89.83 14.39 12.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.927 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -78.39 142.97 37.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.046 0.45 . . . . 0.0 111.232 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.05 26.52 61.15 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.744 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 63.0 mt -120.24 140.79 30.61 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.607 0.242 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.67 -166.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.507 2.138 . . . . 0.0 112.168 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -101.6 -24.97 14.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.105 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -45.84 84.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.686 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.08 -50.48 58.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.409 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -55.91 -48.36 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 15.7 t80 -64.3 -30.98 72.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.13 -50.9 35.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.958 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.5 -35.51 79.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 110.396 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.418 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 2.6 m-85 -69.77 -28.85 66.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.217 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 21.1 mtmt -84.98 -36.52 21.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.739 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.61 -20.0 67.15 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.976 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HB3' ' HG3' ' A' ' 10' ' ' LYS . . . -45.34 126.93 6.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.752 0.311 . . . . 0.0 111.532 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -154.78 103.73 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.28 85.78 1.8 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.063 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.93 116.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.456 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -131.19 107.72 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.632 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.6 t -99.41 114.3 27.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.33 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.79 125.34 48.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.478 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -86.76 103.8 15.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.928 0.394 . . . . 0.0 110.091 178.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.514 HG22 ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -95.17 143.1 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.521 -179.491 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.7 m -108.32 116.77 32.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -102.69 89.8 1.97 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.062 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.344 0.322 0 C-N-CA 122.525 2.15 . . . . 0.0 112.213 179.904 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.506 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 14.5 mm100 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.932 0.396 . . . . 0.0 111.715 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.519 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 1.3 t80 -81.49 96.07 7.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.62 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 33.4 m95 -100.91 136.98 39.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.113 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.427 HG11 ' CE1' ' A' ' 67' ' ' TYR . 25.6 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.171 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.8 155.65 27.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 9.4 mttt -149.39 129.72 13.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.069 0.462 . . . . 0.0 110.708 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.495 ' CE1' ' CG2' ' A' ' 81' ' ' VAL . 28.1 p90 -138.49 169.58 17.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.688 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.58 135.88 49.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.158 0.504 . . . . 0.0 111.382 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 43' ' ' LYS . 19.2 t -114.42 107.06 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.157 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 1.5 p30 -111.74 127.27 55.74 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.016 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.568 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -151.68 157.8 42.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.55 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.33 118.33 14.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 110.696 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.6 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -101.14 129.13 47.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.812 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 3.5 mmtp -119.61 68.61 0.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.166 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.9 77.33 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.422 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 48.95 100.78 0.01 OUTLIER Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.329 -0.462 . . . . 0.0 114.167 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.464 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -159.4 -101.58 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 22.3 mt-10 -69.22 -5.41 22.57 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.53 ' HG ' ' HE2' ' A' ' 10' ' ' LYS . 2.7 mt -45.5 -30.32 1.39 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.963 0.411 . . . . 0.0 109.906 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 24.81 63.05 0.05 OUTLIER Glycine 0 C--N 1.331 0.284 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 178.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.474 HD21 ' CD2' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -145.85 92.02 2.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.108 0.48 . . . . 0.0 110.098 178.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 30' ' ' ALA . 1.5 t -63.42 120.73 12.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.175 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -100.0 158.07 16.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.585 -179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.41 163.33 51.28 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.348 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.33 117.56 5.22 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.492 2.128 . . . . 0.0 112.77 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.9 162.61 29.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -79.66 -37.26 36.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.99 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 pt -94.34 -6.03 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.888 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.27 -122.65 1.08 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.619 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -138.99 106.23 5.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.727 0.298 . . . . 0.0 110.924 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -66.82 121.04 14.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.246 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.0 mt -62.85 104.59 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.561 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -72.1 -25.5 61.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -172.54 -178.02 1.87 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.386 0.612 . . . . 0.0 111.38 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.428 ' HA ' ' HZ3' ' A' ' 105' ' ' TRP . 0.2 OUTLIER -164.36 136.73 4.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.553 178.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.593 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 3.1 pt -96.0 100.32 10.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.303 0.573 . . . . 0.0 110.334 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -63.6 153.24 36.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.86 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.8 -16.15 61.46 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.703 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.2 mp0 -77.77 -50.08 13.09 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.712 0.291 . . . . 0.0 110.727 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -135.07 139.69 32.68 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.766 0.317 . . . . 0.0 110.829 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.15 -50.27 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.693 2.262 . . . . 0.0 113.05 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.7 mp0 -59.56 -49.25 78.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 110.838 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.476 HG13 ' HB3' ' A' ' 37' ' ' TYR . 4.2 mt -56.04 -48.22 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.92 -30.3 70.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.511 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 m -99.16 3.37 46.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.367 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -125.32 -71.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.4 mt -71.13 156.24 39.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.466 0.65 . . . . 0.0 112.498 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -153.95 -175.78 5.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.857 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -92.83 117.55 30.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.888 0.375 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.35 17.53 4.38 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.896 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -115.32 167.35 10.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.783 0.291 . . . . 0.0 110.82 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.5 mp -137.01 120.61 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.453 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 9.8 mt -74.21 100.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.07 0.462 . . . . 0.0 110.567 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.2 p -95.71 -3.71 45.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.245 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -144.52 143.96 31.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.984 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.452 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 32.0 t80 -150.1 111.74 4.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.954 0.407 . . . . 0.0 111.369 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.68 46.17 26.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.132 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.95 24.26 76.55 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.391 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -126.68 104.47 8.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.693 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.3 117.28 3.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.223 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mt -92.8 17.67 10.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.968 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -87.21 127.72 35.15 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.891 0.376 . . . . 0.0 111.226 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.4 -23.84 28.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.791 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.24 153.81 66.25 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.998 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.01 -172.57 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.578 2.186 . . . . 0.0 112.244 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.429 ' CE1' ' HB2' ' A' ' 67' ' ' TYR . 55.0 t80 -91.95 -29.18 16.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.713 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -53.96 -43.43 69.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.58 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 p -65.28 -46.22 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.423 ' HA ' HD21 ' A' ' 69' ' ' LEU . 89.4 m -60.21 -49.62 76.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.661 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 16.1 t80 -58.52 -31.97 68.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.599 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.01 -50.85 20.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.213 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.452 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.46 -37.02 82.29 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.473 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.453 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 5.0 m-85 -67.49 -34.02 76.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.419 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 34.9 mtmt -82.18 -29.76 31.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.28 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.85 15.93 61.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.637 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.482 ' O ' ' HD3' ' A' ' 10' ' ' LYS . . . -78.12 138.14 38.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.709 0.29 . . . . 0.0 110.591 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 2.2 p30 -169.52 100.07 0.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.989 0.424 . . . . 0.0 110.785 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.17 78.32 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.961 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.36 114.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.962 0.411 . . . . 0.0 110.27 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.6 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -124.82 107.85 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.614 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.7 t -102.71 109.81 21.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.303 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.418 ' CE ' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -116.63 123.77 48.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.57 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tt0 -86.66 106.24 17.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 110.307 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.495 ' CG2' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -95.95 142.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.626 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.403 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 94.2 m -108.78 120.81 43.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -103.9 91.43 3.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.74 -175.22 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.45 2.1 . . . . 0.0 112.325 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -67.27 158.88 80.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.36 169.14 17.65 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.521 2.147 . . . . 0.0 112.22 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 146.5 -54.73 0.54 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.571 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.3 m -96.59 125.3 40.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.08 70.71 0.8 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.477 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.04 -44.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.551 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -99.06 -44.05 6.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.74 -32.35 4.18 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.501 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.17 155.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.309 . . . . 0.0 110.923 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.28 -30.6 63.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.406 ' CG2' ' NE2' ' A' ' 103' ' ' GLN . 13.4 p -99.34 113.63 64.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.437 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 59.1 Cg_endo -72.83 -167.94 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.625 2.217 . . . . 0.0 112.198 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.63 62.84 7.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.781 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.437 ' CD1' ' HG2' ' A' ' 96' ' ' PRO . 1.6 mp -89.28 -71.73 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.001 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.33 -163.74 1.75 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.854 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -54.55 -55.3 30.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.821 0.343 . . . . 0.0 110.746 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.46 ' HG3' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -142.13 26.22 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -52.36 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.979 0.418 . . . . 0.0 110.441 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.515 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 17.1 mm-40 -139.13 170.66 15.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.155 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.508 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.0 t80 -79.44 96.1 5.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.593 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 54.3 m95 -99.3 139.83 34.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.095 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.416 HG11 ' CD1' ' A' ' 67' ' ' TYR . 10.8 m . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.125 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.736 0.303 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.15 162.21 22.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.912 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.9 mttp -154.43 129.64 9.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.816 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.523 ' CE1' HG22 ' A' ' 81' ' ' VAL . 12.7 p90 -137.71 169.73 17.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.882 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.46 135.82 49.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.002 0.429 . . . . 0.0 111.069 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 81' ' ' VAL . 11.3 t -117.07 107.27 21.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.574 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 6.8 p-10 -108.56 127.15 53.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.805 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.96 155.05 40.27 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.955 0.407 . . . . 0.0 110.481 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.94 119.04 11.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.246 0.546 . . . . 0.0 110.459 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.67 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -101.89 149.79 23.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.092 -178.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 16.7 mmtt -138.55 68.94 1.38 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.182 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.09 27.16 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.425 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.483 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 96.18 116.9 3.25 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.099 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -169.75 -99.09 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 111.533 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.667 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 26.6 mt-10 -69.37 -4.77 19.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.529 ' CD1' ' HE2' ' A' ' 10' ' ' LYS . 4.2 mt -44.16 -37.96 3.43 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.832 0.348 . . . . 0.0 110.33 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 33.37 55.43 0.58 Allowed Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.802 -0.635 . . . . 0.0 114.146 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.429 ' CD1' ' CD2' ' A' ' 20' ' ' LEU . 1.1 pp -138.33 91.94 2.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.822 0.344 . . . . 0.0 110.365 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -63.07 110.37 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.577 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.429 ' CD2' ' CD1' ' A' ' 18' ' ' LEU . 3.3 mt -91.62 161.11 15.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.736 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 7.0 m -142.94 152.2 58.13 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.68 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.69 135.87 70.14 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.661 2.241 . . . . 0.0 112.706 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.3 162.68 36.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.141 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -81.56 -19.76 41.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.272 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.8 pt -115.34 -4.61 11.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.753 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.79 -123.39 1.15 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.166 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 21' ' ' SER . 0.9 OUTLIER -140.68 106.05 5.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.774 0.321 . . . . 0.0 111.265 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.4 m -70.82 128.61 36.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.598 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.6 mt -71.65 104.92 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.712 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.34 66.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.174 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.51 164.34 38.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.87 128.79 11.71 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.262 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.575 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 11.5 pt -104.78 100.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.347 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -72.16 159.98 33.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.086 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.56 64.72 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.125 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -81.54 -41.67 21.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.941 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.667 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -139.29 136.28 17.86 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.197 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.9 -44.46 5.4 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.622 2.214 . . . . 0.0 113.137 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 43' ' ' LYS . 3.9 mm-40 -64.86 -52.88 54.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.66 0.267 . . . . 0.0 110.943 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 5.2 mt -54.54 -48.02 70.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.052 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -63.46 -30.21 71.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.552 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 m -97.01 3.24 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.268 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -131.62 -73.46 0.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.397 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.8 mt -72.34 149.28 44.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.077 0.465 . . . . 0.0 111.363 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.64 160.09 42.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.538 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -59.22 105.0 0.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.97 37.27 0.62 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.596 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.65 139.3 47.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.784 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.5 mt -110.99 117.26 54.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.977 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.446 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 15.2 mt -77.42 100.22 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.995 0.426 . . . . 0.0 110.539 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.1 p -94.63 0.33 55.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.207 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -148.53 142.05 25.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.029 179.258 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.431 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 36.3 t80 -145.68 108.43 4.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.86 0.362 . . . . 0.0 111.061 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 51.88 53.95 11.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.949 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.43 69.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.371 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -123.33 103.25 8.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.802 0.334 . . . . 0.0 110.604 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.28 113.32 1.52 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.332 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.425 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 15.1 mt -88.61 9.93 22.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -68.42 145.91 53.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.879 0.371 . . . . 0.0 111.085 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.96 26.11 47.47 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.633 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.6 mt -116.73 148.12 41.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.686 0.279 . . . . 0.0 110.849 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.64 -167.38 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.551 2.167 . . . . 0.0 112.227 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.9 t80 -97.77 -26.56 14.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.767 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -57.43 -47.93 80.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.968 0.413 . . . . 0.0 110.273 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.6 m -63.8 -47.03 92.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.087 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.402 ' HA ' HD23 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -59.27 -53.8 54.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.699 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 21.8 t80 -56.02 -31.14 62.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.692 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.33 -51.08 18.76 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.431 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.74 -34.76 76.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.851 0.358 . . . . 0.0 110.356 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.446 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 5.8 m-85 -69.06 -34.0 74.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.445 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 7.4 mtpt -81.31 -32.83 32.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.358 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.41 -26.47 57.09 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.51 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.472 ' CB ' ' HD2' ' A' ' 10' ' ' LYS . . . -45.13 139.52 3.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.881 0.372 . . . . 0.0 111.412 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -167.11 99.6 0.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.72 80.12 0.84 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.819 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.19 112.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 110.158 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.67 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -124.42 107.96 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.752 -178.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 t -98.5 114.43 26.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.45 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.82 122.21 42.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.666 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -83.31 102.93 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.609 HG23 HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -95.26 142.45 13.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.739 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.402 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 53.2 m -108.86 126.06 52.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.014 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -108.71 96.37 19.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.236 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 82' ' ' THR . 41.5 Cg_exo -56.03 -175.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.564 2.176 . . . . 0.0 112.202 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -110.76 161.25 25.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.771 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.76 169.23 18.05 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.556 2.17 . . . . 0.0 112.285 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.49 -52.91 0.29 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -91.07 -176.01 4.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.63 -28.79 7.3 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.64 28.24 16.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.591 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -91.02 -40.85 11.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.12 117.29 5.57 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.419 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.33 154.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.963 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.9 mt -121.04 20.8 11.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.25 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.55 128.57 7.63 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.41 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.74 13.4 2.32 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.707 2.272 . . . . 0.0 112.978 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 66.64 79.69 0.23 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.858 0.361 . . . . 0.0 111.146 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -93.23 -64.97 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.117 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.28 -163.24 1.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.237 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.46 ' O ' ' CD ' ' A' ' 101' ' ' ARG . 0.1 OUTLIER -66.88 72.73 0.09 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.288 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.588 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER 62.7 -49.32 0.19 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.588 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 1.5 p30 20.16 86.89 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.901 0.48 . . . . 0.0 112.164 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 101' ' ' ARG . 6.9 mm-40 -145.36 179.1 7.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.086 0.47 . . . . 0.0 111.852 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.525 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.6 t80 -83.18 96.09 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.575 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 27.7 m95 -103.39 126.52 50.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.046 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.457 ' CG1' ' CD1' ' A' ' 67' ' ' TYR . 8.6 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.079 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.822 0.344 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.27 157.13 38.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.699 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 4.5 mttt -151.43 129.68 11.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.973 0.416 . . . . 0.0 110.992 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.52 ' CE1' HG22 ' A' ' 81' ' ' VAL . 26.9 p90 -138.13 170.71 15.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.694 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.56 135.95 48.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.01 0.433 . . . . 0.0 111.349 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 43' ' ' LYS . 13.3 t -116.77 107.04 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.604 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 38.9 t0 -110.29 127.22 54.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.908 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.565 HD11 HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -148.92 157.57 43.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.57 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.02 110.05 5.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.962 0.41 . . . . 0.0 110.889 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.672 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -95.18 150.91 19.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.324 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 20.5 mmtt -138.45 69.28 1.38 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.5 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.4 22.25 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.253 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.29 113.97 1.38 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.411 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -162.28 -94.23 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.963 0.411 . . . . 0.0 111.351 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 15.1 mt-10 -69.15 -5.07 20.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.979 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.454 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 2.7 mt -45.09 -40.7 7.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.138 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.474 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 34.24 53.08 0.73 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 114.485 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.424 ' CD2' HD21 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -136.88 92.88 2.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.035 0.445 . . . . 0.0 110.232 178.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 30' ' ' ALA . 6.0 t -63.92 122.33 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.05 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -100.98 169.33 9.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.438 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.22 167.72 13.82 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.358 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.43 121.63 6.92 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.489 2.126 . . . . 0.0 112.59 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.67 162.52 31.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.03 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.32 -32.84 43.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 pt -99.81 -7.09 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.867 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.27 -123.57 1.12 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.243 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -140.55 106.2 5.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.93 0.395 . . . . 0.0 111.195 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.6 m -66.63 132.08 47.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.548 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 32' ' ' LEU . 43.3 mt -68.58 104.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.903 0.382 . . . . 0.0 110.583 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -68.19 -23.38 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.223 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 5.5 m-20 -171.83 174.38 4.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.995 0.426 . . . . 0.0 111.13 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.405 ' CD1' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -152.05 127.28 9.85 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.535 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.543 HG23 ' CZ2' ' A' ' 105' ' ' TRP . 6.0 pt -101.32 100.59 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.212 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -65.91 173.85 2.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.822 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.44 18.93 72.16 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.608 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -111.25 -46.28 3.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.767 0.318 . . . . 0.0 110.289 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -142.75 139.61 17.36 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.368 179.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.5 -49.36 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 113.085 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 43' ' ' LYS . 30.4 mm-40 -61.12 -51.48 68.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 6.1 mt -54.17 -50.89 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.056 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.41 -30.21 69.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.562 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 m -96.92 2.48 51.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.255 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.56 -73.58 0.58 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.867 0.365 . . . . 0.0 111.759 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.0 mt -72.16 149.52 44.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.006 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -147.4 -175.8 4.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.487 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -87.16 115.04 24.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.09 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.23 31.84 1.78 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.705 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.53 162.63 25.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.649 0.261 . . . . 0.0 110.748 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -133.18 119.21 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.062 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 5.7 mt -74.5 100.49 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 110.51 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -93.94 -4.53 49.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.154 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 80' ' ' GLU . 2.0 mttt -144.56 144.29 31.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CD2' ' CE1' ' A' ' 70' ' ' PHE . 51.3 t80 -149.01 110.89 4.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.917 0.389 . . . . 0.0 111.194 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.83 46.05 23.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.75 21.46 76.51 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.47 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -123.62 107.32 11.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.779 0.323 . . . . 0.0 110.758 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.55 118.57 4.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.318 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.407 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 12.4 mt -92.6 16.93 11.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.32 144.76 42.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.965 0.412 . . . . 0.0 111.195 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.19 20.53 58.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.695 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.0 mt -115.4 137.73 23.26 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.54 0.21 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.45 -160.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.421 2.081 . . . . 0.0 112.1 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -103.32 -24.96 13.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -56.01 -47.81 77.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.562 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.8 m -67.44 -45.63 85.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.817 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 15.8 m -56.56 -48.4 77.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.665 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 22.0 t80 -64.75 -30.89 71.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.747 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.45 -50.9 41.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.125 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.448 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -68.73 -35.33 76.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.938 0.399 . . . . 0.0 110.444 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.496 ' CE1' ' CD2' ' A' ' 53' ' ' PHE . 6.3 m-85 -70.31 -27.38 64.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.299 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.447 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 1.5 mtmp? -84.12 -41.68 16.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.14 -22.46 76.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.845 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' CB ' HG13 ' A' ' 77' ' ' VAL . . . -43.26 127.12 4.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.876 0.37 . . . . 0.0 111.698 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -156.05 104.21 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.87 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.44 85.39 1.76 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.271 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.36 115.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 110.357 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.672 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -129.84 107.81 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.648 -179.023 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -99.92 112.86 25.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.314 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.4 124.48 47.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.434 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tt0 -86.87 104.53 16.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.928 0.394 . . . . 0.0 110.047 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.52 HG22 ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -95.17 143.05 12.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.522 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.404 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 98.0 m -108.42 120.17 41.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.638 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -103.5 92.52 4.12 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.39 -176.17 1.83 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.505 2.137 . . . . 0.0 112.222 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.0 pttt -126.01 153.42 73.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.26 160.46 49.74 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.529 2.153 . . . . 0.0 112.409 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.99 -55.01 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.531 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 t -88.79 -41.98 12.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.345 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.97 162.15 11.04 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.43 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.43 57.54 1.27 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.504 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.1 t -102.43 26.25 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.92 -166.2 19.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.415 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.02 169.82 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 110.83 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.38 -34.55 18.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.949 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.3 p -72.19 138.94 81.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.475 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 69.1 Cg_endo -85.32 28.43 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.701 2.268 . . . . 0.0 113.142 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 57.84 56.22 4.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.899 0.38 . . . . 0.0 111.313 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.475 ' CD1' ' HG2' ' A' ' 96' ' ' PRO . 3.0 mp -93.21 -58.56 2.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.21 -165.0 2.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -52.88 -79.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.275 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.507 ' HG2' HG21 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -162.08 80.22 0.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.1 0.476 . . . . 0.0 111.345 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -100.77 29.4 4.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.146 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.515 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 10.9 mm-40 -68.59 -177.51 0.96 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.449 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.523 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 2.6 t80 -86.82 96.46 10.21 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.056 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.543 ' CZ2' HG23 ' A' ' 33' ' ' ILE . 18.1 m95 -103.34 139.32 38.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.575 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.413 HG12 ' CE1' ' A' ' 67' ' ' TYR . 11.4 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.111 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.4 mt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.695 0.283 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -77.54 157.54 30.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.985 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 10.2 mttt -154.87 129.71 9.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.666 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.546 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 28.0 p90 -138.44 171.85 13.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.194 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.57 135.99 48.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.96 0.409 . . . . 0.0 111.256 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 3.5 t -120.19 107.71 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.827 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 11.9 p30 -108.5 127.18 53.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.718 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -145.56 154.49 42.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.931 0.395 . . . . 0.0 110.553 179.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.2 111.92 4.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.059 0.457 . . . . 0.0 110.691 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.622 ' HB2' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -97.4 148.47 23.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.675 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 21.5 mmtt -138.12 69.29 1.39 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.278 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.71 27.69 9.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.184 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.66 111.52 0.56 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.439 ' CG ' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.64 -96.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 111.263 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' A' ' 36' ' ' GLN . 3.6 mt-10 -67.31 -5.73 15.53 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.032 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.484 ' HG ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -46.1 -43.46 14.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.768 0.318 . . . . 0.0 110.445 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 33.46 61.82 0.43 Allowed Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 114.611 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.484 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -141.96 104.19 4.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.933 0.397 . . . . 0.0 110.375 178.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 t -71.55 119.39 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.148 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' CD2' HD13 ' A' ' 50' ' ' ILE . 76.4 mt -108.86 169.17 8.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.551 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -148.16 167.79 12.53 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.529 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.56 135.89 32.09 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.502 2.135 . . . . 0.0 112.747 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.49 162.53 36.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.07 -21.53 46.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.226 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.5 pt -114.81 5.38 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.713 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.95 -123.74 1.41 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.129 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 21' ' ' SER . 1.9 p -140.47 109.05 5.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.922 0.392 . . . . 0.0 111.155 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -72.04 136.9 46.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.58 104.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.625 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.83 66.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.474 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 3.4 m-20 -161.3 168.37 24.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.28 126.76 10.07 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.244 0.545 . . . . 0.0 111.967 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.71 ' O ' ' HG3' ' A' ' 36' ' ' GLN . 5.3 pt -96.4 100.72 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.224 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -73.67 136.67 43.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.037 0.446 . . . . 0.0 111.368 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.65 32.98 4.59 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.71 ' HG3' ' O ' ' A' ' 33' ' ' ILE . 1.1 pp0? -122.72 -21.9 5.5 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -161.19 143.86 9.34 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.106 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.04 -48.42 2.76 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.483 2.122 . . . . 0.0 112.915 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 43' ' ' LYS . 52.6 mm-40 -67.62 -53.26 29.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 110.838 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.3 mt -54.7 -40.38 51.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.414 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.97 -30.66 65.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.806 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -98.17 3.64 49.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.163 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -128.34 -72.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.959 0.409 . . . . 0.0 111.571 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -59.0 149.42 27.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.669 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -153.94 146.81 24.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.58 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -59.54 112.43 1.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.67 38.16 0.93 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.585 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.49 155.01 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 110.821 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -124.62 119.42 56.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.983 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 6.3 mt -74.57 100.52 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.104 0.478 . . . . 0.0 110.338 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 p -97.36 26.81 4.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.924 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' CB ' ' HB2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -172.71 144.36 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.091 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 69' ' ' LEU . 64.3 t80 -151.54 108.5 3.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 111.066 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 53.22 52.55 13.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.792 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.93 20.91 71.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.428 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -122.56 103.94 9.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.839 0.352 . . . . 0.0 110.766 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.43 115.58 2.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.276 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.402 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 13.7 mt -87.64 7.85 27.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -67.74 146.13 54.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.841 0.353 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.73 23.66 55.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.666 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.9 mt -116.84 149.13 43.49 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.653 0.263 . . . . 0.0 110.896 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.38 -169.22 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.553 2.169 . . . . 0.0 112.299 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 67' ' ' TYR . 11.3 t80 -96.97 -26.43 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.785 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -57.08 -46.33 82.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.414 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 t -68.4 -47.03 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.763 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 88.3 m -56.54 -53.74 54.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 6.2 t80 -60.95 -30.98 70.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.671 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.05 36.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.125 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -69.55 -33.4 72.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.235 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 5.6 m-85 -72.15 -27.26 62.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.299 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -85.22 -37.74 19.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.701 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.52 -19.39 68.72 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.056 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HB1' ' HG3' ' A' ' 10' ' ' LYS . . . -44.18 131.28 6.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.711 0.291 . . . . 0.0 111.676 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -157.2 102.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.2 82.8 1.3 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.307 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.29 115.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.882 0.373 . . . . 0.0 110.509 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -128.78 107.95 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.964 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -98.89 116.02 30.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.195 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.54 128.43 52.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.303 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -88.77 105.46 17.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 0.0 110.252 179.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.501 ' CG2' ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -95.14 142.86 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.249 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.9 m -108.51 119.61 40.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.608 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.99 89.89 1.76 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.044 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.55 -175.71 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.445 2.096 . . . . 0.0 112.075 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -106.19 157.65 34.39 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.025 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.85 -174.02 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.561 2.174 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.32 -36.81 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.534 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.9 t -107.09 -174.14 2.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 0.0 110.902 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.5 76.85 1.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.454 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.12 93.57 1.55 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.485 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.5 p -100.03 26.21 6.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.51 -126.45 0.87 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.496 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.38 -174.58 4.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.322 . . . . 0.0 110.85 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -11.27 60.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.428 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.5 p -98.48 120.56 59.0 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 56.3 Cg_endo -71.63 -168.37 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.439 2.093 . . . . 0.0 112.221 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -80.68 60.29 3.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.1 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.468 ' CD1' ' HG2' ' A' ' 96' ' ' PRO . 3.5 mp -93.11 -71.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.971 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.43 -164.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.568 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -64.25 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 110.581 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.774 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.5 mpt_? -140.38 -79.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.82 28.04 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 110.838 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.515 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 15.2 mm100 -82.64 -177.33 6.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.167 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 1.1 t80 -84.74 96.23 9.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.053 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.774 ' HZ2' ' HB3' ' A' ' 101' ' ' ARG . 18.7 m95 -105.94 135.37 47.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.183 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.43 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 16.0 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.707 0.289 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -79.81 159.46 26.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.88 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 11.0 mttt -146.18 129.43 16.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.682 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.502 ' CE1' HG22 ' A' ' 81' ' ' VAL . 12.6 p90 -137.07 169.25 18.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.055 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.57 135.92 49.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.316 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.552 HG23 HG23 ' A' ' 81' ' ' VAL . 17.0 t -115.56 107.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.471 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 12.4 t0 -112.69 127.28 56.08 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.586 HD13 HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -153.63 157.84 40.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 110.735 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.67 123.62 20.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.118 0.485 . . . . 0.0 111.005 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.597 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -108.02 128.37 54.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.297 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 4.1 mmtp -118.36 68.52 0.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.892 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.76 78.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.262 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.414 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 46.91 99.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.276 -0.42 . . . . 0.0 114.018 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.443 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 6.3 ptpt -157.06 -99.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 16.6 mt-10 -69.15 -5.3 21.57 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.523 ' HG ' ' HE2' ' A' ' 10' ' ' LYS . 3.0 mt -45.48 -30.61 1.46 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.063 0.458 . . . . 0.0 109.803 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.544 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 24.79 62.41 0.05 OUTLIER Glycine 0 CA--C 1.519 0.314 0 N-CA-C 115.453 0.941 . . . . 0.0 115.453 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.452 HD21 ' CD2' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -146.33 91.83 2.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.175 0.512 . . . . 0.0 110.252 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 t -60.17 115.22 3.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.413 ' CD2' HD12 ' A' ' 50' ' ' ILE . 62.7 mt -97.37 163.75 12.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.313 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.43 166.85 19.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.488 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.47 130.05 16.69 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.351 2.034 . . . . 0.0 112.682 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.01 162.4 35.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -26.59 37.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.299 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 pt -106.84 -7.04 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.826 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.64 -125.14 1.24 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.854 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.2 p -140.61 106.07 5.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.906 0.384 . . . . 0.0 111.162 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.8 m -66.03 134.44 52.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.458 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.8 mt -75.88 104.88 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.559 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.43 -26.77 63.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.989 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.449 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.3 OUTLIER -161.01 169.8 21.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.046 0.451 . . . . 0.0 111.221 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.25 124.68 6.98 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.267 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.547 HG23 ' CZ2' ' A' ' 105' ' ' TRP . 5.1 pt -96.43 100.49 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.194 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -68.9 153.59 43.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.981 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.37 -23.02 36.78 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.787 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.575 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.9 mp0 -67.63 -46.74 71.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.77 0.319 . . . . 0.0 110.811 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -138.24 141.82 33.17 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.477 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.19 -49.04 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.522 2.148 . . . . 0.0 112.96 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 26.9 mm-40 -62.3 -50.95 69.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.338 . . . . 0.0 110.962 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.4 mt -54.47 -50.1 60.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.243 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -60.96 -30.48 70.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.565 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -97.98 3.41 49.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.149 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.46 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -128.79 -72.99 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.918 0.389 . . . . 0.0 111.625 -178.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.403 HD22 HG21 ' A' ' 81' ' ' VAL . 87.3 mt -75.8 145.76 40.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.744 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.67 163.53 38.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.473 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -59.41 110.88 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.92 0.39 . . . . 0.0 110.991 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.67 46.89 0.55 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.682 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.03 139.43 28.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 110.711 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.47 117.59 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.23 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.429 HD11 ' CZ ' ' A' ' 70' ' ' PHE . 5.0 mt -76.85 100.69 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 0.0 110.601 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.7 p -98.18 16.0 22.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.164 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 7.2 mttt -162.42 132.68 4.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.003 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 58.3 t80 -136.78 108.76 7.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 111.067 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 55.27 52.93 10.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.851 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.62 17.51 66.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.358 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -121.01 103.4 9.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 110.634 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.49 120.38 7.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.436 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 9.5 mt -92.82 18.11 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.807 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -73.77 142.83 46.22 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.948 0.404 . . . . 0.0 111.312 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.77 18.22 52.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.753 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.9 mt -109.69 137.85 20.49 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.701 0.251 . . . . 0.0 110.826 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.72 -159.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.302 2.001 . . . . 0.0 112.148 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -106.0 -23.7 12.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.016 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -54.98 -48.8 72.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.3 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.47 -44.36 83.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.823 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.412 ' HA ' HD23 ' A' ' 69' ' ' LEU . 1.5 m -55.95 -54.05 49.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.729 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.548 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 5.1 t80 -62.13 -30.97 71.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.926 0.393 . . . . 0.0 110.437 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.63 -51.13 37.72 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.484 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.37 -42.27 83.72 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.361 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.429 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 11.4 m-85 -63.33 -31.13 72.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 25.9 mtmt -83.03 -31.95 27.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.037 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.407 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -88.83 11.04 70.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.734 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 10' ' ' LYS . . . -76.8 136.93 38.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.663 0.268 . . . . 0.0 110.484 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 2.2 p30 -168.13 100.72 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.144 0.497 . . . . 0.0 110.886 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.91 77.68 0.74 Allowed Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.919 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.08 115.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.141 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.597 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -124.22 107.66 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.727 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 t -99.5 115.15 28.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.46 120.89 35.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -81.83 111.24 17.87 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.552 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -102.69 142.28 17.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.95 -178.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.7 m -109.06 118.39 36.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.289 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.96 97.23 20.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.139 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -50.8 162.1 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.55 2.166 . . . . 0.0 112.383 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 154.49 93.7 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.905 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.75 -175.65 0.79 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.564 2.176 . . . . 0.0 112.255 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.44 -69.89 2.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.445 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.46 143.37 34.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.37 . . . . 0.0 110.861 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.91 -67.4 0.55 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.564 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -138.75 100.12 0.28 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.431 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.0 t -74.94 -39.38 61.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 110.961 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.35 -174.68 19.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.9 p -88.18 177.84 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.755 0.312 . . . . 0.0 110.838 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.65 23.96 13.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.7 t -123.99 135.66 26.59 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.906 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 61.9 Cg_endo -88.33 25.66 0.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.831 2.354 . . . . 0.0 113.0 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.64 53.22 13.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.184 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.449 ' CD1' ' HG2' ' A' ' 96' ' ' PRO . 5.6 mp -93.22 -71.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.229 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 mt -138.91 -169.56 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.061 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -71.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.349 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.514 ' HG2' HG21 ' A' ' 33' ' ' ILE . 2.2 mpt_? -164.3 78.19 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.155 0.503 . . . . 0.0 111.326 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -101.22 27.41 6.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.096 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.4 mm-40 -66.22 -177.66 0.55 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.432 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.548 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.5 t80 -85.03 96.18 9.32 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.547 ' CZ2' HG23 ' A' ' 33' ' ' ILE . 20.0 m95 -104.14 132.05 50.8 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.197 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.41 HG13 ' CE1' ' A' ' 67' ' ' TYR . 20.4 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.131 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.844 0.354 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.88 154.07 23.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.636 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -147.75 129.65 15.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.042 0.448 . . . . 0.0 110.929 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.521 ' CE2' HG23 ' A' ' 6' ' ' VAL . 29.6 p90 -138.23 172.09 13.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.666 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.01 136.02 49.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 111.813 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 43' ' ' LYS . 15.9 t -116.3 107.28 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.124 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.574 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.6 p30 -114.44 127.4 55.81 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.779 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.518 HD13 HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -155.28 160.95 41.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.753 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.49 127.63 33.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.609 ' HB2' HG21 ' A' ' 77' ' ' VAL . 4.2 tmtt? -112.5 136.97 51.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.26 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HB2' ' HG2' ' A' ' 14' ' ' LYS . 13.2 mmtt -131.07 68.92 1.48 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.59 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 34.56 82.94 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.387 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.33 57.66 8.99 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.632 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HG2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -98.48 -138.41 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.862 0.363 . . . . 0.0 111.198 -179.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.0 mt-10 -69.19 -4.54 18.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.529 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 0.3 OUTLIER -44.68 -44.2 8.91 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.286 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 23.86 68.05 0.03 OUTLIER Glycine 0 CA--C 1.518 0.25 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.592 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.47 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -133.1 92.91 3.09 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.049 0.452 . . . . 0.0 109.895 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.8 t -56.48 113.73 1.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.179 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.26 166.82 11.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.259 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.2 m -143.32 157.49 59.72 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.92 127.0 16.86 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.427 2.085 . . . . 0.0 112.574 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.7 162.59 34.75 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.823 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -81.35 -26.58 35.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.392 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 25' ' ' ILE . 2.9 pt -106.57 -8.41 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.895 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.74 -125.05 1.18 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.125 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -140.6 105.96 5.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.916 0.389 . . . . 0.0 111.189 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.401 ' OG1' HG12 ' A' ' 49' ' ' ILE . 85.0 m -67.33 126.91 30.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.516 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 mt -69.02 104.91 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.797 0.332 . . . . 0.0 110.685 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.15 -29.0 67.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.419 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 15.3 m-20 -163.88 167.25 20.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.73 132.74 16.19 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.349 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.597 ' CG2' ' HG3' ' A' ' 101' ' ' ARG . 4.3 pt -99.03 100.62 10.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.623 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -70.52 166.19 21.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.931 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.73 -0.39 88.28 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.009 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.523 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.32 -44.19 7.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.77 0.319 . . . . 0.0 110.453 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -139.59 139.6 22.74 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.998 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.53 -48.83 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.544 2.163 . . . . 0.0 112.834 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 43' ' ' LYS . 75.6 mm-40 -59.58 -51.23 70.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.654 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 6.2 mt -57.98 -44.54 87.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.972 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.87 -30.34 71.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.059 0.457 . . . . 0.0 110.218 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 m -99.96 3.41 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.074 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.535 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -126.32 -74.6 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.43 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.9 mt -76.41 151.88 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.582 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.86 -175.88 5.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.391 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -80.98 109.41 15.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.726 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.35 27.29 2.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.689 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.2 139.28 53.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 110.681 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.401 HG12 ' OG1' ' A' ' 28' ' ' THR . 2.0 mt -112.31 117.65 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.16 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.442 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 5.9 mt -75.6 100.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.398 . . . . 0.0 110.683 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.3 p -97.76 6.33 48.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.376 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -152.67 139.38 18.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.931 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.475 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 28.8 t80 -149.08 111.76 4.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.012 0.434 . . . . 0.0 111.217 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 55.62 48.9 17.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.71 23.03 68.69 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.321 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -125.4 98.03 5.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.889 0.376 . . . . 0.0 110.473 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.87 120.27 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.369 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mt -92.37 19.87 6.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.977 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -77.02 143.28 39.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.919 0.39 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.33 24.51 61.43 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.732 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.4 mt -116.21 144.42 32.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.576 0.227 . . . . 0.0 110.906 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.84 -170.62 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.466 2.111 . . . . 0.0 111.902 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -93.43 -26.4 17.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.972 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -43.42 88.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 0.0 110.528 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.22 -47.13 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.998 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.4 m -58.59 -53.81 54.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 110.567 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.541 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 73.2 t80 -61.32 -30.7 70.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.679 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.03 -51.25 41.08 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.475 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.44 -41.11 85.27 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.259 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.442 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 5.7 m-85 -61.64 -35.23 77.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 2.3 mtpt -78.36 -34.06 48.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.065 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.404 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -83.92 8.67 65.57 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.601 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.419 ' CB ' ' HD2' ' A' ' 10' ' ' LYS . . . -74.84 137.76 42.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.768 0.318 . . . . 0.0 110.558 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 72' ' ' GLY . 4.8 p30 -176.41 85.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.078 0.466 . . . . 0.0 110.746 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.2 71.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.183 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.43 96.5 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.011 0.434 . . . . 0.0 110.711 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.609 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -101.12 150.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.373 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.2 t -140.68 117.93 11.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.484 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.0 124.77 38.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -88.25 105.2 17.39 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.494 HG21 ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -95.12 142.76 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.15 -178.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 m -108.57 118.98 38.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.414 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -102.82 94.04 4.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.201 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.45 -175.08 1.64 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.475 2.117 . . . . 0.0 112.107 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -75.77 155.73 84.93 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.98 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.79 168.92 17.27 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.601 2.2 . . . . 0.0 112.322 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.12 -136.2 3.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.507 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.2 m -62.59 97.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 0.0 110.943 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.07 -178.74 21.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.515 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.85 -101.54 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -64.11 -32.83 74.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.834 0.349 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.09 52.89 10.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.511 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 m -59.32 165.74 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mp -98.18 -32.72 11.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.9 t -109.27 130.61 22.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.328 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.499 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 53.1 Cg_endo -68.33 -162.45 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.457 2.105 . . . . 0.0 111.443 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.53 55.09 3.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.015 0.436 . . . . 0.0 110.557 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.499 ' CD1' ' HG2' ' A' ' 96' ' ' PRO . 1.9 mp -81.46 -71.56 0.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.01 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.73 -166.95 1.3 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.691 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -47.38 51.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.903 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.597 ' HG3' ' CG2' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -177.59 27.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.402 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.24 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.517 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 7.2 mm-40 -137.43 171.35 14.59 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.541 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.0 t80 -81.03 96.05 7.01 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.564 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 47.3 m95 -99.21 143.6 29.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.51 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.48 HG12 ' CE1' ' A' ' 67' ' ' TYR . 20.4 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.24 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.766 0.317 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.77 159.04 30.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.864 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -153.68 129.57 10.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.502 ' CE1' HG22 ' A' ' 81' ' ' VAL . 28.9 p90 -138.17 170.7 15.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.748 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.58 135.78 49.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.977 0.417 . . . . 0.0 111.366 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 14.3 t -116.6 106.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.213 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.554 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 9.0 p-10 -113.82 127.07 55.85 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.085 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -154.05 156.26 37.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 110.742 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.18 117.32 8.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.067 0.46 . . . . 0.0 111.151 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.642 ' HB2' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -101.47 142.0 33.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.132 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -126.95 69.49 1.27 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.533 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.73 21.49 5.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.34 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.85 113.01 1.45 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.777 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.07 -93.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.893 0.378 . . . . 0.0 110.925 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 25.0 mt-10 -69.44 -4.96 20.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.674 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.465 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 0.7 OUTLIER -44.97 -31.6 1.34 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.114 0.483 . . . . 0.0 109.94 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.522 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 28.39 61.82 0.12 Allowed Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.514 -0.766 . . . . 0.0 114.618 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.437 HD21 HD23 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -142.48 91.96 2.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.898 0.38 . . . . 0.0 110.273 178.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -67.92 109.33 3.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.424 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.433 ' CD2' HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -84.5 163.18 19.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.773 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.71 160.01 68.14 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.031 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.33 120.66 7.13 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.518 2.145 . . . . 0.0 112.759 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.61 162.7 33.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.002 0.429 . . . . 0.0 111.192 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.8 -39.43 30.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.315 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 pt -90.24 -12.99 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.863 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.95 -125.23 1.13 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.256 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -140.46 106.08 5.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.916 0.389 . . . . 0.0 110.851 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 94.5 m -63.7 134.68 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.766 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.3 mt -74.41 104.54 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.916 0.389 . . . . 0.0 110.141 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.412 ' CB ' HD11 ' A' ' 94' ' ' LEU . . . -75.29 -33.76 61.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.705 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 19' ' ' SER . 4.1 m-20 -162.24 174.01 13.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.278 0.561 . . . . 0.0 111.495 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.468 ' HA ' ' HZ3' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -157.83 136.62 11.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.93 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.589 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 4.2 pt -95.63 99.98 10.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 109.673 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -66.91 147.5 53.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.012 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.24 -17.63 56.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.768 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.441 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 2.2 mp0 -76.31 -48.45 20.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.733 0.302 . . . . 0.0 110.938 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -134.98 139.74 32.98 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.844 0.354 . . . . 0.0 110.692 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.99 -48.62 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.789 2.326 . . . . 0.0 113.112 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 43' ' ' LYS . 16.3 mm-40 -62.54 -48.42 79.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.0 mt -58.11 -42.71 83.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -30.25 70.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.386 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -99.85 3.55 44.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.351 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.496 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -123.36 -70.51 0.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.07 156.99 38.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.398 0.618 . . . . 0.0 112.409 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -153.94 -175.85 5.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.978 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.2 mtp-105 -91.87 99.79 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.47 39.28 0.21 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.586 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 28' ' ' THR . 0.5 OUTLIER -131.61 174.62 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.6 mt -145.82 118.53 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 7.1 mt -73.93 100.23 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.142 0.496 . . . . 0.0 110.402 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 p -98.73 2.43 47.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.054 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.7 mttt -150.27 139.55 21.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.816 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 41.8 t80 -147.18 113.09 5.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.932 0.396 . . . . 0.0 111.264 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 55.54 48.07 19.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.18 21.7 72.13 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.413 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -127.33 104.95 8.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.371 . . . . 0.0 110.669 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.26 125.42 20.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.251 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.52 27.45 3.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.802 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -82.83 142.42 31.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.04 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.7 21.81 65.5 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.661 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.8 mt -117.29 136.26 23.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.501 0.191 . . . . 0.0 110.811 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.4 -161.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.419 2.079 . . . . 0.0 112.065 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -98.83 -26.66 14.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.026 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -57.41 -46.02 83.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.7 t -64.1 -51.93 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.973 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 90.5 m -56.91 -50.2 73.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 29.3 t80 -59.43 -31.12 69.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.991 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.76 -50.85 26.35 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.462 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.76 -32.48 72.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 110.523 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.438 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 4.7 m-85 -73.82 -28.55 61.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.269 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.432 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 21.6 mtmt -83.44 -36.68 24.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.802 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.81 -18.0 68.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.102 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' ' HG3' ' A' ' 10' ' ' LYS . . . -46.44 130.81 11.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.894 0.378 . . . . 0.0 111.588 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -160.9 102.74 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.736 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.99 85.44 1.64 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.165 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.08 109.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.552 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.642 HG22 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -122.91 107.82 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.515 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.6 t -100.72 112.0 24.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.295 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.54 123.44 43.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.444 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -86.8 104.51 16.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.502 HG22 ' CE1' ' A' ' 4' ' ' PHE . 0.7 OUTLIER -95.09 142.54 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.588 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.6 m -108.94 123.45 49.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.369 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -104.24 92.93 5.08 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.159 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.17 -174.66 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.622 2.214 . . . . 0.0 112.235 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 157.2 34.17 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.798 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.49 162.74 32.63 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.578 2.186 . . . . 0.0 112.411 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.94 -87.06 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.8 t -169.23 152.05 4.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.59 179.18 16.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.409 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.7 130.23 1.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m -96.89 -30.96 12.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.851 0.358 . . . . 0.0 110.996 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -151.94 -94.75 0.11 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.444 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -161.77 142.79 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.852 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -132.26 73.23 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.446 0.641 . . . . 0.0 110.528 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.43 ' CG2' ' CD2' ' A' ' 98' ' ' LEU . 14.6 p -44.96 137.7 4.43 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.651 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.407 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 88.6 Cg_endo -78.74 20.13 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.664 2.243 . . . . 0.0 113.314 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.81 76.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.802 0.334 . . . . 0.0 111.688 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.43 ' CD2' ' CG2' ' A' ' 95' ' ' VAL . 1.4 mm? -93.27 -33.64 13.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.105 0.479 . . . . 0.0 110.133 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.33 -156.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.059 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.17 -75.64 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.419 0.152 . . . . 0.0 111.254 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.557 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -176.97 -50.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.855 -0.157 . . . . 0.0 111.185 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.557 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 5.9 p30 30.19 81.9 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.689 0.395 . . . . 0.0 111.809 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.501 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 5.6 mm-40 -145.9 178.27 8.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.074 0.464 . . . . 0.0 111.98 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.519 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.1 t80 -83.3 96.44 8.49 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.589 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 38.4 m95 -102.96 138.75 39.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.696 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.427 HG12 ' CD1' ' A' ' 67' ' ' TYR . 15.7 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.08 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.753 0.311 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -78.31 157.62 29.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 5.9 mttp -149.57 129.61 13.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.509 ' CE2' HG21 ' A' ' 6' ' ' VAL . 24.6 p90 -137.74 169.6 17.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.616 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.56 135.78 49.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.081 0.467 . . . . 0.0 111.142 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 43' ' ' LYS . 12.4 t -115.8 107.16 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.506 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.0 p30 -110.06 127.19 54.7 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.796 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.566 HD13 HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -148.68 155.37 40.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 110.61 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.51 113.86 6.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.94 0.4 . . . . 0.0 110.823 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.632 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -98.87 140.52 32.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.545 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 6.1 mmtp -127.55 69.34 1.31 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.304 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.18 23.43 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.275 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.27 113.62 1.17 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.612 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -161.78 -94.15 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.639 ' O ' ' HB3' ' A' ' 36' ' ' GLN . 24.0 mt-10 -69.24 -5.66 24.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.732 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' HG ' ' CD2' ' A' ' 18' ' ' LEU . 1.7 tp -45.53 -31.44 1.81 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.008 0.432 . . . . 0.0 109.843 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.547 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 23.24 59.59 0.04 OUTLIER Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.154 -0.93 . . . . 0.0 114.953 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 2.8 pp -138.79 99.34 3.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.073 0.464 . . . . 0.0 110.303 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -68.98 115.86 8.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.598 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' CD2' HD12 ' A' ' 50' ' ' ILE . 62.2 mt -98.81 161.79 13.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.023 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.79 166.32 28.19 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.425 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.01 98.56 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.711 2.274 . . . . 0.0 113.439 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -107.72 162.83 13.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.916 0.389 . . . . 0.0 111.358 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.76 -42.31 61.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.391 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 pt -92.68 -7.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.874 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.31 -130.22 1.93 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.858 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 p -140.64 106.39 5.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.904 0.383 . . . . 0.0 111.357 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.452 ' OG1' HG12 ' A' ' 49' ' ' ILE . 69.0 m -69.52 133.21 47.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.628 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.8 mt -69.08 104.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.282 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.67 -24.41 61.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.963 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.411 ' HB2' ' NE2' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -162.48 163.73 27.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.749 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.31 124.82 10.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.313 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.568 HG21 ' CZ2' ' A' ' 105' ' ' TRP . 6.0 pt -96.45 100.53 10.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.256 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.28 154.25 42.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.025 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.5 -21.68 43.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.754 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.639 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 6.0 mp0 -68.93 -48.55 63.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.678 0.275 . . . . 0.0 110.829 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -138.08 139.29 25.4 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.55 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.54 -43.72 3.81 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.628 2.218 . . . . 0.0 112.871 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' LYS . 19.0 mp0 -65.3 -51.72 58.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.966 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.8 mt -55.62 -49.36 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.964 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -61.34 -30.22 70.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.2 m -96.76 1.84 51.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.072 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -127.89 -74.16 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 0.0 111.504 -179.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.4 mt -73.53 148.31 43.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.418 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -153.17 158.61 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.635 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -58.89 98.27 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.982 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.91 44.81 0.13 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.604 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.4 146.57 30.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.935 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.452 HG12 ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -116.21 117.78 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.472 HD12 ' CD2' ' A' ' 20' ' ' LEU . 6.2 mt -74.7 100.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.005 0.431 . . . . 0.0 110.136 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 p -97.7 8.17 45.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.051 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 3.9 mttt -154.11 141.17 19.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.817 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.459 ' CD1' ' CD1' ' A' ' 69' ' ' LEU . 57.2 t80 -146.51 109.05 4.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.91 0.386 . . . . 0.0 111.229 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.21 49.65 16.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.56 18.79 74.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -124.34 105.9 9.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.661 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.52 124.99 20.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.293 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 mt -95.97 24.5 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -85.63 125.06 32.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.282 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.75 -20.6 40.99 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.853 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.07 149.46 69.91 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.684 0.278 . . . . 0.0 111.084 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.84 -167.51 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.625 2.216 . . . . 0.0 112.213 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -96.12 -24.45 16.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.82 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -58.99 -46.49 88.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.984 0.421 . . . . 0.0 110.013 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.95 -43.4 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.735 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 83.5 m -59.13 -53.64 56.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.568 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.541 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 8.6 t80 -59.64 -31.01 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.636 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.93 -51.1 35.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.339 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -69.78 -34.06 73.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.385 . . . . 0.0 110.184 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.452 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 4.0 m-85 -70.55 -27.68 64.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.031 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -85.18 -39.9 17.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.43 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.37 -21.77 74.63 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.914 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.488 ' CB ' HG11 ' A' ' 77' ' ' VAL . . . -42.95 129.44 4.38 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.74 0.305 . . . . 0.0 111.546 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -157.65 102.84 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.017 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.04 83.42 1.37 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.225 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.16 113.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.426 . . . . 0.0 110.395 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.632 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -125.25 107.78 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.724 -179.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.9 t -98.91 114.76 27.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.228 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.19 122.4 40.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.473 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 1.9 tt0 -85.27 104.53 15.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -95.24 142.55 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.774 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.401 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 92.1 m -108.82 119.54 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.674 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -103.87 93.3 5.14 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.09 -174.05 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.493 2.129 . . . . 0.0 112.281 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.83 157.45 38.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.84 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.02 177.1 5.39 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.563 2.176 . . . . 0.0 112.313 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.36 37.29 1.8 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.556 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -165.07 168.37 17.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.22 -137.41 29.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.527 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.99 -120.37 3.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.417 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.97 -35.48 15.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.847 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.88 178.21 15.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.443 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.2 155.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.899 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.23 -28.21 8.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.2 p -119.8 129.23 25.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.61 15.27 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.569 2.179 . . . . 0.0 113.136 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 65.44 78.44 0.27 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.794 0.33 . . . . 0.0 111.369 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -93.24 -65.25 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.797 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.57 -158.49 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.701 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -46.29 -53.51 10.62 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.81 0.338 . . . . 0.0 111.152 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.577 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -164.53 -51.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.577 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 0.3 OUTLIER 36.05 77.25 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.888 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.491 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 3.8 mm100 -143.13 179.0 7.32 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.541 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.2 t80 -84.48 96.34 9.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.209 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.568 ' CZ2' HG21 ' A' ' 33' ' ' ILE . 23.5 m95 -104.62 131.14 52.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.215 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.409 HG11 ' CD1' ' A' ' 67' ' ' TYR . 16.1 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.12 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.816 0.341 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.58 157.94 19.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.99 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HG2' HG21 ' A' ' 82' ' ' THR . 16.1 mttt -153.49 129.54 10.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.816 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.513 ' CE1' HG23 ' A' ' 81' ' ' VAL . 26.1 p90 -136.78 171.23 14.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.451 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.76 135.5 49.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.081 0.467 . . . . 0.0 111.144 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 43' ' ' LYS . 12.9 t -114.32 107.27 22.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.928 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.68 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.3 p30 -115.83 127.48 55.08 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.795 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.511 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -153.62 160.91 42.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.637 179.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 128.05 34.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.109 0.48 . . . . 0.0 110.784 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.554 ' HB2' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -114.92 127.89 55.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.319 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.423 ' HB2' ' HD2' ' A' ' 14' ' ' LYS . 6.5 mmtt -121.69 69.13 0.92 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.038 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 43.75 89.91 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.413 ' N ' ' NZ ' ' A' ' 10' ' ' LYS . . . 39.05 96.46 0.01 OUTLIER Glycine 0 C--N 1.337 0.597 0 CA-C-N 116.082 -0.508 . . . . 0.0 114.202 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.5 -106.27 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -69.15 -5.67 23.85 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.435 ' HG ' ' CE ' ' A' ' 10' ' ' LYS . 4.5 mt -45.83 -33.44 3.14 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.551 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 24.83 62.97 0.05 OUTLIER Glycine 0 C--N 1.333 0.407 0 CA-C-N 114.979 -1.01 . . . . 0.0 115.159 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.427 ' CD1' ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -141.13 91.71 2.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.934 0.397 . . . . 0.0 110.173 178.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 31' ' ' ASP . 2.1 t -60.38 113.16 2.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.778 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.436 HD22 ' CD1' ' A' ' 50' ' ' ILE . 16.8 mt -94.28 160.84 14.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.514 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.48 167.58 21.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.268 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.03 120.52 5.04 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.437 2.091 . . . . 0.0 112.799 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.08 162.62 30.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.209 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -77.55 -33.09 54.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.1 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 pt -100.25 -4.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.913 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.17 -126.48 1.47 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.067 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.2 p -140.51 106.16 5.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.946 0.403 . . . . 0.0 111.162 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.7 m -68.74 131.26 44.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.719 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.9 mt -72.03 105.06 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.607 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.27 -24.16 59.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.303 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -157.33 165.67 35.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.014 0.435 . . . . 0.0 111.283 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.66 125.83 7.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.294 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.565 HG21 ' CZ2' ' A' ' 105' ' ' TRP . 5.4 pt -97.15 100.55 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.652 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -68.31 154.36 41.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.978 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.36 -20.92 47.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.806 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.565 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.1 mp0 -71.73 -49.75 36.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.688 0.28 . . . . 0.0 110.887 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -136.95 139.7 29.46 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.867 0.365 . . . . 0.0 110.731 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.97 -48.15 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.653 2.236 . . . . 0.0 112.726 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -60.01 -50.4 73.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.701 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 37' ' ' TYR . 6.3 mt -56.85 -47.26 83.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.17 -30.41 71.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.548 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -97.03 1.83 50.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.07 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.545 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.32 -73.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.916 0.388 . . . . 0.0 111.458 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.6 mt -75.22 153.28 38.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.522 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.14 -175.83 5.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.572 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -86.82 87.46 7.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.87 0.367 . . . . 0.0 111.014 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.9 43.11 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.697 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.56 156.82 45.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 110.666 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -124.53 117.74 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.359 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.459 HD11 ' CZ ' ' A' ' 70' ' ' PHE . 6.2 mt -74.59 100.46 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.031 0.443 . . . . 0.0 110.474 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.0 p -93.46 -4.44 51.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.359 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.42 144.93 31.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.097 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.453 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 41.9 t80 -151.31 108.8 3.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 53.3 52.91 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.31 24.09 67.08 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.332 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -123.91 98.18 5.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.661 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.67 114.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.377 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.5 11.95 15.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.999 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.73 142.98 42.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.862 0.363 . . . . 0.0 111.113 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.1 24.23 64.87 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.775 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.07 141.26 31.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.526 0.203 . . . . 0.0 110.766 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.58 -160.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.518 2.145 . . . . 0.0 112.24 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -104.7 -24.54 12.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -55.87 -49.11 74.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 0.0 110.387 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.2 m -67.13 -45.85 85.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.778 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 91.0 m -55.57 -52.86 62.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.022 0.439 . . . . 0.0 110.81 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 26.7 t80 -62.17 -30.88 71.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.739 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.32 -51.37 45.42 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.453 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -65.96 -44.06 86.09 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.668 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.459 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 12.5 m-85 -61.44 -32.41 72.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.133 0.492 . . . . 0.0 109.905 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 6.4 mtpt -80.39 -34.28 36.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.958 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -87.88 10.85 68.7 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.435 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 10' ' ' LYS . . . -73.26 135.22 44.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.58 0.229 . . . . 0.0 110.544 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 72' ' ' GLY . 4.1 p30 -172.97 92.93 0.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 111.013 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.58 76.24 0.19 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.259 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.02 98.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.023 0.44 . . . . 0.0 110.698 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.68 ' O ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -101.95 152.85 5.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.468 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 t -140.48 119.63 12.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.516 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.12 122.82 30.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.5 106.99 17.89 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.513 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -97.0 143.02 13.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.719 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.424 HG21 ' HG2' ' A' ' 3' ' ' LYS . 45.3 m -108.48 119.39 39.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.527 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -103.91 89.33 2.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.112 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.61 -175.2 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.581 2.187 . . . . 0.0 112.319 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 162.47 50.11 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.18 165.75 29.22 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.564 2.176 . . . . 0.0 112.211 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.3 83.69 0.9 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.443 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.54 -51.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.357 . . . . 0.0 110.806 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.28 -58.16 15.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.443 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.27 -107.07 0.23 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.593 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.2 m -101.3 -31.06 11.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.984 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.7 -59.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.35 177.89 8.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -26.13 68.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.033 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.31 136.02 18.87 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.363 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.424 ' HG2' ' CG ' ' A' ' 98' ' ' LEU . 57.9 Cg_endo -74.61 -164.78 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.402 2.068 . . . . 0.0 112.293 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.05 70.01 2.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.903 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.424 ' CG ' ' HG2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -89.86 -67.37 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.992 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.11 -170.97 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.75 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -71.47 0.07 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.577 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -149.83 -51.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.097 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.577 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 0.4 OUTLIER 33.35 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.483 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.479 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.0 mm-40 -143.88 178.04 8.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.167 0.508 . . . . 0.0 112.204 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.52 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 2.1 t80 -84.54 96.4 9.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.565 ' CZ2' HG21 ' A' ' 33' ' ' ILE . 28.7 m95 -102.88 137.28 41.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.512 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 67' ' ' TYR . 6.4 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.095 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.738 0.304 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 157.9 31.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.8 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -151.93 129.58 11.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.513 ' CE1' HG23 ' A' ' 81' ' ' VAL . 27.6 p90 -138.54 171.82 13.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.813 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.68 135.94 49.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.955 0.407 . . . . 0.0 111.582 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' A' ' 43' ' ' LYS . 12.6 t -117.43 107.15 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.381 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.2 p30 -113.47 127.13 55.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.922 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -152.36 156.39 39.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.393 . . . . 0.0 110.735 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.35 119.66 12.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.506 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -100.96 137.5 39.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.388 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -126.62 69.1 1.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.703 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 33.75 91.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.174 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.6 96.26 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.324 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 33.5 ttmt -156.75 -114.1 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.755 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 9.3 mt-10 -70.88 -5.56 31.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.458 ' HG ' ' HE3' ' A' ' 10' ' ' LYS . 1.6 mt -45.43 -34.2 3.0 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.591 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 19.47 64.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 114.8 -1.091 . . . . 0.0 115.454 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.436 HD21 HD13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -143.46 91.73 2.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.145 0.498 . . . . 0.0 110.107 178.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -59.29 114.58 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.942 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -91.79 163.04 14.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.39 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.14 162.47 53.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.352 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.14 120.54 7.25 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.512 2.142 . . . . 0.0 112.723 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.25 162.46 31.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.721 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -82.65 -29.27 30.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.097 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.2 pt -103.49 -6.37 9.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.918 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.66 -125.57 1.29 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.249 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -140.59 106.1 5.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.954 0.407 . . . . 0.0 111.07 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.6 m -68.14 127.71 33.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.389 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.0 mt -70.69 104.92 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.851 0.358 . . . . 0.0 110.622 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.27 -25.64 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.047 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.18 166.97 31.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.043 0.449 . . . . 0.0 111.238 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.46 126.88 7.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.006 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.591 ' CG1' ' HA3' ' A' ' 17' ' ' GLY . 4.1 pt -96.46 100.58 11.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.64 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -72.7 139.67 47.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.842 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.69 -27.91 8.07 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.601 ' OE1' ' HA ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -67.21 -60.81 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.759 0.314 . . . . 0.0 110.712 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -123.77 136.75 27.72 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.129 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.98 -49.12 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.62 2.213 . . . . 0.0 112.903 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -56.82 -49.2 76.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.884 0.373 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.5 HG13 ' HB3' ' A' ' 37' ' ' TYR . 5.3 mt -57.49 -47.01 85.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.77 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.21 -30.39 71.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.606 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -97.2 1.6 49.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.226 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.548 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.56 -73.67 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 111.388 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.92 145.3 42.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.546 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.36 164.94 36.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.572 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -59.9 108.18 0.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.953 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.24 40.78 0.61 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.603 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -138.17 134.02 34.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.834 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.9 mt -106.36 117.39 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.908 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.428 ' CG1' HG12 ' A' ' 81' ' ' VAL . 5.8 mt -75.68 100.47 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 p -102.16 24.52 10.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 7.1 mttt -169.13 133.76 1.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.178 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.489 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 56.9 t80 -141.25 109.22 5.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.238 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 54.98 53.56 10.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.65 16.96 66.38 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -122.52 101.06 7.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.822 0.344 . . . . 0.0 110.608 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.98 123.41 14.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.344 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.439 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 3.8 mt -94.96 23.04 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.789 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.82 122.05 33.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.333 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.78 15.08 38.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.048 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.41 159.46 65.44 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.9 0.35 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.92 -171.77 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.765 2.31 . . . . 0.0 112.44 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -92.91 -33.46 14.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.486 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -48.63 -46.24 39.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.994 0.426 . . . . 0.0 110.649 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.9 m -65.46 -39.0 83.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.783 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 42.2 m -63.86 -53.74 45.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.737 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 26.8 t80 -57.6 -30.78 65.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.01 -51.1 42.8 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.489 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.4 -40.84 81.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.522 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.412 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 16.5 m-85 -64.24 -30.95 71.98 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.437 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -79.64 -33.52 41.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.026 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -90.55 15.53 60.02 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.668 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.92 133.7 38.03 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 72' ' ' GLY . 2.7 p30 -167.8 89.24 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 111.202 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.92 86.14 0.77 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.58 109.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.075 0.464 . . . . 0.0 110.783 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.57 HG23 HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -122.61 107.77 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.639 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.6 t -99.96 113.99 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.983 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.03 124.53 44.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.638 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -86.93 104.93 16.72 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.513 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -95.13 142.53 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.772 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.9 m -108.86 121.45 45.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.529 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -104.19 92.85 4.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.099 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.48 -175.17 1.69 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.528 2.152 . . . . 0.0 112.227 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 158.7 62.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.04 173.81 6.67 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.602 2.201 . . . . 0.0 112.248 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.89 -91.96 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.581 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 t -77.1 -41.48 41.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.75 155.46 10.48 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.87 -178.69 26.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.485 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.95 -33.02 34.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.773 0.32 . . . . 0.0 110.94 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.21 -105.66 1.11 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.477 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.4 m -103.47 179.61 4.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 0.0 110.805 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.42 -31.56 7.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.025 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.71 114.45 7.24 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.65 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 73.6 Cg_endo -75.85 -166.6 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.598 2.198 . . . . 0.0 112.036 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -88.68 64.66 7.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.437 . . . . 0.0 110.644 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.48 ' CD1' ' HG2' ' A' ' 96' ' ' PRO . 1.5 mp -88.07 -71.69 0.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.442 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.54 -163.85 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.159 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.63 -78.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.008 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.578 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -147.42 -51.84 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.318 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.578 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 6.5 m-80 32.92 79.76 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.637 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.3 mm-40 -143.37 177.99 8.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.303 0.573 . . . . 0.0 112.37 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 4.8 t80 -84.88 96.42 9.32 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.211 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.565 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 18.7 m95 -104.59 136.5 44.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.114 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 67' ' ' TYR . 30.1 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.069 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.801 0.334 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -78.85 158.76 28.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.707 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -150.97 129.54 12.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.506 ' CE1' ' CG2' ' A' ' 81' ' ' VAL . 9.3 p90 -136.93 170.87 15.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.743 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.57 135.92 49.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.103 0.478 . . . . 0.0 111.253 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.684 HG21 HG22 ' A' ' 81' ' ' VAL . 14.8 t -116.42 107.01 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.432 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.1 p30 -110.4 127.05 54.9 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.792 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.603 HD11 HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -149.05 153.56 38.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 0.0 110.591 178.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.27 117.43 8.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.066 0.46 . . . . 0.0 110.827 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.634 ' HB2' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -101.93 128.6 48.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.598 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 7.7 mmtt -119.24 68.56 0.81 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.118 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.02 78.9 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.196 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.99 99.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.463 -0.398 . . . . 0.0 113.822 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.446 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 5.6 ptpt -155.79 -103.92 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 36' ' ' GLN . 7.1 mt-10 -69.13 -5.57 23.17 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.548 ' HG ' ' HE2' ' A' ' 10' ' ' LYS . 3.8 mt -45.54 -33.7 2.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.601 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.582 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 26.38 61.98 0.08 OUTLIER Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.024 -0.989 . . . . 0.0 115.201 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -142.82 91.87 2.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.046 0.451 . . . . 0.0 110.003 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 t -62.29 117.75 6.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.773 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.453 HD22 ' CD1' ' A' ' 50' ' ' ILE . 16.2 mt -97.7 167.65 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.462 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 66.1 m -141.62 156.56 66.34 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.441 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.21 118.63 5.72 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.476 2.117 . . . . 0.0 112.429 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.85 162.75 26.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -24.69 41.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.448 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 pt -108.71 -9.68 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.941 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 171.41 -122.18 0.94 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.143 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 21' ' ' SER . 8.7 m -140.55 106.46 5.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.812 0.339 . . . . 0.0 111.4 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.2 m -68.89 125.96 28.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.9 mt -67.81 104.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.628 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.49 -29.0 65.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.967 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 6.8 m-20 -161.89 170.69 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.061 0.458 . . . . 0.0 111.023 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.28 127.37 9.05 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.429 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.582 ' CG1' ' HA3' ' A' ' 17' ' ' GLY . 5.3 pt -96.74 100.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.165 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.05 153.2 43.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.047 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.11 -22.34 41.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.751 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 1.5 mp0 -69.94 -45.28 67.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.825 0.345 . . . . 0.0 110.862 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -141.12 139.73 19.79 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.646 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.46 -49.3 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.629 2.22 . . . . 0.0 112.977 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.2 -50.74 72.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 5.4 mt -55.87 -52.15 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.01 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -59.15 -30.23 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.583 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.2 m -96.46 0.68 50.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.24 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.98 -73.79 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 111.538 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.2 mt -72.87 145.31 46.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.564 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -149.59 159.78 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.621 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -60.94 109.32 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.072 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.46 -17.39 4.76 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.985 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.61 148.62 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.991 0.424 . . . . 0.0 111.13 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.57 117.78 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.599 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.453 ' CD1' HD22 ' A' ' 20' ' ' LEU . 5.1 mt -74.53 100.38 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 111.162 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 p -102.39 20.84 16.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.1 mttt -167.33 126.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.998 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CD1' ' CD1' ' A' ' 69' ' ' LEU . 44.0 t80 -132.23 109.58 10.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.19 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 50.52 62.96 2.42 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.021 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.74 20.59 48.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.464 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -125.31 98.04 5.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.699 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.71 121.49 8.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.387 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 9.1 mt -93.11 19.48 7.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.813 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.85 143.72 39.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.934 0.397 . . . . 0.0 111.176 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.89 26.61 48.32 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.704 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.8 mt -118.77 143.58 33.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.635 0.255 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.26 -164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.548 2.165 . . . . 0.0 112.035 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -110.58 -22.79 11.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.176 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -58.36 -50.99 71.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 110.687 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -65.52 -41.44 90.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.94 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.426 ' HA ' HD23 ' A' ' 69' ' ' LEU . 81.4 m -60.47 -52.3 65.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 25.9 t80 -60.34 -30.68 69.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.292 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.46 -51.03 39.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.247 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.457 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.69 -40.72 84.34 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.148 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.41 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 5.4 m-85 -61.16 -33.25 73.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 26.0 mtmt -83.41 -30.9 26.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.184 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.401 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -90.48 12.35 68.6 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.612 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.499 ' O ' ' HD3' ' A' ' 10' ' ' LYS . . . -75.59 138.78 41.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.637 0.256 . . . . 0.0 110.379 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 2.6 p30 -169.77 99.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.179 0.514 . . . . 0.0 111.101 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.44 76.35 0.53 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.044 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.82 108.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.938 0.399 . . . . 0.0 110.17 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.634 HG22 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -117.13 107.74 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.753 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.0 t -100.01 114.77 28.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.316 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.8 122.16 40.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.679 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 2.7 tt0 -84.17 102.38 12.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.684 HG22 HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -95.07 142.95 12.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.731 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 54.4 m -108.36 121.97 46.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.4 97.45 22.79 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 82' ' ' THR . 36.6 Cg_exo -57.24 167.06 3.72 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.533 2.156 . . . . 0.0 112.197 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -115.48 156.48 45.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.972 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.28 172.13 9.34 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.702 2.268 . . . . 0.0 112.181 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.12 80.09 0.31 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.533 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.5 m 61.45 98.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.869 0.366 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.47 75.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.501 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.57 96.42 1.06 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.514 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.23 26.29 9.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.731 0.301 . . . . 0.0 110.969 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.17 -120.06 8.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.531 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -151.54 169.91 20.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 mp -86.51 -64.86 1.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 p -113.43 122.89 34.34 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.429 ' HG2' ' CG ' ' A' ' 98' ' ' LEU . 45.2 Cg_endo -70.58 -167.02 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.337 2.025 . . . . 0.0 112.366 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.63 67.31 4.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.023 0.44 . . . . 0.0 110.961 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.429 ' CG ' ' HG2' ' A' ' 96' ' ' PRO . 0.3 OUTLIER -88.17 -65.91 0.97 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.819 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.79 179.05 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.653 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.76 -71.57 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.115 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.763 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.6 mpt_? -139.48 -80.53 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.021 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.2 t30 48.85 28.0 1.78 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.135 0.493 . . . . 0.0 110.939 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.52 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 8.5 mm100 -81.86 -177.52 6.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.259 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.8 t80 -85.99 96.3 9.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.094 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.763 ' HZ2' ' HB3' ' A' ' 101' ' ' ARG . 13.3 m95 -105.36 136.17 45.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.237 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.435 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.3 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.122 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.8 0.333 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.79 158.8 22.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -152.73 129.65 11.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 110.867 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.518 ' CE1' HG23 ' A' ' 81' ' ' VAL . 28.0 p90 -137.91 171.18 14.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.784 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.61 135.91 49.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.957 0.408 . . . . 0.0 111.414 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.54 HG23 ' HB3' ' A' ' 43' ' ' LYS . 12.0 t -117.63 107.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.452 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 8.6 p-10 -111.02 127.26 55.48 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.972 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.04 153.68 39.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 110.758 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.19 114.87 6.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.058 0.456 . . . . 0.0 110.51 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.596 ' HB2' HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -98.03 145.34 26.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.882 -179.288 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 48.5 mmtt -132.66 69.23 1.48 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.183 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.25 21.89 4.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.493 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.65 115.05 1.52 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.69 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 7.9 ptpt -163.79 -94.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.3 mm-40 -69.21 -4.91 19.57 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.906 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.506 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 0.3 OUTLIER -44.95 -38.59 4.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.228 0.537 . . . . 0.0 109.643 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.561 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 33.64 59.06 0.56 Allowed Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.171 -0.922 . . . . 0.0 115.362 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.497 ' CD1' HD13 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -143.06 91.49 2.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.124 0.462 . . . . 0.0 110.059 177.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 30' ' ' ALA . 1.6 t -63.32 120.85 12.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.638 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.497 HD13 ' CD1' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -96.13 167.82 10.98 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.579 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -142.57 163.13 40.75 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.269 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 21' ' ' SER . 57.6 Cg_endo -71.71 126.11 11.74 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.269 1.979 . . . . 0.0 112.734 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.48 162.74 34.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.076 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.33 -32.71 37.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.4 pt -99.64 -6.94 9.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.87 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.21 -127.49 1.58 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.865 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 75.0 m -140.72 106.41 5.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.855 0.359 . . . . 0.0 111.644 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.7 m -63.64 133.42 53.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.289 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.8 mt -71.65 104.77 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.879 0.371 . . . . 0.0 110.422 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -68.51 -32.93 73.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.164 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.447 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -156.91 174.71 15.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.05 0.452 . . . . 0.0 111.457 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.74 128.98 7.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.508 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.588 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 6.2 pt -101.12 100.46 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.088 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -70.58 153.76 42.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.012 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.81 -21.92 43.36 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.682 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.575 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 6.4 mp0 -69.87 -52.57 23.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.672 0.272 . . . . 0.0 110.8 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -133.27 139.33 33.8 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.669 179.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.58 -48.23 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.662 2.241 . . . . 0.0 113.109 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -61.12 -49.32 77.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.761 0.315 . . . . 0.0 110.964 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.506 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.3 mt -57.91 -49.93 79.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -60.34 -30.33 69.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.976 0.417 . . . . 0.0 110.452 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -95.3 -1.43 51.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.129 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.54 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -123.93 -73.19 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.462 -178.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.8 mt -73.25 147.8 44.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.631 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.03 157.78 43.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.65 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.7 mtp-105 -59.73 96.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.073 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.81 43.38 0.17 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.722 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.18 140.13 35.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.72 0.295 . . . . 0.0 110.686 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.0 mt -107.52 117.54 53.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.091 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.431 ' CG1' HG12 ' A' ' 81' ' ' VAL . 8.8 mt -75.14 100.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.956 0.408 . . . . 0.0 110.461 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 p -101.79 23.43 11.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 4.5 mttt -170.21 137.01 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.982 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.455 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 35.9 t80 -144.82 115.6 7.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 0.0 111.272 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 53.35 54.42 10.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.75 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.7 22.5 64.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.353 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -128.44 103.16 6.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.935 0.397 . . . . 0.0 110.7 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.42 123.52 13.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.399 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 9.3 mt -93.7 22.11 5.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.584 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -77.81 119.58 21.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.888 0.375 . . . . 0.0 111.225 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -16.83 57.21 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.708 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 72.1 mt -76.23 135.6 69.55 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.589 0.194 . . . . 0.0 111.041 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -57.69 -160.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.412 2.074 . . . . 0.0 112.213 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 37.4 t80 -101.24 -25.6 13.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.89 -47.69 84.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.792 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.9 m -67.58 -46.81 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.414 ' HA ' HD21 ' A' ' 69' ' ' LEU . 19.0 m -59.62 -50.08 75.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 110.767 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.517 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 50.0 t80 -59.31 -33.3 70.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.982 0.42 . . . . 0.0 110.338 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.61 -50.98 39.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.172 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.455 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.83 -34.92 76.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 110.367 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.426 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 3.8 m-85 -69.52 -27.83 65.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.049 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.433 ' HD3' ' CZ ' ' A' ' 67' ' ' TYR . 19.8 mtmt -85.06 -41.55 15.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.911 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.3 -20.47 77.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.233 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.463 ' HB3' ' HG3' ' A' ' 10' ' ' LYS . . . -42.97 132.88 3.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 111.64 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -162.96 102.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.783 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.39 81.75 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.129 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.81 109.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.905 0.384 . . . . 0.0 110.553 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.596 HG23 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -121.46 107.69 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.751 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -98.88 114.76 27.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.404 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.16 123.59 43.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.378 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -87.05 104.69 16.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.964 0.411 . . . . 0.0 109.997 178.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.518 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -95.17 142.68 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.655 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.8 m -108.77 123.84 49.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.339 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 -104.61 92.68 5.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.225 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.62 -175.07 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.535 2.157 . . . . 0.0 112.133 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.18 159.58 30.13 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.13 -173.77 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.565 2.176 . . . . 0.0 112.195 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 138.13 46.51 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.579 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.3 t -163.35 179.41 7.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.99 160.51 26.15 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.14 -37.91 3.32 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.85 -31.48 18.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.351 . . . . 0.0 110.909 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.45 -146.76 33.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.539 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.6 158.05 31.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.775 0.321 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.96 -21.1 64.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.224 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 p -127.86 114.32 20.58 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.439 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 59.4 Cg_endo -72.81 -167.93 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.593 2.196 . . . . 0.0 112.317 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.51 61.52 4.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.859 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.439 ' CD1' ' HG2' ' A' ' 96' ' ' PRO . 2.9 mp -93.09 -71.45 0.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.01 -168.64 3.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.692 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -58.57 -63.52 1.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.796 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.772 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -140.25 -80.21 0.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.083 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.6 m120 49.81 27.31 2.25 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.114 0.483 . . . . 0.0 110.93 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.529 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 27.2 mm-40 -81.89 -178.38 6.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.312 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.517 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.7 t80 -86.58 96.21 10.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.338 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.772 ' HZ2' ' HB3' ' A' ' 101' ' ' ARG . 7.7 m95 -106.16 132.58 52.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.055 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.455 ' CG1' ' CD1' ' A' ' 67' ' ' TYR . 20.3 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.057 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.791 0.329 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.06 159.3 16.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -151.15 129.62 12.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.513 ' CE1' HG21 ' A' ' 81' ' ' VAL . 30.7 p90 -137.76 172.17 13.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.109 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.71 135.95 49.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 111.544 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 43' ' ' LYS . 15.7 t -117.05 107.25 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.265 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 5.7 p-10 -113.13 127.2 56.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.884 0.373 . . . . 0.0 111.139 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.576 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.86 156.24 40.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.38 178.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.47 117.6 12.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.9 0.381 . . . . 0.0 110.638 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.599 ' HB2' HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -100.03 128.39 46.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.538 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.435 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 10.7 mmtt -120.9 68.75 0.88 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.219 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.42 79.73 0.07 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.427 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 44.79 98.63 0.01 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 114.231 0.452 . . . . 0.0 114.231 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 7.5 ptpt -155.85 -102.37 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 1.8 mm-40 -69.23 -5.42 22.68 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.532 ' HG ' ' HE2' ' A' ' 10' ' ' LYS . 3.3 mt -45.53 -30.11 1.36 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.996 0.427 . . . . 0.0 110.17 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.528 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 26.76 62.64 0.08 OUTLIER Glycine 0 C--N 1.332 0.337 0 N-CA-C 115.149 0.82 . . . . 0.0 115.149 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.483 HD21 HD12 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -146.18 92.28 2.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.006 0.431 . . . . 0.0 110.331 178.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.3 t -66.8 116.69 7.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.277 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -92.87 162.74 13.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.199 0.523 . . . . 0.0 111.961 -179.055 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -139.17 148.11 55.95 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.35 124.84 17.24 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.634 2.223 . . . . 0.0 112.816 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.37 162.57 35.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.979 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.57 -38.89 28.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.086 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pt -91.33 -9.24 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.959 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.87 -123.2 1.07 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.452 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -140.51 106.19 5.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.771 0.32 . . . . 0.0 110.939 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.405 ' N ' HG23 ' A' ' 49' ' ' ILE . 86.5 m -67.07 119.37 11.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.532 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.51 104.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.52 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.58 66.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.342 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -165.63 178.72 6.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.342 0.591 . . . . 0.0 111.336 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.442 ' HA ' ' HZ3' ' A' ' 105' ' ' TRP . 0.2 OUTLIER -163.9 136.1 4.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.747 178.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.635 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 5.5 pt -95.9 100.32 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.244 0.545 . . . . 0.0 110.572 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -65.07 154.04 39.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.869 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.04 -27.46 16.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.522 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 3.5 mp0 -65.76 -49.56 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 110.461 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -133.98 140.21 35.64 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.475 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.31 -49.28 0.95 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.644 2.229 . . . . 0.0 113.169 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 43' ' ' LYS . 13.5 mm-40 -60.94 -50.48 73.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 111.036 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.483 HD12 HD21 ' A' ' 18' ' ' LEU . 3.3 mt -55.98 -51.2 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.257 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -59.37 -30.14 68.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.028 0.442 . . . . 0.0 110.632 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -99.42 3.45 45.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.425 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -122.94 -70.18 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.0 mt -70.9 153.72 42.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.266 0.555 . . . . 0.0 112.259 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.94 137.34 15.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.26 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.7 mtp-105 -48.18 114.07 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 111.435 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.93 7.1 6.16 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.18 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -106.61 163.96 12.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.913 0.357 . . . . 0.0 111.099 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.405 HG23 ' N ' ' A' ' 28' ' ' THR . 1.2 mp -131.48 120.14 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.027 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.447 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 6.9 mt -74.61 100.28 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.496 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.7 p -93.55 -9.58 37.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.238 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -139.18 145.97 39.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.455 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 31.1 t80 -152.55 112.54 3.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.865 0.364 . . . . 0.0 111.109 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 56.81 42.86 25.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.851 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.22 22.74 77.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.427 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -121.82 108.15 13.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.343 . . . . 0.0 110.75 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.66 107.95 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.308 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 mt -80.72 0.65 33.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.54 145.2 52.8 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.932 0.396 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.66 19.13 66.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.736 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.0 mt -120.15 141.51 31.81 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.575 0.226 . . . . 0.0 110.924 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.92 -158.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.507 2.138 . . . . 0.0 112.259 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -105.39 -23.91 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.929 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -56.32 -49.0 75.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 110.544 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.0 m -67.02 -45.36 87.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.996 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.0 m -56.97 -49.7 74.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.701 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.504 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 25.3 t80 -63.74 -31.01 72.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.835 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.99 33.09 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.455 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -65.83 -42.21 90.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.814 0.34 . . . . 0.0 110.519 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 5.7 m-85 -63.74 -32.62 74.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.919 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.44 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -82.65 -30.37 29.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.324 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.12 17.26 58.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.542 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 10' ' ' LYS . . . -79.23 136.21 37.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.764 0.316 . . . . 0.0 110.626 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -170.12 98.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.126 0.489 . . . . 0.0 110.728 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.56 77.25 0.52 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.887 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.54 110.39 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.857 0.36 . . . . 0.0 110.412 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.599 HG23 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -119.41 107.96 22.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.629 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.8 t -105.49 106.25 16.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.303 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.417 ' CE ' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -113.27 127.79 56.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.938 -178.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -89.06 107.62 19.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.919 0.39 . . . . 0.0 109.985 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.513 HG21 ' CE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -98.23 143.05 13.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.875 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.9 m -108.49 124.49 50.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.188 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -105.64 93.57 7.44 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.372 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.3 -174.12 2.07 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.555 2.17 . . . . 0.0 112.199 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -105.47 154.18 39.26 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.812 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.08 162.44 35.56 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.539 2.159 . . . . 0.0 112.272 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.1 107.85 1.11 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.546 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.3 t 61.13 164.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.94 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.51 51.62 57.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.45 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.72 109.61 0.97 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.44 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.9 m -97.79 -35.17 10.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.23 -170.8 38.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.569 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.3 m -59.52 161.2 6.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.839 0.352 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mp -83.04 -30.53 28.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.99 137.18 21.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.848 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.457 ' HD2' ' CD1' ' A' ' 98' ' ' LEU . 96.1 Cg_endo -81.87 21.73 0.92 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.661 2.24 . . . . 0.0 113.483 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.09 69.28 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 0.0 111.29 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.457 ' CD1' ' HD2' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -93.3 -62.5 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.774 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.21 -163.29 1.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.511 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.71 -77.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.63 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.493 ' HD3' HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -134.29 24.26 3.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.655 179.149 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -51.06 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.896 0.379 . . . . 0.0 110.549 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.486 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 4.5 mm100 -141.54 173.55 11.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.952 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.504 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 3.3 t80 -79.4 95.9 5.88 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.635 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 53.2 m95 -100.86 145.61 28.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.036 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 67' ' ' TYR . 8.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.22 160.53 19.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.949 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -155.37 129.61 8.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.706 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.556 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 33.0 p90 -136.26 173.29 11.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.272 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.65 137.61 46.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 111.258 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' A' ' 4' ' ' PHE . 6.9 t -122.76 107.28 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.84 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 25.7 t0 -110.14 127.18 54.76 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.78 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.54 159.17 44.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.674 179.044 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.38 114.24 9.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.608 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -95.39 140.83 29.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.347 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 3.8 mmtp -132.57 69.27 1.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.36 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.36 22.09 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.336 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.92 114.27 0.96 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.536 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.401 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -162.08 -96.42 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.959 0.409 . . . . 0.0 111.367 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 16.7 mt-10 -68.23 -4.39 13.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.122 0.569 . . . . 0.0 112.156 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.534 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 2.8 mm? -44.48 -32.71 1.47 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.136 0.493 . . . . 0.0 110.03 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 32.93 51.24 0.47 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.333 -0.849 . . . . 0.0 114.65 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.463 ' CD1' HD13 ' A' ' 20' ' ' LEU . 1.3 pp -141.27 91.62 2.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.019 0.438 . . . . 0.0 110.323 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 30' ' ' ALA . 6.0 t -68.63 119.52 13.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.812 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 18' ' ' LEU . 5.5 mp -94.23 167.89 11.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.52 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -143.88 164.69 28.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.074 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.56 128.68 15.62 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.347 2.032 . . . . 0.0 112.672 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.02 162.66 34.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.039 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.04 -16.74 45.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.52 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 pt -118.1 -7.14 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.787 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 169.75 -124.98 1.2 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.839 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 21' ' ' SER . 21.0 m -140.81 106.16 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.905 0.383 . . . . 0.0 111.413 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.3 m -65.79 128.89 37.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.212 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -68.8 104.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.953 0.406 . . . . 0.0 110.534 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -67.42 -31.45 71.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.11 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.6 172.25 16.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 111.268 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.5 125.36 7.8 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.335 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.584 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 9.0 pt -97.09 100.49 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.967 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.88 160.4 31.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.93 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.16 3.39 88.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.93 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.91 -41.88 8.58 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.897 0.38 . . . . 0.0 110.734 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -143.5 140.95 18.1 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.428 179.177 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.09 -48.75 0.42 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.61 2.207 . . . . 0.0 113.241 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.7 mp0 -62.85 -45.58 91.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 111.065 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.9 mt -61.48 -49.84 82.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.962 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.23 -30.15 68.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.722 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -94.53 -12.87 26.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.234 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.556 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -111.75 -75.08 0.62 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.844 -178.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.8 mt -70.54 151.6 44.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.858 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -153.11 172.91 16.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.458 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -73.57 113.31 10.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.81 0.338 . . . . 0.0 111.052 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.98 27.34 2.99 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.812 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.09 136.45 54.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.731 0.301 . . . . 0.0 110.91 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mt -105.96 118.09 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.425 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 2.9 mt -75.24 100.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 p -104.42 27.8 7.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.181 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.1 mttt -172.76 138.3 0.82 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.166 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CD1' ' CD1' ' A' ' 69' ' ' LEU . 25.7 t80 -150.07 112.28 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.393 . . . . 0.0 111.237 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 55.66 51.0 13.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.69 21.51 65.15 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.367 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -124.03 101.27 7.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.575 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.4 120.93 6.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.369 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.6 mt -92.36 18.78 7.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.07 126.12 32.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.974 0.416 . . . . 0.0 111.429 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -19.67 43.5 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.069 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.6 mt -81.2 140.63 49.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.542 0.211 . . . . 0.0 111.171 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.51 -157.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.633 2.222 . . . . 0.0 112.16 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -104.45 -23.56 13.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.021 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -56.69 -49.06 76.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.06 0.457 . . . . 0.0 110.377 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -71.46 -45.44 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.856 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.4 ' HA ' HD23 ' A' ' 69' ' ' LEU . 91.2 m -55.0 -51.98 64.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.757 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 13.8 t80 -66.74 -30.65 70.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.656 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.73 -51.06 60.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.233 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.484 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.12 -41.44 86.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.856 0.36 . . . . 0.0 110.192 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.499 ' O ' ' HE2' ' A' ' 10' ' ' LYS . 3.4 m-85 -62.58 -33.7 75.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.672 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 13.0 mtmt -79.73 -35.73 38.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.373 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.71 7.66 72.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.566 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.443 ' HB3' ' HG3' ' A' ' 10' ' ' LYS . . . -71.4 141.44 50.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 0.0 110.808 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -175.25 99.17 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.681 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.42 74.68 0.51 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.819 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.26 120.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 110.081 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -132.0 107.91 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.84 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -99.75 111.88 24.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.473 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.93 128.81 55.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.397 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.87 104.74 17.29 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.526 HG22 ' CE1' ' A' ' 4' ' ' PHE . 1.7 m -95.05 143.16 12.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.781 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 62.0 m -108.22 127.91 54.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.205 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.11 95.44 15.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 82' ' ' THR . 52.7 Cg_exo -53.93 -174.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.496 2.13 . . . . 0.0 112.147 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -84.53 158.97 59.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.36 -179.75 2.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.623 2.215 . . . . 0.0 112.288 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 146.79 -133.57 4.88 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.551 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.86 173.09 17.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.714 0.293 . . . . 0.0 110.892 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.11 -46.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.64 -89.59 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.2 p -100.01 -31.25 11.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.942 0.401 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.38 140.73 6.48 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.533 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 m 60.67 171.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 mp -90.76 -29.04 17.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 p -84.66 138.94 37.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.081 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 59.3 Cg_endo -87.96 29.22 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.757 2.304 . . . . 0.0 113.066 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 53.09 51.09 16.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 111.319 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.459 ' CD1' ' HG2' ' A' ' 96' ' ' PRO . 5.9 mp -93.28 -39.45 10.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.674 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.8 tp -153.05 175.56 12.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.585 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.21 -69.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.963 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.764 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.4 mpt_? -140.86 -79.34 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.058 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 t30 48.63 27.54 1.53 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 111.076 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.533 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 5.2 mm100 -81.18 -177.91 6.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.153 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.53 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -86.83 96.28 10.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.764 ' HZ2' ' HB3' ' A' ' 101' ' ' ARG . 14.7 m95 -104.22 138.64 40.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 111.783 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.45 ' CG1' ' CE1' ' A' ' 67' ' ' TYR . 18.6 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.113 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.748 0.309 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.23 158.23 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.804 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -151.62 129.67 11.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.746 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.546 ' CE2' HG23 ' A' ' 6' ' ' VAL . 30.1 p90 -138.29 170.87 15.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.69 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.62 136.02 48.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.043 0.449 . . . . 0.0 111.431 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.546 HG23 ' CE2' ' A' ' 4' ' ' PHE . 19.6 t -114.93 106.93 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.681 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 15.4 p-10 -110.65 127.01 55.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.894 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.573 HD13 HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -149.87 159.27 44.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.377 . . . . 0.0 110.39 178.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.67 113.62 11.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.998 0.428 . . . . 0.0 110.941 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.628 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -97.66 151.63 19.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.431 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 8.0 mmtt -138.34 69.43 1.38 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.637 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.55 23.2 5.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.282 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.7 113.64 1.45 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.558 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.4 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -161.88 -96.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 0.0 110.985 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 19.4 mt-10 -69.41 -5.56 24.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.659 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.509 HD22 ' CD2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.6 -36.02 4.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.267 0.556 . . . . 0.0 109.583 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 25.32 62.6 0.06 OUTLIER Glycine 0 CA--C 1.52 0.352 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.509 ' CD2' HD22 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -138.56 91.69 2.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.166 0.508 . . . . 0.0 109.992 177.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -59.51 112.35 1.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.824 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 7.0 mt -96.21 168.3 10.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.613 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -146.6 158.33 46.66 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.335 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.35 125.07 13.37 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.475 2.117 . . . . 0.0 112.488 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.71 162.52 31.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.002 0.429 . . . . 0.0 111.105 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -81.63 -18.01 46.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.425 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 pt -117.8 -4.61 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.706 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.83 -123.51 1.14 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.183 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 1.3 m -140.76 106.47 5.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.825 0.345 . . . . 0.0 111.575 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 97.0 m -69.64 137.56 52.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.5 mt -79.46 104.92 8.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.865 0.364 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.59 -28.08 63.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.967 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -160.54 169.36 23.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 111.205 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.42 127.24 9.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.349 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.539 HG22 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -98.19 100.47 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.296 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.53 154.37 42.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.024 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.05 -20.72 47.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.903 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.58 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 11.9 mp0 -70.74 -48.03 56.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.71 142.2 33.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.787 0.327 . . . . 0.0 110.703 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.56 -48.85 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.545 2.163 . . . . 0.0 112.901 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' LYS . 23.1 mm-40 -61.41 -50.14 74.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 111.027 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.1 mt -56.44 -51.45 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.142 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -59.89 -30.31 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.819 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -97.79 1.98 48.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.427 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -125.6 -72.23 0.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.779 0.323 . . . . 0.0 111.552 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.1 mt -77.51 152.91 33.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.089 0.471 . . . . 0.0 111.61 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -150.35 -175.91 5.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.503 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -81.62 95.0 7.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.048 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.34 43.09 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.799 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.78 145.38 40.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 110.877 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.55 118.13 57.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.426 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 6.4 mt -74.62 100.46 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 110.83 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -100.45 26.5 6.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.724 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -172.61 136.16 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.905 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.449 ' CD1' ' CD1' ' A' ' 69' ' ' LEU . 61.3 t80 -142.62 109.98 5.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.219 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.57 48.71 19.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.914 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.78 76.98 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.396 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -124.71 105.61 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 0.0 110.712 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.92 121.81 10.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.316 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 11.4 mt -92.72 16.87 11.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.965 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.39 141.46 52.17 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.868 0.366 . . . . 0.0 111.081 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.79 29.65 55.12 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.667 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.8 mt -115.36 135.32 22.56 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.5 0.19 . . . . 0.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.69 -169.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.404 2.069 . . . . 0.0 112.167 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -98.39 -26.38 14.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.038 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -58.53 -46.84 85.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.032 0.444 . . . . 0.0 110.584 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.3 t -66.45 -48.97 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.897 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.5 -53.75 54.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.769 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 104' ' ' TYR . 38.3 t80 -58.07 -31.25 66.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.81 -51.04 24.52 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.449 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.99 -32.71 72.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 110.26 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.426 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 4.8 m-85 -72.42 -29.01 63.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.04 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.44 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 7.2 mtpt -85.15 -35.88 21.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.581 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.12 -22.7 65.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.874 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HB3' ' HG3' ' A' ' 10' ' ' LYS . . . -42.98 128.14 4.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.563 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -155.25 103.26 2.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 110.945 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.04 86.62 1.88 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.265 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.27 114.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 110.622 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.628 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -128.51 107.78 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.227 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 4.3 t -102.64 108.45 19.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.488 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.53 125.31 52.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.522 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -86.47 112.04 21.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.874 0.369 . . . . 0.0 110.216 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.494 HG21 ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -101.28 142.39 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.616 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.2 m -108.85 124.61 50.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.392 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -107.07 90.34 5.36 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.104 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.33 -173.12 1.66 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.656 2.238 . . . . 0.0 112.502 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -123.19 156.02 63.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.777 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.19 161.8 41.29 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.564 2.176 . . . . 0.0 112.249 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.99 -65.63 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.513 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.1 p -75.56 -39.46 58.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.388 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.73 -104.15 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.44 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.77 -117.14 0.95 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.69 26.14 6.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.51 154.54 21.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -132.37 166.53 21.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.294 . . . . 0.0 110.952 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 mp -79.93 -49.6 11.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.796 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.0 p -136.98 113.83 9.85 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 57.8 Cg_endo -72.41 -175.52 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.527 2.152 . . . . 0.0 112.165 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.73 61.18 3.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.081 0.467 . . . . 0.0 110.783 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.49 ' CD1' ' HG2' ' A' ' 96' ' ' PRO . 2.0 mp -93.07 -71.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.04 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.73 169.29 9.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -79.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.953 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.782 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -141.7 -79.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.917 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.33 28.39 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.096 0.475 . . . . 0.0 111.062 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.508 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 18.1 mm-40 -82.05 -178.94 7.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.243 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 1.8 t80 -84.8 96.13 9.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.782 ' HZ2' ' HB3' ' A' ' 101' ' ' ARG . 25.6 m95 -102.55 132.21 48.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.316 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.455 ' CG1' ' CD1' ' A' ' 67' ' ' TYR . 11.4 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.178 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.797 0.332 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.01 162.44 14.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -155.77 129.62 8.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.503 ' CE1' ' CG2' ' A' ' 81' ' ' VAL . 30.0 p90 -140.04 175.38 9.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.785 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.49 139.27 47.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.159 0.504 . . . . 0.0 111.84 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.52 HG21 ' HB3' ' A' ' 43' ' ' LYS . 17.5 t -120.91 107.02 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.239 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 25.8 p-10 -112.24 127.24 55.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.568 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.06 156.14 42.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.008 0.432 . . . . 0.0 110.47 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.06 114.82 9.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.014 0.435 . . . . 0.0 110.539 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.517 ' HG2' HD23 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -96.4 145.01 26.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.739 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 23.8 mmtt -134.99 69.32 1.45 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.32 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.43 26.58 9.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.182 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.01 112.98 0.51 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.304 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -157.11 -94.46 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.027 0.442 . . . . 0.0 111.296 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 15.3 mt-10 -68.25 -4.45 14.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.154 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.517 HD23 ' HG2' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -44.58 -30.12 0.85 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.548 0.213 . . . . 0.0 110.552 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 19.47 53.22 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 114.62 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.444 ' CD2' ' CD1' ' A' ' 16' ' ' LEU . 2.0 pp -135.57 103.15 5.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.945 0.402 . . . . 0.0 110.066 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 103' ' ' GLN . 1.2 t -69.06 122.08 17.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.138 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mt -105.0 159.75 15.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.63 167.72 20.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.479 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.74 135.15 21.2 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.556 2.171 . . . . 0.0 112.585 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.4 162.64 38.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.088 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -32.89 38.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.154 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 pt -99.12 -7.95 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.82 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.78 -122.81 1.04 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.416 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 m -140.52 106.45 5.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.75 0.309 . . . . 0.0 111.246 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.6 m -66.95 127.33 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.399 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.7 mt -68.93 104.75 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.683 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.1 -23.38 62.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.945 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -171.68 172.45 4.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.825 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.442 ' HA ' ' HZ3' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -163.48 131.76 3.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.986 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.679 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -95.53 144.14 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.597 -179.112 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -94.0 169.39 10.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.937 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.87 21.38 71.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.764 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -111.77 -33.51 6.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 110.891 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -156.25 144.91 14.69 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.15 -47.91 4.12 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.469 2.112 . . . . 0.0 112.779 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 43' ' ' LYS . 14.2 mp0 -65.77 -52.27 52.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.221 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 2.6 mt -54.91 -40.95 55.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.558 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -71.23 -30.09 65.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.153 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.56 3.71 32.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.062 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.52 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -127.47 -73.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.459 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -60.12 148.88 34.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.884 -178.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -153.85 -175.71 5.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.539 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -92.93 116.8 29.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.51 -14.86 8.13 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.074 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -85.87 158.8 19.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 111.267 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.4 121.84 51.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.736 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.429 HD11 ' CZ ' ' A' ' 70' ' ' PHE . 14.6 mt -74.26 100.63 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.034 0.445 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 p -102.4 26.88 7.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.906 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 2.8 mttt -172.7 135.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.982 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.456 ' CD2' ' CD1' ' A' ' 69' ' ' LEU . 68.0 t80 -139.34 120.83 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.93 0.395 . . . . 0.0 111.37 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.63 39.88 22.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.985 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.17 17.52 78.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.498 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -124.23 106.5 10.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 0.0 110.714 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.62 124.57 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.431 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 10.4 mt -94.91 23.34 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.81 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.95 144.28 38.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.091 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.89 24.01 57.29 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.695 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.46 139.03 24.89 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.539 0.209 . . . . 0.0 110.803 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.95 -161.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.408 2.072 . . . . 0.0 112.17 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -106.73 -24.27 12.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -56.8 -50.65 71.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.063 0.459 . . . . 0.0 110.599 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.21 -47.45 92.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.067 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.401 ' HA ' HD21 ' A' ' 69' ' ' LEU . 63.5 m -57.5 -53.79 54.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 110.895 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.518 ' CZ ' ' CE2' ' A' ' 104' ' ' TYR . 18.6 t80 -57.37 -31.0 65.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.715 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.23 -51.11 18.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.233 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' CD1' ' CD2' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.31 -32.29 72.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 110.331 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.429 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 5.5 m-85 -73.1 -31.32 64.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.976 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.432 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -85.11 -29.87 24.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.577 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.27 -22.45 44.5 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.855 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 10' ' ' LYS . . . -43.46 131.52 4.92 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.809 0.338 . . . . 0.0 111.519 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -157.06 101.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.05 85.27 1.49 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.623 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 110.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.824 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -124.6 108.0 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.685 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -99.25 111.29 23.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.479 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.23 124.03 46.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -88.31 107.29 18.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 110.289 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.503 ' CG2' ' CE1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -95.29 142.94 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.422 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 92.8 m -108.45 128.4 54.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.079 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -110.54 93.43 16.37 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.208 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 82' ' ' THR . 38.8 Cg_exo -60.07 -174.17 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.584 2.189 . . . . 0.0 112.218 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -109.38 160.98 25.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.59 167.03 23.88 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.491 2.127 . . . . 0.0 112.297 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.1 -104.97 0.27 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.477 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.3 m -102.83 -176.8 3.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.63 -173.38 30.25 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.448 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.08 66.1 3.47 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.496 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.44 -30.85 64.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.963 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.09 65.98 3.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.7 m 60.72 -179.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 0.0 110.94 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.4 -44.34 3.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.948 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.08 141.44 38.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.029 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.461 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 19.1 Cg_endo -84.8 169.12 10.65 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.627 2.218 . . . . 0.0 112.387 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.53 61.52 3.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.12 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.461 ' CD1' ' HG2' ' A' ' 96' ' ' PRO . 6.0 mp -80.73 -68.97 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.081 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.28 -170.76 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.021 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.29 64.34 4.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.98 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.746 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER 64.5 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.178 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.7 m120 50.03 26.59 2.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 110.745 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.496 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 29.3 mm-40 -85.9 176.64 7.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.807 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.518 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -80.88 96.0 6.89 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.746 ' HZ2' ' HB3' ' A' ' 101' ' ' ARG . 54.7 m95 -100.71 138.05 38.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.698 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' A' ' 67' ' ' TYR . 34.4 m . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.211 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.794 0.331 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.09 162.51 5.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.824 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.9 mttt -156.19 129.52 8.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.61 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.517 ' CE2' HG21 ' A' ' 6' ' ' VAL . 35.0 p90 -136.92 173.94 11.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.791 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.8 135.87 49.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.955 0.407 . . . . 0.0 111.389 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.517 HG21 ' CE2' ' A' ' 4' ' ' PHE . 12.6 t -117.58 107.34 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.142 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -109.98 127.94 55.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.07 0.462 . . . . 0.0 110.9 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.538 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -159.52 153.07 22.61 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.928 179.318 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.94 127.14 31.67 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.529 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.451 ' HB2' ' CG2' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -103.79 136.58 43.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.79 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -115.45 69.6 0.73 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.94 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.93 27.61 0.74 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.398 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.77 73.07 1.13 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.281 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.585 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 29.6 ttmt -120.26 -102.82 0.41 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.571 0.224 . . . . 0.0 111.023 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.585 ' N ' ' HG2' ' A' ' 14' ' ' LYS . 7.7 mt-10 -70.95 -6.35 37.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.507 ' HG ' ' CD2' ' A' ' 18' ' ' LEU . 7.7 tp -46.16 -39.13 9.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 12.33 62.99 0.01 OUTLIER Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.434 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.507 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -127.88 91.77 3.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.135 0.493 . . . . 0.0 109.798 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.8 119.35 4.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.844 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.3 mt -107.39 165.26 11.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.542 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.19 167.68 13.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.361 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -75.2 135.81 19.19 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.494 2.129 . . . . 0.0 112.82 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.64 162.56 38.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.013 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.45 -28.85 41.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.183 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 pt -103.82 -2.01 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.919 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.8 -124.9 1.33 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.135 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.9 p -140.22 106.39 5.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.822 0.344 . . . . 0.0 111.078 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 84.8 m -65.45 128.85 37.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.69 104.74 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.618 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.11 -27.58 67.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.588 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -171.66 179.94 2.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.779 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.86 134.92 3.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.003 178.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.652 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 2.8 pt -95.99 119.39 43.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.79 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -72.22 175.24 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.308 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.41 -51.58 4.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.635 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -46.26 -74.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.672 0.272 . . . . 0.0 110.723 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -117.74 131.4 24.13 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.691 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.64 -42.74 8.68 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.457 2.105 . . . . 0.0 112.502 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.97 -48.45 81.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 37' ' ' TYR . 6.0 mt -59.43 -42.33 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.567 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.27 -30.12 69.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.679 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -99.67 3.36 45.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.505 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.513 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -125.08 -71.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.819 -179.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -72.17 150.33 43.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.248 0.547 . . . . 0.0 112.156 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -153.84 149.6 27.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.248 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 -55.64 107.97 0.39 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.186 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.24 41.0 0.42 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.624 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -142.06 164.07 31.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.573 0.225 . . . . 0.0 110.619 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.6 mp -133.32 120.29 38.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.238 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.461 ' CG1' HG13 ' A' ' 81' ' ' VAL . 6.1 mt -74.59 100.65 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.045 0.45 . . . . 0.0 110.471 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 p -99.84 18.63 17.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.948 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -162.27 142.52 9.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.138 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 60.2 t80 -151.67 109.85 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.911 0.386 . . . . 0.0 111.1 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 51.94 55.31 9.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.01 23.35 65.79 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.358 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.91 99.72 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.804 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.46 120.57 7.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.285 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -92.81 16.97 11.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.45 127.34 32.04 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.827 0.346 . . . . 0.0 111.142 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.65 -23.26 31.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.777 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.5 mt -79.6 148.34 69.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 111.096 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.21 -168.37 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.499 2.132 . . . . 0.0 112.205 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -87.76 -28.45 21.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.618 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.73 -42.33 83.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.406 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -66.2 -53.94 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.744 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 89.4 m -56.07 -53.82 52.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.056 0.455 . . . . 0.0 110.781 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 28.3 t80 -56.89 -30.88 64.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.18 -51.16 22.48 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.49 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.88 -37.18 81.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.351 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.445 ' CE1' ' HG2' ' A' ' 79' ' ' MET . 10.1 m-85 -68.34 -32.04 71.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.955 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 2.9 mtpt -81.34 -34.4 31.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.17 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.36 -23.77 55.87 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.458 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.432 ' HB3' ' HG3' ' A' ' 10' ' ' LYS . . . -45.99 138.92 4.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.658 0.266 . . . . 0.0 111.301 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -170.87 97.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.038 0.447 . . . . 0.0 111.571 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.46 96.36 2.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.93 87.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.128 0.489 . . . . 0.0 110.442 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 10' ' ' LYS . 3.5 t -114.4 130.72 68.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.147 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.7 t -122.82 139.62 53.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.445 ' HG2' ' CE1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -142.66 129.23 20.25 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.825 0.345 . . . . 0.0 111.675 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -91.21 108.12 19.66 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.515 ' CG2' ' CE1' ' A' ' 4' ' ' PHE . 1.9 m -95.16 142.64 13.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.837 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 45.3 m -108.65 125.33 51.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.196 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -107.68 97.63 21.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.097 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.5 -176.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.532 2.155 . . . . 0.0 112.286 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.04 161.44 23.31 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.884 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.16 176.4 4.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.579 2.186 . . . . 0.0 112.309 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.98 -73.35 0.2 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.5 t -135.2 98.14 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 0.0 110.852 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.77 -71.26 0.18 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.554 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -108.08 91.66 0.69 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.595 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 p -73.86 -39.73 63.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.854 0.359 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -157.12 -70.84 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.51 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.4 p -160.08 170.5 21.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.4 -29.43 14.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.7 p -95.28 132.88 26.95 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.05 16.54 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.708 2.272 . . . . 0.0 113.109 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.8 mmm-85 64.61 78.28 0.29 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.796 0.331 . . . . 0.0 111.314 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -93.28 -57.73 2.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.78 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mt -134.34 -167.26 1.93 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.637 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.66 -63.97 0.84 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.421 ' HG3' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -151.74 25.53 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -51.93 91.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.955 0.407 . . . . 0.0 110.361 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 17.9 mm-40 -142.53 174.37 10.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.083 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.6 t80 -76.81 95.98 4.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.652 ' CH2' ' CG2' ' A' ' 33' ' ' ILE . 68.4 m95 -101.71 138.14 39.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.352 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.42 HG21 HD22 ' A' ' 16' ' ' LEU . 16.0 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.196 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.796 0.331 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.14 155.43 18.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 8.9 mttp -144.86 129.57 18.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.848 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.515 ' CE1' HG23 ' A' ' 81' ' ' VAL . 26.5 p90 -137.03 171.49 14.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.818 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.72 136.03 48.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.057 0.456 . . . . 0.0 111.394 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 43' ' ' LYS . 16.0 t -116.26 107.33 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.551 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 12.3 t0 -110.66 127.21 55.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.027 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.581 HD12 HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -149.53 157.72 43.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 110.481 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.31 110.21 5.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.987 0.422 . . . . 0.0 111.037 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.654 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -94.56 144.39 25.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.093 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 6.6 mmtp -130.05 69.33 1.44 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.436 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.5 20.92 6.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.274 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.31 114.56 1.88 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.459 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -164.56 -94.29 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 111.444 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 29.1 mt-10 -69.2 -4.49 17.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.126 0.57 . . . . 0.0 112.359 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 2.5 mt -44.65 -32.13 1.38 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.47 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 30.34 59.61 0.22 Allowed Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 115.13 177.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.451 HD23 ' CD2' ' A' ' 16' ' ' LEU . 1.3 pp -148.11 91.83 1.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.034 0.445 . . . . 0.0 110.202 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 30' ' ' ALA . 3.0 t -65.75 117.28 7.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.549 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.449 HD11 HD13 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -88.0 170.35 11.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.603 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.81 159.39 56.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.11 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.76 111.52 2.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.427 2.085 . . . . 0.0 112.727 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.24 162.51 23.54 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.718 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -83.46 -29.06 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.349 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 pt -102.09 -8.66 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.763 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.43 -123.81 1.06 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.136 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.53 105.86 5.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.906 0.384 . . . . 0.0 111.046 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.415 ' OG1' HG12 ' A' ' 49' ' ' ILE . 92.3 m -68.64 128.95 38.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.179 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.8 mt -70.25 104.8 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.858 0.361 . . . . 0.0 110.639 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -69.86 -30.66 68.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.959 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.441 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.8 OUTLIER -158.34 173.65 16.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.413 . . . . 0.0 111.299 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.8 126.89 7.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.397 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.568 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 6.6 pt -96.9 100.38 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.972 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -69.16 155.4 40.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.075 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.0 -14.66 64.72 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.859 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 4.1 mp0 -76.83 -47.61 20.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.711 0.291 . . . . 0.0 110.717 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.4 138.96 23.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.653 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.22 -51.02 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.662 2.241 . . . . 0.0 113.012 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -58.54 -48.78 79.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.769 0.318 . . . . 0.0 111.044 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.488 HG13 ' HB3' ' A' ' 37' ' ' TYR . 4.6 mt -57.32 -50.44 76.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.133 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.39 -30.26 68.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.562 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -97.48 0.65 47.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.173 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.522 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.21 -73.74 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.838 0.351 . . . . 0.0 111.697 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.1 mt -73.29 157.29 37.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.045 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -153.94 -175.9 5.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.221 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -90.56 104.96 17.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 111.127 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.49 -8.7 3.72 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.21 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.18 160.43 15.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 111.182 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.415 HG12 ' OG1' ' A' ' 28' ' ' THR . 1.0 OUTLIER -126.9 119.69 53.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.431 ' CG1' HG12 ' A' ' 81' ' ' VAL . 4.3 mt -74.57 100.6 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 110.997 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.7 p -101.07 22.6 12.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.735 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.2 mttt -167.54 136.54 2.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.887 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 56.7 t80 -142.73 111.02 6.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.93 0.395 . . . . 0.0 111.265 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 54.17 46.84 24.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.26 22.15 78.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.431 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -126.16 106.41 9.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 110.737 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.68 121.49 9.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.324 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 7.9 mt -94.36 21.37 7.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.752 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -78.4 143.34 36.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.955 0.407 . . . . 0.0 111.097 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.23 24.02 60.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.792 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.6 mt -116.42 138.54 24.45 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.56 0.219 . . . . 0.0 110.841 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.36 -159.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.466 2.111 . . . . 0.0 112.182 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 67' ' ' TYR . 30.4 t80 -103.06 -24.44 13.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.984 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -57.73 -48.79 78.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.46 . . . . 0.0 110.515 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -63.96 -46.92 92.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.084 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 m -58.8 -51.86 68.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.85 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.514 ' CZ ' ' CE2' ' A' ' 104' ' ' TYR . 10.8 t80 -58.55 -31.22 67.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.23 -51.08 22.7 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.483 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -69.06 -32.24 71.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 110.268 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.415 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 8.9 m-85 -73.76 -28.69 61.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.283 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 29.2 mtmt -85.02 -38.99 18.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.7 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.16 -22.27 74.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.855 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' CB ' HG11 ' A' ' 77' ' ' VAL . . . -44.16 127.87 5.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.832 0.348 . . . . 0.0 111.691 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -159.45 104.02 1.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.089 0.471 . . . . 0.0 110.756 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.96 84.35 1.64 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.072 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 114.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 0.0 110.366 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -127.38 107.61 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.406 -179.165 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 t -99.57 114.96 28.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.062 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.83 123.49 41.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.574 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -85.84 105.78 16.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.189 179.107 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.515 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -96.61 142.68 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.893 -179.079 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.401 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 91.7 m -108.85 117.78 35.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.603 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -104.53 93.78 6.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.04 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.79 -176.86 2.22 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.512 2.141 . . . . 0.0 112.337 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.3 157.02 41.22 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.939 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.75 163.44 27.79 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.587 2.192 . . . . 0.0 112.289 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.36 -142.65 3.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.564 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.57 106.9 18.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.805 0.336 . . . . 0.0 110.952 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.89 -85.37 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.451 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -179.36 -117.75 0.55 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.468 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 p -69.85 -27.09 64.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.747 0.308 . . . . 0.0 110.942 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.66 -53.59 0.76 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.392 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.32 171.88 9.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.728 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.83 22.45 8.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.097 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.55 125.52 12.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.166 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 98.9 Cg_endo -85.31 22.12 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.831 2.354 . . . . 0.0 113.012 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 59.67 61.45 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.926 0.393 . . . . 0.0 110.959 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.468 ' CD1' ' HG2' ' A' ' 96' ' ' PRO . 1.4 mp -93.24 -65.91 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.046 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.14 176.9 6.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.01 78.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.186 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.765 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER 62.14 -79.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.272 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 46.21 28.57 0.69 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.083 0.468 . . . . 0.0 111.115 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.533 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 5.1 mm100 -79.43 -177.47 5.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.224 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.514 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -86.87 96.03 10.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.765 ' HZ2' ' HB3' ' A' ' 101' ' ' ARG . 8.5 m95 -104.67 134.54 47.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.254 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.435 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.7 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.139 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.61 156.34 29.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.772 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -150.93 129.58 12.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.513 ' CE2' HG23 ' A' ' 6' ' ' VAL . 28.8 p90 -137.66 170.14 16.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.68 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.65 135.87 49.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.057 0.456 . . . . 0.0 111.305 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 43' ' ' LYS . 11.5 t -116.37 107.01 21.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.289 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 1.6 p30 -110.44 127.28 55.04 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.053 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.564 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.1 156.35 42.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.95 0.405 . . . . 0.0 110.663 178.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 113.45 7.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.026 0.441 . . . . 0.0 110.586 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.609 ' HB2' HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -96.33 151.26 19.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.434 0.635 . . . . 0.0 111.896 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 20.2 mmtt -138.0 69.27 1.39 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.246 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 53.84 24.06 4.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.3 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.43 113.94 1.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.551 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -159.28 -97.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.765 0.317 . . . . 0.0 111.312 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.0 mm-40 -69.14 -5.78 24.5 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.161 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HG ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -45.23 -33.97 2.59 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.885 0.374 . . . . 0.0 110.497 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.403 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 26.17 62.22 0.07 OUTLIER Glycine 0 CA--C 1.522 0.483 0 N-CA-C 115.379 0.912 . . . . 0.0 115.379 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -139.62 91.81 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.023 0.439 . . . . 0.0 110.244 177.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 t -61.74 114.28 3.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.023 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -93.78 161.59 14.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.36 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 p -136.3 164.77 40.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.577 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.56 122.0 8.48 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.773 2.316 . . . . 0.0 112.841 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.14 162.44 34.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -80.09 -36.83 34.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.115 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 pt -94.93 -7.65 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.02 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.76 -125.18 1.27 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.366 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -140.69 106.28 5.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.882 0.372 . . . . 0.0 111.522 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 ' OG1' HG12 ' A' ' 49' ' ' ILE . 98.7 m -69.76 128.37 36.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.197 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.6 mt -64.41 104.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.855 0.359 . . . . 0.0 110.446 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.96 -26.84 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 1.8 m-20 -159.47 163.96 34.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.739 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.68 129.14 9.9 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.113 0.482 . . . . 0.0 111.971 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.621 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 3.0 pt -96.17 108.92 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.083 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -82.38 128.61 34.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.079 0.466 . . . . 0.0 111.294 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.2 30.37 3.17 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.814 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.614 ' HG3' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -117.49 -29.89 5.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.708 0.29 . . . . 0.0 111.279 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -151.31 143.11 15.86 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.79 -47.18 2.83 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.453 2.102 . . . . 0.0 112.894 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 43' ' ' LYS . 7.2 mm-40 -66.02 -51.53 57.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.2 mt -55.47 -46.6 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.229 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.65 -30.37 71.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.991 0.424 . . . . 0.0 110.524 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -97.46 3.52 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.229 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.534 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -128.71 -72.67 0.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.944 0.402 . . . . 0.0 111.821 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.8 mt -73.7 149.11 42.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.119 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -153.96 155.8 36.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.357 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -57.81 104.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.151 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.03 45.2 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.899 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -144.77 145.05 31.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.366 . . . . 0.0 110.888 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.471 HG12 ' OG1' ' A' ' 28' ' ' THR . 0.9 OUTLIER -112.58 117.57 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.351 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.451 ' CD1' ' CZ ' ' A' ' 70' ' ' PHE . 7.0 mt -74.89 100.23 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.264 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.9 p -93.68 -3.93 51.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.278 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -144.89 147.28 32.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.454 ' CG ' ' CD1' ' A' ' 69' ' ' LEU . 22.8 t80 -153.32 114.05 4.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.884 0.373 . . . . 0.0 111.323 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.42 46.36 25.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.002 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.54 24.73 76.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.353 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -124.98 102.98 7.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 110.654 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.97 114.95 1.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.457 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -91.12 15.78 11.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.59 125.36 35.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.72 15.62 51.94 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.373 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.64 159.74 66.43 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.976 0.388 . . . . 0.0 111.131 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.3 -171.7 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.695 2.264 . . . . 0.0 112.524 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 12.4 t80 -94.05 -32.11 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.594 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.72 -46.6 50.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.999 0.428 . . . . 0.0 110.449 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 m -64.26 -41.05 91.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.86 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 17.1 m -62.77 -51.77 65.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.919 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 37.2 t80 -58.49 -30.96 67.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.713 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.67 -50.96 31.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.454 ' CD1' ' CG ' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -70.07 -31.49 69.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.411 . . . . 0.0 110.239 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.455 ' O ' ' NZ ' ' A' ' 10' ' ' LYS . 3.4 m-85 -72.86 -27.61 62.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.138 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.442 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 1.8 mtpt -85.2 -43.84 13.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.794 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.28 -23.41 78.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.016 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.471 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -42.16 128.89 3.73 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 111.735 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -157.32 103.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.09 83.6 1.44 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.267 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.08 114.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.469 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.609 HG23 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -128.31 107.83 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.687 -179.056 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 t -100.35 111.98 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.501 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.9 124.02 49.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.323 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -87.13 104.66 16.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.066 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.503 HG22 ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -94.94 142.52 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.421 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 83.9 m -108.92 119.95 41.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.636 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -102.77 91.33 2.77 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.69 -174.2 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.531 2.154 . . . . 0.0 112.544 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -105.47 157.76 33.76 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.38 174.4 3.47 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.569 2.179 . . . . 0.0 112.297 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.46 27.88 46.07 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.526 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.85 101.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.957 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.73 -147.42 14.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.545 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.12 179.56 14.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.526 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.9 m -61.14 -31.12 70.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.765 0.316 . . . . 0.0 110.92 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.27 -40.81 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.61 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.0 m -143.23 -174.24 4.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mp -107.75 -33.84 7.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.009 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 95' ' ' VAL . 7.7 p -128.5 129.19 23.57 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' A' ' 98' ' ' LEU . 33.5 Cg_endo -68.63 -162.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.2 1.933 . . . . 0.0 112.097 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.7 mmt-85 -93.71 66.35 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 111.527 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.444 ' CD1' ' HG2' ' A' ' 96' ' ' PRO . 0.7 OUTLIER -80.15 -71.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.677 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.41 ' CD1' ' HG2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -153.55 -166.48 2.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.566 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.41 ' HG2' ' CD1' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -46.22 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.226 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.772 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.5 mpt_? -140.23 -79.01 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.649 0.261 . . . . 0.0 110.916 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.9 t30 46.65 29.09 0.88 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.244 0.545 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.533 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 26.5 mm100 -81.51 -176.36 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.448 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 5.7 t80 -86.85 96.47 10.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.243 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.772 ' HZ2' ' HB3' ' A' ' 101' ' ' ARG . 9.0 m95 -106.48 137.16 44.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.414 HG12 ' CE1' ' A' ' 67' ' ' TYR . 27.5 m . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.207 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.858 0.361 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.66 156.07 25.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -150.74 129.59 12.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.962 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.514 ' CE1' HG22 ' A' ' 81' ' ' VAL . 25.5 p90 -136.85 171.58 14.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.801 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.62 135.65 49.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.031 0.443 . . . . 0.0 111.223 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 43' ' ' LYS . 12.3 t -116.11 107.28 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.361 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 14.5 p-10 -110.0 127.23 54.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD11 HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -149.36 158.6 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.527 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.02 113.32 8.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.103 0.478 . . . . 0.0 110.913 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.644 ' HB2' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -97.51 145.59 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.425 -179.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.406 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 12.4 mmtt -131.46 69.43 1.47 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.225 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.14 23.19 5.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.3 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.12 113.48 1.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.59 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 6.6 ptpt -161.5 -94.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 9.5 mt-10 -69.47 -5.9 26.95 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.669 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.492 ' HG ' HD23 ' A' ' 18' ' ' LEU . 2.1 tp -45.8 -34.36 3.67 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.515 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 22.74 62.16 0.03 OUTLIER Glycine 0 C--N 1.331 0.262 0 CA-C-N 114.933 -1.031 . . . . 0.0 115.008 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.492 HD23 ' HG ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -139.43 91.7 2.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 110.097 178.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.0 t -61.59 118.94 7.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.021 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -100.25 159.12 15.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.359 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 56.0 m -130.41 156.71 79.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.629 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.91 111.4 2.18 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.531 2.154 . . . . 0.0 112.474 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.85 162.57 21.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.064 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.09 -31.66 44.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.189 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 pt -101.12 -8.3 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.969 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 170.26 -121.19 0.9 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.484 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' SER . 3.0 m -140.47 106.48 5.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 111.224 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 97.5 m -69.69 119.96 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.561 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.35 104.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.741 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.72 -29.58 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.445 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.5 OUTLIER -158.67 171.45 20.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.064 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.31 128.2 5.26 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.454 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.62 ' CG2' ' CH2' ' A' ' 105' ' ' TRP . 2.4 pt -96.47 100.69 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.274 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -69.79 145.32 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.085 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.13 -25.34 23.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.915 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.553 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 1.8 mp0 -66.71 -47.52 72.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.722 0.296 . . . . 0.0 110.858 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -136.65 140.21 31.44 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.68 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.43 -50.15 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.635 2.223 . . . . 0.0 112.924 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -59.37 -49.71 76.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 110.997 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 37' ' ' TYR . 5.2 mt -55.85 -53.01 42.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -58.43 -30.17 66.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.6 m -97.17 0.99 49.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.338 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.552 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.37 -73.41 0.62 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 0.0 111.566 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.3 mt -72.81 155.59 39.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.908 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.5 -175.77 5.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.474 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -90.57 98.0 11.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.035 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.43 -18.53 1.68 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.046 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.79 162.44 21.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 111.236 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -128.9 120.36 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.419 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 5.9 mt -74.48 100.22 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 110.644 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 p -94.71 -7.4 40.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.43 147.95 38.77 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 69' ' ' LEU . 26.8 t80 -152.58 110.38 3.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 0.0 111.256 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 54.14 47.44 23.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.858 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.35 24.81 73.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.231 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -123.88 102.41 7.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 0.0 110.584 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.11 114.01 1.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.427 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.3 mt -89.83 14.39 12.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.927 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -78.39 142.97 37.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.046 0.45 . . . . 0.0 111.232 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.05 26.52 61.15 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.744 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 63.0 mt -120.24 140.79 30.61 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.607 0.242 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.67 -166.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.507 2.138 . . . . 0.0 112.168 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -101.6 -24.97 14.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.105 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -45.84 84.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.686 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.08 -50.48 58.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.409 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -55.91 -48.36 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 15.7 t80 -64.3 -30.98 72.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.13 -50.9 35.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.958 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.5 -35.51 79.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 110.396 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.418 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 2.6 m-85 -69.77 -28.85 66.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.217 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 21.1 mtmt -84.98 -36.52 21.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.739 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.61 -20.0 67.15 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.976 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HB3' ' HG3' ' A' ' 10' ' ' LYS . . . -45.34 126.93 6.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.752 0.311 . . . . 0.0 111.532 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -154.78 103.73 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.28 85.78 1.8 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.063 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.93 116.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.456 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -131.19 107.72 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.632 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.6 t -99.41 114.3 27.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.33 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.79 125.34 48.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.478 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -86.76 103.8 15.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.928 0.394 . . . . 0.0 110.091 178.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.514 HG22 ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -95.17 143.1 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.521 -179.491 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.7 m -108.32 116.77 32.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -102.69 89.8 1.97 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.062 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.83 -178.86 1.41 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.525 2.15 . . . . 0.0 112.213 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.4 mtmm -75.58 157.41 84.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.986 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.4 166.56 28.0 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.658 2.239 . . . . 0.0 112.328 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.42 168.86 39.71 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.528 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.35 106.34 9.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.803 0.335 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -130.14 65.59 0.59 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.395 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.46 -88.39 0.38 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.471 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.58 -34.53 6.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.76 -51.42 0.73 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.413 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -104.96 171.61 7.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.769 0.318 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.1 -41.27 18.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.905 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 p -117.44 124.23 29.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.8 12.85 1.57 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.561 2.174 . . . . 0.0 113.252 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 68.47 74.52 0.27 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.887 0.375 . . . . 0.0 111.412 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -93.14 -35.76 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.301 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.3 -163.19 1.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.204 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.86 -74.58 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.771 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -141.88 -72.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.628 179.515 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.25 27.24 3.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 110.671 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.506 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 14.5 mm100 -89.87 171.84 9.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.715 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.519 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 1.3 t80 -81.49 96.07 7.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.771 ' HZ2' ' HB3' ' A' ' 101' ' ' ARG . 33.4 m95 -100.91 136.98 39.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.113 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.427 HG11 ' CE1' ' A' ' 67' ' ' TYR . 25.6 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.171 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.8 155.65 27.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HG2' HG23 ' A' ' 82' ' ' THR . 9.4 mttt -149.39 129.72 13.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.069 0.462 . . . . 0.0 110.708 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.775 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.1 p90 -138.49 169.58 17.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.688 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.458 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.58 135.88 49.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.158 0.504 . . . . 0.0 111.382 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.822 HG21 ' CD2' ' A' ' 44' ' ' LEU . 19.2 t -114.42 107.06 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.157 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 1.5 p30 -111.74 127.27 55.74 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.016 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.698 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -151.68 157.8 42.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.55 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.401 ' HB3' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -71.33 118.33 14.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 110.696 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.933 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -101.14 129.13 47.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.812 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 3.5 mmtp -119.61 68.61 0.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.166 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.9 77.33 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.436 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 48.95 100.78 0.01 OUTLIER Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.329 -0.462 . . . . 0.0 114.167 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -159.4 -101.58 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.141 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 22.3 mt-10 -69.22 -5.41 22.57 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.785 HD22 HD21 ' A' ' 18' ' ' LEU . 2.7 mt -45.5 -30.32 1.39 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.963 0.411 . . . . 0.0 109.906 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.551 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 24.81 63.05 0.05 OUTLIER Glycine 0 C--N 1.331 0.284 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.785 HD21 HD22 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -145.85 92.02 2.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.108 0.48 . . . . 0.0 110.098 178.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.5 t -63.42 120.73 12.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.175 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.461 HD21 HD12 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -100.0 158.07 16.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.585 -179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.41 163.33 51.28 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.348 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.33 117.56 5.22 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.492 2.128 . . . . 0.0 112.77 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.469 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -130.9 162.61 29.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.531 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG3' HG23 ' A' ' 25' ' ' ILE . 17.1 pt-20 -79.66 -37.26 36.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.643 HG23 ' HG3' ' A' ' 24' ' ' GLU . 2.3 pt -94.34 -6.03 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.888 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.27 -122.65 1.08 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.619 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -138.99 106.23 5.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.727 0.298 . . . . 0.0 110.924 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.439 ' N ' HG23 ' A' ' 49' ' ' ILE . 88.6 m -66.82 121.04 14.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.246 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.685 HD12 ' HB2' ' A' ' 48' ' ' ASP . 32.0 mt -62.85 104.59 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.561 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.496 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -72.1 -25.5 61.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -172.54 -178.02 1.87 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.386 0.612 . . . . 0.0 111.38 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -164.36 136.73 4.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.553 178.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.145 HG23 ' CH2' ' A' ' 105' ' ' TRP . 3.1 pt -96.0 100.32 10.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.303 0.573 . . . . 0.0 110.334 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -63.6 153.24 36.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.86 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.8 -16.15 61.46 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.703 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.2 mp0 -77.77 -50.08 13.09 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.712 0.291 . . . . 0.0 110.727 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -135.07 139.69 32.68 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.766 0.317 . . . . 0.0 110.829 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.15 -50.27 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.693 2.262 . . . . 0.0 113.05 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.7 mp0 -59.56 -49.25 78.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 110.838 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.66 HD13 HD23 ' A' ' 18' ' ' LEU . 4.2 mt -56.04 -48.22 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.92 -30.3 70.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.511 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 m -99.16 3.37 46.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.367 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.474 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -125.32 -71.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.574 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.822 ' CD2' HG21 ' A' ' 6' ' ' VAL . 14.4 mt -71.13 156.24 39.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.466 0.65 . . . . 0.0 112.498 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.71 ' HA ' HD21 ' A' ' 32' ' ' LEU . 5.2 mt-30 -153.95 -175.78 5.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.857 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -92.83 117.55 30.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.888 0.375 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.35 17.53 4.38 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.896 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.685 ' HB2' HD12 ' A' ' 29' ' ' ILE . 6.1 m-20 -115.32 167.35 10.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.783 0.291 . . . . 0.0 110.82 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.469 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.5 mp -137.01 120.61 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.014 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 9.8 mt -74.21 100.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.07 0.462 . . . . 0.0 110.567 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 25' ' ' ILE . 11.2 p -95.71 -3.71 45.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.245 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -144.52 143.96 31.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.984 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.95 ' HB2' HD11 ' A' ' 58' ' ' LEU . 32.0 t80 -150.1 111.74 4.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.954 0.407 . . . . 0.0 111.369 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.68 46.17 26.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.132 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.95 24.26 76.55 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.391 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -126.68 104.47 8.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.693 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.3 117.28 3.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.223 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.95 HD11 ' HB2' ' A' ' 53' ' ' PHE . 8.5 mt -92.8 17.67 10.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.968 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -87.21 127.72 35.15 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.891 0.376 . . . . 0.0 111.226 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.4 -23.84 28.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.791 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.24 153.81 66.25 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.998 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.01 -172.57 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.578 2.186 . . . . 0.0 112.244 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 67' ' ' TYR . 55.0 t80 -91.95 -29.18 16.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.713 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -53.96 -43.43 69.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.58 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.509 ' O ' HD23 ' A' ' 69' ' ' LEU . 10.1 p -65.28 -46.22 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.5 ' N ' HG13 ' A' ' 65' ' ' VAL . 89.4 m -60.21 -49.62 76.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.661 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.59 ' CD1' HG12 ' A' ' 106' ' ' VAL . 16.1 t80 -58.52 -31.97 68.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.599 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.01 -50.85 20.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.213 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.732 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.46 -37.02 82.29 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.473 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 1.014 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.0 m-85 -67.49 -34.02 76.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 34.9 mtmt -82.18 -29.76 31.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.28 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.85 15.93 61.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.637 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.933 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -78.12 138.14 38.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.709 0.29 . . . . 0.0 110.591 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 4.3 p-10 -169.52 100.07 0.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.989 0.424 . . . . 0.0 110.785 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.17 78.32 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.961 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.36 114.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.962 0.411 . . . . 0.0 110.27 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.73 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.82 107.85 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.614 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.7 t -102.71 109.81 21.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.303 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.63 123.77 48.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.57 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tt0 -86.66 106.24 17.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 110.307 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.686 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -95.95 142.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.626 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.439 HG23 ' HG2' ' A' ' 3' ' ' LYS . 94.2 m -108.78 120.81 43.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -103.9 91.43 3.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.405 ' HD3' HD12 ' A' ' 49' ' ' ILE . 56.6 Cg_endo . . . . . 0 C--N 1.343 0.249 0 C-N-CA 122.45 2.1 . . . . 0.0 112.325 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.515 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 17.1 mm-40 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.508 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.0 t80 -79.44 96.1 5.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.145 ' CH2' HG23 ' A' ' 33' ' ' ILE . 54.3 m95 -99.3 139.83 34.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.095 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.59 HG12 ' CD1' ' A' ' 67' ' ' TYR . 10.8 m . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.125 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.736 0.303 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.15 162.21 22.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.912 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.9 mttp -154.43 129.64 9.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.816 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.714 ' CE2' HG22 ' A' ' 6' ' ' VAL . 12.7 p90 -137.71 169.73 17.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.882 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.458 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.46 135.82 49.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.002 0.429 . . . . 0.0 111.069 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.894 HG21 ' CD2' ' A' ' 44' ' ' LEU . 11.3 t -117.07 107.27 21.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.574 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 6.8 p-10 -108.56 127.15 53.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.805 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.96 155.05 40.27 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.955 0.407 . . . . 0.0 110.481 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.94 119.04 11.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.246 0.546 . . . . 0.0 110.459 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.744 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -101.89 149.79 23.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.092 -178.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 16.7 mmtt -138.55 68.94 1.38 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.182 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.09 27.16 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.425 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 96.18 116.9 3.25 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.099 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -169.75 -99.09 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 111.533 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.683 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 26.6 mt-10 -69.37 -4.77 19.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.692 HD22 ' CD2' ' A' ' 18' ' ' LEU . 4.2 mt -44.16 -37.96 3.43 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.832 0.348 . . . . 0.0 110.33 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.551 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 33.37 55.43 0.58 Allowed Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.802 -0.635 . . . . 0.0 114.146 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.731 ' CD1' HD21 ' A' ' 20' ' ' LEU . 1.1 pp -138.33 91.94 2.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.822 0.344 . . . . 0.0 110.365 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -63.07 110.37 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.577 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.731 HD21 ' CD1' ' A' ' 18' ' ' LEU . 3.3 mt -91.62 161.11 15.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.736 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.828 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 7.0 m -142.94 152.2 58.13 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.68 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.69 135.87 70.14 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.661 2.241 . . . . 0.0 112.706 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.559 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -145.3 162.68 36.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.141 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 25' ' ' ILE . 8.0 pt-20 -81.56 -19.76 41.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' A' ' 24' ' ' GLU . 5.8 pt -115.34 -4.61 11.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.753 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.79 -123.39 1.15 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.166 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' SER . 0.9 OUTLIER -140.68 106.05 5.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.774 0.321 . . . . 0.0 111.265 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.4 ' OG1' HG12 ' A' ' 49' ' ' ILE . 88.4 m -70.82 128.61 36.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.598 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.086 HG21 HD12 ' A' ' 32' ' ' LEU . 16.6 mt -71.65 104.92 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.712 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.828 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -69.84 -29.34 66.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.174 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.51 164.34 38.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.086 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -150.87 128.79 11.71 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.262 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.128 HG23 ' CH2' ' A' ' 105' ' ' TRP . 11.5 pt -104.78 100.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.347 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -72.16 159.98 33.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.086 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.56 64.72 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.125 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.555 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -81.54 -41.67 21.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.941 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.683 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -139.29 136.28 17.86 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.197 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.9 -44.46 5.4 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.622 2.214 . . . . 0.0 113.137 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 3.9 mm-40 -64.86 -52.88 54.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.66 0.267 . . . . 0.0 110.943 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.625 HD11 HD23 ' A' ' 16' ' ' LEU . 5.2 mt -54.54 -48.02 70.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.052 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -63.46 -30.21 71.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.552 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 m -97.01 3.24 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.268 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.671 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -131.62 -73.46 0.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.397 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.894 ' CD2' HG21 ' A' ' 6' ' ' VAL . 54.8 mt -72.34 149.28 44.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.077 0.465 . . . . 0.0 111.363 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.64 160.09 42.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.538 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -59.22 105.0 0.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.97 37.27 0.62 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.596 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.571 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -132.65 139.3 47.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.784 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.559 HG21 ' OD1' ' A' ' 23' ' ' ASN . 2.5 mt -110.99 117.26 54.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.977 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.971 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 15.2 mt -77.42 100.22 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.995 0.426 . . . . 0.0 110.539 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.1 p -94.63 0.33 55.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.207 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -148.53 142.05 25.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.029 179.258 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.99 ' HB2' HD11 ' A' ' 58' ' ' LEU . 36.3 t80 -145.68 108.43 4.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.86 0.362 . . . . 0.0 111.061 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 51.88 53.95 11.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.949 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.43 69.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.371 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -123.33 103.25 8.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.802 0.334 . . . . 0.0 110.604 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.28 113.32 1.52 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.332 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.99 HD11 ' HB2' ' A' ' 53' ' ' PHE . 15.1 mt -88.61 9.93 22.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -68.42 145.91 53.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.879 0.371 . . . . 0.0 111.085 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.96 26.11 47.47 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.633 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 58' ' ' LEU . 21.6 mt -116.73 148.12 41.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.686 0.279 . . . . 0.0 110.849 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.64 -167.38 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.551 2.167 . . . . 0.0 112.227 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.9 t80 -97.77 -26.56 14.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.767 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -57.43 -47.93 80.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.968 0.413 . . . . 0.0 110.273 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.528 ' O ' HD23 ' A' ' 69' ' ' LEU . 22.6 m -63.8 -47.03 92.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.087 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.468 ' N ' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -59.27 -53.8 54.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.699 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.553 ' CD1' HG12 ' A' ' 106' ' ' VAL . 21.8 t80 -56.02 -31.14 62.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.692 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.33 -51.08 18.76 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.652 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.74 -34.76 76.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.851 0.358 . . . . 0.0 110.356 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.971 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.8 m-85 -69.06 -34.0 74.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.466 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 7.4 mtpt -81.31 -32.83 32.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.358 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.41 -26.47 57.09 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.51 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.828 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -45.13 139.52 3.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.881 0.372 . . . . 0.0 111.412 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -167.11 99.6 0.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.72 80.12 0.84 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.819 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.19 112.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 110.158 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.828 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.42 107.96 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.752 -178.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 t -98.5 114.43 26.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.45 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.82 122.21 42.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.666 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -83.31 102.93 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.669 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -95.26 142.45 13.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.739 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 53.2 m -108.86 126.06 52.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.014 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -108.71 96.37 19.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.236 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 82' ' ' THR . 41.5 Cg_exo . . . . . 0 C--N 1.345 0.394 0 C-N-CA 122.564 2.176 . . . . 0.0 112.202 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.477 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 6.9 mm-40 . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.086 0.47 . . . . 0.0 111.852 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.525 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.6 t80 -83.18 96.09 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.128 ' CH2' HG23 ' A' ' 33' ' ' ILE . 27.7 m95 -103.39 126.52 50.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.046 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.553 HG12 ' CD1' ' A' ' 67' ' ' TYR . 8.6 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.079 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.822 0.344 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.27 157.13 38.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.699 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 4.5 mttt -151.43 129.68 11.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.973 0.416 . . . . 0.0 110.992 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.798 ' CE2' HG22 ' A' ' 6' ' ' VAL . 26.9 p90 -138.13 170.71 15.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.694 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.461 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.56 135.95 48.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.01 0.433 . . . . 0.0 111.349 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.893 HG21 ' CD2' ' A' ' 44' ' ' LEU . 13.3 t -116.77 107.04 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.604 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 38.9 t0 -110.29 127.22 54.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.908 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.708 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.92 157.57 43.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.57 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.02 110.05 5.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.962 0.41 . . . . 0.0 110.889 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.803 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -95.18 150.91 19.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.324 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 20.5 mmtt -138.45 69.28 1.38 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.5 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.4 22.25 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.253 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.29 113.97 1.38 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -162.28 -94.23 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.963 0.411 . . . . 0.0 111.351 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 15.1 mt-10 -69.15 -5.07 20.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.979 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.625 HD21 HD21 ' A' ' 8' ' ' LEU . 2.7 mt -45.09 -40.7 7.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.138 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.521 ' HA2' HD11 ' A' ' 33' ' ' ILE . . . 34.24 53.08 0.73 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 114.485 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.779 HD12 HD11 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -136.88 92.88 2.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.035 0.445 . . . . 0.0 110.232 178.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.529 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 6.0 t -63.92 122.33 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.05 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.779 HD11 HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -100.98 169.33 9.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.438 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.22 167.72 13.82 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.358 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.43 121.63 6.92 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.489 2.126 . . . . 0.0 112.59 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.437 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -133.67 162.52 31.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.03 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.537 ' HG3' HG23 ' A' ' 25' ' ' ILE . 10.7 pt-20 -79.32 -32.84 43.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.537 HG23 ' HG3' ' A' ' 24' ' ' GLU . 3.6 pt -99.81 -7.09 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.867 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.27 -123.57 1.12 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.243 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -140.55 106.2 5.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.93 0.395 . . . . 0.0 111.195 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.6 m -66.63 132.08 47.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.548 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.928 HG21 HD12 ' A' ' 32' ' ' LEU . 43.3 mt -68.58 104.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.903 0.382 . . . . 0.0 110.583 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.529 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -68.19 -23.38 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.223 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 5.5 m-20 -171.83 174.38 4.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.995 0.426 . . . . 0.0 111.13 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.928 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -152.05 127.28 9.85 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.535 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.067 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.0 pt -101.32 100.59 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.212 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -65.91 173.85 2.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.822 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.44 18.93 72.16 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.608 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -111.25 -46.28 3.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.767 0.318 . . . . 0.0 110.289 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -142.75 139.61 17.36 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.368 179.003 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.5 -49.36 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 113.085 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 43' ' ' LYS . 30.4 mm-40 -61.12 -51.48 68.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.541 HD11 HD23 ' A' ' 16' ' ' LEU . 6.1 mt -54.17 -50.89 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.056 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.41 -30.21 69.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.562 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 m -96.92 2.48 51.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.255 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.606 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.56 -73.58 0.58 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.867 0.365 . . . . 0.0 111.759 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.893 ' CD2' HG21 ' A' ' 6' ' ' VAL . 54.0 mt -72.16 149.52 44.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.006 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -147.4 -175.8 4.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.487 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -87.16 115.04 24.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.09 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.23 31.84 1.78 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.705 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.53 162.63 25.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.649 0.261 . . . . 0.0 110.748 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.437 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.2 mp -133.18 119.21 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.062 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.004 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.7 mt -74.5 100.49 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 110.51 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -93.94 -4.53 49.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.154 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.433 ' CB ' ' HB2' ' A' ' 80' ' ' GLU . 2.0 mttt -144.56 144.29 31.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.968 ' HB2' HD11 ' A' ' 58' ' ' LEU . 51.3 t80 -149.01 110.89 4.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.917 0.389 . . . . 0.0 111.194 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.83 46.05 23.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.75 21.46 76.51 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.47 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -123.62 107.32 11.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.779 0.323 . . . . 0.0 110.758 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.55 118.57 4.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.318 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.968 HD11 ' HB2' ' A' ' 53' ' ' PHE . 12.4 mt -92.6 16.93 11.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.32 144.76 42.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.965 0.412 . . . . 0.0 111.195 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.19 20.53 58.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.695 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 58' ' ' LEU . 81.0 mt -115.4 137.73 23.26 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.54 0.21 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.45 -160.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.421 2.081 . . . . 0.0 112.1 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -103.32 -24.96 13.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -56.01 -47.81 77.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.562 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.505 ' O ' HD23 ' A' ' 69' ' ' LEU . 26.8 m -67.44 -45.63 85.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.817 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.493 ' N ' HG23 ' A' ' 65' ' ' VAL . 15.8 m -56.56 -48.4 77.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.665 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 22.0 t80 -64.75 -30.89 71.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.747 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.45 -50.9 41.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.125 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -68.73 -35.33 76.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.938 0.399 . . . . 0.0 110.444 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 1.004 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 6.3 m-85 -70.31 -27.38 64.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.299 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HG3' HG12 ' A' ' 106' ' ' VAL . 1.5 mtmp? -84.12 -41.68 16.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.14 -22.46 76.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.845 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.803 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . . . -43.26 127.12 4.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.876 0.37 . . . . 0.0 111.698 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -156.05 104.21 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.87 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.44 85.39 1.76 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.271 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.36 115.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 110.357 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.794 HG11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -129.84 107.81 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.648 -179.023 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -99.92 112.86 25.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.314 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.4 124.48 47.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.434 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' OE2' ' ND2' ' A' ' 5' ' ' ASN . 1.5 tt0 -86.87 104.53 16.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.928 0.394 . . . . 0.0 110.047 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.806 HG11 HD22 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -95.17 143.05 12.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.522 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.415 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 98.0 m -108.42 120.17 41.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.638 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -103.5 92.52 4.12 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.505 2.137 . . . . 0.0 112.222 179.77 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.519 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 10.9 mm-40 . . . . . 0 N--CA 1.456 -0.138 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.523 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 2.6 t80 -86.82 96.46 10.21 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.056 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.067 ' CH2' HG23 ' A' ' 33' ' ' ILE . 18.1 m95 -103.34 139.32 38.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.575 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.52 HG23 HD12 ' A' ' 16' ' ' LEU . 11.4 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.111 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 84' ' ' PRO . 10.4 mt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.695 0.283 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -77.54 157.54 30.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.985 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.483 ' HG2' HG23 ' A' ' 82' ' ' THR . 10.2 mttt -154.87 129.71 9.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.666 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.857 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.0 p90 -138.44 171.85 13.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.194 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.455 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.57 135.99 48.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.96 0.409 . . . . 0.0 111.256 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.912 HG21 ' CD2' ' A' ' 44' ' ' LEU . 3.5 t -120.19 107.71 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.827 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.581 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 11.9 p30 -108.5 127.18 53.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.718 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.713 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -145.56 154.49 42.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.931 0.395 . . . . 0.0 110.553 179.064 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.2 111.92 4.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.059 0.457 . . . . 0.0 110.691 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.857 ' HE2' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -97.4 148.47 23.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.675 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.423 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 21.5 mmtt -138.12 69.29 1.39 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.278 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.71 27.69 9.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.184 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.66 111.52 0.56 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' CG ' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.64 -96.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 111.263 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 36' ' ' GLN . 3.6 mt-10 -67.31 -5.73 15.53 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.032 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.857 HD22 ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -46.1 -43.46 14.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.768 0.318 . . . . 0.0 110.445 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.727 ' CA ' HD11 ' A' ' 33' ' ' ILE . . . 33.46 61.82 0.43 Allowed Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 114.611 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.589 HD12 HD21 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -141.96 104.19 4.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.933 0.397 . . . . 0.0 110.375 178.487 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 t -71.55 119.39 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.148 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.589 HD21 HD12 ' A' ' 18' ' ' LEU . 76.4 mt -108.86 169.17 8.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.551 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -148.16 167.79 12.53 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.529 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.56 135.89 32.09 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.502 2.135 . . . . 0.0 112.747 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.49 162.53 36.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.603 ' HG3' HG23 ' A' ' 25' ' ' ILE . 12.6 pt-20 -79.07 -21.53 46.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.226 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.603 HG23 ' HG3' ' A' ' 24' ' ' GLU . 5.5 pt -114.81 5.38 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.713 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.95 -123.74 1.41 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.129 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 21' ' ' SER . 1.9 p -140.47 109.05 5.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.922 0.392 . . . . 0.0 111.155 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.499 ' N ' HG23 ' A' ' 49' ' ' ILE . 53.2 m -72.04 136.9 46.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.04 HG21 HD12 ' A' ' 32' ' ' LEU . 51.2 mt -73.58 104.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.625 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.83 66.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 3.4 m-20 -161.3 168.37 24.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.04 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -151.28 126.76 10.07 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.244 0.545 . . . . 0.0 111.967 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.101 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -96.4 100.72 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.224 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -73.67 136.67 43.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.037 0.446 . . . . 0.0 111.368 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.65 32.98 4.59 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.743 ' HG3' ' O ' ' A' ' 33' ' ' ILE . 1.1 pp0? -122.72 -21.9 5.5 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -161.19 143.86 9.34 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.106 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.04 -48.42 2.76 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.483 2.122 . . . . 0.0 112.915 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 52.6 mm-40 -67.62 -53.26 29.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 110.838 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.3 mt -54.7 -40.38 51.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.414 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.97 -30.66 65.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.806 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -98.17 3.64 49.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.163 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.577 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.34 -72.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.959 0.409 . . . . 0.0 111.571 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.912 ' CD2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -59.0 149.42 27.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.669 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -153.94 146.81 24.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.58 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -59.54 112.43 1.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.67 38.16 0.93 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.585 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.49 155.01 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 110.821 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 28' ' ' THR . 1.1 mp -124.62 119.42 56.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.983 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.98 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.3 mt -74.57 100.52 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.104 0.478 . . . . 0.0 110.338 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 p -97.36 26.81 4.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.924 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' CB ' ' HB2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -172.71 144.36 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.091 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.899 ' HB2' HD11 ' A' ' 58' ' ' LEU . 64.3 t80 -151.54 108.5 3.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 111.066 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 53.22 52.55 13.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.792 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.93 20.91 71.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.428 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -122.56 103.94 9.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.839 0.352 . . . . 0.0 110.766 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.43 115.58 2.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.276 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 53' ' ' PHE . 13.7 mt -87.64 7.85 27.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -67.74 146.13 54.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.841 0.353 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.73 23.66 55.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.666 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 58' ' ' LEU . 38.9 mt -116.84 149.13 43.49 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.653 0.263 . . . . 0.0 110.896 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.475 ' HG2' HG23 ' A' ' 65' ' ' VAL . 45.3 Cg_endo -68.38 -169.22 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.553 2.169 . . . . 0.0 112.299 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 67' ' ' TYR . 11.3 t80 -96.97 -26.43 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.785 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -57.08 -46.33 82.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.414 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.557 HG12 HD23 ' A' ' 69' ' ' LEU . 28.9 t -68.4 -47.03 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.763 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 88.3 m -56.54 -53.74 54.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.586 ' CE1' HG13 ' A' ' 106' ' ' VAL . 6.2 t80 -60.95 -30.98 70.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.671 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.05 36.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.125 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.722 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -69.55 -33.4 72.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.235 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.98 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.6 m-85 -72.15 -27.26 62.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.299 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HG3' HG12 ' A' ' 106' ' ' VAL . 18.0 mtmt -85.22 -37.74 19.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.701 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.52 -19.39 68.72 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.056 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HB3' ' CE ' ' A' ' 10' ' ' LYS . . . -44.18 131.28 6.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.711 0.291 . . . . 0.0 111.676 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -157.2 102.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.2 82.8 1.3 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.307 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.29 115.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.882 0.373 . . . . 0.0 110.509 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.807 HG11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.78 107.95 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.964 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -98.89 116.02 30.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.195 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.54 128.43 52.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.303 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -88.77 105.46 17.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 0.0 110.252 179.287 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.676 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -95.14 142.86 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.249 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.483 HG23 ' HG2' ' A' ' 3' ' ' LYS . 95.9 m -108.51 119.61 40.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.608 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.99 89.89 1.76 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.044 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.567 ' HA ' HD22 ' A' ' 1' ' ' LEU . 38.3 Cg_endo . . . . . 0 C--N 1.345 0.357 0 C-N-CA 122.445 2.096 . . . . 0.0 112.075 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.516 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 15.2 mm100 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 121.096 0.474 . . . . 0.0 112.167 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 1.1 t80 -84.74 96.23 9.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.053 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.101 ' CH2' HG23 ' A' ' 33' ' ' ILE . 18.7 m95 -105.94 135.37 47.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.183 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.586 HG13 ' CE1' ' A' ' 67' ' ' TYR . 16.0 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.503 HD23 ' HG3' ' A' ' 84' ' ' PRO . 1.1 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.707 0.289 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.411 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 2.4 tp10 -79.81 159.46 26.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 11.0 mttt -146.18 129.43 16.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.682 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.667 ' CE2' HG22 ' A' ' 6' ' ' VAL . 12.6 p90 -137.07 169.25 18.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.055 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.438 ' ND2' ' OE1' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.57 135.92 49.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.316 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.699 HG21 ' CD2' ' A' ' 44' ' ' LEU . 17.0 t -115.56 107.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.471 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 12.4 t0 -112.69 127.28 56.08 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.675 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -153.63 157.84 40.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 110.735 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.67 123.62 20.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.118 0.485 . . . . 0.0 111.005 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.936 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -108.02 128.37 54.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.297 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 4.1 mmtp -118.36 68.52 0.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.892 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.76 78.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.262 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.426 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 46.91 99.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.276 -0.42 . . . . 0.0 114.018 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.453 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 6.3 ptpt -157.06 -99.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 16.6 mt-10 -69.15 -5.3 21.57 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.739 HD22 HD21 ' A' ' 18' ' ' LEU . 3.0 mt -45.48 -30.61 1.46 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.063 0.458 . . . . 0.0 109.803 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.567 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 24.79 62.41 0.05 OUTLIER Glycine 0 CA--C 1.519 0.314 0 N-CA-C 115.453 0.941 . . . . 0.0 115.453 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.777 HD22 ' CD1' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -146.33 91.83 2.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.175 0.512 . . . . 0.0 110.252 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 1.7 t -60.17 115.22 3.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.675 HD13 ' SG ' ' A' ' 27' ' ' CYS . 62.7 mt -97.37 163.75 12.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.313 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -141.43 166.85 19.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.488 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.47 130.05 16.69 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.351 2.034 . . . . 0.0 112.682 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.496 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -141.01 162.4 35.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -26.59 37.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.299 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.543 HD11 HD13 ' A' ' 49' ' ' ILE . 3.2 pt -106.84 -7.04 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.826 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.64 -125.14 1.24 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.854 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.675 ' SG ' HD13 ' A' ' 20' ' ' LEU . 25.2 p -140.61 106.07 5.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.906 0.384 . . . . 0.0 111.162 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.408 ' OG1' HG12 ' A' ' 49' ' ' ILE . 87.8 m -66.03 134.44 52.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.458 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.048 HG21 HD12 ' A' ' 32' ' ' LEU . 45.8 mt -75.88 104.88 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.559 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.43 -26.77 63.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.989 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.3 OUTLIER -161.01 169.8 21.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.046 0.451 . . . . 0.0 111.221 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.048 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -154.25 124.68 6.98 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.267 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.09 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.1 pt -96.43 100.49 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.194 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -68.9 153.59 43.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.981 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.37 -23.02 36.78 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.787 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.9 mp0 -67.63 -46.74 71.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.77 0.319 . . . . 0.0 110.811 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -138.24 141.82 33.17 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.477 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.19 -49.04 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.522 2.148 . . . . 0.0 112.96 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 26.9 mm-40 -62.3 -50.95 69.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.338 . . . . 0.0 110.962 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.668 HD13 HD23 ' A' ' 18' ' ' LEU . 4.4 mt -54.47 -50.1 60.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.243 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -60.96 -30.48 70.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.565 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -97.98 3.41 49.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.149 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HD3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.79 -72.99 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.918 0.389 . . . . 0.0 111.625 -178.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.777 ' CD1' HD22 ' A' ' 18' ' ' LEU . 87.3 mt -75.8 145.76 40.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.744 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.67 163.53 38.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.473 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -59.41 110.88 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.92 0.39 . . . . 0.0 110.991 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.67 46.89 0.55 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.682 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.435 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -144.03 139.43 28.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 110.711 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.543 HD13 HD11 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -112.47 117.59 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.23 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.786 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.0 mt -76.85 100.69 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 0.0 110.601 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.52 HG22 HG13 ' A' ' 25' ' ' ILE . 8.7 p -98.18 16.0 22.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.164 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 7.2 mttt -162.42 132.68 4.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.003 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.941 ' HB2' HD11 ' A' ' 58' ' ' LEU . 58.3 t80 -136.78 108.76 7.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 111.067 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 55.27 52.93 10.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.851 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.62 17.51 66.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.358 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -121.01 103.4 9.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 110.634 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . . . -55.49 120.38 7.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.436 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.941 HD11 ' HB2' ' A' ' 53' ' ' PHE . 9.5 mt -92.82 18.11 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.807 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -73.77 142.83 46.22 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.948 0.404 . . . . 0.0 111.312 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.77 18.22 52.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.753 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 58' ' ' LEU . 50.9 mt -109.69 137.85 20.49 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.701 0.251 . . . . 0.0 110.826 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.72 -159.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.302 2.001 . . . . 0.0 112.148 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -106.0 -23.7 12.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.016 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -54.98 -48.8 72.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.3 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.507 ' O ' HD23 ' A' ' 69' ' ' LEU . 30.8 m -68.47 -44.36 83.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.823 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.461 ' N ' HG23 ' A' ' 65' ' ' VAL . 1.5 m -55.95 -54.05 49.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.729 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.548 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 5.1 t80 -62.13 -30.97 71.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.926 0.393 . . . . 0.0 110.437 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.63 -51.13 37.72 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.712 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.37 -42.27 83.72 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.361 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.786 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 11.4 m-85 -63.33 -31.13 72.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 25.9 mtmt -83.03 -31.95 27.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.037 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -88.83 11.04 70.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.734 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.936 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -76.8 136.93 38.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.663 0.268 . . . . 0.0 110.484 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 4.6 p-10 -168.13 100.72 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.144 0.497 . . . . 0.0 110.886 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.91 77.68 0.74 Allowed Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.919 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.08 115.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.141 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.75 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.22 107.66 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.727 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 t -99.5 115.15 28.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.46 120.89 35.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -81.83 111.24 17.87 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.681 HG11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.69 142.28 17.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.95 -178.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.7 m -109.06 118.39 36.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.289 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -107.96 97.23 20.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.139 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HG3' HD23 ' A' ' 1' ' ' LEU . 63.0 Cg_exo . . . . . 0 C--N 1.345 0.343 0 C-N-CA 122.55 2.166 . . . . 0.0 112.383 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.5 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.4 mm-40 . . . . . 0 C--O 1.232 0.132 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.548 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.5 t80 -85.03 96.18 9.32 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.09 ' CH2' HG23 ' A' ' 33' ' ' ILE . 20.0 m95 -104.14 132.05 50.8 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.197 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 70' ' ' PHE . 20.4 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.131 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.844 0.354 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.88 154.07 23.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.636 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -147.75 129.65 15.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.042 0.448 . . . . 0.0 110.929 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.762 ' CE2' HG22 ' A' ' 6' ' ' VAL . 29.6 p90 -138.23 172.09 13.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.666 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.01 136.02 49.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 111.813 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.793 HG21 ' CD2' ' A' ' 44' ' ' LEU . 15.9 t -116.3 107.28 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.124 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.591 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.6 p30 -114.44 127.4 55.81 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.779 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -155.28 160.95 41.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.753 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.49 127.63 33.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.803 ' CE ' HD13 ' A' ' 16' ' ' LEU . 4.2 tmtt? -112.5 136.97 51.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.26 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HB2' ' HG2' ' A' ' 14' ' ' LYS . 13.2 mmtt -131.07 68.92 1.48 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.59 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.405 ' H ' ' HB3' ' A' ' 74' ' ' ASN . . . 34.56 82.94 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.387 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.33 57.66 8.99 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.632 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.464 ' HG2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -98.48 -138.41 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.862 0.363 . . . . 0.0 111.198 -179.033 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.0 mt-10 -69.19 -4.54 18.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.803 HD13 ' CE ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -44.68 -44.2 8.91 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.286 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.649 ' HA3' HD11 ' A' ' 33' ' ' ILE . . . 23.86 68.05 0.03 OUTLIER Glycine 0 CA--C 1.518 0.25 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.592 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.689 HD21 ' HG ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -133.1 92.91 3.09 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.049 0.452 . . . . 0.0 109.895 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.8 t -56.48 113.73 1.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.179 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.431 HD21 HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -94.26 166.82 11.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.259 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.748 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 1.2 m -143.32 157.49 59.72 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.92 127.0 16.86 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.427 2.085 . . . . 0.0 112.574 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.455 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -139.7 162.59 34.75 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.823 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -81.35 -26.58 35.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.392 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.463 HG13 HG22 ' A' ' 51' ' ' THR . 2.9 pt -106.57 -8.41 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.895 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.74 -125.05 1.18 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.125 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -140.6 105.96 5.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.916 0.389 . . . . 0.0 111.189 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.405 ' OG1' HG12 ' A' ' 49' ' ' ILE . 85.0 m -67.33 126.91 30.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.516 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.098 HG21 HD12 ' A' ' 32' ' ' LEU . 24.5 mt -69.02 104.91 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.797 0.332 . . . . 0.0 110.685 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.748 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -68.15 -29.0 67.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.423 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 15.3 m-20 -163.88 167.25 20.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.098 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -149.73 132.74 16.19 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.349 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.124 HG23 ' CH2' ' A' ' 105' ' ' TRP . 4.3 pt -99.03 100.62 10.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.623 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -70.52 166.19 21.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.931 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.73 -0.39 88.28 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.009 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.533 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.32 -44.19 7.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.77 0.319 . . . . 0.0 110.453 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -139.59 139.6 22.74 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.998 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.53 -48.83 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.544 2.163 . . . . 0.0 112.834 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 43' ' ' LYS . 75.6 mm-40 -59.58 -51.23 70.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.654 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.572 HG22 HD21 ' A' ' 32' ' ' LEU . 6.2 mt -57.98 -44.54 87.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.972 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.87 -30.34 71.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.059 0.457 . . . . 0.0 110.218 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 m -99.96 3.41 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.074 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.495 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -126.32 -74.6 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.43 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.849 HD22 HG11 ' A' ' 81' ' ' VAL . 46.9 mt -76.41 151.88 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.582 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.86 -175.88 5.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.391 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -80.98 109.41 15.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.726 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.35 27.29 2.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.689 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.681 ' HB2' HD12 ' A' ' 29' ' ' ILE . 1.7 m-20 -121.2 139.28 53.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 110.681 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.455 HG21 ' OD1' ' A' ' 23' ' ' ASN . 2.0 mt -112.31 117.65 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.16 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.988 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.9 mt -75.6 100.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.398 . . . . 0.0 110.683 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.463 HG22 HG13 ' A' ' 25' ' ' ILE . 8.3 p -97.76 6.33 48.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.376 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -152.67 139.38 18.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.931 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.938 ' HB2' HD11 ' A' ' 58' ' ' LEU . 28.8 t80 -149.08 111.76 4.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.012 0.434 . . . . 0.0 111.217 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 55.62 48.9 17.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.71 23.03 68.69 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.321 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -125.4 98.03 5.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.889 0.376 . . . . 0.0 110.473 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.87 120.27 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.369 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.938 HD11 ' HB2' ' A' ' 53' ' ' PHE . 7.4 mt -92.37 19.87 6.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.977 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -77.02 143.28 39.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.919 0.39 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.33 24.51 61.43 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.732 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 58' ' ' LEU . 26.4 mt -116.21 144.42 32.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.576 0.227 . . . . 0.0 110.906 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.84 -170.62 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.466 2.111 . . . . 0.0 111.902 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -93.43 -26.4 17.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.972 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -43.42 88.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 0.0 110.528 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.543 ' O ' HD23 ' A' ' 69' ' ' LEU . 11.1 p -71.22 -47.13 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.998 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.505 ' N ' HG13 ' A' ' 65' ' ' VAL . 94.4 m -58.59 -53.81 54.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 110.567 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.541 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 73.2 t80 -61.32 -30.7 70.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.679 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.03 -51.25 41.08 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.44 -41.11 85.27 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.259 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.988 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.7 m-85 -61.64 -35.23 77.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.497 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 2.3 mtpt -78.36 -34.06 48.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.065 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.92 8.67 65.57 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.601 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.698 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -74.84 137.76 42.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.768 0.318 . . . . 0.0 110.558 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.405 ' HB3' ' H ' ' A' ' 12' ' ' ALA . 4.6 p-10 -176.41 85.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.078 0.466 . . . . 0.0 110.746 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.2 71.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.183 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.43 96.5 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.011 0.434 . . . . 0.0 110.711 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.698 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -101.12 150.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.373 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.2 t -140.68 117.93 11.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.484 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.0 124.77 38.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -88.25 105.2 17.39 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.437 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.849 HG11 HD22 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -95.12 142.76 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.15 -178.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 m -108.57 118.98 38.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.414 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -102.82 94.04 4.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.201 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 C--N 1.344 0.308 0 C-N-CA 122.475 2.117 . . . . 0.0 112.107 179.763 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.517 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 7.2 mm-40 . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.541 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.0 t80 -81.03 96.05 7.01 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.124 ' CH2' HG23 ' A' ' 33' ' ' ILE . 47.3 m95 -99.21 143.6 29.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.51 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' A' ' 70' ' ' PHE . 20.4 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.24 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.766 0.317 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.77 159.04 30.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.864 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.407 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 9.7 mttt -153.68 129.57 10.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.811 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.9 p90 -138.17 170.7 15.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.748 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.58 135.78 49.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.977 0.417 . . . . 0.0 111.366 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.811 HG22 ' CE2' ' A' ' 4' ' ' PHE . 14.3 t -116.6 106.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.213 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 9.0 p-10 -113.82 127.07 55.85 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.085 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.695 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -154.05 156.26 37.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 110.742 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.18 117.32 8.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.067 0.46 . . . . 0.0 111.151 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.808 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -101.47 142.0 33.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.132 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HB2' ' NZ ' ' A' ' 14' ' ' LYS . 4.7 mmtp -126.95 69.49 1.27 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.533 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.73 21.49 5.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.34 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.85 113.01 1.45 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.777 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -163.07 -93.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.893 0.378 . . . . 0.0 110.925 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 25.0 mt-10 -69.44 -4.96 20.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.674 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.872 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -44.97 -31.6 1.34 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.114 0.483 . . . . 0.0 109.94 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.543 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 28.39 61.82 0.12 Allowed Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.514 -0.766 . . . . 0.0 114.618 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -142.48 91.96 2.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.898 0.38 . . . . 0.0 110.273 178.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -67.92 109.33 3.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.424 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.607 HD11 HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -84.5 163.18 19.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.773 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.71 160.01 68.14 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.031 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.33 120.66 7.13 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.518 2.145 . . . . 0.0 112.759 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.61 162.7 33.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.002 0.429 . . . . 0.0 111.192 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.592 ' HG3' HG23 ' A' ' 25' ' ' ILE . 16.6 pt-20 -79.8 -39.43 30.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.315 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.592 HG23 ' HG3' ' A' ' 24' ' ' GLU . 1.8 pt -90.24 -12.99 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.863 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.95 -125.23 1.13 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.256 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -140.46 106.08 5.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.916 0.389 . . . . 0.0 110.851 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 94.5 m -63.7 134.68 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.766 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 48' ' ' ASP . 36.3 mt -74.41 104.54 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.916 0.389 . . . . 0.0 110.141 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.29 -33.76 61.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.705 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 19' ' ' SER . 4.1 m-20 -162.24 174.01 13.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.278 0.561 . . . . 0.0 111.495 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.706 HD21 ' CA ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -157.83 136.62 11.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.93 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.137 HG23 ' CH2' ' A' ' 105' ' ' TRP . 4.2 pt -95.63 99.98 10.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 109.673 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -66.91 147.5 53.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.012 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.24 -17.63 56.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.768 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 2.2 mp0 -76.31 -48.45 20.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.733 0.302 . . . . 0.0 110.938 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -134.98 139.74 32.98 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.844 0.354 . . . . 0.0 110.692 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.99 -48.62 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.789 2.326 . . . . 0.0 113.112 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 43' ' ' LYS . 16.3 mm-40 -62.54 -48.42 79.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.0 mt -58.11 -42.71 83.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -30.25 70.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.386 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -99.85 3.55 44.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.351 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -123.36 -70.51 0.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.494 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.71 ' CD2' HG21 ' A' ' 6' ' ' VAL . 15.1 mt -72.07 156.99 38.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.398 0.618 . . . . 0.0 112.409 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.706 ' CA ' HD21 ' A' ' 32' ' ' LEU . 1.2 tt0 -153.94 -175.85 5.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.978 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.2 mtp-105 -91.87 99.79 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.47 39.28 0.21 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.586 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.606 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -131.61 174.62 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.6 mt -145.82 118.53 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.992 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 7.1 mt -73.93 100.23 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.142 0.496 . . . . 0.0 110.402 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.467 HG22 HG13 ' A' ' 25' ' ' ILE . 16.9 p -98.73 2.43 47.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.054 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.7 mttt -150.27 139.55 21.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.816 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.952 ' HB2' HD11 ' A' ' 58' ' ' LEU . 41.8 t80 -147.18 113.09 5.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.932 0.396 . . . . 0.0 111.264 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 55.54 48.07 19.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.18 21.7 72.13 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.413 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -127.33 104.95 8.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.371 . . . . 0.0 110.669 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.26 125.42 20.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.251 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.952 HD11 ' HB2' ' A' ' 53' ' ' PHE . 7.4 mt -96.52 27.45 3.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.802 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -82.83 142.42 31.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.04 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.7 21.81 65.5 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.661 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 58' ' ' LEU . 56.8 mt -117.29 136.26 23.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.501 0.191 . . . . 0.0 110.811 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.4 -161.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.419 2.079 . . . . 0.0 112.065 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -98.83 -26.66 14.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.026 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -57.41 -46.02 83.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.406 ' O ' HD23 ' A' ' 69' ' ' LEU . 25.7 t -64.1 -51.93 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.973 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 90.5 m -56.91 -50.2 73.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.584 ' CD1' HG12 ' A' ' 106' ' ' VAL . 29.3 t80 -59.43 -31.12 69.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.991 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.76 -50.85 26.35 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.726 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.76 -32.48 72.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 110.523 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.992 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 4.7 m-85 -73.82 -28.55 61.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.269 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 21.6 mtmt -83.44 -36.68 24.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.802 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.81 -18.0 68.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.102 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.819 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -46.44 130.81 11.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.894 0.378 . . . . 0.0 111.588 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -160.9 102.74 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.736 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.99 85.44 1.64 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.165 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.08 109.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.552 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.819 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -122.91 107.82 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.515 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.6 t -100.72 112.0 24.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.295 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.54 123.44 43.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.444 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.8 104.51 16.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.673 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.7 OUTLIER -95.09 142.54 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.588 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.407 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 51.6 m -108.94 123.45 49.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.369 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -104.24 92.93 5.08 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.159 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 C--N 1.345 0.354 0 C-N-CA 122.622 2.214 . . . . 0.0 112.235 179.87 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.514 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 5.6 mm-40 . . . . . 0 CA--C 1.523 -0.072 0 CA-C-O 121.074 0.464 . . . . 0.0 111.98 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.519 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.1 t80 -83.3 96.44 8.49 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.137 ' CH2' HG23 ' A' ' 33' ' ' ILE . 38.4 m95 -102.96 138.75 39.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.696 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.584 HG12 ' CD1' ' A' ' 67' ' ' TYR . 15.7 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.08 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.753 0.311 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -78.31 157.62 29.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 5.9 mttp -149.57 129.61 13.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.794 ' CE2' HG22 ' A' ' 6' ' ' VAL . 24.6 p90 -137.74 169.6 17.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.616 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.453 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -108.56 135.78 49.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.081 0.467 . . . . 0.0 111.142 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.89 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.4 t -115.8 107.16 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.506 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.0 p30 -110.06 127.19 54.7 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.796 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.715 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.68 155.37 40.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 110.61 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.51 113.86 6.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.94 0.4 . . . . 0.0 110.823 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.866 ' HE2' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -98.87 140.52 32.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.545 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.414 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 6.1 mmtp -127.55 69.34 1.31 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.304 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.18 23.43 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.275 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.27 113.62 1.17 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.612 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -161.78 -94.15 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 36' ' ' GLN . 24.0 mt-10 -69.24 -5.66 24.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.732 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.866 HD22 ' HE2' ' A' ' 10' ' ' LYS . 1.7 tp -45.53 -31.44 1.81 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.008 0.432 . . . . 0.0 109.843 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.568 ' HA2' HD11 ' A' ' 33' ' ' ILE . . . 23.24 59.59 0.04 OUTLIER Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.154 -0.93 . . . . 0.0 114.953 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 18' ' ' LEU . 2.8 pp -138.79 99.34 3.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.073 0.464 . . . . 0.0 110.303 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -68.98 115.86 8.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.598 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.863 HD13 ' SG ' ' A' ' 27' ' ' CYS . 62.2 mt -98.81 161.79 13.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.023 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.79 166.32 28.19 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.425 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.01 98.56 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.711 2.274 . . . . 0.0 113.439 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -107.72 162.83 13.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.916 0.389 . . . . 0.0 111.358 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.773 ' HG3' HG23 ' A' ' 25' ' ' ILE . 12.8 pt-20 -73.76 -42.31 61.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.391 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.773 HG23 ' HG3' ' A' ' 24' ' ' GLU . 3.3 pt -92.68 -7.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.874 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.31 -130.22 1.93 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.858 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.863 ' SG ' HD13 ' A' ' 20' ' ' LEU . 26.0 p -140.64 106.39 5.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.904 0.383 . . . . 0.0 111.357 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.483 ' OG1' HG12 ' A' ' 49' ' ' ILE . 69.0 m -69.52 133.21 47.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.628 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.012 HG21 HD12 ' A' ' 32' ' ' LEU . 39.8 mt -69.08 104.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.282 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.67 -24.41 61.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.963 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -162.48 163.73 27.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.749 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.012 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -149.31 124.82 10.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.313 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.107 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.0 pt -96.45 100.53 10.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.256 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.28 154.25 42.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.025 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.5 -21.68 43.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.754 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.66 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 6.0 mp0 -68.93 -48.55 63.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.678 0.275 . . . . 0.0 110.829 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -138.08 139.29 25.4 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.55 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.54 -43.72 3.81 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.628 2.218 . . . . 0.0 112.871 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' LYS . 19.0 mp0 -65.3 -51.72 58.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.966 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.589 HG22 HD21 ' A' ' 32' ' ' LEU . 3.8 mt -55.62 -49.36 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.964 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -61.34 -30.22 70.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.2 m -96.76 1.84 51.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.072 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.623 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -127.89 -74.16 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 0.0 111.504 -179.173 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.89 ' CD2' HG21 ' A' ' 6' ' ' VAL . 76.4 mt -73.53 148.31 43.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.418 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -153.17 158.61 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.635 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -58.89 98.27 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.982 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.91 44.81 0.13 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.604 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.4 146.57 30.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.935 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.483 HG12 ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -116.21 117.78 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.867 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.2 mt -74.7 100.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.005 0.431 . . . . 0.0 110.136 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.44 HG22 HG13 ' A' ' 25' ' ' ILE . 11.5 p -97.7 8.17 45.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.051 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 3.9 mttt -154.11 141.17 19.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.817 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.931 ' HB2' HD11 ' A' ' 58' ' ' LEU . 57.2 t80 -146.51 109.05 4.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.91 0.386 . . . . 0.0 111.229 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.21 49.65 16.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.56 18.79 74.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -124.34 105.9 9.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.661 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.52 124.99 20.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.293 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.931 HD11 ' HB2' ' A' ' 53' ' ' PHE . 8.4 mt -95.97 24.5 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -85.63 125.06 32.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.282 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.75 -20.6 40.99 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.853 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.0 mt -80.07 149.46 69.91 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.684 0.278 . . . . 0.0 111.084 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.84 -167.51 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.625 2.216 . . . . 0.0 112.213 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -96.12 -24.45 16.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.82 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -58.99 -46.49 88.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.984 0.421 . . . . 0.0 110.013 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.536 ' O ' HD23 ' A' ' 69' ' ' LEU . 29.7 m -67.95 -43.4 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.735 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.439 ' N ' HG23 ' A' ' 65' ' ' VAL . 83.5 m -59.13 -53.64 56.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.568 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.541 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 8.6 t80 -59.64 -31.01 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.636 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.93 -51.1 35.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.339 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.72 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -69.78 -34.06 73.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.385 . . . . 0.0 110.184 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.867 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 4.0 m-85 -70.55 -27.68 64.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.031 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.472 ' HG3' HG12 ' A' ' 106' ' ' VAL . 15.5 mtmt -85.18 -39.9 17.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.43 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.37 -21.77 74.63 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.914 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.833 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . . . -42.95 129.44 4.38 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.74 0.305 . . . . 0.0 111.546 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -157.65 102.84 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.017 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.04 83.42 1.37 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.225 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.16 113.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.426 . . . . 0.0 110.395 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.803 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -125.25 107.78 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.724 -179.093 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.9 t -98.91 114.76 27.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.228 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.19 122.4 40.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.473 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 1.9 tt0 -85.27 104.53 15.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.77 HG11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.24 142.55 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.774 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.408 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 92.1 m -108.82 119.54 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.674 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -103.87 93.3 5.14 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.404 ' HG3' HD11 ' A' ' 49' ' ' ILE . 67.8 Cg_endo . . . . . 0 C--N 1.345 0.384 0 C-N-CA 122.493 2.129 . . . . 0.0 112.281 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.503 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 27.1 mm-40 . . . . . 0 C--O 1.231 0.112 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.541 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.2 t80 -84.48 96.34 9.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.209 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.107 ' CH2' HG23 ' A' ' 33' ' ' ILE . 23.5 m95 -104.62 131.14 52.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.215 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.529 ' CG2' HD23 ' A' ' 16' ' ' LEU . 16.1 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.12 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.555 HD22 ' CB ' ' A' ' 84' ' ' PRO . 9.5 mt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.816 0.341 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.58 157.94 19.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.99 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.583 ' HG2' HG23 ' A' ' 82' ' ' THR . 16.1 mttt -153.49 129.54 10.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.816 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.784 ' CE2' HG22 ' A' ' 6' ' ' VAL . 26.1 p90 -136.78 171.23 14.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.451 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.76 135.5 49.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.081 0.467 . . . . 0.0 111.144 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.9 t -114.32 107.27 22.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.928 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.697 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.3 p30 -115.83 127.48 55.08 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.795 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.673 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -153.62 160.91 42.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.637 179.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 128.05 34.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.109 0.48 . . . . 0.0 110.784 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.757 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -114.92 127.89 55.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.319 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.428 ' H ' ' HZ3' ' A' ' 10' ' ' LYS . 6.5 mmtt -121.69 69.13 0.92 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.038 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 43.75 89.91 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.413 ' N ' ' NZ ' ' A' ' 10' ' ' LYS . . . 39.05 96.46 0.01 OUTLIER Glycine 0 C--N 1.337 0.597 0 CA-C-N 116.082 -0.508 . . . . 0.0 114.202 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.5 -106.27 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -69.15 -5.67 23.85 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.113 HD22 HD21 ' A' ' 18' ' ' LEU . 4.5 mt -45.83 -33.44 3.14 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.57 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 24.83 62.97 0.05 OUTLIER Glycine 0 C--N 1.333 0.407 0 CA-C-N 114.979 -1.01 . . . . 0.0 115.159 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.113 HD21 HD22 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -141.13 91.71 2.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.934 0.397 . . . . 0.0 110.173 178.478 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.414 ' HB3' ' CB ' ' A' ' 31' ' ' ASP . 2.1 t -60.38 113.16 2.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.778 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.962 HD21 HD12 ' A' ' 18' ' ' LEU . 16.8 mt -94.28 160.84 14.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.514 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.48 167.58 21.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.268 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.03 120.52 5.04 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.437 2.091 . . . . 0.0 112.799 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.08 162.62 30.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.209 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.561 ' HG3' HG23 ' A' ' 25' ' ' ILE . 7.8 pt-20 -77.55 -33.09 54.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.1 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.561 HG23 ' HG3' ' A' ' 24' ' ' GLU . 3.6 pt -100.25 -4.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.913 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.17 -126.48 1.47 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.067 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 50' ' ' ILE . 26.2 p -140.51 106.16 5.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.946 0.403 . . . . 0.0 111.162 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.408 ' OG1' HG12 ' A' ' 49' ' ' ILE . 88.7 m -68.74 131.26 44.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.719 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.11 HG21 HD12 ' A' ' 32' ' ' LEU . 10.9 mt -72.03 105.06 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.607 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.27 -24.16 59.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.303 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.414 ' CB ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -157.33 165.67 35.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.014 0.435 . . . . 0.0 111.283 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.11 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -153.66 125.83 7.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.294 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.105 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.4 pt -97.15 100.55 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.652 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -68.31 154.36 41.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.978 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.36 -20.92 47.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.806 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.1 mp0 -71.73 -49.75 36.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.688 0.28 . . . . 0.0 110.887 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -136.95 139.7 29.46 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.867 0.365 . . . . 0.0 110.731 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.97 -48.15 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.653 2.236 . . . . 0.0 112.726 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -60.01 -50.4 73.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.701 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.638 HG22 HD21 ' A' ' 32' ' ' LEU . 6.3 mt -56.85 -47.26 83.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.17 -30.41 71.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.548 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -97.03 1.83 50.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.07 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.32 -73.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.916 0.388 . . . . 0.0 111.458 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.843 HD22 HG11 ' A' ' 81' ' ' VAL . 33.6 mt -75.22 153.28 38.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.522 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.14 -175.83 5.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.572 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -86.82 87.46 7.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.87 0.367 . . . . 0.0 111.014 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.9 43.11 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.697 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.56 156.82 45.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 110.666 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.408 HG12 ' OG1' ' A' ' 28' ' ' THR . 1.1 mp -124.53 117.74 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.359 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.94 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.2 mt -74.59 100.46 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.031 0.443 . . . . 0.0 110.474 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.0 p -93.46 -4.44 51.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.359 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -144.42 144.93 31.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.097 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.967 ' HB2' HD11 ' A' ' 58' ' ' LEU . 41.9 t80 -151.31 108.8 3.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 53.3 52.91 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.31 24.09 67.08 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.332 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -123.91 98.18 5.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.661 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.67 114.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.377 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.967 HD11 ' HB2' ' A' ' 53' ' ' PHE . 12.3 mt -88.5 11.95 15.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.999 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.73 142.98 42.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.862 0.363 . . . . 0.0 111.113 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.1 24.23 64.87 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.775 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 58' ' ' LEU . 59.0 mt -120.07 141.26 31.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.526 0.203 . . . . 0.0 110.766 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.58 -160.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.518 2.145 . . . . 0.0 112.24 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -104.7 -24.54 12.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -55.87 -49.11 74.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 0.0 110.387 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 66' ' ' CYS . 22.2 m -67.13 -45.85 85.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.778 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.467 ' N ' HG23 ' A' ' 65' ' ' VAL . 91.0 m -55.57 -52.86 62.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.022 0.439 . . . . 0.0 110.81 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 26.7 t80 -62.17 -30.88 71.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.739 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.32 -51.37 45.42 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.762 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -65.96 -44.06 86.09 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.668 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.94 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 12.5 m-85 -61.44 -32.41 72.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.133 0.492 . . . . 0.0 109.905 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 6.4 mtpt -80.39 -34.28 36.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.958 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -87.88 10.85 68.7 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.435 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.757 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -73.26 135.22 44.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.58 0.229 . . . . 0.0 110.544 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 4.1 p30 -172.97 92.93 0.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 111.013 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.58 76.24 0.19 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.259 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.02 98.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.023 0.44 . . . . 0.0 110.698 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.712 HG11 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -101.95 152.85 5.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.468 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 t -140.48 119.63 12.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.516 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.12 122.82 30.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.5 106.99 17.89 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.843 HG11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -97.0 143.02 13.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.719 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 3' ' ' LYS . 45.3 m -108.48 119.39 39.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.527 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -103.91 89.33 2.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.112 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.555 ' CB ' HD22 ' A' ' 1' ' ' LEU . 54.4 Cg_endo . . . . . 0 C--N 1.344 0.292 0 C-N-CA 122.581 2.187 . . . . 0.0 112.319 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.493 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.0 mm-40 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 121.167 0.508 . . . . 0.0 112.204 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.52 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 2.1 t80 -84.54 96.4 9.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.105 ' CH2' HG23 ' A' ' 33' ' ' ILE . 28.7 m95 -102.88 137.28 41.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.512 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 70' ' ' PHE . 6.4 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.095 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.738 0.304 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 157.9 31.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.8 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -151.93 129.58 11.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.8 ' CE2' HG22 ' A' ' 6' ' ' VAL . 27.6 p90 -138.54 171.82 13.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.813 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.68 135.94 49.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.955 0.407 . . . . 0.0 111.582 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.849 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.6 t -117.43 107.15 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.381 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.2 p30 -113.47 127.13 55.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.922 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.702 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -152.36 156.39 39.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.393 . . . . 0.0 110.735 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.35 119.66 12.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.647 ' HG3' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -100.96 137.5 39.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.388 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -126.62 69.1 1.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.703 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 33.75 91.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.174 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.6 96.26 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.324 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 33.5 ttmt -156.75 -114.1 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.755 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 9.3 mt-10 -70.88 -5.56 31.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.866 HD22 HD21 ' A' ' 18' ' ' LEU . 1.6 mt -45.43 -34.2 3.0 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.611 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 19.47 64.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 114.8 -1.091 . . . . 0.0 115.454 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.866 HD21 HD22 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -143.46 91.73 2.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.145 0.498 . . . . 0.0 110.107 178.125 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 2.1 t -59.29 114.58 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.942 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -91.79 163.04 14.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.39 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.14 162.47 53.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.352 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.14 120.54 7.25 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.512 2.142 . . . . 0.0 112.723 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.595 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -133.25 162.46 31.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.721 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -82.65 -29.27 30.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.097 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.533 HG13 HG22 ' A' ' 51' ' ' THR . 2.2 pt -103.49 -6.37 9.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.918 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.66 -125.57 1.29 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.249 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -140.59 106.1 5.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.954 0.407 . . . . 0.0 111.07 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.6 m -68.14 127.71 33.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.389 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.124 HG21 HD12 ' A' ' 32' ' ' LEU . 13.0 mt -70.69 104.92 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.851 0.358 . . . . 0.0 110.622 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.27 -25.64 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.047 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -157.18 166.97 31.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.043 0.449 . . . . 0.0 111.238 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.124 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -155.46 126.88 7.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.006 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.117 HG23 ' CH2' ' A' ' 105' ' ' TRP . 4.1 pt -96.46 100.58 11.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.64 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -72.7 139.67 47.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.842 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.69 -27.91 8.07 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.622 ' HA ' ' OE1' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -67.21 -60.81 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.759 0.314 . . . . 0.0 110.712 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -123.77 136.75 27.72 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.129 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.98 -49.12 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.62 2.213 . . . . 0.0 112.903 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -56.82 -49.2 76.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.884 0.373 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.709 HG22 HD21 ' A' ' 32' ' ' LEU . 5.3 mt -57.49 -47.01 85.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.77 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.21 -30.39 71.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.606 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -97.2 1.6 49.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.226 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.515 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.56 -73.67 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 111.388 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.849 ' CD2' HG21 ' A' ' 6' ' ' VAL . 38.8 mt -74.92 145.3 42.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.546 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.36 164.94 36.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.572 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -59.9 108.18 0.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.953 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.24 40.78 0.61 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.603 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.643 ' HB2' HD12 ' A' ' 29' ' ' ILE . 12.0 m-20 -138.17 134.02 34.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.834 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.595 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.9 mt -106.36 117.39 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.908 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.72 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.8 mt -75.68 100.47 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.533 HG22 HG13 ' A' ' 25' ' ' ILE . 4.6 p -102.16 24.52 10.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.879 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 7.1 mttt -169.13 133.76 1.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.178 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.946 ' HB2' HD11 ' A' ' 58' ' ' LEU . 56.9 t80 -141.25 109.22 5.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.238 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 54.98 53.56 10.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.65 16.96 66.38 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -122.52 101.06 7.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.822 0.344 . . . . 0.0 110.608 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.98 123.41 14.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.344 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.946 HD11 ' HB2' ' A' ' 53' ' ' PHE . 3.8 mt -94.96 23.04 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.789 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.82 122.05 33.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.333 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.78 15.08 38.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.048 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.748 HD21 ' HA ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -127.41 159.46 65.44 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.9 0.35 . . . . 0.0 111.136 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.92 -171.77 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.765 2.31 . . . . 0.0 112.44 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -92.91 -33.46 14.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.486 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -48.63 -46.24 39.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.994 0.426 . . . . 0.0 110.649 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' HD23 ' A' ' 69' ' ' LEU . 26.9 m -65.46 -39.0 83.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.783 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 42.2 m -63.86 -53.74 45.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.737 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.693 ' CD1' HG12 ' A' ' 106' ' ' VAL . 26.8 t80 -57.6 -30.78 65.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.01 -51.1 42.8 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.729 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.4 -40.84 81.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.522 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.72 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 16.5 m-85 -64.24 -30.95 71.98 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.419 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -79.64 -33.52 41.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.026 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.55 15.53 60.02 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.668 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.638 ' HB1' HG11 ' A' ' 77' ' ' VAL . . . -77.92 133.7 38.03 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -167.8 89.24 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 111.202 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.92 86.14 0.77 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.58 109.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.075 0.464 . . . . 0.0 110.783 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.647 HG11 ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -122.61 107.77 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.639 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.6 t -99.96 113.99 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.983 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.03 124.53 44.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.638 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.93 104.93 16.72 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.841 HG11 HD22 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -95.13 142.53 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.772 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.9 m -108.86 121.45 45.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.529 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -104.19 92.85 4.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.099 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--N 1.344 0.327 0 C-N-CA 122.528 2.152 . . . . 0.0 112.227 179.891 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.489 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.3 mm-40 . . . . . 0 CA--C 1.523 -0.087 0 CA-C-O 121.303 0.573 . . . . 0.0 112.37 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 4.8 t80 -84.88 96.42 9.32 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.211 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.117 ' CH2' HG23 ' A' ' 33' ' ' ILE . 18.7 m95 -104.59 136.5 44.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.114 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' A' ' 70' ' ' PHE . 30.1 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.069 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.801 0.334 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -78.85 158.76 28.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.707 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 6.6 mttt -150.97 129.54 12.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.777 ' CE1' HG23 ' A' ' 81' ' ' VAL . 9.3 p90 -136.93 170.87 15.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.743 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.458 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -108.57 135.92 49.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.103 0.478 . . . . 0.0 111.253 -179.546 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.898 HG21 ' CD2' ' A' ' 44' ' ' LEU . 14.8 t -116.42 107.01 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.432 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.1 p30 -110.4 127.05 54.9 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.792 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.697 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.05 153.56 38.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 0.0 110.591 178.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.27 117.43 8.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.066 0.46 . . . . 0.0 110.827 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.948 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -101.93 128.6 48.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.598 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.454 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 7.7 mmtt -119.24 68.56 0.81 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.118 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.02 78.9 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.196 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.99 99.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.463 -0.398 . . . . 0.0 113.822 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 5.6 ptpt -155.79 -103.92 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 7.1 mt-10 -69.13 -5.57 23.17 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.995 HD22 HD21 ' A' ' 18' ' ' LEU . 3.8 mt -45.54 -33.7 2.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.601 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.603 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 26.38 61.98 0.08 OUTLIER Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.024 -0.989 . . . . 0.0 115.201 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.995 HD21 HD22 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -142.82 91.87 2.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.046 0.451 . . . . 0.0 110.003 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 t -62.29 117.75 6.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.773 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.895 HD21 ' CD1' ' A' ' 18' ' ' LEU . 16.2 mt -97.7 167.65 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.462 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.796 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 66.1 m -141.62 156.56 66.34 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.441 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.21 118.63 5.72 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.476 2.117 . . . . 0.0 112.429 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.679 HD21 HG21 ' A' ' 49' ' ' ILE . 1.3 t30 -128.85 162.75 26.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -24.69 41.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.448 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.425 HG13 HG22 ' A' ' 51' ' ' THR . 4.6 pt -108.71 -9.68 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.941 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 171.41 -122.18 0.94 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.143 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 21' ' ' SER . 8.7 m -140.55 106.46 5.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.812 0.339 . . . . 0.0 111.4 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 49' ' ' ILE . 93.2 m -68.89 125.96 28.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.079 HG21 HD12 ' A' ' 32' ' ' LEU . 40.9 mt -67.81 104.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.628 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.796 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -70.49 -29.0 65.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.967 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.434 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 6.8 m-20 -161.89 170.69 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.061 0.458 . . . . 0.0 111.023 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.079 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -153.28 127.37 9.05 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.429 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.122 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -96.74 100.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.165 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.05 153.2 43.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.047 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.11 -22.34 41.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.751 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 1.5 mp0 -69.94 -45.28 67.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.825 0.345 . . . . 0.0 110.862 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -141.12 139.73 19.79 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.646 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.46 -49.3 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.629 2.22 . . . . 0.0 112.977 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.2 -50.74 72.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.656 HD13 HD23 ' A' ' 18' ' ' LEU . 5.4 mt -55.87 -52.15 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.01 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -59.15 -30.23 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.583 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.2 m -96.46 0.68 50.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.24 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.569 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.98 -73.79 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 111.538 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.898 ' CD2' HG21 ' A' ' 6' ' ' VAL . 45.2 mt -72.87 145.31 46.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.564 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -149.59 159.78 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.621 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -60.94 109.32 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.072 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.46 -17.39 4.76 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.985 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.632 ' HB2' HD12 ' A' ' 29' ' ' ILE . 2.7 m-20 -83.61 148.62 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.991 0.424 . . . . 0.0 111.13 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.679 HG21 HD21 ' A' ' 23' ' ' ASN . 2.9 mt -119.57 117.78 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.599 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.874 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.1 mt -74.53 100.38 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 111.162 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.425 HG22 HG13 ' A' ' 25' ' ' ILE . 9.7 p -102.39 20.84 16.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.1 mttt -167.33 126.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.998 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.958 ' HB2' HD11 ' A' ' 58' ' ' LEU . 44.0 t80 -132.23 109.58 10.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.19 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 50.52 62.96 2.42 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.021 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.74 20.59 48.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.464 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -125.31 98.04 5.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.699 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.71 121.49 8.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.387 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.958 HD11 ' HB2' ' A' ' 53' ' ' PHE . 9.1 mt -93.11 19.48 7.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.813 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.85 143.72 39.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.934 0.397 . . . . 0.0 111.176 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.89 26.61 48.32 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.704 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 58' ' ' LEU . 23.8 mt -118.77 143.58 33.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.635 0.255 . . . . 0.0 110.866 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.26 -164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.548 2.165 . . . . 0.0 112.035 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -110.58 -22.79 11.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.176 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -58.36 -50.99 71.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 110.687 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.517 ' O ' HD23 ' A' ' 69' ' ' LEU . 14.6 m -65.52 -41.44 90.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.94 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 81.4 m -60.47 -52.3 65.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 25.9 t80 -60.34 -30.68 69.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.292 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.46 -51.03 39.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.247 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.734 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.69 -40.72 84.34 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.148 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.874 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.4 m-85 -61.16 -33.25 73.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.422 ' HG3' HG12 ' A' ' 106' ' ' VAL . 26.0 mtmt -83.41 -30.9 26.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.184 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.48 12.35 68.6 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.612 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.948 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -75.59 138.78 41.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.637 0.256 . . . . 0.0 110.379 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 4.9 p-10 -169.77 99.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.179 0.514 . . . . 0.0 111.101 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.44 76.35 0.53 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.044 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.82 108.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.938 0.399 . . . . 0.0 110.17 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.788 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -117.13 107.74 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.753 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.0 t -100.01 114.77 28.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.316 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.8 122.16 40.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.679 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 2.7 tt0 -84.17 102.38 12.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.777 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -95.07 142.95 12.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.731 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 54.4 m -108.36 121.97 46.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.4 97.45 22.79 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 82' ' ' THR . 36.6 Cg_exo . . . . . 0 C--N 1.343 0.252 0 C-N-CA 122.533 2.156 . . . . 0.0 112.197 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.528 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 43.7 mm-40 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.243 0.544 . . . . 0.0 112.259 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.8 t80 -85.99 96.3 9.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.094 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.122 ' CH2' HG23 ' A' ' 33' ' ' ILE . 13.3 m95 -105.36 136.17 45.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.237 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.673 HG21 ' HB3' ' A' ' 70' ' ' PHE . 11.3 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.122 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.709 HD22 ' HA ' ' A' ' 84' ' ' PRO . 7.1 mt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.8 0.333 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.79 158.8 22.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 11.3 mttt -152.73 129.65 11.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 110.867 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.814 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.0 p90 -137.91 171.18 14.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.784 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.61 135.91 49.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.957 0.408 . . . . 0.0 111.414 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.874 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.0 t -117.63 107.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.452 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 8.6 p-10 -111.02 127.26 55.48 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.972 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.73 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.04 153.68 39.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 110.758 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.19 114.87 6.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.058 0.456 . . . . 0.0 110.51 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.822 ' CE ' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -98.03 145.34 26.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.882 -179.288 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 48.5 mmtt -132.66 69.23 1.48 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.183 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.25 21.89 4.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.493 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.65 115.05 1.52 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.69 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 7.9 ptpt -163.79 -94.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.3 mm-40 -69.21 -4.91 19.57 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.906 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.861 ' CD2' HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -44.95 -38.59 4.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.228 0.537 . . . . 0.0 109.643 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.584 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 33.64 59.06 0.56 Allowed Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.171 -0.922 . . . . 0.0 115.362 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.861 HD21 ' CD2' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -143.06 91.49 2.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.124 0.462 . . . . 0.0 110.059 177.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.6 t -63.32 120.85 12.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.638 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -96.13 167.82 10.98 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.579 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.642 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -142.57 163.13 40.75 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.269 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 21' ' ' SER . 57.6 Cg_endo -71.71 126.11 11.74 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.269 1.979 . . . . 0.0 112.734 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.48 162.74 34.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.076 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.33 -32.71 37.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 51' ' ' THR . 2.4 pt -99.64 -6.94 9.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.87 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.21 -127.49 1.58 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.865 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 75.0 m -140.72 106.41 5.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.855 0.359 . . . . 0.0 111.644 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.7 m -63.64 133.42 53.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.289 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.029 HG21 HD12 ' A' ' 32' ' ' LEU . 47.8 mt -71.65 104.77 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.879 0.371 . . . . 0.0 110.422 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.642 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -68.51 -32.93 73.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.164 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -156.91 174.71 15.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.05 0.452 . . . . 0.0 111.457 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.029 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.74 128.98 7.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.508 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.14 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.2 pt -101.12 100.46 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.088 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -70.58 153.76 42.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.012 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.81 -21.92 43.36 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.682 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.599 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 6.4 mp0 -69.87 -52.57 23.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.672 0.272 . . . . 0.0 110.8 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -133.27 139.33 33.8 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.669 179.59 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.58 -48.23 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.662 2.241 . . . . 0.0 113.109 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -61.12 -49.32 77.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.761 0.315 . . . . 0.0 110.964 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.3 mt -57.91 -49.93 79.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -60.34 -30.33 69.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.976 0.417 . . . . 0.0 110.452 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -95.3 -1.43 51.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.129 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.587 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -123.93 -73.19 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.462 -178.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.874 ' CD2' HG21 ' A' ' 6' ' ' VAL . 47.8 mt -73.25 147.8 44.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.631 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.03 157.78 43.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.65 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.7 mtp-105 -59.73 96.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.073 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.81 43.38 0.17 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.722 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.18 140.13 35.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.72 0.295 . . . . 0.0 110.686 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.47 ' CD1' HD11 ' A' ' 25' ' ' ILE . 2.0 mt -107.52 117.54 53.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.091 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.9 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 8.8 mt -75.14 100.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.956 0.408 . . . . 0.0 110.461 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.524 HG22 HG13 ' A' ' 25' ' ' ILE . 10.2 p -101.79 23.43 11.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 4.5 mttt -170.21 137.01 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.982 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.98 ' HB2' HD11 ' A' ' 58' ' ' LEU . 35.9 t80 -144.82 115.6 7.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 0.0 111.272 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m120 53.35 54.42 10.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.75 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.7 22.5 64.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.353 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -128.44 103.16 6.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.935 0.397 . . . . 0.0 110.7 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . . . -54.42 123.52 13.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.399 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.98 HD11 ' HB2' ' A' ' 53' ' ' PHE . 9.3 mt -93.7 22.11 5.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.584 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -77.81 119.58 21.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.888 0.375 . . . . 0.0 111.225 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -16.83 57.21 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.708 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 58' ' ' LEU . 72.1 mt -76.23 135.6 69.55 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.589 0.194 . . . . 0.0 111.041 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -57.69 -160.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.412 2.074 . . . . 0.0 112.213 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 37.4 t80 -101.24 -25.6 13.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.89 -47.69 84.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.792 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HD23 ' A' ' 69' ' ' LEU . 27.9 m -67.58 -46.81 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.502 ' N ' HG23 ' A' ' 65' ' ' VAL . 19.0 m -59.62 -50.08 75.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 110.767 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.722 ' CD1' HG12 ' A' ' 106' ' ' VAL . 50.0 t80 -59.31 -33.3 70.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.982 0.42 . . . . 0.0 110.338 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.61 -50.98 39.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.172 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.711 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.83 -34.92 76.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 110.367 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.9 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 3.8 m-85 -69.52 -27.83 65.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.049 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.422 ' HD3' ' CZ ' ' A' ' 67' ' ' TYR . 19.8 mtmt -85.06 -41.55 15.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.911 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.3 -20.47 77.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.233 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.822 ' HB3' ' CE ' ' A' ' 10' ' ' LYS . . . -42.97 132.88 3.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 111.64 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -162.96 102.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.783 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.39 81.75 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.129 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.81 109.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.905 0.384 . . . . 0.0 110.553 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.786 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -121.46 107.69 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.751 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -98.88 114.76 27.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.404 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.16 123.59 43.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.378 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -87.05 104.69 16.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.964 0.411 . . . . 0.0 109.997 178.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.805 HG11 HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -95.17 142.68 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.655 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.408 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 96.8 m -108.77 123.84 49.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.339 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 -104.61 92.68 5.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.225 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.709 ' HA ' HD22 ' A' ' 1' ' ' LEU . 61.7 Cg_endo . . . . . 0 C--N 1.345 0.367 0 C-N-CA 122.535 2.157 . . . . 0.0 112.133 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.537 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 27.2 mm-40 . . . . . 0 C--O 1.232 0.136 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.517 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.7 t80 -86.58 96.21 10.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.338 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.14 ' CH2' HG23 ' A' ' 33' ' ' ILE . 7.7 m95 -106.16 132.58 52.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.055 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.722 HG12 ' CD1' ' A' ' 67' ' ' TYR . 20.3 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.057 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.791 0.329 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.06 159.3 16.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -151.15 129.62 12.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.799 ' CE2' HG22 ' A' ' 6' ' ' VAL . 30.7 p90 -137.76 172.17 13.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.109 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.71 135.95 49.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 111.544 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.799 HG22 ' CE2' ' A' ' 4' ' ' PHE . 15.7 t -117.05 107.25 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.265 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 5.7 p-10 -113.13 127.2 56.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.884 0.373 . . . . 0.0 111.139 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.704 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.86 156.24 40.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.38 178.776 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.47 117.6 12.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.9 0.381 . . . . 0.0 110.638 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.903 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -100.03 128.39 46.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.538 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 10.7 mmtt -120.9 68.75 0.88 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.219 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.42 79.73 0.07 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.439 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 44.79 98.63 0.01 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 114.231 0.452 . . . . 0.0 114.231 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 7.5 ptpt -155.85 -102.37 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 1.8 mm-40 -69.23 -5.42 22.68 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.992 HD22 HD21 ' A' ' 18' ' ' LEU . 3.3 mt -45.53 -30.11 1.36 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.996 0.427 . . . . 0.0 110.17 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.549 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 26.76 62.64 0.08 OUTLIER Glycine 0 C--N 1.332 0.337 0 N-CA-C 115.149 0.82 . . . . 0.0 115.149 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.992 HD21 HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -146.18 92.28 2.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.006 0.431 . . . . 0.0 110.331 178.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 26.3 t -66.8 116.69 7.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.277 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -92.87 162.74 13.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.199 0.523 . . . . 0.0 111.961 -179.055 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.663 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 1.2 m -139.17 148.11 55.95 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.35 124.84 17.24 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.634 2.223 . . . . 0.0 112.816 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.37 162.57 35.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.979 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HG3' HG23 ' A' ' 25' ' ' ILE . 10.0 pt-20 -80.57 -38.89 28.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.086 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.562 HG23 ' HG3' ' A' ' 24' ' ' GLU . 1.9 pt -91.33 -9.24 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.959 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 168.87 -123.2 1.07 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.452 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -140.51 106.19 5.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.771 0.32 . . . . 0.0 110.939 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.413 ' N ' HG23 ' A' ' 49' ' ' ILE . 86.5 m -67.07 119.37 11.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.532 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.692 HD12 ' HB2' ' A' ' 48' ' ' ASP . 7.6 mt -66.51 104.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.52 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.663 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -68.89 -28.58 66.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.342 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -165.63 178.72 6.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.342 0.591 . . . . 0.0 111.336 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -163.9 136.1 4.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.747 178.314 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.189 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.5 pt -95.9 100.32 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.244 0.545 . . . . 0.0 110.572 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -65.07 154.04 39.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.869 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.04 -27.46 16.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.522 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 3.5 mp0 -65.76 -49.56 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 110.461 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.663 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -133.98 140.21 35.64 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.475 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.31 -49.28 0.95 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.644 2.229 . . . . 0.0 113.169 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 43' ' ' LYS . 13.5 mm-40 -60.94 -50.48 73.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 111.036 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.615 HD13 HD23 ' A' ' 18' ' ' LEU . 3.3 mt -55.98 -51.2 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.257 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -59.37 -30.14 68.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.028 0.442 . . . . 0.0 110.632 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -99.42 3.45 45.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.425 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.518 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -122.94 -70.18 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.701 ' CD2' HG21 ' A' ' 6' ' ' VAL . 15.0 mt -70.9 153.72 42.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.266 0.555 . . . . 0.0 112.259 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.476 ' HA ' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -153.94 137.34 15.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.26 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HG3' HD11 ' A' ' 32' ' ' LEU . 13.7 mtp-105 -48.18 114.07 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 111.435 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.93 7.1 6.16 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.18 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.692 ' HB2' HD12 ' A' ' 29' ' ' ILE . 54.0 m-20 -106.61 163.96 12.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.913 0.357 . . . . 0.0 111.099 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 25' ' ' ILE . 1.2 mp -131.48 120.14 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.027 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.004 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.9 mt -74.61 100.28 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.496 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.43 HG22 HG13 ' A' ' 25' ' ' ILE . 15.7 p -93.55 -9.58 37.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.238 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -139.18 145.97 39.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.963 ' HB2' HD11 ' A' ' 58' ' ' LEU . 31.1 t80 -152.55 112.54 3.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.865 0.364 . . . . 0.0 111.109 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 56.81 42.86 25.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.851 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.22 22.74 77.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.427 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -121.82 108.15 13.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.343 . . . . 0.0 110.75 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.66 107.95 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.308 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.963 HD11 ' HB2' ' A' ' 53' ' ' PHE . 20.6 mt -80.72 0.65 33.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.54 145.2 52.8 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.932 0.396 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.66 19.13 66.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.736 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.0 mt -120.15 141.51 31.81 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.575 0.226 . . . . 0.0 110.924 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.92 -158.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.507 2.138 . . . . 0.0 112.259 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -105.39 -23.91 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.929 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -56.32 -49.0 75.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 110.544 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.48 ' O ' HD23 ' A' ' 69' ' ' LEU . 19.0 m -67.02 -45.36 87.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.996 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.445 ' N ' HG23 ' A' ' 65' ' ' VAL . 57.0 m -56.97 -49.7 74.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.701 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.529 ' CD1' HG12 ' A' ' 106' ' ' VAL . 25.3 t80 -63.74 -31.01 72.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.835 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.99 33.09 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.749 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -65.83 -42.21 90.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.814 0.34 . . . . 0.0 110.519 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 1.004 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.7 m-85 -63.74 -32.62 74.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.919 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -82.65 -30.37 29.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.324 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.12 17.26 58.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.542 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.903 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -79.23 136.21 37.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.764 0.316 . . . . 0.0 110.626 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -170.12 98.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.126 0.489 . . . . 0.0 110.728 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.56 77.25 0.52 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.887 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.54 110.39 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.857 0.36 . . . . 0.0 110.412 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.725 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -119.41 107.96 22.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.629 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.8 t -105.49 106.25 16.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.303 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.27 127.79 56.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.938 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -89.06 107.62 19.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.919 0.39 . . . . 0.0 109.985 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.669 HG23 ' CE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -98.23 143.05 13.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.875 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.9 m -108.49 124.49 50.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.188 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -105.64 93.57 7.44 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.372 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.445 ' HG3' HD11 ' A' ' 49' ' ' ILE . 73.7 Cg_endo . . . . . 0 C--N 1.345 0.353 0 C-N-CA 122.555 2.17 . . . . 0.0 112.199 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.492 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 29.1 mm-40 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 121.053 0.454 . . . . 0.0 111.952 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.504 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 3.3 t80 -79.4 95.9 5.88 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.189 ' CH2' HG23 ' A' ' 33' ' ' ILE . 53.2 m95 -100.86 145.61 28.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.036 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.529 HG12 ' CD1' ' A' ' 67' ' ' TYR . 8.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.22 160.53 19.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.949 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HG2' HG23 ' A' ' 82' ' ' THR . 9.6 mttt -155.37 129.61 8.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.706 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.81 ' CE2' HG22 ' A' ' 6' ' ' VAL . 33.0 p90 -136.26 173.29 11.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.272 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.65 137.61 46.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 111.258 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.881 HG21 ' CD2' ' A' ' 44' ' ' LEU . 6.9 t -122.76 107.28 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.84 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 25.7 t0 -110.14 127.18 54.76 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.78 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.723 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.54 159.17 44.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.674 179.044 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.38 114.24 9.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.794 ' HG2' HD21 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -95.39 140.83 29.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.347 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 3.8 mmtp -132.57 69.27 1.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.36 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.36 22.09 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.336 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.92 114.27 0.96 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.536 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -162.08 -96.42 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.959 0.409 . . . . 0.0 111.367 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 16.7 mt-10 -68.23 -4.39 13.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.122 0.569 . . . . 0.0 112.156 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.987 HD12 HD21 ' A' ' 18' ' ' LEU . 2.8 mm? -44.48 -32.71 1.47 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.136 0.493 . . . . 0.0 110.03 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.556 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 32.93 51.24 0.47 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.333 -0.849 . . . . 0.0 114.65 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.987 HD21 HD12 ' A' ' 16' ' ' LEU . 1.3 pp -141.27 91.62 2.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.019 0.438 . . . . 0.0 110.323 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 6.0 t -68.63 119.52 13.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.812 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.861 HD21 HD12 ' A' ' 50' ' ' ILE . 5.5 mp -94.23 167.89 11.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.52 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -143.88 164.69 28.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.074 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.56 128.68 15.62 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.347 2.032 . . . . 0.0 112.672 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.591 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -140.02 162.66 34.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.039 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.04 -16.74 45.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.52 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.535 HD11 HD13 ' A' ' 49' ' ' ILE . 6.8 pt -118.1 -7.14 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.787 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 169.75 -124.98 1.2 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.839 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.495 ' CB ' HD23 ' A' ' 20' ' ' LEU . 21.0 m -140.81 106.16 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.905 0.383 . . . . 0.0 111.413 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 98.3 m -65.79 128.89 37.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.212 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.02 HG21 HD12 ' A' ' 32' ' ' LEU . 56.2 mt -68.8 104.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.953 0.406 . . . . 0.0 110.534 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -67.42 -31.45 71.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.11 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.6 172.25 16.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 111.268 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.02 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -153.5 125.36 7.8 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.335 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.135 HG23 ' CH2' ' A' ' 105' ' ' TRP . 9.0 pt -97.09 100.49 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.967 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.88 160.4 31.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.93 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.16 3.39 88.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.93 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.91 -41.88 8.58 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.897 0.38 . . . . 0.0 110.734 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -143.5 140.95 18.1 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.428 179.177 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.09 -48.75 0.42 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.61 2.207 . . . . 0.0 113.241 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.7 mp0 -62.85 -45.58 91.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 111.065 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.586 HD13 HD23 ' A' ' 18' ' ' LEU . 3.9 mt -61.48 -49.84 82.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.962 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.23 -30.15 68.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.722 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -94.53 -12.87 26.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.234 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.601 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -111.75 -75.08 0.62 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.844 -178.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.881 ' CD2' HG21 ' A' ' 6' ' ' VAL . 32.8 mt -70.54 151.6 44.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.858 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -153.11 172.91 16.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.458 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -73.57 113.31 10.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.81 0.338 . . . . 0.0 111.052 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.98 27.34 2.99 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.812 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.842 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -122.09 136.45 54.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.731 0.301 . . . . 0.0 110.91 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.591 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.2 mt -105.96 118.09 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.861 HD12 HD21 ' A' ' 20' ' ' LEU . 2.9 mt -75.24 100.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 p -104.42 27.8 7.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.181 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.1 mttt -172.76 138.3 0.82 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.166 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.915 ' HB2' HD11 ' A' ' 58' ' ' LEU . 25.7 t80 -150.07 112.28 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.393 . . . . 0.0 111.237 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 55.66 51.0 13.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.69 21.51 65.15 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.367 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -124.03 101.27 7.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.575 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.4 120.93 6.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.369 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.915 HD11 ' HB2' ' A' ' 53' ' ' PHE . 14.6 mt -92.36 18.78 7.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.07 126.12 32.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.974 0.416 . . . . 0.0 111.429 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -19.67 43.5 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.069 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.6 mt -81.2 140.63 49.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.542 0.211 . . . . 0.0 111.171 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.51 -157.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.633 2.222 . . . . 0.0 112.16 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -104.45 -23.56 13.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.021 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -56.69 -49.06 76.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.06 0.457 . . . . 0.0 110.377 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.505 ' O ' HD23 ' A' ' 69' ' ' LEU . 30.7 m -71.46 -45.44 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.856 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.469 ' N ' HG23 ' A' ' 65' ' ' VAL . 91.2 m -55.0 -51.98 64.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.757 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 13.8 t80 -66.74 -30.65 70.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.656 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.73 -51.06 60.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.233 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.753 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.12 -41.44 86.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.856 0.36 . . . . 0.0 110.192 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.615 ' HB3' HG21 ' A' ' 106' ' ' VAL . 3.4 m-85 -62.58 -33.7 75.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.672 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.407 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 13.0 mtmt -79.73 -35.73 38.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.373 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.71 7.66 72.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.566 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.659 ' HB1' HG11 ' A' ' 77' ' ' VAL . . . -71.4 141.44 50.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 0.0 110.808 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -175.25 99.17 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.681 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.42 74.68 0.51 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.819 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.26 120.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 110.081 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.701 HG11 ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -132.0 107.91 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.84 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -99.75 111.88 24.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.473 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.93 128.81 55.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.397 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.87 104.74 17.29 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.782 HG11 HD22 ' A' ' 44' ' ' LEU . 1.7 m -95.05 143.16 12.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.781 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 62.0 m -108.22 127.91 54.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.205 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.11 95.44 15.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 82' ' ' THR . 52.7 Cg_exo . . . . . 0 C--N 1.343 0.265 0 C-N-CA 122.496 2.13 . . . . 0.0 112.147 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.538 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 31.8 mm-40 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 121.119 0.485 . . . . 0.0 112.153 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.53 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -86.83 96.28 10.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.135 ' CH2' HG23 ' A' ' 33' ' ' ILE . 14.7 m95 -104.22 138.64 40.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 111.783 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 70' ' ' PHE . 18.6 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.113 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.748 0.309 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.23 158.23 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.804 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HG2' HG23 ' A' ' 82' ' ' THR . 16.0 mttp -151.62 129.67 11.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.746 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.774 ' CE2' HG22 ' A' ' 6' ' ' VAL . 30.1 p90 -138.29 170.87 15.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.69 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.62 136.02 48.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.043 0.449 . . . . 0.0 111.431 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.878 HG21 ' CD2' ' A' ' 44' ' ' LEU . 19.6 t -114.93 106.93 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.681 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 15.4 p-10 -110.65 127.01 55.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.894 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.687 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.87 159.27 44.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.377 . . . . 0.0 110.39 178.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.67 113.62 11.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.998 0.428 . . . . 0.0 110.941 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.837 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -97.66 151.63 19.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.431 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 8.0 mmtt -138.34 69.43 1.38 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.637 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.55 23.2 5.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.282 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.7 113.64 1.45 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.558 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -161.88 -96.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 0.0 110.985 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 19.4 mt-10 -69.41 -5.56 24.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.659 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.786 HD22 ' CD2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.6 -36.02 4.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.267 0.556 . . . . 0.0 109.583 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.553 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 25.32 62.6 0.06 OUTLIER Glycine 0 CA--C 1.52 0.352 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.999 HD12 HD21 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -138.56 91.69 2.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.166 0.508 . . . . 0.0 109.992 177.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.452 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.4 t -59.51 112.35 1.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.824 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.999 HD21 HD12 ' A' ' 18' ' ' LEU . 7.0 mt -96.21 168.3 10.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.613 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -146.6 158.33 46.66 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.335 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.35 125.07 13.37 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.475 2.117 . . . . 0.0 112.488 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.531 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -132.71 162.52 31.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.002 0.429 . . . . 0.0 111.105 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -81.63 -18.01 46.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.425 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 49' ' ' ILE . 6.5 pt -117.8 -4.61 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.706 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.83 -123.51 1.14 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.183 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 1.3 m -140.76 106.47 5.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.825 0.345 . . . . 0.0 111.575 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.4 ' OG1' HG12 ' A' ' 49' ' ' ILE . 97.0 m -69.64 137.56 52.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.039 HG21 HD12 ' A' ' 32' ' ' LEU . 22.5 mt -79.46 104.92 8.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.865 0.364 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -71.59 -28.08 63.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -160.54 169.36 23.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 111.205 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.039 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -152.42 127.24 9.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.349 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.086 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -98.19 100.47 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.296 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.53 154.37 42.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.024 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.05 -20.72 47.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.903 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 11.9 mp0 -70.74 -48.03 56.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.71 142.2 33.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.787 0.327 . . . . 0.0 110.703 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.56 -48.85 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.545 2.163 . . . . 0.0 112.901 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' LYS . 23.1 mm-40 -61.41 -50.14 74.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 111.027 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.734 HD11 HD23 ' A' ' 16' ' ' LEU . 4.1 mt -56.44 -51.45 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.142 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -59.89 -30.31 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.819 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -97.79 1.98 48.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.427 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -125.6 -72.23 0.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.779 0.323 . . . . 0.0 111.552 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.878 ' CD2' HG21 ' A' ' 6' ' ' VAL . 49.1 mt -77.51 152.91 33.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.089 0.471 . . . . 0.0 111.61 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -150.35 -175.91 5.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.503 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -81.62 95.0 7.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.048 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.34 43.09 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.799 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.579 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -138.78 145.38 40.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 110.877 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.531 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.0 OUTLIER -116.55 118.13 57.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -179.523 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.971 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.4 mt -74.62 100.46 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 110.83 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -100.45 26.5 6.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.724 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.8 mttt -172.61 136.16 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.905 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB2' HD11 ' A' ' 58' ' ' LEU . 61.3 t80 -142.62 109.98 5.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.219 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.57 48.71 19.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.914 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.78 76.98 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.396 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -124.71 105.61 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 0.0 110.712 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.92 121.81 10.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.316 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.918 HD11 ' HB2' ' A' ' 53' ' ' PHE . 11.4 mt -92.72 16.87 11.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.965 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.39 141.46 52.17 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.868 0.366 . . . . 0.0 111.081 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.79 29.65 55.12 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.667 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 58' ' ' LEU . 10.8 mt -115.36 135.32 22.56 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.5 0.19 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 61' ' ' LEU . 53.2 Cg_exo -54.69 -169.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.404 2.069 . . . . 0.0 112.167 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -98.39 -26.38 14.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.038 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -58.53 -46.84 85.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.032 0.444 . . . . 0.0 110.584 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.507 ' O ' HD23 ' A' ' 69' ' ' LEU . 20.3 t -66.45 -48.97 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.897 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 1.3 m -57.5 -53.75 54.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.769 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.549 ' CD1' HG12 ' A' ' 106' ' ' VAL . 38.3 t80 -58.07 -31.25 66.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.81 -51.04 24.52 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.714 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.99 -32.71 72.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 110.26 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.971 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 4.8 m-85 -72.42 -29.01 63.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.04 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 7.2 mtpt -85.15 -35.88 21.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.581 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.12 -22.7 65.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.874 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.837 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . . . -42.98 128.14 4.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.563 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -155.25 103.26 2.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 110.945 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.04 86.62 1.88 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.265 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.27 114.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 110.622 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.829 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.51 107.78 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.227 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 4.3 t -102.64 108.45 19.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.488 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.53 125.31 52.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.522 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -86.47 112.04 21.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.874 0.369 . . . . 0.0 110.216 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.847 HG11 HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -101.28 142.39 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.616 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.431 HG23 ' HG2' ' A' ' 3' ' ' LYS . 94.2 m -108.85 124.61 50.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.392 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -107.07 90.34 5.36 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.104 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--N 1.344 0.293 0 C-N-CA 122.656 2.238 . . . . 0.0 112.502 179.866 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.515 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 18.1 mm-40 . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 121.093 0.473 . . . . 0.0 112.243 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 1.8 t80 -84.8 96.13 9.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.086 ' CH2' HG23 ' A' ' 33' ' ' ILE . 25.6 m95 -102.55 132.21 48.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.316 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.549 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.4 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.178 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.797 0.332 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.01 162.44 14.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.428 ' HG2' HG23 ' A' ' 82' ' ' THR . 10.6 mttt -155.77 129.62 8.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.759 ' CE2' HG22 ' A' ' 6' ' ' VAL . 30.0 p90 -140.04 175.38 9.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.785 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.411 ' ND2' ' CD ' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -111.49 139.27 47.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.159 0.504 . . . . 0.0 111.84 -178.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.889 HG21 ' CD2' ' A' ' 44' ' ' LEU . 17.5 t -120.91 107.02 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.239 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 25.8 p-10 -112.24 127.24 55.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.714 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.06 156.14 42.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.008 0.432 . . . . 0.0 110.47 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.06 114.82 9.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.014 0.435 . . . . 0.0 110.539 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.925 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -96.4 145.01 26.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.739 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 23.8 mmtt -134.99 69.32 1.45 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.32 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.43 26.58 9.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.182 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.01 112.98 0.51 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.304 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.422 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -157.11 -94.46 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.027 0.442 . . . . 0.0 111.296 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 15.3 mt-10 -68.25 -4.45 14.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.154 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.075 HD13 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -44.58 -30.12 0.85 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.548 0.213 . . . . 0.0 110.552 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 19.47 53.22 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 114.62 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.075 HD21 HD13 ' A' ' 16' ' ' LEU . 2.0 pp -135.57 103.15 5.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.945 0.402 . . . . 0.0 110.066 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.2 t -69.06 122.08 17.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.138 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.743 HD22 HD12 ' A' ' 50' ' ' ILE . 10.6 mt -105.0 159.75 15.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.63 167.72 20.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.479 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.74 135.15 21.2 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.556 2.171 . . . . 0.0 112.585 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.444 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -147.4 162.64 38.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.088 179.734 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -32.89 38.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.154 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.574 HG13 HG22 ' A' ' 51' ' ' THR . 2.3 pt -99.12 -7.95 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.82 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.78 -122.81 1.04 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.416 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 m -140.52 106.45 5.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.75 0.309 . . . . 0.0 111.246 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.519 ' N ' HG23 ' A' ' 49' ' ' ILE . 93.6 m -66.95 127.33 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.399 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.547 HD11 HD13 ' A' ' 44' ' ' LEU . 30.7 mt -68.93 104.75 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.683 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -71.1 -23.38 62.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.945 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -171.68 172.45 4.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.825 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.745 ' O ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -163.48 131.76 3.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.986 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.173 HG23 ' CH2' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -95.53 144.14 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.597 -179.112 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -94.0 169.39 10.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.937 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.87 21.38 71.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.764 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -111.77 -33.51 6.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 110.891 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -156.25 144.91 14.69 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.116 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.15 -47.91 4.12 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.469 2.112 . . . . 0.0 112.779 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 43' ' ' LYS . 14.2 mp0 -65.77 -52.27 52.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.221 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.888 HD13 HD23 ' A' ' 18' ' ' LEU . 2.6 mt -54.91 -40.95 55.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.558 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -71.23 -30.09 65.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.153 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.56 3.71 32.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.062 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -127.47 -73.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.889 ' CD2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -60.12 148.88 34.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.884 -178.664 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -153.85 -175.71 5.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.539 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -92.93 116.8 29.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.51 -14.86 8.13 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.074 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.516 ' HB2' HD12 ' A' ' 29' ' ' ILE . 14.6 m-20 -85.87 158.8 19.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 111.267 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 28' ' ' THR . 1.1 mp -130.4 121.84 51.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.736 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.755 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 14.6 mt -74.26 100.63 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.034 0.445 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.574 HG22 HG13 ' A' ' 25' ' ' ILE . 7.5 p -102.4 26.88 7.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.906 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 2.8 mttt -172.7 135.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.982 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB2' HD11 ' A' ' 58' ' ' LEU . 68.0 t80 -139.34 120.83 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.93 0.395 . . . . 0.0 111.37 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.63 39.88 22.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.985 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.17 17.52 78.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.498 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -124.23 106.5 10.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 0.0 110.714 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.62 124.57 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.431 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.918 HD11 ' HB2' ' A' ' 53' ' ' PHE . 10.4 mt -94.91 23.34 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.81 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.95 144.28 38.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.091 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.89 24.01 57.29 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.695 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.703 HD12 ' HA ' ' A' ' 58' ' ' LEU . 83.3 mt -116.46 139.03 24.89 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.539 0.209 . . . . 0.0 110.803 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.95 -161.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.408 2.072 . . . . 0.0 112.17 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -106.73 -24.27 12.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -56.8 -50.65 71.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.063 0.459 . . . . 0.0 110.599 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.51 ' O ' HD23 ' A' ' 69' ' ' LEU . 16.4 m -63.21 -47.45 92.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.067 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.454 ' N ' HG23 ' A' ' 65' ' ' VAL . 63.5 m -57.5 -53.79 54.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 110.895 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.607 ' CE1' HG12 ' A' ' 106' ' ' VAL . 18.6 t80 -57.37 -31.0 65.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.715 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.23 -51.11 18.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.233 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.739 HD13 ' CD2' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.31 -32.29 72.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 110.331 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.755 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.5 m-85 -73.1 -31.32 64.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.976 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.448 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -85.11 -29.87 24.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.577 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.27 -22.45 44.5 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.855 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.925 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . . . -43.46 131.52 4.92 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.809 0.338 . . . . 0.0 111.519 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -157.06 101.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.05 85.27 1.49 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.623 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 110.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.824 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.749 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.6 108.0 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.685 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -99.25 111.29 23.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.479 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.23 124.03 46.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -88.31 107.29 18.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 110.289 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.64 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -95.29 142.94 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.443 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 92.8 m -108.45 128.4 54.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.079 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -110.54 93.43 16.37 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.208 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 82' ' ' THR . 38.8 Cg_exo . . . . . 0 C--N 1.344 0.293 0 C-N-CA 122.584 2.189 . . . . 0.0 112.218 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.502 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 29.3 mm-40 . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.906 0.384 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.518 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -80.88 96.0 6.89 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.173 ' CH2' HG23 ' A' ' 33' ' ' ILE . 54.7 m95 -100.71 138.05 38.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.698 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.607 HG12 ' CE1' ' A' ' 67' ' ' TYR . 34.4 m . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.211 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 84' ' ' PRO . 5.6 mp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.794 0.331 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 82' ' ' THR . 1.2 tp10 -60.09 162.51 5.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.824 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.9 mttt -156.19 129.52 8.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.61 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.829 ' CE2' HG22 ' A' ' 6' ' ' VAL . 35.0 p90 -136.92 173.94 11.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.791 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.8 135.87 49.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.955 0.407 . . . . 0.0 111.389 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.855 HG21 HD21 ' A' ' 44' ' ' LEU . 12.6 t -117.58 107.34 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.142 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -109.98 127.94 55.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.07 0.462 . . . . 0.0 110.9 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.66 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -159.52 153.07 22.61 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.928 179.318 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.94 127.14 31.67 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.529 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.959 ' HG2' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -103.79 136.58 43.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.79 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -115.45 69.6 0.73 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.94 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.93 27.61 0.74 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.398 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.77 73.07 1.13 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.281 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.591 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 29.6 ttmt -120.26 -102.82 0.41 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.571 0.224 . . . . 0.0 111.023 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 7.7 mt-10 -70.95 -6.35 37.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.959 HD13 ' HG2' ' A' ' 10' ' ' LYS . 7.7 tp -46.16 -39.13 9.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 12.33 62.99 0.01 OUTLIER Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.434 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -127.88 91.77 3.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.135 0.493 . . . . 0.0 109.798 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.821 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -52.8 119.35 4.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.844 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.642 HD21 HD13 ' A' ' 18' ' ' LEU . 53.3 mt -107.39 165.26 11.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.542 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 0.9 OUTLIER -145.19 167.68 13.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.361 179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 21' ' ' SER . 70.1 Cg_endo -75.2 135.81 19.19 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.494 2.129 . . . . 0.0 112.82 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.64 162.56 38.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.013 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.45 -28.85 41.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.183 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 pt -103.82 -2.01 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.919 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.8 -124.9 1.33 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.135 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.557 ' SG ' HD12 ' A' ' 50' ' ' ILE . 22.9 p -140.22 106.39 5.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.822 0.344 . . . . 0.0 111.078 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 84.8 m -65.45 128.85 37.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.69 104.74 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.618 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.821 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -67.11 -27.58 67.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.588 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -171.66 179.94 2.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.779 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.729 ' O ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.86 134.92 3.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.003 178.785 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.178 HG23 ' CH2' ' A' ' 105' ' ' TRP . 2.8 pt -95.99 119.39 43.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.79 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -72.22 175.24 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.308 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.41 -51.58 4.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.635 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -46.26 -74.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.672 0.272 . . . . 0.0 110.723 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -117.74 131.4 24.13 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.691 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.64 -42.74 8.68 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.457 2.105 . . . . 0.0 112.502 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.97 -48.45 81.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.677 HD13 HD23 ' A' ' 18' ' ' LEU . 6.0 mt -59.43 -42.33 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.567 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.27 -30.12 69.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.679 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -99.67 3.36 45.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.505 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HD3' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -125.08 -71.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.819 -179.12 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.855 HD21 HG21 ' A' ' 6' ' ' VAL . 10.1 mt -72.17 150.33 43.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.248 0.547 . . . . 0.0 112.156 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -153.84 149.6 27.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.248 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 -55.64 107.97 0.39 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.186 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.24 41.0 0.42 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.624 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -142.06 164.07 31.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.573 0.225 . . . . 0.0 110.619 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.6 mp -133.32 120.29 38.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.238 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.834 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.1 mt -74.59 100.65 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.045 0.45 . . . . 0.0 110.471 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 p -99.84 18.63 17.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.948 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -162.27 142.52 9.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.138 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.896 ' HB2' HD11 ' A' ' 58' ' ' LEU . 60.2 t80 -151.67 109.85 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.911 0.386 . . . . 0.0 111.1 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 51.94 55.31 9.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.01 23.35 65.79 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.358 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.91 99.72 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.804 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.46 120.57 7.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.285 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.896 HD11 ' HB2' ' A' ' 53' ' ' PHE . 5.1 mt -92.81 16.97 11.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.45 127.34 32.04 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.827 0.346 . . . . 0.0 111.142 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.65 -23.26 31.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.777 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.5 mt -79.6 148.34 69.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 111.096 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.661 ' HG2' HG23 ' A' ' 65' ' ' VAL . 40.6 Cg_endo -67.21 -168.37 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.499 2.132 . . . . 0.0 112.205 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -87.76 -28.45 21.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.618 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.73 -42.33 83.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.406 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.661 HG23 ' HG2' ' A' ' 62' ' ' PRO . 41.4 t -66.2 -53.94 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.744 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.423 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 89.4 m -56.07 -53.82 52.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.056 0.455 . . . . 0.0 110.781 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CD1' HG12 ' A' ' 106' ' ' VAL . 28.3 t80 -56.89 -30.88 64.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.18 -51.16 22.48 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.731 HD13 ' CD2' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.88 -37.18 81.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.351 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.834 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 10.1 m-85 -68.34 -32.04 71.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.955 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 2.9 mtpt -81.34 -34.4 31.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.17 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.36 -23.77 55.87 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.458 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.017 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -45.99 138.92 4.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.658 0.266 . . . . 0.0 111.301 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -170.87 97.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.038 0.447 . . . . 0.0 111.571 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.46 96.36 2.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.93 87.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.128 0.489 . . . . 0.0 110.442 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.017 HG21 ' HB1' ' A' ' 73' ' ' ALA . 3.5 t -114.4 130.72 68.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.147 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.7 t -122.82 139.62 53.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.449 ' HG2' ' CE1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -142.66 129.23 20.25 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.825 0.345 . . . . 0.0 111.675 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -91.21 108.12 19.66 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.719 HG11 HD22 ' A' ' 44' ' ' LEU . 1.9 m -95.16 142.64 13.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.837 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.414 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 45.3 m -108.65 125.33 51.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.196 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -107.68 97.63 21.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.097 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 82' ' ' THR . 50.9 Cg_exo . . . . . 0 C--N 1.345 0.346 0 C-N-CA 122.532 2.155 . . . . 0.0 112.286 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 17.9 mm-40 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.96 0.409 . . . . 0.0 112.083 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.6 t80 -76.81 95.98 4.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.178 ' CH2' HG23 ' A' ' 33' ' ' ILE . 68.4 m95 -101.71 138.14 39.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.352 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.832 ' CG2' HD23 ' A' ' 16' ' ' LEU . 16.0 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.196 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.796 0.331 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.405 ' HB3' ' CG ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -91.14 155.43 18.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.918 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 8.9 mttp -144.86 129.57 18.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.848 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.773 ' CE2' HG22 ' A' ' 6' ' ' VAL . 26.5 p90 -137.03 171.49 14.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.818 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.445 ' ND2' ' OE1' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.72 136.03 48.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.057 0.456 . . . . 0.0 111.394 -179.365 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.856 HG21 ' CD2' ' A' ' 44' ' ' LEU . 16.0 t -116.26 107.33 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.551 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 12.3 t0 -110.66 127.21 55.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.027 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.714 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.53 157.72 43.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 110.481 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.31 110.21 5.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.987 0.422 . . . . 0.0 111.037 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.79 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -94.56 144.39 25.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.093 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 6.6 mmtp -130.05 69.33 1.44 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.436 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.5 20.92 6.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.274 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' CA ' ' HZ3' ' A' ' 10' ' ' LYS . . . 91.31 114.56 1.88 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -164.56 -94.29 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 111.444 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.633 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 29.1 mt-10 -69.2 -4.49 17.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.126 0.57 . . . . 0.0 112.359 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.137 HD22 HD21 ' A' ' 18' ' ' LEU . 2.5 mt -44.65 -32.13 1.38 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.482 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 30.34 59.61 0.22 Allowed Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 115.13 177.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.137 HD21 HD22 ' A' ' 16' ' ' LEU . 1.3 pp -148.11 91.83 1.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.034 0.445 . . . . 0.0 110.202 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 30' ' ' ALA . 3.0 t -65.75 117.28 7.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.549 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.583 HD11 ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -88.0 170.35 11.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.603 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.81 159.39 56.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.11 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.76 111.52 2.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.427 2.085 . . . . 0.0 112.727 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.807 HD21 HG21 ' A' ' 49' ' ' ILE . 1.5 t30 -124.24 162.51 23.54 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.718 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 25' ' ' ILE . 7.0 pt-20 -83.46 -29.06 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.349 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.57 HG13 HG22 ' A' ' 51' ' ' THR . 1.6 pt -102.09 -8.66 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.763 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.43 -123.81 1.06 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.136 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.53 105.86 5.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.906 0.384 . . . . 0.0 111.046 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.449 ' N ' HG23 ' A' ' 49' ' ' ILE . 92.3 m -68.64 128.95 38.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.179 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.041 HG21 HD12 ' A' ' 32' ' ' LEU . 40.8 mt -70.25 104.8 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.858 0.361 . . . . 0.0 110.639 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -69.86 -30.66 68.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.959 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.442 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.8 OUTLIER -158.34 173.65 16.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.413 . . . . 0.0 111.299 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.041 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -155.8 126.89 7.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.397 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.114 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.6 pt -96.9 100.38 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.972 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -69.16 155.4 40.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.075 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.0 -14.66 64.72 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.859 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.561 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 4.1 mp0 -76.83 -47.61 20.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.711 0.291 . . . . 0.0 110.717 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.633 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.4 138.96 23.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.653 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.22 -51.02 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.662 2.241 . . . . 0.0 113.012 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -58.54 -48.78 79.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.769 0.318 . . . . 0.0 111.044 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.574 HD13 HD23 ' A' ' 18' ' ' LEU . 4.6 mt -57.32 -50.44 76.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.133 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.39 -30.26 68.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.562 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -97.48 0.65 47.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.173 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.466 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.21 -73.74 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.838 0.351 . . . . 0.0 111.697 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.879 HD12 HD22 ' A' ' 18' ' ' LEU . 34.1 mt -73.29 157.29 37.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.045 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -153.94 -175.9 5.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.221 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -90.56 104.96 17.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 111.127 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.49 -8.7 3.72 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.21 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.18 160.43 15.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 111.182 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.807 HG21 HD21 ' A' ' 23' ' ' ASN . 1.0 OUTLIER -126.9 119.69 53.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.849 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 4.3 mt -74.57 100.6 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 110.997 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.57 HG22 HG13 ' A' ' 25' ' ' ILE . 7.7 p -101.07 22.6 12.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.735 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.2 mttt -167.54 136.54 2.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.887 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.929 ' HB2' HD11 ' A' ' 58' ' ' LEU . 56.7 t80 -142.73 111.02 6.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.93 0.395 . . . . 0.0 111.265 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 54.17 46.84 24.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.26 22.15 78.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.431 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -126.16 106.41 9.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 110.737 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.68 121.49 9.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.324 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.929 HD11 ' HB2' ' A' ' 53' ' ' PHE . 7.9 mt -94.36 21.37 7.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.752 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -78.4 143.34 36.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.955 0.407 . . . . 0.0 111.097 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.23 24.02 60.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.792 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.51 ' HB3' HG21 ' A' ' 65' ' ' VAL . 34.6 mt -116.42 138.54 24.45 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.56 0.219 . . . . 0.0 110.841 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.36 -159.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.466 2.111 . . . . 0.0 112.182 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 67' ' ' TYR . 30.4 t80 -103.06 -24.44 13.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.984 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -57.73 -48.79 78.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.46 . . . . 0.0 110.515 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 61' ' ' LEU . 18.3 m -63.96 -46.92 92.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.084 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.458 ' N ' HG23 ' A' ' 65' ' ' VAL . 1.5 m -58.8 -51.86 68.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.85 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.514 ' CZ ' ' CE2' ' A' ' 104' ' ' TYR . 10.8 t80 -58.55 -31.22 67.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.23 -51.08 22.7 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.657 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -69.06 -32.24 71.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 110.268 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.849 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 8.9 m-85 -73.76 -28.69 61.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.283 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.433 ' HG3' HG12 ' A' ' 106' ' ' VAL . 29.2 mtmt -85.02 -38.99 18.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.7 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.16 -22.27 74.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.855 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.798 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -44.16 127.87 5.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.832 0.348 . . . . 0.0 111.691 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -159.45 104.02 1.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.089 0.471 . . . . 0.0 110.756 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.96 84.35 1.64 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.072 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 114.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 0.0 110.366 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.798 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -127.38 107.61 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.406 -179.165 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 t -99.57 114.96 28.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.062 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.83 123.49 41.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.574 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -85.84 105.78 16.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.189 179.107 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.824 HG11 HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -96.61 142.68 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.893 -179.079 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.41 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 91.7 m -108.85 117.78 35.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.603 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.405 ' CG ' ' HB3' ' A' ' 2' ' ' GLU . 22.1 ptt180 -104.53 93.78 6.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.04 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--N 1.344 0.317 0 C-N-CA 122.512 2.141 . . . . 0.0 112.337 179.861 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.538 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 31.5 mm-40 . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.122 0.487 . . . . 0.0 112.224 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.514 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -86.87 96.03 10.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.114 ' CH2' HG23 ' A' ' 33' ' ' ILE . 8.5 m95 -104.67 134.54 47.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.254 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 70' ' ' PHE . 11.7 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.139 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.61 156.34 29.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.772 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 8.9 mttt -150.93 129.58 12.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.812 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.8 p90 -137.66 170.14 16.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.68 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.447 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.65 135.87 49.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.057 0.456 . . . . 0.0 111.305 -179.342 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.873 HG21 ' CD2' ' A' ' 44' ' ' LEU . 11.5 t -116.37 107.01 21.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.289 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 1.6 p30 -110.44 127.28 55.04 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.053 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.1 156.35 42.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.95 0.405 . . . . 0.0 110.663 178.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 113.45 7.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.026 0.441 . . . . 0.0 110.586 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.782 ' CE ' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -96.33 151.26 19.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.434 0.635 . . . . 0.0 111.896 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 20.2 mmtt -138.0 69.27 1.39 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.246 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 53.84 24.06 4.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.3 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.43 113.94 1.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.551 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.426 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -159.28 -97.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.765 0.317 . . . . 0.0 111.312 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.0 mm-40 -69.14 -5.78 24.5 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.161 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.809 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -45.23 -33.97 2.59 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.885 0.374 . . . . 0.0 110.497 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.568 ' HA3' HD11 ' A' ' 33' ' ' ILE . . . 26.17 62.22 0.07 OUTLIER Glycine 0 CA--C 1.522 0.483 0 N-CA-C 115.379 0.912 . . . . 0.0 115.379 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.974 HD12 HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -139.62 91.81 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.023 0.439 . . . . 0.0 110.244 177.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 1.9 t -61.74 114.28 3.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.023 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.974 HD11 HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -93.78 161.59 14.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.36 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 30' ' ' ALA . 19.3 p -136.3 164.77 40.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.577 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.56 122.0 8.48 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.773 2.316 . . . . 0.0 112.841 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.14 162.44 34.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 25' ' ' ILE . 4.8 pt-20 -80.09 -36.83 34.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.115 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.554 HD11 HD13 ' A' ' 49' ' ' ILE . 2.1 pt -94.93 -7.65 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.02 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.76 -125.18 1.27 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.366 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -140.69 106.28 5.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.882 0.372 . . . . 0.0 111.522 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' HG12 ' A' ' 49' ' ' ILE . 98.7 m -69.76 128.37 36.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.197 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.011 HG21 HD12 ' A' ' 32' ' ' LEU . 49.6 mt -64.41 104.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.855 0.359 . . . . 0.0 110.446 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.567 ' HB2' ' HB3' ' A' ' 21' ' ' SER . . . -71.96 -26.84 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.496 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 1.8 m-20 -159.47 163.96 34.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.739 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.011 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -153.68 129.14 9.9 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.113 0.482 . . . . 0.0 111.971 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.173 HG23 ' CH2' ' A' ' 105' ' ' TRP . 3.0 pt -96.17 108.92 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.083 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -82.38 128.61 34.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.079 0.466 . . . . 0.0 111.294 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.2 30.37 3.17 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.814 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -117.49 -29.89 5.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.708 0.29 . . . . 0.0 111.279 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -151.31 143.11 15.86 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.79 -47.18 2.83 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.453 2.102 . . . . 0.0 112.894 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 7.2 mm-40 -66.02 -51.53 57.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.2 mt -55.47 -46.6 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.229 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.65 -30.37 71.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.991 0.424 . . . . 0.0 110.524 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -97.46 3.52 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.229 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.66 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -128.71 -72.67 0.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.944 0.402 . . . . 0.0 111.821 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.873 ' CD2' HG21 ' A' ' 6' ' ' VAL . 26.8 mt -73.7 149.11 42.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.119 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -153.96 155.8 36.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.357 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -57.81 104.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.151 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.03 45.2 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.899 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -144.77 145.05 31.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.366 . . . . 0.0 110.888 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.554 HD13 HD11 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -112.58 117.57 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.351 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.01 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 7.0 mt -74.89 100.23 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.264 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 25' ' ' ILE . 13.9 p -93.68 -3.93 51.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.278 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -144.89 147.28 32.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.979 ' HB2' HD11 ' A' ' 58' ' ' LEU . 22.8 t80 -153.32 114.05 4.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.884 0.373 . . . . 0.0 111.323 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.42 46.36 25.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.002 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.54 24.73 76.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.353 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -124.98 102.98 7.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 110.654 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.97 114.95 1.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.457 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.979 HD11 ' HB2' ' A' ' 53' ' ' PHE . 13.2 mt -91.12 15.78 11.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.59 125.36 35.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.72 15.62 51.94 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.373 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -128.64 159.74 66.43 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.976 0.388 . . . . 0.0 111.131 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.3 -171.7 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.695 2.264 . . . . 0.0 112.524 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 12.4 t80 -94.05 -32.11 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.594 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.72 -46.6 50.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.999 0.428 . . . . 0.0 110.449 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' O ' HD23 ' A' ' 69' ' ' LEU . 24.4 m -64.26 -41.05 91.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.86 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 17.1 m -62.77 -51.77 65.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.919 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.698 ' CD1' HG12 ' A' ' 106' ' ' VAL . 37.2 t80 -58.49 -30.96 67.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.713 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.67 -50.96 31.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.665 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -70.07 -31.49 69.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.411 . . . . 0.0 110.239 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 1.01 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 3.4 m-85 -72.86 -27.61 62.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.138 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 1.8 mtpt -85.2 -43.84 13.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.794 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.28 -23.41 78.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.016 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.782 ' HB3' ' CE ' ' A' ' 10' ' ' LYS . . . -42.16 128.89 3.73 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 111.735 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -157.32 103.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.09 83.6 1.44 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.267 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.08 114.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.469 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.781 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.31 107.83 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.687 -179.056 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 t -100.35 111.98 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.501 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.9 124.02 49.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.323 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -87.13 104.66 16.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.066 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.682 HG11 HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.94 142.52 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.421 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.409 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 83.9 m -108.92 119.95 41.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.636 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -102.77 91.33 2.77 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo . . . . . 0 C--N 1.345 0.379 0 C-N-CA 122.531 2.154 . . . . 0.0 112.544 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.534 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 95.0 mm-40 . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 5.7 t80 -86.85 96.47 10.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.243 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.173 ' CH2' HG23 ' A' ' 33' ' ' ILE . 9.0 m95 -106.48 137.16 44.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.698 HG12 ' CD1' ' A' ' 67' ' ' TYR . 27.5 m . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.207 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.858 0.361 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.66 156.07 25.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.532 ' HG2' HG23 ' A' ' 82' ' ' THR . 25.1 mttp -150.74 129.59 12.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.962 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.806 ' CE2' HG22 ' A' ' 6' ' ' VAL . 25.5 p90 -136.85 171.58 14.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.801 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.45 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.62 135.65 49.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.031 0.443 . . . . 0.0 111.223 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.837 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.3 t -116.11 107.28 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.361 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 14.5 p-10 -110.0 127.23 54.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.7 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.36 158.6 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.527 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.02 113.32 8.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.103 0.478 . . . . 0.0 110.913 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.887 ' HE2' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -97.51 145.59 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.425 -179.654 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 12.4 mmtt -131.46 69.43 1.47 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.225 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.14 23.19 5.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.3 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.12 113.48 1.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.59 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 6.6 ptpt -161.5 -94.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 9.5 mt-10 -69.47 -5.9 26.95 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.669 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.887 HD22 ' HE2' ' A' ' 10' ' ' LYS . 2.1 tp -45.8 -34.36 3.67 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.538 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 22.74 62.16 0.03 OUTLIER Glycine 0 C--N 1.331 0.262 0 CA-C-N 114.933 -1.031 . . . . 0.0 115.008 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.786 HD22 HD12 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.43 91.7 2.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 110.097 178.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 5.0 t -61.59 118.94 7.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.021 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.582 HD21 ' CD1' ' A' ' 50' ' ' ILE . 7.8 mp -100.25 159.12 15.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.359 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.905 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 56.0 m -130.41 156.71 79.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.629 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.91 111.4 2.18 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.531 2.154 . . . . 0.0 112.474 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.669 HD21 HG21 ' A' ' 49' ' ' ILE . 1.8 t30 -122.85 162.57 21.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.064 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.621 ' HG3' HG23 ' A' ' 25' ' ' ILE . 11.1 pt-20 -79.09 -31.66 44.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.189 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.621 HG23 ' HG3' ' A' ' 24' ' ' GLU . 2.8 pt -101.12 -8.3 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.969 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 170.26 -121.19 0.9 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.484 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' SER . 3.0 m -140.47 106.48 5.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 111.224 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.555 ' N ' HG23 ' A' ' 49' ' ' ILE . 97.5 m -69.69 119.96 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.561 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.94 HG21 HD12 ' A' ' 32' ' ' LEU . 52.7 mt -61.35 104.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.741 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.905 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -73.72 -29.58 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.5 OUTLIER -158.67 171.45 20.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.064 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.94 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -159.31 128.2 5.26 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.454 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.166 HG23 ' CH2' ' A' ' 105' ' ' TRP . 2.4 pt -96.47 100.69 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.274 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -69.79 145.32 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.085 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.13 -25.34 23.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.915 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.574 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 1.8 mp0 -66.71 -47.52 72.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.722 0.296 . . . . 0.0 110.858 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -136.65 140.21 31.44 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.68 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.43 -50.15 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.635 2.223 . . . . 0.0 112.924 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -59.37 -49.71 76.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 110.997 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.701 HD13 HD23 ' A' ' 18' ' ' LEU . 5.2 mt -55.85 -53.01 42.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -58.43 -30.17 66.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.6 m -97.17 0.99 49.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.338 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.37 -73.41 0.62 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 0.0 111.566 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.84 HD22 HG11 ' A' ' 81' ' ' VAL . 21.3 mt -72.81 155.59 39.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.908 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.5 -175.77 5.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.474 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -90.57 98.0 11.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.035 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.43 -18.53 1.68 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.046 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.79 162.44 21.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 111.236 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.669 HG21 HD21 ' A' ' 23' ' ' ASN . 1.1 mp -128.9 120.36 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.918 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.884 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.9 mt -74.48 100.22 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 110.644 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.512 HG22 HG13 ' A' ' 25' ' ' ILE . 7.5 p -94.71 -7.4 40.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -141.43 147.95 38.77 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.972 ' HB2' HD11 ' A' ' 58' ' ' LEU . 26.8 t80 -152.58 110.38 3.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 0.0 111.256 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 54.14 47.44 23.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.858 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.35 24.81 73.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.231 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -123.88 102.41 7.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 0.0 110.584 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.11 114.01 1.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.427 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.972 HD11 ' HB2' ' A' ' 53' ' ' PHE . 15.3 mt -89.83 14.39 12.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.927 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -78.39 142.97 37.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.046 0.45 . . . . 0.0 111.232 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.05 26.52 61.15 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.744 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 58' ' ' LEU . 63.0 mt -120.24 140.79 30.61 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.607 0.242 . . . . 0.0 110.96 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.67 -166.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.507 2.138 . . . . 0.0 112.168 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -101.6 -24.97 14.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.105 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -45.84 84.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.686 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' HD23 ' A' ' 69' ' ' LEU . 25.7 t -68.08 -50.48 58.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.499 ' SG ' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -55.91 -48.36 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.566 ' CD1' HG12 ' A' ' 106' ' ' VAL . 15.7 t80 -64.3 -30.98 72.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.13 -50.9 35.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.958 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.685 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.5 -35.51 79.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 110.396 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.884 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 2.6 m-85 -69.77 -28.85 66.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.217 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.405 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 21.1 mtmt -84.98 -36.52 21.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.739 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.61 -20.0 67.15 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.976 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.824 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -45.34 126.93 6.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.752 0.311 . . . . 0.0 111.532 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -154.78 103.73 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.28 85.78 1.8 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.063 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.93 116.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.456 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.824 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -131.19 107.72 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.632 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.6 t -99.41 114.3 27.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.33 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.79 125.34 48.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.478 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' OE2' ' ND2' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -86.76 103.8 15.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.928 0.394 . . . . 0.0 110.091 178.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.84 HG11 HD22 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -95.17 143.1 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.521 -179.491 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.532 HG23 ' HG2' ' A' ' 3' ' ' LYS . 77.7 m -108.32 116.77 32.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -102.69 89.8 1.97 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.062 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.344 0.322 0 C-N-CA 122.525 2.15 . . . . 0.0 112.213 179.904 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.507 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 64.1 mm-40 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.932 0.396 . . . . 0.0 111.715 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.519 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 1.3 t80 -81.49 96.07 7.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 1.166 ' CH2' HG23 ' A' ' 33' ' ' ILE . 33.4 m95 -100.91 136.98 39.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.113 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.739 ' CG2' HD23 ' A' ' 16' ' ' LEU . 25.6 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.171 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.8 155.65 27.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HG2' HG23 ' A' ' 82' ' ' THR . 9.4 mttt -149.39 129.72 13.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.069 0.462 . . . . 0.0 110.708 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.775 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.1 p90 -138.49 169.58 17.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.688 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.458 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.58 135.88 49.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.158 0.504 . . . . 0.0 111.382 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.822 HG21 ' CD2' ' A' ' 44' ' ' LEU . 19.2 t -114.42 107.06 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.157 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 1.5 p30 -111.74 127.27 55.74 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.016 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.698 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -151.68 157.8 42.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.55 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.401 ' HB3' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -71.33 118.33 14.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 110.696 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.933 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -101.14 129.13 47.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.812 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 3.5 mmtp -119.61 68.61 0.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.166 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.9 77.33 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 48.95 100.78 0.01 OUTLIER Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.329 -0.462 . . . . 0.0 114.167 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -159.4 -101.58 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.141 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 22.3 mt-10 -69.22 -5.41 22.57 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.785 HD22 HD21 ' A' ' 18' ' ' LEU . 2.7 mt -45.5 -30.32 1.39 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.963 0.411 . . . . 0.0 109.906 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.551 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 24.81 63.05 0.05 OUTLIER Glycine 0 C--N 1.331 0.284 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.785 HD21 HD22 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -145.85 92.02 2.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.108 0.48 . . . . 0.0 110.098 178.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.5 t -63.42 120.73 12.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.175 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.461 HD21 HD12 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -100.0 158.07 16.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.585 -179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.41 163.33 51.28 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.348 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.33 117.56 5.22 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.492 2.128 . . . . 0.0 112.77 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.469 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -130.9 162.61 29.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG3' HG23 ' A' ' 25' ' ' ILE . 17.1 pt-20 -79.66 -37.26 36.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.643 HG23 ' HG3' ' A' ' 24' ' ' GLU . 2.3 pt -94.34 -6.03 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.888 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.27 -122.65 1.08 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.619 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -138.99 106.23 5.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.727 0.298 . . . . 0.0 110.924 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.439 ' N ' HG23 ' A' ' 49' ' ' ILE . 88.6 m -66.82 121.04 14.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.246 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.685 HD12 ' HB2' ' A' ' 48' ' ' ASP . 32.0 mt -62.85 104.59 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.561 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.568 ' HA ' HD22 ' A' ' 94' ' ' LEU . . . -72.1 -25.5 61.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -172.54 -178.02 1.87 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.386 0.612 . . . . 0.0 111.38 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -164.36 136.73 4.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.553 178.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.145 HG23 ' CH2' ' A' ' 105' ' ' TRP . 3.1 pt -96.0 100.32 10.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.303 0.573 . . . . 0.0 110.334 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -63.6 153.24 36.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.86 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.8 -16.15 61.46 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.703 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.2 mp0 -77.77 -50.08 13.09 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.712 0.291 . . . . 0.0 110.727 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -135.07 139.69 32.68 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.766 0.317 . . . . 0.0 110.829 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.15 -50.27 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.693 2.262 . . . . 0.0 113.05 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.7 mp0 -59.56 -49.25 78.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 110.838 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.66 HD13 HD23 ' A' ' 18' ' ' LEU . 4.2 mt -56.04 -48.22 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.92 -30.3 70.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.511 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 m -99.16 3.37 46.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.367 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -125.32 -71.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.574 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.822 ' CD2' HG21 ' A' ' 6' ' ' VAL . 14.4 mt -71.13 156.24 39.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.466 0.65 . . . . 0.0 112.498 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.71 ' HA ' HD21 ' A' ' 32' ' ' LEU . 5.2 mt-30 -153.95 -175.78 5.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.857 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -92.83 117.55 30.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.888 0.375 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.35 17.53 4.38 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.896 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.685 ' HB2' HD12 ' A' ' 29' ' ' ILE . 6.1 m-20 -115.32 167.35 10.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.783 0.291 . . . . 0.0 110.82 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.469 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.5 mp -137.01 120.61 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.014 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 9.8 mt -74.21 100.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.07 0.462 . . . . 0.0 110.567 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 25' ' ' ILE . 11.2 p -95.71 -3.71 45.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.245 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -144.52 143.96 31.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.984 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.95 ' HB2' HD11 ' A' ' 58' ' ' LEU . 32.0 t80 -150.1 111.74 4.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.954 0.407 . . . . 0.0 111.369 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.68 46.17 26.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.132 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.95 24.26 76.55 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.391 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -126.68 104.47 8.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.693 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.3 117.28 3.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.223 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.95 HD11 ' HB2' ' A' ' 53' ' ' PHE . 8.5 mt -92.8 17.67 10.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.968 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -87.21 127.72 35.15 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.891 0.376 . . . . 0.0 111.226 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.4 -23.84 28.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.791 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.24 153.81 66.25 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.998 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.01 -172.57 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.578 2.186 . . . . 0.0 112.244 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 67' ' ' TYR . 55.0 t80 -91.95 -29.18 16.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.713 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -53.96 -43.43 69.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.58 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.509 ' O ' HD23 ' A' ' 69' ' ' LEU . 10.1 p -65.28 -46.22 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.5 ' N ' HG13 ' A' ' 65' ' ' VAL . 89.4 m -60.21 -49.62 76.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.661 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.59 ' CD1' HG12 ' A' ' 106' ' ' VAL . 16.1 t80 -58.52 -31.97 68.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.599 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.01 -50.85 20.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.213 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.732 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.46 -37.02 82.29 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.473 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 1.014 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.0 m-85 -67.49 -34.02 76.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 34.9 mtmt -82.18 -29.76 31.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.28 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.85 15.93 61.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.637 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.933 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -78.12 138.14 38.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.709 0.29 . . . . 0.0 110.591 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 4.3 p-10 -169.52 100.07 0.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.989 0.424 . . . . 0.0 110.785 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.17 78.32 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.961 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.36 114.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.962 0.411 . . . . 0.0 110.27 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.73 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.82 107.85 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.614 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.7 t -102.71 109.81 21.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.303 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.63 123.77 48.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.57 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tt0 -86.66 106.24 17.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 110.307 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.686 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -95.95 142.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.626 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.439 HG23 ' HG2' ' A' ' 3' ' ' LYS . 94.2 m -108.78 120.81 43.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -103.9 91.43 3.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.405 ' HD3' HD12 ' A' ' 49' ' ' ILE . 56.6 Cg_endo -70.74 -175.22 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.45 2.1 . . . . 0.0 112.325 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -67.27 158.88 80.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.36 169.14 17.65 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.521 2.147 . . . . 0.0 112.22 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 146.5 -54.73 0.54 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.571 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.3 m -96.59 125.3 40.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.08 70.71 0.8 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.477 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.04 -44.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.551 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -99.06 -44.05 6.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.74 -32.35 4.18 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.501 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.17 155.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.309 . . . . 0.0 110.923 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 30' ' ' ALA . 10.2 mp -73.28 -30.6 63.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.745 HG23 ' NE2' ' A' ' 103' ' ' GLN . 13.4 p -99.34 113.63 64.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.777 ' HG2' HD13 ' A' ' 98' ' ' LEU . 59.1 Cg_endo -72.83 -167.94 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.625 2.217 . . . . 0.0 112.198 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.63 62.84 7.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.781 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.777 HD13 ' HG2' ' A' ' 96' ' ' PRO . 1.6 mp -89.28 -71.73 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.001 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.33 -163.74 1.75 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.854 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -54.55 -55.3 30.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.821 0.343 . . . . 0.0 110.746 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -142.13 26.22 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -52.36 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.979 0.418 . . . . 0.0 110.441 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.745 ' NE2' HG23 ' A' ' 95' ' ' VAL . 17.1 mm-40 -139.13 170.66 15.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.155 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.508 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.0 t80 -79.44 96.1 5.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.145 ' CH2' HG23 ' A' ' 33' ' ' ILE . 54.3 m95 -99.3 139.83 34.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.095 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.59 HG12 ' CD1' ' A' ' 67' ' ' TYR . 10.8 m . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.125 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.736 0.303 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.15 162.21 22.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.912 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.9 mttp -154.43 129.64 9.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.816 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.714 ' CE2' HG22 ' A' ' 6' ' ' VAL . 12.7 p90 -137.71 169.73 17.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.882 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.458 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.46 135.82 49.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.002 0.429 . . . . 0.0 111.069 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.894 HG21 ' CD2' ' A' ' 44' ' ' LEU . 11.3 t -117.07 107.27 21.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.574 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 6.8 p-10 -108.56 127.15 53.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.805 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.96 155.05 40.27 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.955 0.407 . . . . 0.0 110.481 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.94 119.04 11.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.246 0.546 . . . . 0.0 110.459 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.744 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -101.89 149.79 23.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.092 -178.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 16.7 mmtt -138.55 68.94 1.38 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.182 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.09 27.16 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.425 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 96.18 116.9 3.25 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.099 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -169.75 -99.09 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 111.533 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.683 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 26.6 mt-10 -69.37 -4.77 19.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.692 HD22 ' CD2' ' A' ' 18' ' ' LEU . 4.2 mt -44.16 -37.96 3.43 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.832 0.348 . . . . 0.0 110.33 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.551 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 33.37 55.43 0.58 Allowed Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.802 -0.635 . . . . 0.0 114.146 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.731 ' CD1' HD21 ' A' ' 20' ' ' LEU . 1.1 pp -138.33 91.94 2.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.822 0.344 . . . . 0.0 110.365 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -63.07 110.37 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.577 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.731 HD21 ' CD1' ' A' ' 18' ' ' LEU . 3.3 mt -91.62 161.11 15.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.736 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.828 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 7.0 m -142.94 152.2 58.13 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.68 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.69 135.87 70.14 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.661 2.241 . . . . 0.0 112.706 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.559 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -145.3 162.68 36.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.141 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 25' ' ' ILE . 8.0 pt-20 -81.56 -19.76 41.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' A' ' 24' ' ' GLU . 5.8 pt -115.34 -4.61 11.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.753 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.79 -123.39 1.15 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.166 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' SER . 0.9 OUTLIER -140.68 106.05 5.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.774 0.321 . . . . 0.0 111.265 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.4 ' OG1' HG12 ' A' ' 49' ' ' ILE . 88.4 m -70.82 128.61 36.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.598 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.086 HG21 HD12 ' A' ' 32' ' ' LEU . 16.6 mt -71.65 104.92 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.712 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.828 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -69.84 -29.34 66.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.174 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.51 164.34 38.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.086 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -150.87 128.79 11.71 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.262 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.128 HG23 ' CH2' ' A' ' 105' ' ' TRP . 11.5 pt -104.78 100.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.347 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -72.16 159.98 33.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.086 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.56 64.72 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.125 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.555 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -81.54 -41.67 21.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.941 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.683 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -139.29 136.28 17.86 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.197 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.9 -44.46 5.4 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.622 2.214 . . . . 0.0 113.137 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 3.9 mm-40 -64.86 -52.88 54.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.66 0.267 . . . . 0.0 110.943 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.625 HD11 HD23 ' A' ' 16' ' ' LEU . 5.2 mt -54.54 -48.02 70.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.052 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -63.46 -30.21 71.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.552 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 m -97.01 3.24 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.268 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.671 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -131.62 -73.46 0.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.397 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.894 ' CD2' HG21 ' A' ' 6' ' ' VAL . 54.8 mt -72.34 149.28 44.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.077 0.465 . . . . 0.0 111.363 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.64 160.09 42.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.538 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -59.22 105.0 0.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.97 37.27 0.62 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.596 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.571 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -132.65 139.3 47.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.784 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.559 HG21 ' OD1' ' A' ' 23' ' ' ASN . 2.5 mt -110.99 117.26 54.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.977 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.971 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 15.2 mt -77.42 100.22 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.995 0.426 . . . . 0.0 110.539 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.1 p -94.63 0.33 55.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.207 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -148.53 142.05 25.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.029 179.258 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.99 ' HB2' HD11 ' A' ' 58' ' ' LEU . 36.3 t80 -145.68 108.43 4.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.86 0.362 . . . . 0.0 111.061 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 51.88 53.95 11.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.949 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.43 69.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.371 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -123.33 103.25 8.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.802 0.334 . . . . 0.0 110.604 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.28 113.32 1.52 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.332 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.99 HD11 ' HB2' ' A' ' 53' ' ' PHE . 15.1 mt -88.61 9.93 22.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -68.42 145.91 53.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.879 0.371 . . . . 0.0 111.085 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.96 26.11 47.47 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.633 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 58' ' ' LEU . 21.6 mt -116.73 148.12 41.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.686 0.279 . . . . 0.0 110.849 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.64 -167.38 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.551 2.167 . . . . 0.0 112.227 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.9 t80 -97.77 -26.56 14.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.767 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -57.43 -47.93 80.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.968 0.413 . . . . 0.0 110.273 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.528 ' O ' HD23 ' A' ' 69' ' ' LEU . 22.6 m -63.8 -47.03 92.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.087 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.468 ' N ' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -59.27 -53.8 54.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.699 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.553 ' CD1' HG12 ' A' ' 106' ' ' VAL . 21.8 t80 -56.02 -31.14 62.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.692 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.33 -51.08 18.76 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.652 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.74 -34.76 76.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.851 0.358 . . . . 0.0 110.356 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.971 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.8 m-85 -69.06 -34.0 74.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.466 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 7.4 mtpt -81.31 -32.83 32.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.358 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.41 -26.47 57.09 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.51 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.828 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -45.13 139.52 3.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.881 0.372 . . . . 0.0 111.412 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -167.11 99.6 0.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.72 80.12 0.84 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.819 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.19 112.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 110.158 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.828 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.42 107.96 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.752 -178.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 t -98.5 114.43 26.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.45 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.82 122.21 42.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.666 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -83.31 102.93 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.669 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -95.26 142.45 13.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.739 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 53.2 m -108.86 126.06 52.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.014 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -108.71 96.37 19.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.236 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 82' ' ' THR . 41.5 Cg_exo -56.03 -175.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.564 2.176 . . . . 0.0 112.202 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -110.76 161.25 25.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.771 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.76 169.23 18.05 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.556 2.17 . . . . 0.0 112.285 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.49 -52.91 0.29 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -91.07 -176.01 4.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.63 -28.79 7.3 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.64 28.24 16.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.591 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -91.02 -40.85 11.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.12 117.29 5.57 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.419 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.33 154.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.963 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 30' ' ' ALA . 45.9 mt -121.04 20.8 11.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.25 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.533 HG22 ' H ' ' A' ' 97' ' ' ARG . 10.4 p -146.55 128.57 7.63 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.41 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.647 ' HD2' HD21 ' A' ' 98' ' ' LEU . 89.8 Cg_endo -80.74 13.4 2.32 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.707 2.272 . . . . 0.0 112.978 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.533 ' H ' HG22 ' A' ' 95' ' ' VAL . 1.2 mpt_? 66.64 79.69 0.23 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.858 0.361 . . . . 0.0 111.146 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.647 HD21 ' HD2' ' A' ' 96' ' ' PRO . 1.6 mm? -93.23 -64.97 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.117 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.28 -163.24 1.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.237 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.46 ' O ' ' CD ' ' A' ' 101' ' ' ARG . 0.1 OUTLIER -66.88 72.73 0.09 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.288 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.599 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER 62.7 -49.32 0.19 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.599 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 11.4 p-10 20.16 86.89 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.901 0.48 . . . . 0.0 112.164 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 101' ' ' ARG . 6.9 mm-40 -145.36 179.1 7.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.086 0.47 . . . . 0.0 111.852 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.525 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.6 t80 -83.18 96.09 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.128 ' CH2' HG23 ' A' ' 33' ' ' ILE . 27.7 m95 -103.39 126.52 50.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.046 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.553 HG12 ' CD1' ' A' ' 67' ' ' TYR . 8.6 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.079 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.822 0.344 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.27 157.13 38.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.699 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 4.5 mttt -151.43 129.68 11.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.973 0.416 . . . . 0.0 110.992 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.798 ' CE2' HG22 ' A' ' 6' ' ' VAL . 26.9 p90 -138.13 170.71 15.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.694 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.461 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.56 135.95 48.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.01 0.433 . . . . 0.0 111.349 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.893 HG21 ' CD2' ' A' ' 44' ' ' LEU . 13.3 t -116.77 107.04 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.604 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 38.9 t0 -110.29 127.22 54.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.908 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.708 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.92 157.57 43.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.57 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.02 110.05 5.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.962 0.41 . . . . 0.0 110.889 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.803 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -95.18 150.91 19.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.324 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 20.5 mmtt -138.45 69.28 1.38 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.5 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.4 22.25 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.253 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.29 113.97 1.38 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -162.28 -94.23 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.963 0.411 . . . . 0.0 111.351 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 15.1 mt-10 -69.15 -5.07 20.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.979 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.625 HD21 HD21 ' A' ' 8' ' ' LEU . 2.7 mt -45.09 -40.7 7.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.138 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.521 ' HA2' HD11 ' A' ' 33' ' ' ILE . . . 34.24 53.08 0.73 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 114.485 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.779 HD12 HD11 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -136.88 92.88 2.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.035 0.445 . . . . 0.0 110.232 178.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.529 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 6.0 t -63.92 122.33 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.05 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.779 HD11 HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -100.98 169.33 9.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.438 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.22 167.72 13.82 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.358 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.43 121.63 6.92 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.489 2.126 . . . . 0.0 112.59 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.437 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -133.67 162.52 31.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.03 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.537 ' HG3' HG23 ' A' ' 25' ' ' ILE . 10.7 pt-20 -79.32 -32.84 43.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.537 HG23 ' HG3' ' A' ' 24' ' ' GLU . 3.6 pt -99.81 -7.09 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.867 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.27 -123.57 1.12 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.243 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -140.55 106.2 5.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.93 0.395 . . . . 0.0 111.195 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.6 m -66.63 132.08 47.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.548 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.928 HG21 HD12 ' A' ' 32' ' ' LEU . 43.3 mt -68.58 104.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.903 0.382 . . . . 0.0 110.583 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.529 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -68.19 -23.38 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.223 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 5.5 m-20 -171.83 174.38 4.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.995 0.426 . . . . 0.0 111.13 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.928 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -152.05 127.28 9.85 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.535 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.067 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.0 pt -101.32 100.59 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.212 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -65.91 173.85 2.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.822 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.44 18.93 72.16 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.608 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -111.25 -46.28 3.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.767 0.318 . . . . 0.0 110.289 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -142.75 139.61 17.36 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.368 179.003 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.5 -49.36 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 113.085 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 43' ' ' LYS . 30.4 mm-40 -61.12 -51.48 68.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.541 HD11 HD23 ' A' ' 16' ' ' LEU . 6.1 mt -54.17 -50.89 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.056 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.41 -30.21 69.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.562 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 m -96.92 2.48 51.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.255 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.606 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.56 -73.58 0.58 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.867 0.365 . . . . 0.0 111.759 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.893 ' CD2' HG21 ' A' ' 6' ' ' VAL . 54.0 mt -72.16 149.52 44.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.006 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -147.4 -175.8 4.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.487 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -87.16 115.04 24.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.09 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.23 31.84 1.78 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.705 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.53 162.63 25.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.649 0.261 . . . . 0.0 110.748 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.437 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.2 mp -133.18 119.21 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.062 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.004 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.7 mt -74.5 100.49 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 110.51 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -93.94 -4.53 49.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.154 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.433 ' CB ' ' HB2' ' A' ' 80' ' ' GLU . 2.0 mttt -144.56 144.29 31.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.968 ' HB2' HD11 ' A' ' 58' ' ' LEU . 51.3 t80 -149.01 110.89 4.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.917 0.389 . . . . 0.0 111.194 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.83 46.05 23.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.75 21.46 76.51 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.47 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -123.62 107.32 11.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.779 0.323 . . . . 0.0 110.758 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.55 118.57 4.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.318 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.968 HD11 ' HB2' ' A' ' 53' ' ' PHE . 12.4 mt -92.6 16.93 11.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.32 144.76 42.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.965 0.412 . . . . 0.0 111.195 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.19 20.53 58.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.695 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 58' ' ' LEU . 81.0 mt -115.4 137.73 23.26 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.54 0.21 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.45 -160.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.421 2.081 . . . . 0.0 112.1 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -103.32 -24.96 13.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -56.01 -47.81 77.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.562 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.505 ' O ' HD23 ' A' ' 69' ' ' LEU . 26.8 m -67.44 -45.63 85.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.817 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.493 ' N ' HG23 ' A' ' 65' ' ' VAL . 15.8 m -56.56 -48.4 77.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.665 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 22.0 t80 -64.75 -30.89 71.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.747 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.45 -50.9 41.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.125 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -68.73 -35.33 76.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.938 0.399 . . . . 0.0 110.444 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 1.004 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 6.3 m-85 -70.31 -27.38 64.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.299 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HG3' HG12 ' A' ' 106' ' ' VAL . 1.5 mtmp? -84.12 -41.68 16.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.14 -22.46 76.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.845 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.803 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . . . -43.26 127.12 4.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.876 0.37 . . . . 0.0 111.698 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -156.05 104.21 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.87 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.44 85.39 1.76 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.271 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.36 115.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 110.357 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.794 HG11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -129.84 107.81 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.648 -179.023 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -99.92 112.86 25.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.314 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.4 124.48 47.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.434 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' OE2' ' ND2' ' A' ' 5' ' ' ASN . 1.5 tt0 -86.87 104.53 16.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.928 0.394 . . . . 0.0 110.047 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.806 HG11 HD22 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -95.17 143.05 12.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.522 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.415 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 98.0 m -108.42 120.17 41.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.638 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -103.5 92.52 4.12 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.39 -176.17 1.83 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.505 2.137 . . . . 0.0 112.222 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.0 pttt -126.01 153.42 73.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.26 160.46 49.74 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.529 2.153 . . . . 0.0 112.409 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.99 -55.01 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.531 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 t -88.79 -41.98 12.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.345 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.97 162.15 11.04 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.43 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.43 57.54 1.27 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.504 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.1 t -102.43 26.25 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.92 -166.2 19.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.415 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.02 169.82 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 110.83 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.38 -34.55 18.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.949 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.407 HG23 ' HD2' ' A' ' 96' ' ' PRO . 10.3 p -72.19 138.94 81.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.833 ' HG2' HD13 ' A' ' 98' ' ' LEU . 69.1 Cg_endo -85.32 28.43 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.701 2.268 . . . . 0.0 113.142 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 57.84 56.22 4.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.899 0.38 . . . . 0.0 111.313 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.833 HD13 ' HG2' ' A' ' 96' ' ' PRO . 3.0 mp -93.21 -58.56 2.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.21 -165.0 2.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -52.88 -79.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.275 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.418 ' CB ' HG22 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -162.08 80.22 0.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.1 0.476 . . . . 0.0 111.345 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -100.77 29.4 4.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.146 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.519 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 10.9 mm-40 -68.59 -177.51 0.96 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.449 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.523 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 2.6 t80 -86.82 96.46 10.21 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.056 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.067 ' CH2' HG23 ' A' ' 33' ' ' ILE . 18.1 m95 -103.34 139.32 38.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.575 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.52 HG23 HD12 ' A' ' 16' ' ' LEU . 11.4 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.111 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 84' ' ' PRO . 10.4 mt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.695 0.283 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -77.54 157.54 30.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.985 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' HG2' HG23 ' A' ' 82' ' ' THR . 10.2 mttt -154.87 129.71 9.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.666 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.857 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.0 p90 -138.44 171.85 13.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.194 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.455 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.57 135.99 48.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.96 0.409 . . . . 0.0 111.256 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.912 HG21 ' CD2' ' A' ' 44' ' ' LEU . 3.5 t -120.19 107.71 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.827 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.581 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 11.9 p30 -108.5 127.18 53.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.718 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.713 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -145.56 154.49 42.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.931 0.395 . . . . 0.0 110.553 179.064 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.2 111.92 4.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.059 0.457 . . . . 0.0 110.691 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.857 ' HE2' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -97.4 148.47 23.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.675 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.423 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 21.5 mmtt -138.12 69.29 1.39 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.278 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.71 27.69 9.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.184 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.66 111.52 0.56 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' CG ' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.64 -96.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 111.263 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 36' ' ' GLN . 3.6 mt-10 -67.31 -5.73 15.53 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.032 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.857 HD22 ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -46.1 -43.46 14.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.768 0.318 . . . . 0.0 110.445 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.727 ' CA ' HD11 ' A' ' 33' ' ' ILE . . . 33.46 61.82 0.43 Allowed Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 114.611 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.589 HD12 HD21 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -141.96 104.19 4.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.933 0.397 . . . . 0.0 110.375 178.487 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 t -71.55 119.39 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.148 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.589 HD21 HD12 ' A' ' 18' ' ' LEU . 76.4 mt -108.86 169.17 8.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.551 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -148.16 167.79 12.53 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.529 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.56 135.89 32.09 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.502 2.135 . . . . 0.0 112.747 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.49 162.53 36.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.603 ' HG3' HG23 ' A' ' 25' ' ' ILE . 12.6 pt-20 -79.07 -21.53 46.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.226 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.603 HG23 ' HG3' ' A' ' 24' ' ' GLU . 5.5 pt -114.81 5.38 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.713 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.95 -123.74 1.41 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.129 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 21' ' ' SER . 1.9 p -140.47 109.05 5.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.922 0.392 . . . . 0.0 111.155 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.499 ' N ' HG23 ' A' ' 49' ' ' ILE . 53.2 m -72.04 136.9 46.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.04 HG21 HD12 ' A' ' 32' ' ' LEU . 51.2 mt -73.58 104.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.625 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.676 ' HA ' HD13 ' A' ' 94' ' ' LEU . . . -69.1 -28.83 66.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 3.4 m-20 -161.3 168.37 24.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.04 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -151.28 126.76 10.07 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.244 0.545 . . . . 0.0 111.967 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.101 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -96.4 100.72 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.224 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -73.67 136.67 43.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.037 0.446 . . . . 0.0 111.368 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.65 32.98 4.59 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.743 ' HG3' ' O ' ' A' ' 33' ' ' ILE . 1.1 pp0? -122.72 -21.9 5.5 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -161.19 143.86 9.34 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.106 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.04 -48.42 2.76 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.483 2.122 . . . . 0.0 112.915 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 52.6 mm-40 -67.62 -53.26 29.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 110.838 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.3 mt -54.7 -40.38 51.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.414 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.97 -30.66 65.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.806 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -98.17 3.64 49.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.163 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.577 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.34 -72.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.959 0.409 . . . . 0.0 111.571 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.912 ' CD2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -59.0 149.42 27.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.669 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -153.94 146.81 24.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.58 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -59.54 112.43 1.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.67 38.16 0.93 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.585 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.49 155.01 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 110.821 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 28' ' ' THR . 1.1 mp -124.62 119.42 56.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.983 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.98 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.3 mt -74.57 100.52 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.104 0.478 . . . . 0.0 110.338 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 p -97.36 26.81 4.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.924 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' CB ' ' HB2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -172.71 144.36 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.091 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.899 ' HB2' HD11 ' A' ' 58' ' ' LEU . 64.3 t80 -151.54 108.5 3.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 111.066 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 53.22 52.55 13.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.792 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.93 20.91 71.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.428 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -122.56 103.94 9.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.839 0.352 . . . . 0.0 110.766 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.43 115.58 2.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.276 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 53' ' ' PHE . 13.7 mt -87.64 7.85 27.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -67.74 146.13 54.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.841 0.353 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.73 23.66 55.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.666 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 58' ' ' LEU . 38.9 mt -116.84 149.13 43.49 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.653 0.263 . . . . 0.0 110.896 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.475 ' HG2' HG23 ' A' ' 65' ' ' VAL . 45.3 Cg_endo -68.38 -169.22 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.553 2.169 . . . . 0.0 112.299 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 67' ' ' TYR . 11.3 t80 -96.97 -26.43 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.785 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -57.08 -46.33 82.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.414 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.557 HG12 HD23 ' A' ' 69' ' ' LEU . 28.9 t -68.4 -47.03 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.763 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 88.3 m -56.54 -53.74 54.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.586 ' CE1' HG13 ' A' ' 106' ' ' VAL . 6.2 t80 -60.95 -30.98 70.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.671 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.05 36.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.125 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.722 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -69.55 -33.4 72.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.235 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.98 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.6 m-85 -72.15 -27.26 62.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.299 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HG3' HG12 ' A' ' 106' ' ' VAL . 18.0 mtmt -85.22 -37.74 19.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.701 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.52 -19.39 68.72 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.056 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HB3' ' CE ' ' A' ' 10' ' ' LYS . . . -44.18 131.28 6.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.711 0.291 . . . . 0.0 111.676 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -157.2 102.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.2 82.8 1.3 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.307 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.29 115.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.882 0.373 . . . . 0.0 110.509 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.807 HG11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.78 107.95 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.964 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -98.89 116.02 30.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.195 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.54 128.43 52.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.303 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -88.77 105.46 17.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 0.0 110.252 179.287 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.676 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -95.14 142.86 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.249 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.483 HG23 ' HG2' ' A' ' 3' ' ' LYS . 95.9 m -108.51 119.61 40.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.608 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.99 89.89 1.76 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.044 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.567 ' HA ' HD22 ' A' ' 1' ' ' LEU . 38.3 Cg_endo -66.55 -175.71 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.445 2.096 . . . . 0.0 112.075 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -106.19 157.65 34.39 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.025 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.85 -174.02 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.561 2.174 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.32 -36.81 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.534 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.9 t -107.09 -174.14 2.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 0.0 110.902 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.5 76.85 1.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.454 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.12 93.57 1.55 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.485 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.5 p -100.03 26.21 6.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.51 -126.45 0.87 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.496 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.38 -174.58 4.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.322 . . . . 0.0 110.85 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.676 HD13 ' HA ' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -70.66 -11.27 60.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.428 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 95' ' ' VAL . 14.5 p -98.48 120.56 59.0 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.107 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.824 ' HG2' HD13 ' A' ' 98' ' ' LEU . 56.3 Cg_endo -71.63 -168.37 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.439 2.093 . . . . 0.0 112.221 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -80.68 60.29 3.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.1 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.824 HD13 ' HG2' ' A' ' 96' ' ' PRO . 3.5 mp -93.11 -71.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.971 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.43 -164.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.568 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -64.25 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 110.581 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.796 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.5 mpt_? -140.38 -79.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.82 28.04 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 110.838 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.516 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.8 mm-40 -82.64 -177.33 6.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.167 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 1.1 t80 -84.74 96.23 9.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.053 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.101 ' CH2' HG23 ' A' ' 33' ' ' ILE . 18.7 m95 -105.94 135.37 47.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.183 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.586 HG13 ' CE1' ' A' ' 67' ' ' TYR . 16.0 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.503 HD23 ' HG3' ' A' ' 84' ' ' PRO . 1.1 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.707 0.289 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.411 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 2.4 tp10 -79.81 159.46 26.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 11.0 mttt -146.18 129.43 16.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.682 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.667 ' CE2' HG22 ' A' ' 6' ' ' VAL . 12.6 p90 -137.07 169.25 18.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.055 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.438 ' ND2' ' OE1' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.57 135.92 49.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.316 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.699 HG21 ' CD2' ' A' ' 44' ' ' LEU . 17.0 t -115.56 107.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.471 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 12.4 t0 -112.69 127.28 56.08 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.675 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -153.63 157.84 40.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 110.735 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.67 123.62 20.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.118 0.485 . . . . 0.0 111.005 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.936 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -108.02 128.37 54.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.297 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 4.1 mmtp -118.36 68.52 0.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.892 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.76 78.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.262 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.426 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 46.91 99.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.276 -0.42 . . . . 0.0 114.018 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.453 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 6.3 ptpt -157.06 -99.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 16.6 mt-10 -69.15 -5.3 21.57 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.739 HD22 HD21 ' A' ' 18' ' ' LEU . 3.0 mt -45.48 -30.61 1.46 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.063 0.458 . . . . 0.0 109.803 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.567 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 24.79 62.41 0.05 OUTLIER Glycine 0 CA--C 1.519 0.314 0 N-CA-C 115.453 0.941 . . . . 0.0 115.453 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.777 HD22 ' CD1' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -146.33 91.83 2.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.175 0.512 . . . . 0.0 110.252 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 1.7 t -60.17 115.22 3.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.675 HD13 ' SG ' ' A' ' 27' ' ' CYS . 62.7 mt -97.37 163.75 12.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.313 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -141.43 166.85 19.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.488 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.47 130.05 16.69 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.351 2.034 . . . . 0.0 112.682 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.496 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -141.01 162.4 35.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -26.59 37.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.299 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.543 HD11 HD13 ' A' ' 49' ' ' ILE . 3.2 pt -106.84 -7.04 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.826 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.64 -125.14 1.24 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.854 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.675 ' SG ' HD13 ' A' ' 20' ' ' LEU . 25.2 p -140.61 106.07 5.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.906 0.384 . . . . 0.0 111.162 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.408 ' OG1' HG12 ' A' ' 49' ' ' ILE . 87.8 m -66.03 134.44 52.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.458 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.048 HG21 HD12 ' A' ' 32' ' ' LEU . 45.8 mt -75.88 104.88 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.559 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.43 -26.77 63.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.989 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.786 ' OD1' HG22 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -161.01 169.8 21.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.046 0.451 . . . . 0.0 111.221 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.048 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -154.25 124.68 6.98 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.267 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.09 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.1 pt -96.43 100.49 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.194 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -68.9 153.59 43.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.981 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.37 -23.02 36.78 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.787 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.9 mp0 -67.63 -46.74 71.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.77 0.319 . . . . 0.0 110.811 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -138.24 141.82 33.17 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.477 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.19 -49.04 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.522 2.148 . . . . 0.0 112.96 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 26.9 mm-40 -62.3 -50.95 69.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.338 . . . . 0.0 110.962 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.668 HD13 HD23 ' A' ' 18' ' ' LEU . 4.4 mt -54.47 -50.1 60.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.243 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -60.96 -30.48 70.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.565 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -97.98 3.41 49.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.149 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HD3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.79 -72.99 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.918 0.389 . . . . 0.0 111.625 -178.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.777 ' CD1' HD22 ' A' ' 18' ' ' LEU . 87.3 mt -75.8 145.76 40.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.744 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.67 163.53 38.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.473 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -59.41 110.88 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.92 0.39 . . . . 0.0 110.991 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.67 46.89 0.55 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.682 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.435 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -144.03 139.43 28.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 110.711 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.543 HD13 HD11 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -112.47 117.59 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.23 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.786 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.0 mt -76.85 100.69 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 0.0 110.601 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.52 HG22 HG13 ' A' ' 25' ' ' ILE . 8.7 p -98.18 16.0 22.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.164 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 7.2 mttt -162.42 132.68 4.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.003 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.941 ' HB2' HD11 ' A' ' 58' ' ' LEU . 58.3 t80 -136.78 108.76 7.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 111.067 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 55.27 52.93 10.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.851 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.62 17.51 66.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.358 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -121.01 103.4 9.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 110.634 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . . . -55.49 120.38 7.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.436 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.941 HD11 ' HB2' ' A' ' 53' ' ' PHE . 9.5 mt -92.82 18.11 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.807 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -73.77 142.83 46.22 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.948 0.404 . . . . 0.0 111.312 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.77 18.22 52.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.753 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 58' ' ' LEU . 50.9 mt -109.69 137.85 20.49 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.701 0.251 . . . . 0.0 110.826 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.72 -159.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.302 2.001 . . . . 0.0 112.148 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -106.0 -23.7 12.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.016 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -54.98 -48.8 72.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.3 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.507 ' O ' HD23 ' A' ' 69' ' ' LEU . 30.8 m -68.47 -44.36 83.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.823 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.461 ' N ' HG23 ' A' ' 65' ' ' VAL . 1.5 m -55.95 -54.05 49.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.729 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.548 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 5.1 t80 -62.13 -30.97 71.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.926 0.393 . . . . 0.0 110.437 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.63 -51.13 37.72 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.712 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.37 -42.27 83.72 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.361 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.786 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 11.4 m-85 -63.33 -31.13 72.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 25.9 mtmt -83.03 -31.95 27.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.037 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -88.83 11.04 70.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.734 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.936 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -76.8 136.93 38.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.663 0.268 . . . . 0.0 110.484 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 4.6 p-10 -168.13 100.72 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.144 0.497 . . . . 0.0 110.886 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.91 77.68 0.74 Allowed Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.919 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.08 115.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.141 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.75 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.22 107.66 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.727 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 t -99.5 115.15 28.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.46 120.89 35.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -81.83 111.24 17.87 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.681 HG11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.69 142.28 17.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.95 -178.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.7 m -109.06 118.39 36.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.289 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -107.96 97.23 20.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.139 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HG3' HD23 ' A' ' 1' ' ' LEU . 63.0 Cg_exo -50.8 162.1 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.55 2.166 . . . . 0.0 112.383 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 154.49 93.7 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.905 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.75 -175.65 0.79 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.564 2.176 . . . . 0.0 112.255 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.44 -69.89 2.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.445 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.46 143.37 34.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.37 . . . . 0.0 110.861 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.91 -67.4 0.55 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.564 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -138.75 100.12 0.28 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.431 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.0 t -74.94 -39.38 61.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 110.961 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.35 -174.68 19.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.9 p -88.18 177.84 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.755 0.312 . . . . 0.0 110.838 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.65 23.96 13.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.786 HG22 ' OD1' ' A' ' 31' ' ' ASP . 10.7 t -123.99 135.66 26.59 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.906 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.767 ' HG2' HD13 ' A' ' 98' ' ' LEU . 61.9 Cg_endo -88.33 25.66 0.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.831 2.354 . . . . 0.0 113.0 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.64 53.22 13.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.184 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.767 HD13 ' HG2' ' A' ' 96' ' ' PRO . 5.6 mp -93.22 -71.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.229 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 mt -138.91 -169.56 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.061 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -71.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.349 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.508 ' HD3' HG22 ' A' ' 33' ' ' ILE . 2.2 mpt_? -164.3 78.19 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.155 0.503 . . . . 0.0 111.326 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -101.22 27.41 6.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.096 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.5 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.4 mm-40 -66.22 -177.66 0.55 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.432 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.548 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.5 t80 -85.03 96.18 9.32 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.09 ' CH2' HG23 ' A' ' 33' ' ' ILE . 20.0 m95 -104.14 132.05 50.8 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.197 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 70' ' ' PHE . 20.4 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.131 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.844 0.354 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.88 154.07 23.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.636 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -147.75 129.65 15.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.042 0.448 . . . . 0.0 110.929 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.762 ' CE2' HG22 ' A' ' 6' ' ' VAL . 29.6 p90 -138.23 172.09 13.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.666 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.01 136.02 49.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 111.813 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.793 HG21 ' CD2' ' A' ' 44' ' ' LEU . 15.9 t -116.3 107.28 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.124 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.591 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.6 p30 -114.44 127.4 55.81 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.779 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -155.28 160.95 41.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.753 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.49 127.63 33.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.803 ' CE ' HD13 ' A' ' 16' ' ' LEU . 4.2 tmtt? -112.5 136.97 51.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.26 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HB2' ' HG2' ' A' ' 14' ' ' LYS . 13.2 mmtt -131.07 68.92 1.48 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.59 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.405 ' H ' ' HB3' ' A' ' 74' ' ' ASN . . . 34.56 82.94 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.387 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.33 57.66 8.99 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.632 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.464 ' HG2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -98.48 -138.41 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.862 0.363 . . . . 0.0 111.198 -179.033 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.0 mt-10 -69.19 -4.54 18.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.803 HD13 ' CE ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -44.68 -44.2 8.91 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.286 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.649 ' HA3' HD11 ' A' ' 33' ' ' ILE . . . 23.86 68.05 0.03 OUTLIER Glycine 0 CA--C 1.518 0.25 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.592 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.689 HD21 ' HG ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -133.1 92.91 3.09 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.049 0.452 . . . . 0.0 109.895 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.8 t -56.48 113.73 1.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.179 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.431 HD21 HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -94.26 166.82 11.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.259 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.748 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 1.2 m -143.32 157.49 59.72 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.92 127.0 16.86 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.427 2.085 . . . . 0.0 112.574 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.455 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -139.7 162.59 34.75 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.823 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -81.35 -26.58 35.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.392 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.463 HG13 HG22 ' A' ' 51' ' ' THR . 2.9 pt -106.57 -8.41 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.895 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.74 -125.05 1.18 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.125 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -140.6 105.96 5.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.916 0.389 . . . . 0.0 111.189 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.405 ' OG1' HG12 ' A' ' 49' ' ' ILE . 85.0 m -67.33 126.91 30.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.516 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.098 HG21 HD12 ' A' ' 32' ' ' LEU . 24.5 mt -69.02 104.91 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.797 0.332 . . . . 0.0 110.685 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.748 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -68.15 -29.0 67.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.423 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 15.3 m-20 -163.88 167.25 20.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.098 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -149.73 132.74 16.19 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.349 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.124 HG23 ' CH2' ' A' ' 105' ' ' TRP . 4.3 pt -99.03 100.62 10.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.623 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -70.52 166.19 21.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.931 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.73 -0.39 88.28 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.009 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.533 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.32 -44.19 7.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.77 0.319 . . . . 0.0 110.453 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -139.59 139.6 22.74 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.998 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.53 -48.83 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.544 2.163 . . . . 0.0 112.834 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 43' ' ' LYS . 75.6 mm-40 -59.58 -51.23 70.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.654 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.572 HG22 HD21 ' A' ' 32' ' ' LEU . 6.2 mt -57.98 -44.54 87.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.972 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.87 -30.34 71.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.059 0.457 . . . . 0.0 110.218 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 m -99.96 3.41 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.074 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.495 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -126.32 -74.6 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.43 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.849 HD22 HG11 ' A' ' 81' ' ' VAL . 46.9 mt -76.41 151.88 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.582 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.86 -175.88 5.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.391 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -80.98 109.41 15.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.726 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.35 27.29 2.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.689 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.681 ' HB2' HD12 ' A' ' 29' ' ' ILE . 1.7 m-20 -121.2 139.28 53.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 110.681 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.455 HG21 ' OD1' ' A' ' 23' ' ' ASN . 2.0 mt -112.31 117.65 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.16 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.988 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.9 mt -75.6 100.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.398 . . . . 0.0 110.683 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.463 HG22 HG13 ' A' ' 25' ' ' ILE . 8.3 p -97.76 6.33 48.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.376 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -152.67 139.38 18.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.931 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.938 ' HB2' HD11 ' A' ' 58' ' ' LEU . 28.8 t80 -149.08 111.76 4.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.012 0.434 . . . . 0.0 111.217 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 55.62 48.9 17.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.71 23.03 68.69 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.321 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -125.4 98.03 5.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.889 0.376 . . . . 0.0 110.473 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.87 120.27 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.369 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.938 HD11 ' HB2' ' A' ' 53' ' ' PHE . 7.4 mt -92.37 19.87 6.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.977 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -77.02 143.28 39.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.919 0.39 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.33 24.51 61.43 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.732 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 58' ' ' LEU . 26.4 mt -116.21 144.42 32.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.576 0.227 . . . . 0.0 110.906 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.84 -170.62 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.466 2.111 . . . . 0.0 111.902 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -93.43 -26.4 17.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.972 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -43.42 88.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 0.0 110.528 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.543 ' O ' HD23 ' A' ' 69' ' ' LEU . 11.1 p -71.22 -47.13 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.998 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.505 ' N ' HG13 ' A' ' 65' ' ' VAL . 94.4 m -58.59 -53.81 54.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 110.567 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.541 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 73.2 t80 -61.32 -30.7 70.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.679 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.03 -51.25 41.08 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.44 -41.11 85.27 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.259 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.988 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.7 m-85 -61.64 -35.23 77.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.497 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 2.3 mtpt -78.36 -34.06 48.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.065 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.92 8.67 65.57 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.601 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.698 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -74.84 137.76 42.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.768 0.318 . . . . 0.0 110.558 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.405 ' HB3' ' H ' ' A' ' 12' ' ' ALA . 4.6 p-10 -176.41 85.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.078 0.466 . . . . 0.0 110.746 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.2 71.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.183 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.43 96.5 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.011 0.434 . . . . 0.0 110.711 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.698 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -101.12 150.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.373 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.2 t -140.68 117.93 11.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.484 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.0 124.77 38.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -88.25 105.2 17.39 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.437 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.849 HG11 HD22 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -95.12 142.76 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.15 -178.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 m -108.57 118.98 38.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.414 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -102.82 94.04 4.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.201 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.45 -175.08 1.64 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.475 2.117 . . . . 0.0 112.107 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -75.77 155.73 84.93 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.98 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.79 168.92 17.27 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.601 2.2 . . . . 0.0 112.322 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.12 -136.2 3.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.507 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.2 m -62.59 97.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 0.0 110.943 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.07 -178.74 21.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.515 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.85 -101.54 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -64.11 -32.83 74.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.834 0.349 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.09 52.89 10.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.511 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 m -59.32 165.74 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 30' ' ' ALA . 1.1 mp -98.18 -32.72 11.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.9 t -109.27 130.61 22.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.328 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.876 ' HG2' HD13 ' A' ' 98' ' ' LEU . 53.1 Cg_endo -68.33 -162.45 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.457 2.105 . . . . 0.0 111.443 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.53 55.09 3.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.015 0.436 . . . . 0.0 110.557 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.876 HD13 ' HG2' ' A' ' 96' ' ' PRO . 1.9 mp -81.46 -71.56 0.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.01 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.488 HD23 ' HD3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -118.73 -166.95 1.3 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.691 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.488 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -72.13 -47.38 51.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.903 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.593 ' HG3' ' CG2' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -177.59 27.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.402 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.438 ' OD1' HD22 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -53.24 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.29 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.517 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 7.2 mm-40 -137.43 171.35 14.59 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.541 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.0 t80 -81.03 96.05 7.01 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.124 ' CH2' HG23 ' A' ' 33' ' ' ILE . 47.3 m95 -99.21 143.6 29.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.51 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' A' ' 70' ' ' PHE . 20.4 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.24 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.766 0.317 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.77 159.04 30.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.864 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.407 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 9.7 mttt -153.68 129.57 10.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.811 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.9 p90 -138.17 170.7 15.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.748 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.58 135.78 49.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.977 0.417 . . . . 0.0 111.366 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.811 HG22 ' CE2' ' A' ' 4' ' ' PHE . 14.3 t -116.6 106.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.213 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 9.0 p-10 -113.82 127.07 55.85 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.085 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.695 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -154.05 156.26 37.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 110.742 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.18 117.32 8.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.067 0.46 . . . . 0.0 111.151 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.808 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -101.47 142.0 33.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.132 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HB2' ' NZ ' ' A' ' 14' ' ' LYS . 4.7 mmtp -126.95 69.49 1.27 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.533 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.73 21.49 5.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.34 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.85 113.01 1.45 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.777 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -163.07 -93.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.893 0.378 . . . . 0.0 110.925 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 25.0 mt-10 -69.44 -4.96 20.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.674 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.872 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -44.97 -31.6 1.34 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.114 0.483 . . . . 0.0 109.94 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.543 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 28.39 61.82 0.12 Allowed Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.514 -0.766 . . . . 0.0 114.618 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -142.48 91.96 2.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.898 0.38 . . . . 0.0 110.273 178.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -67.92 109.33 3.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.424 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.607 HD11 HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -84.5 163.18 19.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.773 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.71 160.01 68.14 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.031 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.33 120.66 7.13 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.518 2.145 . . . . 0.0 112.759 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.61 162.7 33.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.002 0.429 . . . . 0.0 111.192 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.592 ' HG3' HG23 ' A' ' 25' ' ' ILE . 16.6 pt-20 -79.8 -39.43 30.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.315 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.592 HG23 ' HG3' ' A' ' 24' ' ' GLU . 1.8 pt -90.24 -12.99 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.863 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.95 -125.23 1.13 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.256 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -140.46 106.08 5.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.916 0.389 . . . . 0.0 110.851 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 94.5 m -63.7 134.68 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.766 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 48' ' ' ASP . 36.3 mt -74.41 104.54 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.916 0.389 . . . . 0.0 110.141 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.539 ' HA ' HD12 ' A' ' 94' ' ' LEU . . . -75.29 -33.76 61.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.705 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 19' ' ' SER . 4.1 m-20 -162.24 174.01 13.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.278 0.561 . . . . 0.0 111.495 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.706 HD21 ' CA ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -157.83 136.62 11.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.93 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.137 HG23 ' CH2' ' A' ' 105' ' ' TRP . 4.2 pt -95.63 99.98 10.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 109.673 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -66.91 147.5 53.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.012 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.24 -17.63 56.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.768 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 2.2 mp0 -76.31 -48.45 20.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.733 0.302 . . . . 0.0 110.938 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -134.98 139.74 32.98 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.844 0.354 . . . . 0.0 110.692 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.99 -48.62 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.789 2.326 . . . . 0.0 113.112 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 43' ' ' LYS . 16.3 mm-40 -62.54 -48.42 79.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.0 mt -58.11 -42.71 83.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -30.25 70.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.386 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -99.85 3.55 44.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.351 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -123.36 -70.51 0.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.494 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.71 ' CD2' HG21 ' A' ' 6' ' ' VAL . 15.1 mt -72.07 156.99 38.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.398 0.618 . . . . 0.0 112.409 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.706 ' CA ' HD21 ' A' ' 32' ' ' LEU . 1.2 tt0 -153.94 -175.85 5.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.978 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.2 mtp-105 -91.87 99.79 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.47 39.28 0.21 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.586 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.606 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -131.61 174.62 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.6 mt -145.82 118.53 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.992 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 7.1 mt -73.93 100.23 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.142 0.496 . . . . 0.0 110.402 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.467 HG22 HG13 ' A' ' 25' ' ' ILE . 16.9 p -98.73 2.43 47.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.054 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.7 mttt -150.27 139.55 21.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.816 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.952 ' HB2' HD11 ' A' ' 58' ' ' LEU . 41.8 t80 -147.18 113.09 5.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.932 0.396 . . . . 0.0 111.264 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 55.54 48.07 19.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.18 21.7 72.13 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.413 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -127.33 104.95 8.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.371 . . . . 0.0 110.669 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.26 125.42 20.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.251 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.952 HD11 ' HB2' ' A' ' 53' ' ' PHE . 7.4 mt -96.52 27.45 3.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.802 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -82.83 142.42 31.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.04 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.7 21.81 65.5 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.661 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 58' ' ' LEU . 56.8 mt -117.29 136.26 23.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.501 0.191 . . . . 0.0 110.811 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.4 -161.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.419 2.079 . . . . 0.0 112.065 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -98.83 -26.66 14.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.026 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -57.41 -46.02 83.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.406 ' O ' HD23 ' A' ' 69' ' ' LEU . 25.7 t -64.1 -51.93 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.973 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 90.5 m -56.91 -50.2 73.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.584 ' CD1' HG12 ' A' ' 106' ' ' VAL . 29.3 t80 -59.43 -31.12 69.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.991 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.76 -50.85 26.35 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.726 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.76 -32.48 72.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 110.523 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.992 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 4.7 m-85 -73.82 -28.55 61.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.269 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 21.6 mtmt -83.44 -36.68 24.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.802 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.81 -18.0 68.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.102 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.819 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -46.44 130.81 11.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.894 0.378 . . . . 0.0 111.588 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -160.9 102.74 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.736 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.99 85.44 1.64 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.165 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.08 109.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.552 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.819 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -122.91 107.82 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.515 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.6 t -100.72 112.0 24.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.295 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.54 123.44 43.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.444 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.8 104.51 16.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.673 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.7 OUTLIER -95.09 142.54 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.588 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.407 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 51.6 m -108.94 123.45 49.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.369 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -104.24 92.93 5.08 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.159 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.17 -174.66 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.622 2.214 . . . . 0.0 112.235 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 157.2 34.17 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.798 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.49 162.74 32.63 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.578 2.186 . . . . 0.0 112.411 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.94 -87.06 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.8 t -169.23 152.05 4.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.59 179.18 16.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.409 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.7 130.23 1.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m -96.89 -30.96 12.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.851 0.358 . . . . 0.0 110.996 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -151.94 -94.75 0.11 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.444 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.857 ' C ' HD13 ' A' ' 94' ' ' LEU . 1.1 m -161.77 142.79 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.857 HD13 ' C ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -132.26 73.23 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.446 0.641 . . . . 0.0 110.528 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.625 HG12 ' NE2' ' A' ' 103' ' ' GLN . 14.6 p -44.96 137.7 4.43 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.651 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.626 ' HD2' HD21 ' A' ' 98' ' ' LEU . 88.6 Cg_endo -78.74 20.13 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.664 2.243 . . . . 0.0 113.314 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.81 76.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.802 0.334 . . . . 0.0 111.688 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.626 HD21 ' HD2' ' A' ' 96' ' ' PRO . 1.4 mm? -93.27 -33.64 13.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.105 0.479 . . . . 0.0 110.133 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.33 -156.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.059 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.17 -75.64 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.419 0.152 . . . . 0.0 111.254 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.556 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -176.97 -50.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.855 -0.157 . . . . 0.0 111.185 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.556 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 1.7 p-10 30.19 81.9 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.689 0.395 . . . . 0.0 111.809 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.625 ' NE2' HG12 ' A' ' 95' ' ' VAL . 5.6 mm-40 -145.9 178.27 8.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.074 0.464 . . . . 0.0 111.98 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.519 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.1 t80 -83.3 96.44 8.49 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.137 ' CH2' HG23 ' A' ' 33' ' ' ILE . 38.4 m95 -102.96 138.75 39.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.696 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.584 HG12 ' CD1' ' A' ' 67' ' ' TYR . 15.7 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.08 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.753 0.311 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -78.31 157.62 29.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 5.9 mttp -149.57 129.61 13.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.794 ' CE2' HG22 ' A' ' 6' ' ' VAL . 24.6 p90 -137.74 169.6 17.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.616 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.453 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -108.56 135.78 49.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.081 0.467 . . . . 0.0 111.142 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.89 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.4 t -115.8 107.16 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.506 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.0 p30 -110.06 127.19 54.7 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.796 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.715 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.68 155.37 40.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 110.61 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.51 113.86 6.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.94 0.4 . . . . 0.0 110.823 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.866 ' HE2' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -98.87 140.52 32.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.545 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.414 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 6.1 mmtp -127.55 69.34 1.31 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.304 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.18 23.43 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.275 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.27 113.62 1.17 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.612 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -161.78 -94.15 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 36' ' ' GLN . 24.0 mt-10 -69.24 -5.66 24.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.732 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.866 HD22 ' HE2' ' A' ' 10' ' ' LYS . 1.7 tp -45.53 -31.44 1.81 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.008 0.432 . . . . 0.0 109.843 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.568 ' HA2' HD11 ' A' ' 33' ' ' ILE . . . 23.24 59.59 0.04 OUTLIER Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.154 -0.93 . . . . 0.0 114.953 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 18' ' ' LEU . 2.8 pp -138.79 99.34 3.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.073 0.464 . . . . 0.0 110.303 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -68.98 115.86 8.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.598 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.863 HD13 ' SG ' ' A' ' 27' ' ' CYS . 62.2 mt -98.81 161.79 13.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.023 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.79 166.32 28.19 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.425 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.01 98.56 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.711 2.274 . . . . 0.0 113.439 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -107.72 162.83 13.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.916 0.389 . . . . 0.0 111.358 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.773 ' HG3' HG23 ' A' ' 25' ' ' ILE . 12.8 pt-20 -73.76 -42.31 61.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.391 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.773 HG23 ' HG3' ' A' ' 24' ' ' GLU . 3.3 pt -92.68 -7.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.874 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.31 -130.22 1.93 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.858 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.863 ' SG ' HD13 ' A' ' 20' ' ' LEU . 26.0 p -140.64 106.39 5.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.904 0.383 . . . . 0.0 111.357 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.483 ' OG1' HG12 ' A' ' 49' ' ' ILE . 69.0 m -69.52 133.21 47.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.628 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.012 HG21 HD12 ' A' ' 32' ' ' LEU . 39.8 mt -69.08 104.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.282 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.826 ' HA ' HD22 ' A' ' 94' ' ' LEU . . . -71.67 -24.41 61.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.963 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -162.48 163.73 27.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.749 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.012 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -149.31 124.82 10.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.313 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.107 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.0 pt -96.45 100.53 10.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.256 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.28 154.25 42.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.025 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.5 -21.68 43.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.754 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.66 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 6.0 mp0 -68.93 -48.55 63.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.678 0.275 . . . . 0.0 110.829 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -138.08 139.29 25.4 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.55 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.54 -43.72 3.81 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.628 2.218 . . . . 0.0 112.871 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' LYS . 19.0 mp0 -65.3 -51.72 58.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.966 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.589 HG22 HD21 ' A' ' 32' ' ' LEU . 3.8 mt -55.62 -49.36 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.964 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -61.34 -30.22 70.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.2 m -96.76 1.84 51.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.072 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.623 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -127.89 -74.16 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 0.0 111.504 -179.173 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.89 ' CD2' HG21 ' A' ' 6' ' ' VAL . 76.4 mt -73.53 148.31 43.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.418 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -153.17 158.61 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.635 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -58.89 98.27 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.982 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.91 44.81 0.13 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.604 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.4 146.57 30.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.935 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.483 HG12 ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -116.21 117.78 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.867 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.2 mt -74.7 100.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.005 0.431 . . . . 0.0 110.136 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.44 HG22 HG13 ' A' ' 25' ' ' ILE . 11.5 p -97.7 8.17 45.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.051 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 3.9 mttt -154.11 141.17 19.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.817 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.931 ' HB2' HD11 ' A' ' 58' ' ' LEU . 57.2 t80 -146.51 109.05 4.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.91 0.386 . . . . 0.0 111.229 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.21 49.65 16.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.56 18.79 74.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -124.34 105.9 9.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.661 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.52 124.99 20.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.293 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.931 HD11 ' HB2' ' A' ' 53' ' ' PHE . 8.4 mt -95.97 24.5 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -85.63 125.06 32.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.282 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.75 -20.6 40.99 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.853 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.0 mt -80.07 149.46 69.91 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.684 0.278 . . . . 0.0 111.084 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.84 -167.51 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.625 2.216 . . . . 0.0 112.213 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -96.12 -24.45 16.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.82 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -58.99 -46.49 88.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.984 0.421 . . . . 0.0 110.013 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.536 ' O ' HD23 ' A' ' 69' ' ' LEU . 29.7 m -67.95 -43.4 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.735 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.439 ' N ' HG23 ' A' ' 65' ' ' VAL . 83.5 m -59.13 -53.64 56.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.568 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.541 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 8.6 t80 -59.64 -31.01 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.636 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.93 -51.1 35.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.339 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.72 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -69.78 -34.06 73.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.385 . . . . 0.0 110.184 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.867 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 4.0 m-85 -70.55 -27.68 64.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.031 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.472 ' HG3' HG12 ' A' ' 106' ' ' VAL . 15.5 mtmt -85.18 -39.9 17.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.43 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.37 -21.77 74.63 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.914 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.833 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . . . -42.95 129.44 4.38 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.74 0.305 . . . . 0.0 111.546 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -157.65 102.84 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.017 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.04 83.42 1.37 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.225 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.16 113.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.426 . . . . 0.0 110.395 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.803 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -125.25 107.78 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.724 -179.093 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.9 t -98.91 114.76 27.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.228 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.19 122.4 40.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.473 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 1.9 tt0 -85.27 104.53 15.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.77 HG11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.24 142.55 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.774 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.408 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 92.1 m -108.82 119.54 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.674 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -103.87 93.3 5.14 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.404 ' HG3' HD11 ' A' ' 49' ' ' ILE . 67.8 Cg_endo -74.09 -174.05 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.493 2.129 . . . . 0.0 112.281 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.83 157.45 38.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.84 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.02 177.1 5.39 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.563 2.176 . . . . 0.0 112.313 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.36 37.29 1.8 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.556 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -165.07 168.37 17.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.22 -137.41 29.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.527 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.99 -120.37 3.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.417 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.97 -35.48 15.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.847 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.88 178.21 15.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.443 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.2 155.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.899 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.826 HD22 ' HA ' ' A' ' 30' ' ' ALA . 4.9 mp -110.23 -28.21 8.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 97' ' ' ARG . 13.2 p -119.8 129.23 25.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.647 ' HD2' HD21 ' A' ' 98' ' ' LEU . 92.7 Cg_endo -80.61 15.27 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.569 2.179 . . . . 0.0 113.136 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.591 ' H ' HG22 ' A' ' 95' ' ' VAL . 1.3 mmm180 65.44 78.44 0.27 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.794 0.33 . . . . 0.0 111.369 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.647 HD21 ' HD2' ' A' ' 96' ' ' PRO . 1.4 mm? -93.24 -65.25 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.797 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.57 -158.49 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.701 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -46.29 -53.51 10.62 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.81 0.338 . . . . 0.0 111.152 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.575 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -164.53 -51.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.575 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 0.3 OUTLIER 36.05 77.25 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.888 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 101' ' ' ARG . 27.1 mm-40 -143.13 179.0 7.32 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.541 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.2 t80 -84.48 96.34 9.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.209 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.107 ' CH2' HG23 ' A' ' 33' ' ' ILE . 23.5 m95 -104.62 131.14 52.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.215 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.529 ' CG2' HD23 ' A' ' 16' ' ' LEU . 16.1 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.12 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.555 HD22 ' CB ' ' A' ' 84' ' ' PRO . 9.5 mt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.816 0.341 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.58 157.94 19.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.99 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.583 ' HG2' HG23 ' A' ' 82' ' ' THR . 16.1 mttt -153.49 129.54 10.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.816 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.784 ' CE2' HG22 ' A' ' 6' ' ' VAL . 26.1 p90 -136.78 171.23 14.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.451 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.76 135.5 49.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.081 0.467 . . . . 0.0 111.144 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.9 t -114.32 107.27 22.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.928 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.697 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.3 p30 -115.83 127.48 55.08 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.795 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.673 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -153.62 160.91 42.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.637 179.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 128.05 34.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.109 0.48 . . . . 0.0 110.784 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.757 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -114.92 127.89 55.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.319 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' H ' ' HZ3' ' A' ' 10' ' ' LYS . 6.5 mmtt -121.69 69.13 0.92 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.038 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 43.75 89.91 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.413 ' N ' ' NZ ' ' A' ' 10' ' ' LYS . . . 39.05 96.46 0.01 OUTLIER Glycine 0 C--N 1.337 0.597 0 CA-C-N 116.082 -0.508 . . . . 0.0 114.202 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.5 -106.27 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -69.15 -5.67 23.85 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.113 HD22 HD21 ' A' ' 18' ' ' LEU . 4.5 mt -45.83 -33.44 3.14 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.57 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 24.83 62.97 0.05 OUTLIER Glycine 0 C--N 1.333 0.407 0 CA-C-N 114.979 -1.01 . . . . 0.0 115.159 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.113 HD21 HD22 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -141.13 91.71 2.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.934 0.397 . . . . 0.0 110.173 178.478 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.414 ' HB3' ' CB ' ' A' ' 31' ' ' ASP . 2.1 t -60.38 113.16 2.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.778 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.962 HD21 HD12 ' A' ' 18' ' ' LEU . 16.8 mt -94.28 160.84 14.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.514 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.48 167.58 21.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.268 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.03 120.52 5.04 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.437 2.091 . . . . 0.0 112.799 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.08 162.62 30.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.209 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.561 ' HG3' HG23 ' A' ' 25' ' ' ILE . 7.8 pt-20 -77.55 -33.09 54.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.1 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.561 HG23 ' HG3' ' A' ' 24' ' ' GLU . 3.6 pt -100.25 -4.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.913 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.17 -126.48 1.47 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.067 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 50' ' ' ILE . 26.2 p -140.51 106.16 5.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.946 0.403 . . . . 0.0 111.162 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.408 ' OG1' HG12 ' A' ' 49' ' ' ILE . 88.7 m -68.74 131.26 44.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.719 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.11 HG21 HD12 ' A' ' 32' ' ' LEU . 10.9 mt -72.03 105.06 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.607 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.27 -24.16 59.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.303 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.414 ' CB ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -157.33 165.67 35.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.014 0.435 . . . . 0.0 111.283 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.11 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -153.66 125.83 7.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.294 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.105 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.4 pt -97.15 100.55 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.652 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -68.31 154.36 41.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.978 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.36 -20.92 47.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.806 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.1 mp0 -71.73 -49.75 36.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.688 0.28 . . . . 0.0 110.887 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -136.95 139.7 29.46 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.867 0.365 . . . . 0.0 110.731 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.97 -48.15 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.653 2.236 . . . . 0.0 112.726 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -60.01 -50.4 73.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.701 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.638 HG22 HD21 ' A' ' 32' ' ' LEU . 6.3 mt -56.85 -47.26 83.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.17 -30.41 71.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.548 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -97.03 1.83 50.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.07 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.32 -73.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.916 0.388 . . . . 0.0 111.458 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.843 HD22 HG11 ' A' ' 81' ' ' VAL . 33.6 mt -75.22 153.28 38.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.522 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.14 -175.83 5.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.572 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -86.82 87.46 7.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.87 0.367 . . . . 0.0 111.014 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.9 43.11 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.697 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.56 156.82 45.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 110.666 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.408 HG12 ' OG1' ' A' ' 28' ' ' THR . 1.1 mp -124.53 117.74 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.359 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.94 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.2 mt -74.59 100.46 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.031 0.443 . . . . 0.0 110.474 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.0 p -93.46 -4.44 51.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.359 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -144.42 144.93 31.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.097 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.967 ' HB2' HD11 ' A' ' 58' ' ' LEU . 41.9 t80 -151.31 108.8 3.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 53.3 52.91 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.31 24.09 67.08 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.332 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -123.91 98.18 5.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.661 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.67 114.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.377 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.967 HD11 ' HB2' ' A' ' 53' ' ' PHE . 12.3 mt -88.5 11.95 15.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.999 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.73 142.98 42.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.862 0.363 . . . . 0.0 111.113 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.1 24.23 64.87 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.775 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 58' ' ' LEU . 59.0 mt -120.07 141.26 31.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.526 0.203 . . . . 0.0 110.766 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.58 -160.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.518 2.145 . . . . 0.0 112.24 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -104.7 -24.54 12.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -55.87 -49.11 74.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 0.0 110.387 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 66' ' ' CYS . 22.2 m -67.13 -45.85 85.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.778 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.467 ' N ' HG23 ' A' ' 65' ' ' VAL . 91.0 m -55.57 -52.86 62.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.022 0.439 . . . . 0.0 110.81 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 26.7 t80 -62.17 -30.88 71.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.739 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.32 -51.37 45.42 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.762 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -65.96 -44.06 86.09 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.668 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.94 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 12.5 m-85 -61.44 -32.41 72.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.133 0.492 . . . . 0.0 109.905 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 6.4 mtpt -80.39 -34.28 36.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.958 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -87.88 10.85 68.7 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.435 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.757 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -73.26 135.22 44.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.58 0.229 . . . . 0.0 110.544 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 4.1 p30 -172.97 92.93 0.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 111.013 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.58 76.24 0.19 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.259 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.02 98.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.023 0.44 . . . . 0.0 110.698 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.712 HG11 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -101.95 152.85 5.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.468 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 t -140.48 119.63 12.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.516 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.12 122.82 30.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.5 106.99 17.89 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.843 HG11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -97.0 143.02 13.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.719 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 3' ' ' LYS . 45.3 m -108.48 119.39 39.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.527 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -103.91 89.33 2.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.112 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.555 ' CB ' HD22 ' A' ' 1' ' ' LEU . 54.4 Cg_endo -69.61 -175.2 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.581 2.187 . . . . 0.0 112.319 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 162.47 50.11 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.18 165.75 29.22 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.564 2.176 . . . . 0.0 112.211 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.3 83.69 0.9 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.443 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.54 -51.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.357 . . . . 0.0 110.806 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.28 -58.16 15.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.443 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.27 -107.07 0.23 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.593 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.2 m -101.3 -31.06 11.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.984 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.7 -59.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.35 177.89 8.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -26.13 68.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.033 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.413 HG11 ' OD1' ' A' ' 31' ' ' ASP . 14.9 p -138.31 136.02 18.87 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.363 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.573 ' HD2' HD11 ' A' ' 98' ' ' LEU . 57.9 Cg_endo -74.61 -164.78 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.402 2.068 . . . . 0.0 112.293 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.05 70.01 2.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.903 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.639 ' H ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -89.86 -67.37 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.992 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.667 HD22 ' HD3' ' A' ' 100' ' ' ARG . 1.8 mt -135.11 -170.97 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.75 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.667 ' HD3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -45.6 -71.47 0.07 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.57 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -149.83 -51.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.097 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.57 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 0.4 OUTLIER 33.35 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.483 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.493 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.0 mm-40 -143.88 178.04 8.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.167 0.508 . . . . 0.0 112.204 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.52 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 2.1 t80 -84.54 96.4 9.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.105 ' CH2' HG23 ' A' ' 33' ' ' ILE . 28.7 m95 -102.88 137.28 41.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.512 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 70' ' ' PHE . 6.4 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.095 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.738 0.304 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 157.9 31.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.8 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -151.93 129.58 11.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.8 ' CE2' HG22 ' A' ' 6' ' ' VAL . 27.6 p90 -138.54 171.82 13.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.813 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.68 135.94 49.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.955 0.407 . . . . 0.0 111.582 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.849 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.6 t -117.43 107.15 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.381 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.2 p30 -113.47 127.13 55.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.922 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.702 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -152.36 156.39 39.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.393 . . . . 0.0 110.735 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.35 119.66 12.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.647 ' HG3' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -100.96 137.5 39.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.388 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -126.62 69.1 1.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.703 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 33.75 91.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.174 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.6 96.26 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.324 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 33.5 ttmt -156.75 -114.1 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.755 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 9.3 mt-10 -70.88 -5.56 31.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.866 HD22 HD21 ' A' ' 18' ' ' LEU . 1.6 mt -45.43 -34.2 3.0 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.611 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 19.47 64.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 114.8 -1.091 . . . . 0.0 115.454 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.866 HD21 HD22 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -143.46 91.73 2.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.145 0.498 . . . . 0.0 110.107 178.125 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 2.1 t -59.29 114.58 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.942 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -91.79 163.04 14.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.39 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.14 162.47 53.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.352 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.14 120.54 7.25 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.512 2.142 . . . . 0.0 112.723 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.595 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -133.25 162.46 31.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.721 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -82.65 -29.27 30.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.097 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.533 HG13 HG22 ' A' ' 51' ' ' THR . 2.2 pt -103.49 -6.37 9.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.918 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.66 -125.57 1.29 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.249 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -140.59 106.1 5.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.954 0.407 . . . . 0.0 111.07 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.6 m -68.14 127.71 33.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.389 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.124 HG21 HD12 ' A' ' 32' ' ' LEU . 13.0 mt -70.69 104.92 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.851 0.358 . . . . 0.0 110.622 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.27 -25.64 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.047 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -157.18 166.97 31.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.043 0.449 . . . . 0.0 111.238 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.124 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -155.46 126.88 7.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.006 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.117 HG23 ' CH2' ' A' ' 105' ' ' TRP . 4.1 pt -96.46 100.58 11.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.64 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -72.7 139.67 47.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.842 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.69 -27.91 8.07 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.622 ' HA ' ' OE1' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -67.21 -60.81 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.759 0.314 . . . . 0.0 110.712 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -123.77 136.75 27.72 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.129 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.98 -49.12 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.62 2.213 . . . . 0.0 112.903 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -56.82 -49.2 76.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.884 0.373 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.709 HG22 HD21 ' A' ' 32' ' ' LEU . 5.3 mt -57.49 -47.01 85.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.77 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.21 -30.39 71.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.606 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -97.2 1.6 49.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.226 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.515 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.56 -73.67 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 111.388 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.849 ' CD2' HG21 ' A' ' 6' ' ' VAL . 38.8 mt -74.92 145.3 42.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.546 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.36 164.94 36.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.572 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -59.9 108.18 0.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.953 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.24 40.78 0.61 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.603 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.643 ' HB2' HD12 ' A' ' 29' ' ' ILE . 12.0 m-20 -138.17 134.02 34.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.834 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.595 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.9 mt -106.36 117.39 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.908 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.72 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.8 mt -75.68 100.47 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.533 HG22 HG13 ' A' ' 25' ' ' ILE . 4.6 p -102.16 24.52 10.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.879 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 7.1 mttt -169.13 133.76 1.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.178 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.946 ' HB2' HD11 ' A' ' 58' ' ' LEU . 56.9 t80 -141.25 109.22 5.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.238 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 54.98 53.56 10.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.65 16.96 66.38 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -122.52 101.06 7.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.822 0.344 . . . . 0.0 110.608 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.98 123.41 14.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.344 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.946 HD11 ' HB2' ' A' ' 53' ' ' PHE . 3.8 mt -94.96 23.04 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.789 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.82 122.05 33.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.333 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.78 15.08 38.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.048 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.748 HD21 ' HA ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -127.41 159.46 65.44 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.9 0.35 . . . . 0.0 111.136 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.92 -171.77 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.765 2.31 . . . . 0.0 112.44 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -92.91 -33.46 14.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.486 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -48.63 -46.24 39.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.994 0.426 . . . . 0.0 110.649 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' HD23 ' A' ' 69' ' ' LEU . 26.9 m -65.46 -39.0 83.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.783 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 42.2 m -63.86 -53.74 45.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.737 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.693 ' CD1' HG12 ' A' ' 106' ' ' VAL . 26.8 t80 -57.6 -30.78 65.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.01 -51.1 42.8 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.729 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.4 -40.84 81.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.522 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.72 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 16.5 m-85 -64.24 -30.95 71.98 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.419 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -79.64 -33.52 41.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.026 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.55 15.53 60.02 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.668 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.638 ' HB1' HG11 ' A' ' 77' ' ' VAL . . . -77.92 133.7 38.03 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -167.8 89.24 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 111.202 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.92 86.14 0.77 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.58 109.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.075 0.464 . . . . 0.0 110.783 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.647 HG11 ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -122.61 107.77 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.639 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.6 t -99.96 113.99 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.983 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.03 124.53 44.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.638 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.93 104.93 16.72 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.841 HG11 HD22 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -95.13 142.53 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.772 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.9 m -108.86 121.45 45.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.529 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -104.19 92.85 4.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.099 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.48 -175.17 1.69 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.528 2.152 . . . . 0.0 112.227 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 158.7 62.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.04 173.81 6.67 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.602 2.201 . . . . 0.0 112.248 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.89 -91.96 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.581 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 t -77.1 -41.48 41.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.75 155.46 10.48 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.87 -178.69 26.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.485 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.95 -33.02 34.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.773 0.32 . . . . 0.0 110.94 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.21 -105.66 1.11 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.477 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.4 m -103.47 179.61 4.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 0.0 110.805 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.42 -31.56 7.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.025 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 95' ' ' VAL . 14.0 p -140.71 114.45 7.24 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.65 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.872 ' HG2' HD13 ' A' ' 98' ' ' LEU . 73.6 Cg_endo -75.85 -166.6 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.598 2.198 . . . . 0.0 112.036 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -88.68 64.66 7.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.437 . . . . 0.0 110.644 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.872 HD13 ' HG2' ' A' ' 96' ' ' PRO . 1.5 mp -88.07 -71.69 0.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.442 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.54 -163.85 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.159 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.63 -78.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.008 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.577 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -147.42 -51.84 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.318 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.577 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 6.5 m-80 32.92 79.76 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.637 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.489 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.3 mm-40 -143.37 177.99 8.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.303 0.573 . . . . 0.0 112.37 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 4.8 t80 -84.88 96.42 9.32 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.211 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.117 ' CH2' HG23 ' A' ' 33' ' ' ILE . 18.7 m95 -104.59 136.5 44.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.114 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' A' ' 70' ' ' PHE . 30.1 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.069 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.801 0.334 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -78.85 158.76 28.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.707 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 6.6 mttt -150.97 129.54 12.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.777 ' CE1' HG23 ' A' ' 81' ' ' VAL . 9.3 p90 -136.93 170.87 15.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.743 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.458 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -108.57 135.92 49.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.103 0.478 . . . . 0.0 111.253 -179.546 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.898 HG21 ' CD2' ' A' ' 44' ' ' LEU . 14.8 t -116.42 107.01 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.432 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.1 p30 -110.4 127.05 54.9 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.792 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.697 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.05 153.56 38.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 0.0 110.591 178.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.27 117.43 8.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.066 0.46 . . . . 0.0 110.827 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.948 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -101.93 128.6 48.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.598 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.454 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 7.7 mmtt -119.24 68.56 0.81 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.118 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.02 78.9 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.196 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.99 99.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.463 -0.398 . . . . 0.0 113.822 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 5.6 ptpt -155.79 -103.92 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 7.1 mt-10 -69.13 -5.57 23.17 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.995 HD22 HD21 ' A' ' 18' ' ' LEU . 3.8 mt -45.54 -33.7 2.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.601 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.603 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 26.38 61.98 0.08 OUTLIER Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.024 -0.989 . . . . 0.0 115.201 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.995 HD21 HD22 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -142.82 91.87 2.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.046 0.451 . . . . 0.0 110.003 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 t -62.29 117.75 6.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.773 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.895 HD21 ' CD1' ' A' ' 18' ' ' LEU . 16.2 mt -97.7 167.65 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.462 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.796 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 66.1 m -141.62 156.56 66.34 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.441 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.21 118.63 5.72 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.476 2.117 . . . . 0.0 112.429 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.679 HD21 HG21 ' A' ' 49' ' ' ILE . 1.3 t30 -128.85 162.75 26.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -24.69 41.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.448 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.425 HG13 HG22 ' A' ' 51' ' ' THR . 4.6 pt -108.71 -9.68 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.941 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 171.41 -122.18 0.94 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.143 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 21' ' ' SER . 8.7 m -140.55 106.46 5.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.812 0.339 . . . . 0.0 111.4 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 49' ' ' ILE . 93.2 m -68.89 125.96 28.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.079 HG21 HD12 ' A' ' 32' ' ' LEU . 40.9 mt -67.81 104.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.628 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.796 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -70.49 -29.0 65.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.967 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.434 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 6.8 m-20 -161.89 170.69 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.061 0.458 . . . . 0.0 111.023 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.079 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -153.28 127.37 9.05 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.429 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.122 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -96.74 100.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.165 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.05 153.2 43.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.047 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.11 -22.34 41.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.751 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 1.5 mp0 -69.94 -45.28 67.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.825 0.345 . . . . 0.0 110.862 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -141.12 139.73 19.79 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.646 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.46 -49.3 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.629 2.22 . . . . 0.0 112.977 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.2 -50.74 72.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.656 HD13 HD23 ' A' ' 18' ' ' LEU . 5.4 mt -55.87 -52.15 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.01 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -59.15 -30.23 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.583 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.2 m -96.46 0.68 50.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.24 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.98 -73.79 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 111.538 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.898 ' CD2' HG21 ' A' ' 6' ' ' VAL . 45.2 mt -72.87 145.31 46.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.564 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -149.59 159.78 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.621 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -60.94 109.32 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.072 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.46 -17.39 4.76 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.985 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.632 ' HB2' HD12 ' A' ' 29' ' ' ILE . 2.7 m-20 -83.61 148.62 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.991 0.424 . . . . 0.0 111.13 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.679 HG21 HD21 ' A' ' 23' ' ' ASN . 2.9 mt -119.57 117.78 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.599 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.874 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.1 mt -74.53 100.38 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 111.162 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.425 HG22 HG13 ' A' ' 25' ' ' ILE . 9.7 p -102.39 20.84 16.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.1 mttt -167.33 126.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.998 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.958 ' HB2' HD11 ' A' ' 58' ' ' LEU . 44.0 t80 -132.23 109.58 10.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.19 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 50.52 62.96 2.42 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.021 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.74 20.59 48.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.464 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -125.31 98.04 5.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.699 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.71 121.49 8.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.387 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.958 HD11 ' HB2' ' A' ' 53' ' ' PHE . 9.1 mt -93.11 19.48 7.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.813 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.85 143.72 39.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.934 0.397 . . . . 0.0 111.176 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.89 26.61 48.32 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.704 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 58' ' ' LEU . 23.8 mt -118.77 143.58 33.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.635 0.255 . . . . 0.0 110.866 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.26 -164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.548 2.165 . . . . 0.0 112.035 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -110.58 -22.79 11.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.176 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -58.36 -50.99 71.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 110.687 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.517 ' O ' HD23 ' A' ' 69' ' ' LEU . 14.6 m -65.52 -41.44 90.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.94 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 81.4 m -60.47 -52.3 65.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 25.9 t80 -60.34 -30.68 69.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.292 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.46 -51.03 39.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.247 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.734 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.69 -40.72 84.34 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.148 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.874 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.4 m-85 -61.16 -33.25 73.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.422 ' HG3' HG12 ' A' ' 106' ' ' VAL . 26.0 mtmt -83.41 -30.9 26.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.184 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.48 12.35 68.6 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.612 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.948 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -75.59 138.78 41.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.637 0.256 . . . . 0.0 110.379 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 4.9 p-10 -169.77 99.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.179 0.514 . . . . 0.0 111.101 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.44 76.35 0.53 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.044 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.82 108.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.938 0.399 . . . . 0.0 110.17 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.788 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -117.13 107.74 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.753 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.0 t -100.01 114.77 28.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.316 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.8 122.16 40.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.679 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 2.7 tt0 -84.17 102.38 12.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.777 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -95.07 142.95 12.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.731 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 54.4 m -108.36 121.97 46.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.4 97.45 22.79 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 82' ' ' THR . 36.6 Cg_exo -57.24 167.06 3.72 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.533 2.156 . . . . 0.0 112.197 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -115.48 156.48 45.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.972 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.28 172.13 9.34 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.702 2.268 . . . . 0.0 112.181 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.12 80.09 0.31 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.533 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.5 m 61.45 98.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.869 0.366 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.47 75.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.501 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.57 96.42 1.06 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.514 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.23 26.29 9.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.731 0.301 . . . . 0.0 110.969 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.17 -120.06 8.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.531 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -151.54 169.91 20.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 30' ' ' ALA . 6.6 mp -86.51 -64.86 1.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.522 HG21 ' OE1' ' A' ' 103' ' ' GLN . 11.7 p -113.43 122.89 34.34 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.547 ' HD2' HD11 ' A' ' 98' ' ' LEU . 45.2 Cg_endo -70.58 -167.02 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.337 2.025 . . . . 0.0 112.366 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.63 67.31 4.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.023 0.44 . . . . 0.0 110.961 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.646 ' H ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -88.17 -65.91 0.97 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.819 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.79 179.05 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.653 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.411 ' HB3' ' HD2' ' A' ' 101' ' ' ARG . 0.1 OUTLIER -47.76 -71.57 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.115 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.791 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.6 mpt_? -139.48 -80.53 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.021 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.2 t30 48.85 28.0 1.78 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.135 0.493 . . . . 0.0 110.939 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.528 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 8.5 mm100 -81.86 -177.52 6.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.259 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.8 t80 -85.99 96.3 9.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.094 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.122 ' CH2' HG23 ' A' ' 33' ' ' ILE . 13.3 m95 -105.36 136.17 45.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.237 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.673 HG21 ' HB3' ' A' ' 70' ' ' PHE . 11.3 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.122 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.709 HD22 ' HA ' ' A' ' 84' ' ' PRO . 7.1 mt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.8 0.333 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.79 158.8 22.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 11.3 mttt -152.73 129.65 11.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 110.867 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.814 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.0 p90 -137.91 171.18 14.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.784 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.61 135.91 49.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.957 0.408 . . . . 0.0 111.414 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.874 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.0 t -117.63 107.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.452 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 8.6 p-10 -111.02 127.26 55.48 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.972 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.73 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.04 153.68 39.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 110.758 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.19 114.87 6.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.058 0.456 . . . . 0.0 110.51 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.822 ' CE ' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -98.03 145.34 26.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.882 -179.288 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 48.5 mmtt -132.66 69.23 1.48 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.183 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.25 21.89 4.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.493 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.65 115.05 1.52 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.69 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 7.9 ptpt -163.79 -94.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.3 mm-40 -69.21 -4.91 19.57 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.906 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.861 ' CD2' HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -44.95 -38.59 4.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.228 0.537 . . . . 0.0 109.643 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.584 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 33.64 59.06 0.56 Allowed Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.171 -0.922 . . . . 0.0 115.362 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.861 HD21 ' CD2' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -143.06 91.49 2.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.124 0.462 . . . . 0.0 110.059 177.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.6 t -63.32 120.85 12.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.638 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -96.13 167.82 10.98 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.579 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.642 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -142.57 163.13 40.75 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.269 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 21' ' ' SER . 57.6 Cg_endo -71.71 126.11 11.74 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.269 1.979 . . . . 0.0 112.734 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.48 162.74 34.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.076 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.33 -32.71 37.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 51' ' ' THR . 2.4 pt -99.64 -6.94 9.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.87 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.21 -127.49 1.58 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.865 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 75.0 m -140.72 106.41 5.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.855 0.359 . . . . 0.0 111.644 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.7 m -63.64 133.42 53.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.289 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.029 HG21 HD12 ' A' ' 32' ' ' LEU . 47.8 mt -71.65 104.77 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.879 0.371 . . . . 0.0 110.422 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.642 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -68.51 -32.93 73.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.164 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -156.91 174.71 15.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.05 0.452 . . . . 0.0 111.457 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.029 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.74 128.98 7.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.508 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.14 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.2 pt -101.12 100.46 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.088 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -70.58 153.76 42.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.012 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.81 -21.92 43.36 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.682 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.599 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 6.4 mp0 -69.87 -52.57 23.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.672 0.272 . . . . 0.0 110.8 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -133.27 139.33 33.8 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.669 179.59 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.58 -48.23 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.662 2.241 . . . . 0.0 113.109 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -61.12 -49.32 77.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.761 0.315 . . . . 0.0 110.964 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.3 mt -57.91 -49.93 79.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -60.34 -30.33 69.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.976 0.417 . . . . 0.0 110.452 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -95.3 -1.43 51.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.129 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.587 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -123.93 -73.19 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.462 -178.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.874 ' CD2' HG21 ' A' ' 6' ' ' VAL . 47.8 mt -73.25 147.8 44.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.631 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.03 157.78 43.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.65 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.7 mtp-105 -59.73 96.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.073 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.81 43.38 0.17 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.722 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.18 140.13 35.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.72 0.295 . . . . 0.0 110.686 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.47 ' CD1' HD11 ' A' ' 25' ' ' ILE . 2.0 mt -107.52 117.54 53.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.091 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.9 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 8.8 mt -75.14 100.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.956 0.408 . . . . 0.0 110.461 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.524 HG22 HG13 ' A' ' 25' ' ' ILE . 10.2 p -101.79 23.43 11.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 4.5 mttt -170.21 137.01 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.982 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.98 ' HB2' HD11 ' A' ' 58' ' ' LEU . 35.9 t80 -144.82 115.6 7.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 0.0 111.272 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m120 53.35 54.42 10.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.75 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.7 22.5 64.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.353 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -128.44 103.16 6.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.935 0.397 . . . . 0.0 110.7 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . . . -54.42 123.52 13.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.399 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.98 HD11 ' HB2' ' A' ' 53' ' ' PHE . 9.3 mt -93.7 22.11 5.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.584 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -77.81 119.58 21.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.888 0.375 . . . . 0.0 111.225 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -16.83 57.21 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.708 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 58' ' ' LEU . 72.1 mt -76.23 135.6 69.55 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.589 0.194 . . . . 0.0 111.041 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -57.69 -160.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.412 2.074 . . . . 0.0 112.213 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 37.4 t80 -101.24 -25.6 13.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.89 -47.69 84.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.792 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HD23 ' A' ' 69' ' ' LEU . 27.9 m -67.58 -46.81 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.502 ' N ' HG23 ' A' ' 65' ' ' VAL . 19.0 m -59.62 -50.08 75.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 110.767 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.722 ' CD1' HG12 ' A' ' 106' ' ' VAL . 50.0 t80 -59.31 -33.3 70.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.982 0.42 . . . . 0.0 110.338 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.61 -50.98 39.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.172 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.711 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.83 -34.92 76.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 110.367 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.9 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 3.8 m-85 -69.52 -27.83 65.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.049 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.422 ' HD3' ' CZ ' ' A' ' 67' ' ' TYR . 19.8 mtmt -85.06 -41.55 15.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.911 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.3 -20.47 77.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.233 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.822 ' HB3' ' CE ' ' A' ' 10' ' ' LYS . . . -42.97 132.88 3.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 111.64 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -162.96 102.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.783 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.39 81.75 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.129 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.81 109.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.905 0.384 . . . . 0.0 110.553 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.786 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -121.46 107.69 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.751 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -98.88 114.76 27.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.404 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.16 123.59 43.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.378 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -87.05 104.69 16.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.964 0.411 . . . . 0.0 109.997 178.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.805 HG11 HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -95.17 142.68 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.655 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.408 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 96.8 m -108.77 123.84 49.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.339 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 -104.61 92.68 5.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.225 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.709 ' HA ' HD22 ' A' ' 1' ' ' LEU . 61.7 Cg_endo -73.62 -175.07 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.535 2.157 . . . . 0.0 112.133 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.18 159.58 30.13 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.13 -173.77 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.565 2.176 . . . . 0.0 112.195 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 138.13 46.51 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.579 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.3 t -163.35 179.41 7.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.99 160.51 26.15 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.14 -37.91 3.32 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.85 -31.48 18.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.351 . . . . 0.0 110.909 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.45 -146.76 33.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.539 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.6 158.05 31.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.775 0.321 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.96 -21.1 64.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.224 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 95' ' ' VAL . 11.3 p -127.86 114.32 20.58 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.126 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.784 ' HG2' HD13 ' A' ' 98' ' ' LEU . 59.4 Cg_endo -72.81 -167.93 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.593 2.196 . . . . 0.0 112.317 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.51 61.52 4.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.859 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.784 HD13 ' HG2' ' A' ' 96' ' ' PRO . 2.9 mp -93.09 -71.45 0.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.01 -168.64 3.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.692 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -58.57 -63.52 1.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.796 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.801 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -140.25 -80.21 0.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.083 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.6 m120 49.81 27.31 2.25 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.114 0.483 . . . . 0.0 110.93 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.537 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 27.2 mm-40 -81.89 -178.38 6.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.312 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.517 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.7 t80 -86.58 96.21 10.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.338 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.14 ' CH2' HG23 ' A' ' 33' ' ' ILE . 7.7 m95 -106.16 132.58 52.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.055 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.722 HG12 ' CD1' ' A' ' 67' ' ' TYR . 20.3 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.057 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.791 0.329 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.06 159.3 16.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -151.15 129.62 12.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.799 ' CE2' HG22 ' A' ' 6' ' ' VAL . 30.7 p90 -137.76 172.17 13.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.109 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.71 135.95 49.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 111.544 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.799 HG22 ' CE2' ' A' ' 4' ' ' PHE . 15.7 t -117.05 107.25 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.265 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 5.7 p-10 -113.13 127.2 56.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.884 0.373 . . . . 0.0 111.139 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.704 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.86 156.24 40.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.38 178.776 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.47 117.6 12.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.9 0.381 . . . . 0.0 110.638 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.903 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -100.03 128.39 46.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.538 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 10.7 mmtt -120.9 68.75 0.88 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.219 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.42 79.73 0.07 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.439 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 44.79 98.63 0.01 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 114.231 0.452 . . . . 0.0 114.231 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 7.5 ptpt -155.85 -102.37 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 1.8 mm-40 -69.23 -5.42 22.68 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.992 HD22 HD21 ' A' ' 18' ' ' LEU . 3.3 mt -45.53 -30.11 1.36 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.996 0.427 . . . . 0.0 110.17 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.549 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 26.76 62.64 0.08 OUTLIER Glycine 0 C--N 1.332 0.337 0 N-CA-C 115.149 0.82 . . . . 0.0 115.149 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.992 HD21 HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -146.18 92.28 2.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.006 0.431 . . . . 0.0 110.331 178.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 26.3 t -66.8 116.69 7.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.277 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -92.87 162.74 13.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.199 0.523 . . . . 0.0 111.961 -179.055 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.663 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 1.2 m -139.17 148.11 55.95 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.35 124.84 17.24 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.634 2.223 . . . . 0.0 112.816 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.37 162.57 35.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.979 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HG3' HG23 ' A' ' 25' ' ' ILE . 10.0 pt-20 -80.57 -38.89 28.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.086 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.562 HG23 ' HG3' ' A' ' 24' ' ' GLU . 1.9 pt -91.33 -9.24 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.959 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 168.87 -123.2 1.07 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.452 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -140.51 106.19 5.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.771 0.32 . . . . 0.0 110.939 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.413 ' N ' HG23 ' A' ' 49' ' ' ILE . 86.5 m -67.07 119.37 11.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.532 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.692 HD12 ' HB2' ' A' ' 48' ' ' ASP . 7.6 mt -66.51 104.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.52 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.663 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -68.89 -28.58 66.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.342 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -165.63 178.72 6.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.342 0.591 . . . . 0.0 111.336 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -163.9 136.1 4.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.747 178.314 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.189 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.5 pt -95.9 100.32 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.244 0.545 . . . . 0.0 110.572 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -65.07 154.04 39.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.869 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.04 -27.46 16.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.522 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 3.5 mp0 -65.76 -49.56 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 110.461 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.663 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -133.98 140.21 35.64 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.475 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.31 -49.28 0.95 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.644 2.229 . . . . 0.0 113.169 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 43' ' ' LYS . 13.5 mm-40 -60.94 -50.48 73.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 111.036 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.615 HD13 HD23 ' A' ' 18' ' ' LEU . 3.3 mt -55.98 -51.2 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.257 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -59.37 -30.14 68.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.028 0.442 . . . . 0.0 110.632 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -99.42 3.45 45.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.425 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.518 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -122.94 -70.18 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.701 ' CD2' HG21 ' A' ' 6' ' ' VAL . 15.0 mt -70.9 153.72 42.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.266 0.555 . . . . 0.0 112.259 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.476 ' HA ' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -153.94 137.34 15.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.26 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HG3' HD11 ' A' ' 32' ' ' LEU . 13.7 mtp-105 -48.18 114.07 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 111.435 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.93 7.1 6.16 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.18 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.692 ' HB2' HD12 ' A' ' 29' ' ' ILE . 54.0 m-20 -106.61 163.96 12.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.913 0.357 . . . . 0.0 111.099 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 25' ' ' ILE . 1.2 mp -131.48 120.14 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.027 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.004 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.9 mt -74.61 100.28 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.496 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.43 HG22 HG13 ' A' ' 25' ' ' ILE . 15.7 p -93.55 -9.58 37.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.238 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -139.18 145.97 39.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.963 ' HB2' HD11 ' A' ' 58' ' ' LEU . 31.1 t80 -152.55 112.54 3.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.865 0.364 . . . . 0.0 111.109 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 56.81 42.86 25.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.851 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.22 22.74 77.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.427 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -121.82 108.15 13.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.343 . . . . 0.0 110.75 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.66 107.95 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.308 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.963 HD11 ' HB2' ' A' ' 53' ' ' PHE . 20.6 mt -80.72 0.65 33.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.54 145.2 52.8 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.932 0.396 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.66 19.13 66.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.736 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.0 mt -120.15 141.51 31.81 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.575 0.226 . . . . 0.0 110.924 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.92 -158.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.507 2.138 . . . . 0.0 112.259 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -105.39 -23.91 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.929 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -56.32 -49.0 75.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 110.544 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.48 ' O ' HD23 ' A' ' 69' ' ' LEU . 19.0 m -67.02 -45.36 87.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.996 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.445 ' N ' HG23 ' A' ' 65' ' ' VAL . 57.0 m -56.97 -49.7 74.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.701 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.529 ' CD1' HG12 ' A' ' 106' ' ' VAL . 25.3 t80 -63.74 -31.01 72.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.835 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.99 33.09 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.749 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -65.83 -42.21 90.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.814 0.34 . . . . 0.0 110.519 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 1.004 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.7 m-85 -63.74 -32.62 74.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.919 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -82.65 -30.37 29.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.324 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.12 17.26 58.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.542 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.903 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -79.23 136.21 37.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.764 0.316 . . . . 0.0 110.626 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -170.12 98.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.126 0.489 . . . . 0.0 110.728 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.56 77.25 0.52 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.887 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.54 110.39 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.857 0.36 . . . . 0.0 110.412 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.725 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -119.41 107.96 22.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.629 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.8 t -105.49 106.25 16.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.303 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.27 127.79 56.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.938 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -89.06 107.62 19.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.919 0.39 . . . . 0.0 109.985 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.669 HG23 ' CE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -98.23 143.05 13.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.875 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.9 m -108.49 124.49 50.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.188 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -105.64 93.57 7.44 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.372 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.445 ' HG3' HD11 ' A' ' 49' ' ' ILE . 73.7 Cg_endo -77.3 -174.12 2.07 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.555 2.17 . . . . 0.0 112.199 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -105.47 154.18 39.26 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.812 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.08 162.44 35.56 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.539 2.159 . . . . 0.0 112.272 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.1 107.85 1.11 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.546 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.3 t 61.13 164.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.94 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.51 51.62 57.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.45 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.72 109.61 0.97 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.44 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.9 m -97.79 -35.17 10.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.23 -170.8 38.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.569 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.3 m -59.52 161.2 6.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.839 0.352 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 30' ' ' ALA . 1.1 mp -83.04 -30.53 28.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.99 137.18 21.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.848 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.802 ' HD2' HD11 ' A' ' 98' ' ' LEU . 96.1 Cg_endo -81.87 21.73 0.92 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.661 2.24 . . . . 0.0 113.483 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.09 69.28 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 0.0 111.29 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.802 HD11 ' HD2' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -93.3 -62.5 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.774 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.21 -163.29 1.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.511 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.71 -77.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.63 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.498 ' HG3' HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -134.29 24.26 3.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.655 179.149 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.06 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.896 0.379 . . . . 0.0 110.549 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.492 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 4.5 mm100 -141.54 173.55 11.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.952 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.504 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 3.3 t80 -79.4 95.9 5.88 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.189 ' CH2' HG23 ' A' ' 33' ' ' ILE . 53.2 m95 -100.86 145.61 28.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.036 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.529 HG12 ' CD1' ' A' ' 67' ' ' TYR . 8.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.22 160.53 19.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.949 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HG2' HG23 ' A' ' 82' ' ' THR . 9.6 mttt -155.37 129.61 8.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.706 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.81 ' CE2' HG22 ' A' ' 6' ' ' VAL . 33.0 p90 -136.26 173.29 11.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.272 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.65 137.61 46.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 111.258 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.881 HG21 ' CD2' ' A' ' 44' ' ' LEU . 6.9 t -122.76 107.28 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.84 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 25.7 t0 -110.14 127.18 54.76 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.78 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.723 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.54 159.17 44.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.674 179.044 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.38 114.24 9.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.794 ' HG2' HD21 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -95.39 140.83 29.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.347 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 3.8 mmtp -132.57 69.27 1.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.36 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.36 22.09 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.336 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.92 114.27 0.96 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.536 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -162.08 -96.42 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.959 0.409 . . . . 0.0 111.367 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 16.7 mt-10 -68.23 -4.39 13.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.122 0.569 . . . . 0.0 112.156 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.987 HD12 HD21 ' A' ' 18' ' ' LEU . 2.8 mm? -44.48 -32.71 1.47 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.136 0.493 . . . . 0.0 110.03 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.556 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 32.93 51.24 0.47 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.333 -0.849 . . . . 0.0 114.65 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.987 HD21 HD12 ' A' ' 16' ' ' LEU . 1.3 pp -141.27 91.62 2.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.019 0.438 . . . . 0.0 110.323 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 6.0 t -68.63 119.52 13.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.812 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.861 HD21 HD12 ' A' ' 50' ' ' ILE . 5.5 mp -94.23 167.89 11.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.52 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -143.88 164.69 28.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.074 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.56 128.68 15.62 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.347 2.032 . . . . 0.0 112.672 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.591 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -140.02 162.66 34.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.039 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.04 -16.74 45.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.52 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.535 HD11 HD13 ' A' ' 49' ' ' ILE . 6.8 pt -118.1 -7.14 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.787 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 169.75 -124.98 1.2 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.839 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' CB ' HD23 ' A' ' 20' ' ' LEU . 21.0 m -140.81 106.16 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.905 0.383 . . . . 0.0 111.413 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 98.3 m -65.79 128.89 37.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.212 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.02 HG21 HD12 ' A' ' 32' ' ' LEU . 56.2 mt -68.8 104.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.953 0.406 . . . . 0.0 110.534 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HA ' HD22 ' A' ' 94' ' ' LEU . . . -67.42 -31.45 71.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.11 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.6 172.25 16.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 111.268 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.02 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -153.5 125.36 7.8 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.335 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.135 HG23 ' CH2' ' A' ' 105' ' ' TRP . 9.0 pt -97.09 100.49 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.967 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.88 160.4 31.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.93 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.16 3.39 88.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.93 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.91 -41.88 8.58 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.897 0.38 . . . . 0.0 110.734 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -143.5 140.95 18.1 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.428 179.177 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.09 -48.75 0.42 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.61 2.207 . . . . 0.0 113.241 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.7 mp0 -62.85 -45.58 91.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 111.065 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.586 HD13 HD23 ' A' ' 18' ' ' LEU . 3.9 mt -61.48 -49.84 82.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.962 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.23 -30.15 68.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.722 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -94.53 -12.87 26.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.234 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.601 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -111.75 -75.08 0.62 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.844 -178.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.881 ' CD2' HG21 ' A' ' 6' ' ' VAL . 32.8 mt -70.54 151.6 44.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.858 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -153.11 172.91 16.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.458 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -73.57 113.31 10.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.81 0.338 . . . . 0.0 111.052 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.98 27.34 2.99 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.812 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.842 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -122.09 136.45 54.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.731 0.301 . . . . 0.0 110.91 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.591 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.2 mt -105.96 118.09 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.861 HD12 HD21 ' A' ' 20' ' ' LEU . 2.9 mt -75.24 100.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 p -104.42 27.8 7.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.181 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.1 mttt -172.76 138.3 0.82 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.166 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.915 ' HB2' HD11 ' A' ' 58' ' ' LEU . 25.7 t80 -150.07 112.28 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.393 . . . . 0.0 111.237 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 55.66 51.0 13.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.69 21.51 65.15 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.367 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -124.03 101.27 7.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.575 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.4 120.93 6.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.369 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.915 HD11 ' HB2' ' A' ' 53' ' ' PHE . 14.6 mt -92.36 18.78 7.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.07 126.12 32.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.974 0.416 . . . . 0.0 111.429 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -19.67 43.5 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.069 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.6 mt -81.2 140.63 49.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.542 0.211 . . . . 0.0 111.171 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.51 -157.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.633 2.222 . . . . 0.0 112.16 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -104.45 -23.56 13.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.021 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -56.69 -49.06 76.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.06 0.457 . . . . 0.0 110.377 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.505 ' O ' HD23 ' A' ' 69' ' ' LEU . 30.7 m -71.46 -45.44 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.856 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.469 ' N ' HG23 ' A' ' 65' ' ' VAL . 91.2 m -55.0 -51.98 64.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.757 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 13.8 t80 -66.74 -30.65 70.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.656 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.73 -51.06 60.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.233 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.753 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.12 -41.44 86.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.856 0.36 . . . . 0.0 110.192 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.615 ' HB3' HG21 ' A' ' 106' ' ' VAL . 3.4 m-85 -62.58 -33.7 75.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.672 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.407 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 13.0 mtmt -79.73 -35.73 38.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.373 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.71 7.66 72.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.566 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.659 ' HB1' HG11 ' A' ' 77' ' ' VAL . . . -71.4 141.44 50.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 0.0 110.808 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -175.25 99.17 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.681 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.42 74.68 0.51 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.819 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.26 120.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 110.081 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.701 HG11 ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -132.0 107.91 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.84 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -99.75 111.88 24.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.473 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.93 128.81 55.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.397 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.87 104.74 17.29 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.782 HG11 HD22 ' A' ' 44' ' ' LEU . 1.7 m -95.05 143.16 12.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.781 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 62.0 m -108.22 127.91 54.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.205 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.11 95.44 15.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 82' ' ' THR . 52.7 Cg_exo -53.93 -174.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.496 2.13 . . . . 0.0 112.147 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -84.53 158.97 59.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.36 -179.75 2.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.623 2.215 . . . . 0.0 112.288 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 146.79 -133.57 4.88 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.551 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.86 173.09 17.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.714 0.293 . . . . 0.0 110.892 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.11 -46.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.64 -89.59 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.2 p -100.01 -31.25 11.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.942 0.401 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.38 140.73 6.48 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.533 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 m 60.67 171.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 30' ' ' ALA . 2.2 mp -90.76 -29.04 17.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 p -84.66 138.94 37.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.081 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.79 ' HG2' HD13 ' A' ' 98' ' ' LEU . 59.3 Cg_endo -87.96 29.22 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.757 2.304 . . . . 0.0 113.066 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 53.09 51.09 16.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 111.319 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.79 HD13 ' HG2' ' A' ' 96' ' ' PRO . 5.9 mp -93.28 -39.45 10.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.674 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 99' ' ' LEU . 6.8 tp -153.05 175.56 12.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.21 -69.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.963 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.779 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.4 mpt_? -140.86 -79.34 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.058 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 t30 48.63 27.54 1.53 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 111.076 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.538 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 31.8 mm-40 -81.18 -177.91 6.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.153 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.53 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -86.83 96.28 10.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.135 ' CH2' HG23 ' A' ' 33' ' ' ILE . 14.7 m95 -104.22 138.64 40.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 111.783 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 70' ' ' PHE . 18.6 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.113 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.748 0.309 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.23 158.23 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.804 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HG2' HG23 ' A' ' 82' ' ' THR . 16.0 mttp -151.62 129.67 11.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.746 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.774 ' CE2' HG22 ' A' ' 6' ' ' VAL . 30.1 p90 -138.29 170.87 15.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.69 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.62 136.02 48.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.043 0.449 . . . . 0.0 111.431 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.878 HG21 ' CD2' ' A' ' 44' ' ' LEU . 19.6 t -114.93 106.93 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.681 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 15.4 p-10 -110.65 127.01 55.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.894 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.687 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.87 159.27 44.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.377 . . . . 0.0 110.39 178.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.67 113.62 11.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.998 0.428 . . . . 0.0 110.941 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.837 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -97.66 151.63 19.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.431 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 8.0 mmtt -138.34 69.43 1.38 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.637 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.55 23.2 5.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.282 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.7 113.64 1.45 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.558 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -161.88 -96.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 0.0 110.985 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 19.4 mt-10 -69.41 -5.56 24.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.659 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.786 HD22 ' CD2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.6 -36.02 4.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.267 0.556 . . . . 0.0 109.583 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.553 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 25.32 62.6 0.06 OUTLIER Glycine 0 CA--C 1.52 0.352 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.999 HD12 HD21 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -138.56 91.69 2.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.166 0.508 . . . . 0.0 109.992 177.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.452 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.4 t -59.51 112.35 1.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.824 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.999 HD21 HD12 ' A' ' 18' ' ' LEU . 7.0 mt -96.21 168.3 10.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.613 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -146.6 158.33 46.66 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.335 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.35 125.07 13.37 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.475 2.117 . . . . 0.0 112.488 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.531 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -132.71 162.52 31.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.002 0.429 . . . . 0.0 111.105 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -81.63 -18.01 46.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.425 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 49' ' ' ILE . 6.5 pt -117.8 -4.61 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.706 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.83 -123.51 1.14 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.183 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 1.3 m -140.76 106.47 5.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.825 0.345 . . . . 0.0 111.575 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.4 ' OG1' HG12 ' A' ' 49' ' ' ILE . 97.0 m -69.64 137.56 52.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.039 HG21 HD12 ' A' ' 32' ' ' LEU . 22.5 mt -79.46 104.92 8.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.865 0.364 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.779 ' HA ' HD22 ' A' ' 94' ' ' LEU . . . -71.59 -28.08 63.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -160.54 169.36 23.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 111.205 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.039 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -152.42 127.24 9.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.349 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.086 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -98.19 100.47 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.296 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.53 154.37 42.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.024 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.05 -20.72 47.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.903 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 11.9 mp0 -70.74 -48.03 56.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.71 142.2 33.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.787 0.327 . . . . 0.0 110.703 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.56 -48.85 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.545 2.163 . . . . 0.0 112.901 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' LYS . 23.1 mm-40 -61.41 -50.14 74.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 111.027 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.734 HD11 HD23 ' A' ' 16' ' ' LEU . 4.1 mt -56.44 -51.45 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.142 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -59.89 -30.31 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.819 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -97.79 1.98 48.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.427 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -125.6 -72.23 0.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.779 0.323 . . . . 0.0 111.552 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.878 ' CD2' HG21 ' A' ' 6' ' ' VAL . 49.1 mt -77.51 152.91 33.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.089 0.471 . . . . 0.0 111.61 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -150.35 -175.91 5.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.503 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -81.62 95.0 7.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.048 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.34 43.09 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.799 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.579 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -138.78 145.38 40.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 110.877 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.531 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.0 OUTLIER -116.55 118.13 57.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -179.523 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.971 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.4 mt -74.62 100.46 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 110.83 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -100.45 26.5 6.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.724 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.8 mttt -172.61 136.16 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.905 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB2' HD11 ' A' ' 58' ' ' LEU . 61.3 t80 -142.62 109.98 5.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.219 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.57 48.71 19.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.914 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.78 76.98 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.396 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -124.71 105.61 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 0.0 110.712 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.92 121.81 10.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.316 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.918 HD11 ' HB2' ' A' ' 53' ' ' PHE . 11.4 mt -92.72 16.87 11.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.965 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.39 141.46 52.17 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.868 0.366 . . . . 0.0 111.081 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.79 29.65 55.12 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.667 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 58' ' ' LEU . 10.8 mt -115.36 135.32 22.56 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.5 0.19 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 61' ' ' LEU . 53.2 Cg_exo -54.69 -169.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.404 2.069 . . . . 0.0 112.167 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -98.39 -26.38 14.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.038 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -58.53 -46.84 85.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.032 0.444 . . . . 0.0 110.584 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.507 ' O ' HD23 ' A' ' 69' ' ' LEU . 20.3 t -66.45 -48.97 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.897 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 1.3 m -57.5 -53.75 54.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.769 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.549 ' CD1' HG12 ' A' ' 106' ' ' VAL . 38.3 t80 -58.07 -31.25 66.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.81 -51.04 24.52 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.714 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.99 -32.71 72.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 110.26 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.971 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 4.8 m-85 -72.42 -29.01 63.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.04 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 7.2 mtpt -85.15 -35.88 21.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.581 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.12 -22.7 65.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.874 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.837 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . . . -42.98 128.14 4.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.563 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -155.25 103.26 2.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 110.945 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.04 86.62 1.88 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.265 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.27 114.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 110.622 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.829 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.51 107.78 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.227 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 4.3 t -102.64 108.45 19.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.488 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.53 125.31 52.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.522 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -86.47 112.04 21.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.874 0.369 . . . . 0.0 110.216 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.847 HG11 HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -101.28 142.39 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.616 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.431 HG23 ' HG2' ' A' ' 3' ' ' LYS . 94.2 m -108.85 124.61 50.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.392 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -107.07 90.34 5.36 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.104 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.33 -173.12 1.66 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.656 2.238 . . . . 0.0 112.502 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -123.19 156.02 63.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.777 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.19 161.8 41.29 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.564 2.176 . . . . 0.0 112.249 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.99 -65.63 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.513 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.1 p -75.56 -39.46 58.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.388 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.73 -104.15 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.44 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.77 -117.14 0.95 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.69 26.14 6.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.51 154.54 21.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -132.37 166.53 21.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.294 . . . . 0.0 110.952 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.779 HD22 ' HA ' ' A' ' 30' ' ' ALA . 1.7 mp -79.93 -49.6 11.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.796 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 95' ' ' VAL . 11.0 p -136.98 113.83 9.85 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.693 ' HG2' HD13 ' A' ' 98' ' ' LEU . 57.8 Cg_endo -72.41 -175.52 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.527 2.152 . . . . 0.0 112.165 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.73 61.18 3.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.081 0.467 . . . . 0.0 110.783 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.693 HD13 ' HG2' ' A' ' 96' ' ' PRO . 2.0 mp -93.07 -71.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.04 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.73 169.29 9.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -79.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.953 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.812 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -141.7 -79.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.917 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.33 28.39 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.096 0.475 . . . . 0.0 111.062 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.515 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 18.1 mm-40 -82.05 -178.94 7.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.243 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 1.8 t80 -84.8 96.13 9.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.086 ' CH2' HG23 ' A' ' 33' ' ' ILE . 25.6 m95 -102.55 132.21 48.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.316 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.549 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.4 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.178 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.797 0.332 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.01 162.44 14.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' HG2' HG23 ' A' ' 82' ' ' THR . 10.6 mttt -155.77 129.62 8.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.759 ' CE2' HG22 ' A' ' 6' ' ' VAL . 30.0 p90 -140.04 175.38 9.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.785 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.411 ' ND2' ' CD ' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -111.49 139.27 47.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.159 0.504 . . . . 0.0 111.84 -178.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.889 HG21 ' CD2' ' A' ' 44' ' ' LEU . 17.5 t -120.91 107.02 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.239 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 25.8 p-10 -112.24 127.24 55.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.714 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.06 156.14 42.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.008 0.432 . . . . 0.0 110.47 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.06 114.82 9.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.014 0.435 . . . . 0.0 110.539 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.925 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -96.4 145.01 26.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.739 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 23.8 mmtt -134.99 69.32 1.45 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.32 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.43 26.58 9.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.182 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.01 112.98 0.51 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.304 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.422 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -157.11 -94.46 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.027 0.442 . . . . 0.0 111.296 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 15.3 mt-10 -68.25 -4.45 14.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.154 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.075 HD13 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -44.58 -30.12 0.85 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.548 0.213 . . . . 0.0 110.552 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 19.47 53.22 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 114.62 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.075 HD21 HD13 ' A' ' 16' ' ' LEU . 2.0 pp -135.57 103.15 5.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.945 0.402 . . . . 0.0 110.066 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.2 t -69.06 122.08 17.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.138 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.743 HD22 HD12 ' A' ' 50' ' ' ILE . 10.6 mt -105.0 159.75 15.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.63 167.72 20.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.479 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.74 135.15 21.2 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.556 2.171 . . . . 0.0 112.585 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.444 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -147.4 162.64 38.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.088 179.734 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -32.89 38.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.154 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.574 HG13 HG22 ' A' ' 51' ' ' THR . 2.3 pt -99.12 -7.95 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.82 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.78 -122.81 1.04 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.416 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 m -140.52 106.45 5.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.75 0.309 . . . . 0.0 111.246 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.519 ' N ' HG23 ' A' ' 49' ' ' ILE . 93.6 m -66.95 127.33 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.399 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.547 HD11 HD13 ' A' ' 44' ' ' LEU . 30.7 mt -68.93 104.75 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.683 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -71.1 -23.38 62.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.945 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -171.68 172.45 4.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.825 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.745 ' O ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -163.48 131.76 3.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.986 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.173 HG23 ' CH2' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -95.53 144.14 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.597 -179.112 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -94.0 169.39 10.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.937 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.87 21.38 71.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.764 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -111.77 -33.51 6.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 110.891 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -156.25 144.91 14.69 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.116 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.15 -47.91 4.12 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.469 2.112 . . . . 0.0 112.779 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 43' ' ' LYS . 14.2 mp0 -65.77 -52.27 52.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.221 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.888 HD13 HD23 ' A' ' 18' ' ' LEU . 2.6 mt -54.91 -40.95 55.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.558 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -71.23 -30.09 65.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.153 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.56 3.71 32.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.062 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -127.47 -73.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.889 ' CD2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -60.12 148.88 34.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.884 -178.664 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -153.85 -175.71 5.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.539 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -92.93 116.8 29.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.51 -14.86 8.13 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.074 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.516 ' HB2' HD12 ' A' ' 29' ' ' ILE . 14.6 m-20 -85.87 158.8 19.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 111.267 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 28' ' ' THR . 1.1 mp -130.4 121.84 51.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.736 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.755 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 14.6 mt -74.26 100.63 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.034 0.445 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.574 HG22 HG13 ' A' ' 25' ' ' ILE . 7.5 p -102.4 26.88 7.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.906 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 2.8 mttt -172.7 135.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.982 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB2' HD11 ' A' ' 58' ' ' LEU . 68.0 t80 -139.34 120.83 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.93 0.395 . . . . 0.0 111.37 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.63 39.88 22.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.985 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.17 17.52 78.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.498 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -124.23 106.5 10.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 0.0 110.714 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.62 124.57 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.431 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.918 HD11 ' HB2' ' A' ' 53' ' ' PHE . 10.4 mt -94.91 23.34 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.81 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.95 144.28 38.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.091 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.89 24.01 57.29 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.695 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.703 HD12 ' HA ' ' A' ' 58' ' ' LEU . 83.3 mt -116.46 139.03 24.89 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.539 0.209 . . . . 0.0 110.803 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.95 -161.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.408 2.072 . . . . 0.0 112.17 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -106.73 -24.27 12.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -56.8 -50.65 71.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.063 0.459 . . . . 0.0 110.599 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.51 ' O ' HD23 ' A' ' 69' ' ' LEU . 16.4 m -63.21 -47.45 92.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.067 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.454 ' N ' HG23 ' A' ' 65' ' ' VAL . 63.5 m -57.5 -53.79 54.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 110.895 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.607 ' CE1' HG12 ' A' ' 106' ' ' VAL . 18.6 t80 -57.37 -31.0 65.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.715 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.23 -51.11 18.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.233 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.739 HD13 ' CD2' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.31 -32.29 72.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 110.331 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.755 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.5 m-85 -73.1 -31.32 64.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.976 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.448 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -85.11 -29.87 24.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.577 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.27 -22.45 44.5 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.855 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.925 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . . . -43.46 131.52 4.92 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.809 0.338 . . . . 0.0 111.519 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -157.06 101.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.05 85.27 1.49 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.623 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 110.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.824 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.749 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.6 108.0 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.685 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -99.25 111.29 23.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.479 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.23 124.03 46.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -88.31 107.29 18.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 110.289 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.64 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -95.29 142.94 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.443 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 92.8 m -108.45 128.4 54.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.079 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -110.54 93.43 16.37 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.208 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 82' ' ' THR . 38.8 Cg_exo -60.07 -174.17 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.584 2.189 . . . . 0.0 112.218 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -109.38 160.98 25.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.59 167.03 23.88 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.491 2.127 . . . . 0.0 112.297 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.1 -104.97 0.27 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.477 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.3 m -102.83 -176.8 3.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.63 -173.38 30.25 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.448 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.08 66.1 3.47 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.496 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.44 -30.85 64.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.963 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.09 65.98 3.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.7 m 60.72 -179.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 0.0 110.94 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 94' ' ' LEU . 3.8 mm? -112.4 -44.34 3.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.948 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 10.1 p -135.08 141.44 38.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.029 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.552 ' HG2' HD13 ' A' ' 98' ' ' LEU . 19.1 Cg_endo -84.8 169.12 10.65 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.627 2.218 . . . . 0.0 112.387 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.53 61.52 3.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.12 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.552 HD13 ' HG2' ' A' ' 96' ' ' PRO . 6.0 mp -80.73 -68.97 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.081 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.28 -170.76 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.021 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.29 64.34 4.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.98 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.781 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER 64.5 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.178 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.7 m120 50.03 26.59 2.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 110.745 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.502 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 29.3 mm-40 -85.9 176.64 7.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.807 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.518 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -80.88 96.0 6.89 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.173 ' CH2' HG23 ' A' ' 33' ' ' ILE . 54.7 m95 -100.71 138.05 38.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.698 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.607 HG12 ' CE1' ' A' ' 67' ' ' TYR . 34.4 m . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.211 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 84' ' ' PRO . 5.6 mp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.794 0.331 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 82' ' ' THR . 1.2 tp10 -60.09 162.51 5.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.824 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.9 mttt -156.19 129.52 8.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.61 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.829 ' CE2' HG22 ' A' ' 6' ' ' VAL . 35.0 p90 -136.92 173.94 11.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.791 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.8 135.87 49.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.955 0.407 . . . . 0.0 111.389 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.855 HG21 HD21 ' A' ' 44' ' ' LEU . 12.6 t -117.58 107.34 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.142 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -109.98 127.94 55.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.07 0.462 . . . . 0.0 110.9 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.66 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -159.52 153.07 22.61 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.928 179.318 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.94 127.14 31.67 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.529 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.959 ' HG2' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -103.79 136.58 43.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.79 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -115.45 69.6 0.73 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.94 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.93 27.61 0.74 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.398 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.77 73.07 1.13 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.281 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.591 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 29.6 ttmt -120.26 -102.82 0.41 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.571 0.224 . . . . 0.0 111.023 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 7.7 mt-10 -70.95 -6.35 37.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.959 HD13 ' HG2' ' A' ' 10' ' ' LYS . 7.7 tp -46.16 -39.13 9.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 12.33 62.99 0.01 OUTLIER Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.434 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -127.88 91.77 3.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.135 0.493 . . . . 0.0 109.798 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.821 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -52.8 119.35 4.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.844 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.642 HD21 HD13 ' A' ' 18' ' ' LEU . 53.3 mt -107.39 165.26 11.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.542 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 0.9 OUTLIER -145.19 167.68 13.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.361 179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 21' ' ' SER . 70.1 Cg_endo -75.2 135.81 19.19 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.494 2.129 . . . . 0.0 112.82 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.64 162.56 38.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.013 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.45 -28.85 41.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.183 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 pt -103.82 -2.01 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.919 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.8 -124.9 1.33 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.135 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.557 ' SG ' HD12 ' A' ' 50' ' ' ILE . 22.9 p -140.22 106.39 5.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.822 0.344 . . . . 0.0 111.078 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 84.8 m -65.45 128.85 37.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.69 104.74 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.618 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.821 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -67.11 -27.58 67.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.588 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -171.66 179.94 2.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.779 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.729 ' O ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.86 134.92 3.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.003 178.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.178 HG23 ' CH2' ' A' ' 105' ' ' TRP . 2.8 pt -95.99 119.39 43.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.79 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -72.22 175.24 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.308 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.41 -51.58 4.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.635 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -46.26 -74.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.672 0.272 . . . . 0.0 110.723 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -117.74 131.4 24.13 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.691 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.64 -42.74 8.68 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.457 2.105 . . . . 0.0 112.502 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.97 -48.45 81.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.677 HD13 HD23 ' A' ' 18' ' ' LEU . 6.0 mt -59.43 -42.33 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.567 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.27 -30.12 69.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.679 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -99.67 3.36 45.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.505 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HD3' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -125.08 -71.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.819 -179.12 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.855 HD21 HG21 ' A' ' 6' ' ' VAL . 10.1 mt -72.17 150.33 43.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.248 0.547 . . . . 0.0 112.156 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -153.84 149.6 27.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.248 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 -55.64 107.97 0.39 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.186 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.24 41.0 0.42 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.624 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -142.06 164.07 31.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.573 0.225 . . . . 0.0 110.619 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.6 mp -133.32 120.29 38.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.238 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.834 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.1 mt -74.59 100.65 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.045 0.45 . . . . 0.0 110.471 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 p -99.84 18.63 17.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.948 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -162.27 142.52 9.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.138 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.896 ' HB2' HD11 ' A' ' 58' ' ' LEU . 60.2 t80 -151.67 109.85 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.911 0.386 . . . . 0.0 111.1 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 51.94 55.31 9.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.01 23.35 65.79 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.358 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.91 99.72 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.804 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.46 120.57 7.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.285 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.896 HD11 ' HB2' ' A' ' 53' ' ' PHE . 5.1 mt -92.81 16.97 11.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.45 127.34 32.04 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.827 0.346 . . . . 0.0 111.142 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.65 -23.26 31.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.777 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.5 mt -79.6 148.34 69.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 111.096 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.661 ' HG2' HG23 ' A' ' 65' ' ' VAL . 40.6 Cg_endo -67.21 -168.37 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.499 2.132 . . . . 0.0 112.205 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -87.76 -28.45 21.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.618 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.73 -42.33 83.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.406 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.661 HG23 ' HG2' ' A' ' 62' ' ' PRO . 41.4 t -66.2 -53.94 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.744 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.423 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 89.4 m -56.07 -53.82 52.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.056 0.455 . . . . 0.0 110.781 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CD1' HG12 ' A' ' 106' ' ' VAL . 28.3 t80 -56.89 -30.88 64.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.18 -51.16 22.48 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.731 HD13 ' CD2' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.88 -37.18 81.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.351 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.834 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 10.1 m-85 -68.34 -32.04 71.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.955 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 2.9 mtpt -81.34 -34.4 31.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.17 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.36 -23.77 55.87 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.458 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.017 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -45.99 138.92 4.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.658 0.266 . . . . 0.0 111.301 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -170.87 97.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.038 0.447 . . . . 0.0 111.571 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.46 96.36 2.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.93 87.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.128 0.489 . . . . 0.0 110.442 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.017 HG21 ' HB1' ' A' ' 73' ' ' ALA . 3.5 t -114.4 130.72 68.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.147 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.7 t -122.82 139.62 53.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.449 ' HG2' ' CE1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -142.66 129.23 20.25 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.825 0.345 . . . . 0.0 111.675 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -91.21 108.12 19.66 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.719 HG11 HD22 ' A' ' 44' ' ' LEU . 1.9 m -95.16 142.64 13.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.837 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.414 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 45.3 m -108.65 125.33 51.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.196 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -107.68 97.63 21.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.097 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 82' ' ' THR . 50.9 Cg_exo -53.5 -176.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.532 2.155 . . . . 0.0 112.286 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.04 161.44 23.31 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.884 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.16 176.4 4.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.579 2.186 . . . . 0.0 112.309 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.98 -73.35 0.2 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.5 t -135.2 98.14 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 0.0 110.852 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.77 -71.26 0.18 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.554 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -108.08 91.66 0.69 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.595 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 p -73.86 -39.73 63.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.854 0.359 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -157.12 -70.84 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.51 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.4 p -160.08 170.5 21.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.4 -29.43 14.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 97' ' ' ARG . 13.7 p -95.28 132.88 26.95 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.674 ' HD2' HD21 ' A' ' 98' ' ' LEU . 95.8 Cg_endo -80.05 16.54 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.708 2.272 . . . . 0.0 113.109 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.457 ' H ' HG22 ' A' ' 95' ' ' VAL . 6.8 mmm-85 64.61 78.28 0.29 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.796 0.331 . . . . 0.0 111.314 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.674 HD21 ' HD2' ' A' ' 96' ' ' PRO . 1.4 mm? -93.28 -57.73 2.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.78 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mt -134.34 -167.26 1.93 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.637 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.66 -63.97 0.84 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.502 ' HG3' HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -151.74 25.53 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -51.93 91.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.955 0.407 . . . . 0.0 110.361 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 17.9 mm-40 -142.53 174.37 10.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.083 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.6 t80 -76.81 95.98 4.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.178 ' CH2' HG23 ' A' ' 33' ' ' ILE . 68.4 m95 -101.71 138.14 39.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.352 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.832 ' CG2' HD23 ' A' ' 16' ' ' LEU . 16.0 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.196 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.796 0.331 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.405 ' HB3' ' CG ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -91.14 155.43 18.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.918 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 8.9 mttp -144.86 129.57 18.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.848 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.773 ' CE2' HG22 ' A' ' 6' ' ' VAL . 26.5 p90 -137.03 171.49 14.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.818 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.445 ' ND2' ' OE1' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.72 136.03 48.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.057 0.456 . . . . 0.0 111.394 -179.365 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.856 HG21 ' CD2' ' A' ' 44' ' ' LEU . 16.0 t -116.26 107.33 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.551 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 12.3 t0 -110.66 127.21 55.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.027 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.714 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.53 157.72 43.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 110.481 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.31 110.21 5.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.987 0.422 . . . . 0.0 111.037 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.79 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -94.56 144.39 25.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.093 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 6.6 mmtp -130.05 69.33 1.44 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.436 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.5 20.92 6.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.274 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' CA ' ' HZ3' ' A' ' 10' ' ' LYS . . . 91.31 114.56 1.88 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -164.56 -94.29 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 111.444 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.633 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 29.1 mt-10 -69.2 -4.49 17.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.126 0.57 . . . . 0.0 112.359 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.137 HD22 HD21 ' A' ' 18' ' ' LEU . 2.5 mt -44.65 -32.13 1.38 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.482 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 30.34 59.61 0.22 Allowed Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 115.13 177.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.137 HD21 HD22 ' A' ' 16' ' ' LEU . 1.3 pp -148.11 91.83 1.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.034 0.445 . . . . 0.0 110.202 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 30' ' ' ALA . 3.0 t -65.75 117.28 7.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.549 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.583 HD11 ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -88.0 170.35 11.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.603 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.81 159.39 56.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.11 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.76 111.52 2.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.427 2.085 . . . . 0.0 112.727 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.807 HD21 HG21 ' A' ' 49' ' ' ILE . 1.5 t30 -124.24 162.51 23.54 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.718 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 25' ' ' ILE . 7.0 pt-20 -83.46 -29.06 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.349 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.57 HG13 HG22 ' A' ' 51' ' ' THR . 1.6 pt -102.09 -8.66 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.763 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.43 -123.81 1.06 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.136 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.53 105.86 5.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.906 0.384 . . . . 0.0 111.046 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.449 ' N ' HG23 ' A' ' 49' ' ' ILE . 92.3 m -68.64 128.95 38.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.179 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.041 HG21 HD12 ' A' ' 32' ' ' LEU . 40.8 mt -70.25 104.8 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.858 0.361 . . . . 0.0 110.639 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HA ' HD22 ' A' ' 94' ' ' LEU . . . -69.86 -30.66 68.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.959 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.442 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.8 OUTLIER -158.34 173.65 16.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.413 . . . . 0.0 111.299 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.041 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -155.8 126.89 7.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.397 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.114 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.6 pt -96.9 100.38 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.972 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -69.16 155.4 40.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.075 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.0 -14.66 64.72 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.859 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.561 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 4.1 mp0 -76.83 -47.61 20.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.711 0.291 . . . . 0.0 110.717 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.633 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.4 138.96 23.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.653 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.22 -51.02 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.662 2.241 . . . . 0.0 113.012 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -58.54 -48.78 79.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.769 0.318 . . . . 0.0 111.044 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.574 HD13 HD23 ' A' ' 18' ' ' LEU . 4.6 mt -57.32 -50.44 76.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.133 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.39 -30.26 68.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.562 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -97.48 0.65 47.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.173 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.21 -73.74 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.838 0.351 . . . . 0.0 111.697 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.879 HD12 HD22 ' A' ' 18' ' ' LEU . 34.1 mt -73.29 157.29 37.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.045 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -153.94 -175.9 5.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.221 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -90.56 104.96 17.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 111.127 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.49 -8.7 3.72 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.21 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.18 160.43 15.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 111.182 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.807 HG21 HD21 ' A' ' 23' ' ' ASN . 1.0 OUTLIER -126.9 119.69 53.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.849 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 4.3 mt -74.57 100.6 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 110.997 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.57 HG22 HG13 ' A' ' 25' ' ' ILE . 7.7 p -101.07 22.6 12.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.735 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.2 mttt -167.54 136.54 2.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.887 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.929 ' HB2' HD11 ' A' ' 58' ' ' LEU . 56.7 t80 -142.73 111.02 6.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.93 0.395 . . . . 0.0 111.265 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 54.17 46.84 24.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.26 22.15 78.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.431 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -126.16 106.41 9.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 110.737 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.68 121.49 9.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.324 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.929 HD11 ' HB2' ' A' ' 53' ' ' PHE . 7.9 mt -94.36 21.37 7.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.752 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -78.4 143.34 36.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.955 0.407 . . . . 0.0 111.097 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.23 24.02 60.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.792 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.51 ' HB3' HG21 ' A' ' 65' ' ' VAL . 34.6 mt -116.42 138.54 24.45 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.56 0.219 . . . . 0.0 110.841 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.36 -159.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.466 2.111 . . . . 0.0 112.182 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 67' ' ' TYR . 30.4 t80 -103.06 -24.44 13.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.984 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -57.73 -48.79 78.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.46 . . . . 0.0 110.515 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 61' ' ' LEU . 18.3 m -63.96 -46.92 92.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.084 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.458 ' N ' HG23 ' A' ' 65' ' ' VAL . 1.5 m -58.8 -51.86 68.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.85 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.514 ' CZ ' ' CE2' ' A' ' 104' ' ' TYR . 10.8 t80 -58.55 -31.22 67.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.23 -51.08 22.7 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.657 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -69.06 -32.24 71.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 110.268 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.849 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 8.9 m-85 -73.76 -28.69 61.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.283 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.433 ' HG3' HG12 ' A' ' 106' ' ' VAL . 29.2 mtmt -85.02 -38.99 18.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.7 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.16 -22.27 74.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.855 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.798 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -44.16 127.87 5.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.832 0.348 . . . . 0.0 111.691 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -159.45 104.02 1.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.089 0.471 . . . . 0.0 110.756 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.96 84.35 1.64 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.072 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 114.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 0.0 110.366 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.798 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -127.38 107.61 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.406 -179.165 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 t -99.57 114.96 28.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.062 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.83 123.49 41.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.574 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -85.84 105.78 16.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.189 179.107 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.824 HG11 HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -96.61 142.68 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.893 -179.079 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.41 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 91.7 m -108.85 117.78 35.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.603 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.405 ' CG ' ' HB3' ' A' ' 2' ' ' GLU . 22.1 ptt180 -104.53 93.78 6.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.04 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.79 -176.86 2.22 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.512 2.141 . . . . 0.0 112.337 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.3 157.02 41.22 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.939 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.75 163.44 27.79 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.587 2.192 . . . . 0.0 112.289 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.36 -142.65 3.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.564 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.57 106.9 18.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.805 0.336 . . . . 0.0 110.952 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.89 -85.37 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.451 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -179.36 -117.75 0.55 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.468 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 p -69.85 -27.09 64.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.747 0.308 . . . . 0.0 110.942 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.66 -53.59 0.76 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.392 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.32 171.88 9.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.728 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 30' ' ' ALA . 7.5 mp -96.83 22.45 8.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.097 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.575 HG22 ' H ' ' A' ' 97' ' ' ARG . 12.1 p -139.55 125.52 12.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.827 ' HG2' HD13 ' A' ' 98' ' ' LEU . 98.9 Cg_endo -85.31 22.12 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.831 2.354 . . . . 0.0 113.012 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.575 ' H ' HG22 ' A' ' 95' ' ' VAL . 19.7 mmt85 59.67 61.45 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.926 0.393 . . . . 0.0 110.959 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.827 HD13 ' HG2' ' A' ' 96' ' ' PRO . 1.4 mp -93.24 -65.91 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.046 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -126.14 176.9 6.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -65.01 78.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.186 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.797 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER 62.14 -79.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.272 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 46.21 28.57 0.69 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.083 0.468 . . . . 0.0 111.115 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.538 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 31.5 mm-40 -79.43 -177.47 5.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.224 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.514 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -86.87 96.03 10.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.114 ' CH2' HG23 ' A' ' 33' ' ' ILE . 8.5 m95 -104.67 134.54 47.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.254 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 70' ' ' PHE . 11.7 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.139 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.61 156.34 29.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.772 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 8.9 mttt -150.93 129.58 12.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.812 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.8 p90 -137.66 170.14 16.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.68 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.447 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.65 135.87 49.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.057 0.456 . . . . 0.0 111.305 -179.342 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.873 HG21 ' CD2' ' A' ' 44' ' ' LEU . 11.5 t -116.37 107.01 21.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.289 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 1.6 p30 -110.44 127.28 55.04 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.053 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.1 156.35 42.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.95 0.405 . . . . 0.0 110.663 178.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 113.45 7.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.026 0.441 . . . . 0.0 110.586 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.782 ' CE ' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -96.33 151.26 19.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.434 0.635 . . . . 0.0 111.896 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 20.2 mmtt -138.0 69.27 1.39 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.246 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 53.84 24.06 4.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.3 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.43 113.94 1.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.551 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -159.28 -97.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.765 0.317 . . . . 0.0 111.312 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.0 mm-40 -69.14 -5.78 24.5 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.161 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.809 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -45.23 -33.97 2.59 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.885 0.374 . . . . 0.0 110.497 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.568 ' HA3' HD11 ' A' ' 33' ' ' ILE . . . 26.17 62.22 0.07 OUTLIER Glycine 0 CA--C 1.522 0.483 0 N-CA-C 115.379 0.912 . . . . 0.0 115.379 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.974 HD12 HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -139.62 91.81 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.023 0.439 . . . . 0.0 110.244 177.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 1.9 t -61.74 114.28 3.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.023 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.974 HD11 HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -93.78 161.59 14.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.36 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 30' ' ' ALA . 19.3 p -136.3 164.77 40.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.577 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.56 122.0 8.48 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.773 2.316 . . . . 0.0 112.841 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.14 162.44 34.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 25' ' ' ILE . 4.8 pt-20 -80.09 -36.83 34.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.115 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.554 HD11 HD13 ' A' ' 49' ' ' ILE . 2.1 pt -94.93 -7.65 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.02 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.76 -125.18 1.27 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.366 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -140.69 106.28 5.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.882 0.372 . . . . 0.0 111.522 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' HG12 ' A' ' 49' ' ' ILE . 98.7 m -69.76 128.37 36.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.197 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.011 HG21 HD12 ' A' ' 32' ' ' LEU . 49.6 mt -64.41 104.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.855 0.359 . . . . 0.0 110.446 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.589 ' HA ' HD13 ' A' ' 94' ' ' LEU . . . -71.96 -26.84 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.611 ' OD1' HG11 ' A' ' 95' ' ' VAL . 1.8 m-20 -159.47 163.96 34.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.739 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.011 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -153.68 129.14 9.9 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.113 0.482 . . . . 0.0 111.971 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.173 HG23 ' CH2' ' A' ' 105' ' ' TRP . 3.0 pt -96.17 108.92 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.083 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -82.38 128.61 34.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.079 0.466 . . . . 0.0 111.294 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.2 30.37 3.17 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.814 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -117.49 -29.89 5.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.708 0.29 . . . . 0.0 111.279 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -151.31 143.11 15.86 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.79 -47.18 2.83 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.453 2.102 . . . . 0.0 112.894 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 7.2 mm-40 -66.02 -51.53 57.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.2 mt -55.47 -46.6 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.229 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.65 -30.37 71.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.991 0.424 . . . . 0.0 110.524 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -97.46 3.52 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.229 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.66 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -128.71 -72.67 0.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.944 0.402 . . . . 0.0 111.821 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.873 ' CD2' HG21 ' A' ' 6' ' ' VAL . 26.8 mt -73.7 149.11 42.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.119 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -153.96 155.8 36.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.357 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -57.81 104.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.151 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.03 45.2 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.899 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -144.77 145.05 31.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.366 . . . . 0.0 110.888 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.554 HD13 HD11 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -112.58 117.57 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.351 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.01 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 7.0 mt -74.89 100.23 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.264 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 25' ' ' ILE . 13.9 p -93.68 -3.93 51.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.278 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -144.89 147.28 32.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.979 ' HB2' HD11 ' A' ' 58' ' ' LEU . 22.8 t80 -153.32 114.05 4.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.884 0.373 . . . . 0.0 111.323 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.42 46.36 25.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.002 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.54 24.73 76.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.353 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -124.98 102.98 7.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 110.654 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.97 114.95 1.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.457 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.979 HD11 ' HB2' ' A' ' 53' ' ' PHE . 13.2 mt -91.12 15.78 11.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.59 125.36 35.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.72 15.62 51.94 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.373 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -128.64 159.74 66.43 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.976 0.388 . . . . 0.0 111.131 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.3 -171.7 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.695 2.264 . . . . 0.0 112.524 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 12.4 t80 -94.05 -32.11 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.594 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.72 -46.6 50.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.999 0.428 . . . . 0.0 110.449 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' O ' HD23 ' A' ' 69' ' ' LEU . 24.4 m -64.26 -41.05 91.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.86 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 17.1 m -62.77 -51.77 65.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.919 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.698 ' CD1' HG12 ' A' ' 106' ' ' VAL . 37.2 t80 -58.49 -30.96 67.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.713 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.67 -50.96 31.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.665 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -70.07 -31.49 69.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.411 . . . . 0.0 110.239 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 1.01 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 3.4 m-85 -72.86 -27.61 62.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.138 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 1.8 mtpt -85.2 -43.84 13.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.794 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.28 -23.41 78.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.016 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.782 ' HB3' ' CE ' ' A' ' 10' ' ' LYS . . . -42.16 128.89 3.73 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 111.735 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -157.32 103.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.09 83.6 1.44 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.267 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.08 114.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.469 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.781 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.31 107.83 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.687 -179.056 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 t -100.35 111.98 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.501 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.9 124.02 49.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.323 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -87.13 104.66 16.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.066 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.682 HG11 HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.94 142.52 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.421 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.409 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 83.9 m -108.92 119.95 41.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.636 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -102.77 91.33 2.77 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.69 -174.2 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.531 2.154 . . . . 0.0 112.544 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -105.47 157.76 33.76 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.38 174.4 3.47 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.569 2.179 . . . . 0.0 112.297 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.46 27.88 46.07 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.526 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.85 101.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.957 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.73 -147.42 14.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.545 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.12 179.56 14.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.526 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.9 m -61.14 -31.12 70.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.765 0.316 . . . . 0.0 110.92 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.27 -40.81 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.61 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.0 m -143.23 -174.24 4.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.589 HD13 ' HA ' ' A' ' 30' ' ' ALA . 1.1 mp -107.75 -33.84 7.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.009 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.611 HG11 ' OD1' ' A' ' 31' ' ' ASP . 7.7 p -128.5 129.19 23.57 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.636 ' HG2' HD11 ' A' ' 98' ' ' LEU . 33.5 Cg_endo -68.63 -162.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.2 1.933 . . . . 0.0 112.097 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.7 mmt-85 -93.71 66.35 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 111.527 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.636 HD11 ' HG2' ' A' ' 96' ' ' PRO . 0.7 OUTLIER -80.15 -71.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.677 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.866 HD12 ' HG2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -153.55 -166.48 2.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.566 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.866 ' HG2' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -46.22 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.226 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.799 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.5 mpt_? -140.23 -79.01 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.649 0.261 . . . . 0.0 110.916 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.623 ' CB ' HD11 ' A' ' 99' ' ' LEU . 56.9 t30 46.65 29.09 0.88 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.244 0.545 . . . . 0.0 110.88 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.534 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 26.5 mm100 -81.51 -176.36 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.448 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 5.7 t80 -86.85 96.47 10.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.243 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.173 ' CH2' HG23 ' A' ' 33' ' ' ILE . 9.0 m95 -106.48 137.16 44.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.698 HG12 ' CD1' ' A' ' 67' ' ' TYR . 27.5 m . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.207 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.858 0.361 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.66 156.07 25.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.532 ' HG2' HG23 ' A' ' 82' ' ' THR . 25.1 mttp -150.74 129.59 12.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.962 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.806 ' CE2' HG22 ' A' ' 6' ' ' VAL . 25.5 p90 -136.85 171.58 14.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.801 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.45 ' ND2' ' OE2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -108.62 135.65 49.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.031 0.443 . . . . 0.0 111.223 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.837 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.3 t -116.11 107.28 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.361 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 14.5 p-10 -110.0 127.23 54.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.7 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.36 158.6 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.527 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.02 113.32 8.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.103 0.478 . . . . 0.0 110.913 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.887 ' HE2' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -97.51 145.59 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.425 -179.654 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 12.4 mmtt -131.46 69.43 1.47 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.225 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.14 23.19 5.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.3 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.12 113.48 1.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.59 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 6.6 ptpt -161.5 -94.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 9.5 mt-10 -69.47 -5.9 26.95 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.669 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.887 HD22 ' HE2' ' A' ' 10' ' ' LYS . 2.1 tp -45.8 -34.36 3.67 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.538 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 22.74 62.16 0.03 OUTLIER Glycine 0 C--N 1.331 0.262 0 CA-C-N 114.933 -1.031 . . . . 0.0 115.008 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.786 HD22 HD12 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.43 91.7 2.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 110.097 178.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 5.0 t -61.59 118.94 7.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.021 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.582 HD21 ' CD1' ' A' ' 50' ' ' ILE . 7.8 mp -100.25 159.12 15.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.359 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.905 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 56.0 m -130.41 156.71 79.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.629 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.91 111.4 2.18 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.531 2.154 . . . . 0.0 112.474 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.669 HD21 HG21 ' A' ' 49' ' ' ILE . 1.8 t30 -122.85 162.57 21.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.064 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.621 ' HG3' HG23 ' A' ' 25' ' ' ILE . 11.1 pt-20 -79.09 -31.66 44.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.189 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.621 HG23 ' HG3' ' A' ' 24' ' ' GLU . 2.8 pt -101.12 -8.3 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.969 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 170.26 -121.19 0.9 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.484 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' SER . 3.0 m -140.47 106.48 5.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 111.224 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.555 ' N ' HG23 ' A' ' 49' ' ' ILE . 97.5 m -69.69 119.96 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.561 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.94 HG21 HD12 ' A' ' 32' ' ' LEU . 52.7 mt -61.35 104.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.741 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.905 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -73.72 -29.58 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.5 OUTLIER -158.67 171.45 20.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.064 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.94 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -159.31 128.2 5.26 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.454 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.166 HG23 ' CH2' ' A' ' 105' ' ' TRP . 2.4 pt -96.47 100.69 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.274 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -69.79 145.32 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.085 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.13 -25.34 23.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.915 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.574 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 1.8 mp0 -66.71 -47.52 72.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.722 0.296 . . . . 0.0 110.858 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -136.65 140.21 31.44 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.68 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.43 -50.15 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.635 2.223 . . . . 0.0 112.924 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -59.37 -49.71 76.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 110.997 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.701 HD13 HD23 ' A' ' 18' ' ' LEU . 5.2 mt -55.85 -53.01 42.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -58.43 -30.17 66.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.6 m -97.17 0.99 49.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.338 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.37 -73.41 0.62 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 0.0 111.566 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.84 HD22 HG11 ' A' ' 81' ' ' VAL . 21.3 mt -72.81 155.59 39.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.908 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.5 -175.77 5.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.474 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -90.57 98.0 11.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.035 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.43 -18.53 1.68 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.046 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.79 162.44 21.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 111.236 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.669 HG21 HD21 ' A' ' 23' ' ' ASN . 1.1 mp -128.9 120.36 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.918 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.884 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.9 mt -74.48 100.22 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 110.644 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.512 HG22 HG13 ' A' ' 25' ' ' ILE . 7.5 p -94.71 -7.4 40.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -141.43 147.95 38.77 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.972 ' HB2' HD11 ' A' ' 58' ' ' LEU . 26.8 t80 -152.58 110.38 3.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 0.0 111.256 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 54.14 47.44 23.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.858 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.35 24.81 73.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.231 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -123.88 102.41 7.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 0.0 110.584 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.11 114.01 1.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.427 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.972 HD11 ' HB2' ' A' ' 53' ' ' PHE . 15.3 mt -89.83 14.39 12.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.927 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -78.39 142.97 37.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.046 0.45 . . . . 0.0 111.232 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.05 26.52 61.15 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.744 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 58' ' ' LEU . 63.0 mt -120.24 140.79 30.61 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.607 0.242 . . . . 0.0 110.96 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.67 -166.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.507 2.138 . . . . 0.0 112.168 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -101.6 -24.97 14.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.105 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -45.84 84.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.686 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' HD23 ' A' ' 69' ' ' LEU . 25.7 t -68.08 -50.48 58.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.499 ' SG ' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -55.91 -48.36 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.566 ' CD1' HG12 ' A' ' 106' ' ' VAL . 15.7 t80 -64.3 -30.98 72.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.13 -50.9 35.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.958 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.685 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.5 -35.51 79.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 110.396 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.884 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 2.6 m-85 -69.77 -28.85 66.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.217 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.405 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 21.1 mtmt -84.98 -36.52 21.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.739 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.61 -20.0 67.15 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.976 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.824 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -45.34 126.93 6.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.752 0.311 . . . . 0.0 111.532 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -154.78 103.73 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.28 85.78 1.8 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.063 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.93 116.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.456 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.824 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -131.19 107.72 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.632 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.6 t -99.41 114.3 27.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.33 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.79 125.34 48.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.478 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' OE2' ' ND2' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -86.76 103.8 15.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.928 0.394 . . . . 0.0 110.091 178.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.84 HG11 HD22 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -95.17 143.1 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.521 -179.491 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.532 HG23 ' HG2' ' A' ' 3' ' ' LYS . 77.7 m -108.32 116.77 32.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -102.69 89.8 1.97 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.062 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.83 -178.86 1.41 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.525 2.15 . . . . 0.0 112.213 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.4 mtmm -75.58 157.41 84.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.986 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.4 166.56 28.0 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.658 2.239 . . . . 0.0 112.328 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.42 168.86 39.71 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.528 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.35 106.34 9.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.803 0.335 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -130.14 65.59 0.59 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.395 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.46 -88.39 0.38 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.471 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.58 -34.53 6.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.76 -51.42 0.73 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.413 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -104.96 171.61 7.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.769 0.318 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.1 -41.27 18.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.905 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 97' ' ' ARG . 14.9 p -117.44 124.23 29.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.603 ' HD2' HD21 ' A' ' 98' ' ' LEU . 73.0 Cg_endo -76.8 12.85 1.57 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.561 2.174 . . . . 0.0 113.252 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.578 ' H ' HG22 ' A' ' 95' ' ' VAL . 1.8 mtt180 68.47 74.52 0.27 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.887 0.375 . . . . 0.0 111.412 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.603 HD21 ' HD2' ' A' ' 96' ' ' PRO . 1.4 mm? -93.14 -35.76 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.301 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.3 -163.19 1.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.204 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.86 -74.58 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.801 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -141.88 -72.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.628 179.515 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.25 27.24 3.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 110.671 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.507 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 64.1 mm-40 -89.87 171.84 9.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.715 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.519 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 1.3 t80 -81.49 96.07 7.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.166 ' CH2' HG23 ' A' ' 33' ' ' ILE . 33.4 m95 -100.91 136.98 39.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.113 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.739 ' CG2' HD23 ' A' ' 16' ' ' LEU . 25.6 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.171 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.8 155.65 27.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HG2' HG23 ' A' ' 82' ' ' THR . 9.4 mttt -149.39 129.72 13.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.069 0.462 . . . . 0.0 110.708 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.775 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.1 p90 -138.49 169.58 17.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.688 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.58 135.88 49.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.158 0.504 . . . . 0.0 111.382 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.822 HG21 ' CD2' ' A' ' 44' ' ' LEU . 19.2 t -114.42 107.06 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.157 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 1.5 p30 -111.74 127.27 55.74 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.016 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.698 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -151.68 157.8 42.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.55 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.401 ' HB3' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -71.33 118.33 14.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 110.696 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.933 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -101.14 129.13 47.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.812 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 3.5 mmtp -119.61 68.61 0.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.166 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.9 77.33 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.436 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 48.95 100.78 0.01 OUTLIER Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.329 -0.462 . . . . 0.0 114.167 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -159.4 -101.58 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 22.3 mt-10 -69.22 -5.41 22.57 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.785 HD22 HD21 ' A' ' 18' ' ' LEU . 2.7 mt -45.5 -30.32 1.39 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.963 0.411 . . . . 0.0 109.906 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.551 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 24.81 63.05 0.05 OUTLIER Glycine 0 C--N 1.331 0.284 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.785 HD21 HD22 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -145.85 92.02 2.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.108 0.48 . . . . 0.0 110.098 178.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.5 t -63.42 120.73 12.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.175 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.461 HD21 HD12 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -100.0 158.07 16.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.585 -179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.41 163.33 51.28 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.348 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.33 117.56 5.22 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.492 2.128 . . . . 0.0 112.77 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.469 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -130.9 162.61 29.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG3' HG23 ' A' ' 25' ' ' ILE . 17.1 pt-20 -79.66 -37.26 36.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.643 HG23 ' HG3' ' A' ' 24' ' ' GLU . 2.3 pt -94.34 -6.03 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.888 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.27 -122.65 1.08 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.619 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -138.99 106.23 5.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.727 0.298 . . . . 0.0 110.924 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.439 ' N ' HG23 ' A' ' 49' ' ' ILE . 88.6 m -66.82 121.04 14.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.246 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.685 HD12 ' HB2' ' A' ' 48' ' ' ASP . 32.0 mt -62.85 104.59 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.561 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.496 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -72.1 -25.5 61.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -172.54 -178.02 1.87 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.386 0.612 . . . . 0.0 111.38 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -164.36 136.73 4.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.553 178.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.145 HG23 ' CH2' ' A' ' 105' ' ' TRP . 3.1 pt -96.0 100.32 10.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.303 0.573 . . . . 0.0 110.334 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -63.6 153.24 36.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.86 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.8 -16.15 61.46 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.703 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.2 mp0 -77.77 -50.08 13.09 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.712 0.291 . . . . 0.0 110.727 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -135.07 139.69 32.68 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.766 0.317 . . . . 0.0 110.829 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.15 -50.27 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.693 2.262 . . . . 0.0 113.05 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.7 mp0 -59.56 -49.25 78.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 110.838 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.66 HD13 HD23 ' A' ' 18' ' ' LEU . 4.2 mt -56.04 -48.22 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.92 -30.3 70.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.511 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 m -99.16 3.37 46.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.367 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.474 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -125.32 -71.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.822 ' CD2' HG21 ' A' ' 6' ' ' VAL . 14.4 mt -71.13 156.24 39.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.466 0.65 . . . . 0.0 112.498 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.71 ' HA ' HD21 ' A' ' 32' ' ' LEU . 5.2 mt-30 -153.95 -175.78 5.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.857 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -92.83 117.55 30.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.888 0.375 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.35 17.53 4.38 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.896 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.685 ' HB2' HD12 ' A' ' 29' ' ' ILE . 6.1 m-20 -115.32 167.35 10.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.783 0.291 . . . . 0.0 110.82 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.469 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.5 mp -137.01 120.61 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.014 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 9.8 mt -74.21 100.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.07 0.462 . . . . 0.0 110.567 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 25' ' ' ILE . 11.2 p -95.71 -3.71 45.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.245 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -144.52 143.96 31.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.984 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.95 ' HB2' HD11 ' A' ' 58' ' ' LEU . 32.0 t80 -150.1 111.74 4.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.954 0.407 . . . . 0.0 111.369 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.68 46.17 26.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.132 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.95 24.26 76.55 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.391 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -126.68 104.47 8.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.693 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.3 117.28 3.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.223 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.95 HD11 ' HB2' ' A' ' 53' ' ' PHE . 8.5 mt -92.8 17.67 10.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.968 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -87.21 127.72 35.15 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.891 0.376 . . . . 0.0 111.226 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.4 -23.84 28.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.791 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.24 153.81 66.25 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.998 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.01 -172.57 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.578 2.186 . . . . 0.0 112.244 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 67' ' ' TYR . 55.0 t80 -91.95 -29.18 16.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.713 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -53.96 -43.43 69.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.58 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.509 ' O ' HD23 ' A' ' 69' ' ' LEU . 10.1 p -65.28 -46.22 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.5 ' N ' HG13 ' A' ' 65' ' ' VAL . 89.4 m -60.21 -49.62 76.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.661 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.59 ' CD1' HG12 ' A' ' 106' ' ' VAL . 16.1 t80 -58.52 -31.97 68.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.599 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.01 -50.85 20.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.213 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.732 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.46 -37.02 82.29 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.473 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 1.014 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.0 m-85 -67.49 -34.02 76.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 34.9 mtmt -82.18 -29.76 31.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.28 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.85 15.93 61.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.637 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.933 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -78.12 138.14 38.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.709 0.29 . . . . 0.0 110.591 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 2.2 p30 -169.52 100.07 0.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.989 0.424 . . . . 0.0 110.785 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.17 78.32 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.961 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.36 114.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.962 0.411 . . . . 0.0 110.27 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.73 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.82 107.85 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.614 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.7 t -102.71 109.81 21.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.303 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.63 123.77 48.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.57 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tt0 -86.66 106.24 17.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 110.307 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.686 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -95.95 142.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.626 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.439 HG23 ' HG2' ' A' ' 3' ' ' LYS . 94.2 m -108.78 120.81 43.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -103.9 91.43 3.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.405 ' HD3' HD12 ' A' ' 49' ' ' ILE . 56.6 Cg_endo . . . . . 0 C--N 1.343 0.249 0 C-N-CA 122.45 2.1 . . . . 0.0 112.325 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.515 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 17.1 mm-40 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.508 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.0 t80 -79.44 96.1 5.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.145 ' CH2' HG23 ' A' ' 33' ' ' ILE . 54.3 m95 -99.3 139.83 34.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.095 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.59 HG12 ' CD1' ' A' ' 67' ' ' TYR . 10.8 m . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.125 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.736 0.303 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.15 162.21 22.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.912 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.9 mttp -154.43 129.64 9.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.816 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.714 ' CE2' HG22 ' A' ' 6' ' ' VAL . 12.7 p90 -137.71 169.73 17.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.882 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.46 135.82 49.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.002 0.429 . . . . 0.0 111.069 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.894 HG21 ' CD2' ' A' ' 44' ' ' LEU . 11.3 t -117.07 107.27 21.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.574 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 6.8 p-10 -108.56 127.15 53.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.805 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.96 155.05 40.27 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.955 0.407 . . . . 0.0 110.481 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.94 119.04 11.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.246 0.546 . . . . 0.0 110.459 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.744 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -101.89 149.79 23.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.092 -178.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 16.7 mmtt -138.55 68.94 1.38 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.182 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.09 27.16 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.425 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 96.18 116.9 3.25 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.099 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -169.75 -99.09 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 111.533 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.683 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 26.6 mt-10 -69.37 -4.77 19.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.692 HD22 ' CD2' ' A' ' 18' ' ' LEU . 4.2 mt -44.16 -37.96 3.43 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.832 0.348 . . . . 0.0 110.33 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.551 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 33.37 55.43 0.58 Allowed Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.802 -0.635 . . . . 0.0 114.146 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.731 ' CD1' HD21 ' A' ' 20' ' ' LEU . 1.1 pp -138.33 91.94 2.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.822 0.344 . . . . 0.0 110.365 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -63.07 110.37 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.577 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.731 HD21 ' CD1' ' A' ' 18' ' ' LEU . 3.3 mt -91.62 161.11 15.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.736 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.828 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 7.0 m -142.94 152.2 58.13 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.68 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.69 135.87 70.14 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.661 2.241 . . . . 0.0 112.706 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.559 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -145.3 162.68 36.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.141 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 25' ' ' ILE . 8.0 pt-20 -81.56 -19.76 41.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' A' ' 24' ' ' GLU . 5.8 pt -115.34 -4.61 11.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.753 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.79 -123.39 1.15 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.166 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' SER . 0.9 OUTLIER -140.68 106.05 5.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.774 0.321 . . . . 0.0 111.265 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.4 ' OG1' HG12 ' A' ' 49' ' ' ILE . 88.4 m -70.82 128.61 36.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.598 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.086 HG21 HD12 ' A' ' 32' ' ' LEU . 16.6 mt -71.65 104.92 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.712 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.828 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -69.84 -29.34 66.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.174 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.51 164.34 38.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.086 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -150.87 128.79 11.71 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.262 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.128 HG23 ' CH2' ' A' ' 105' ' ' TRP . 11.5 pt -104.78 100.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.347 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -72.16 159.98 33.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.086 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.56 64.72 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.125 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.555 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -81.54 -41.67 21.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.941 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.683 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -139.29 136.28 17.86 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.197 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.9 -44.46 5.4 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.622 2.214 . . . . 0.0 113.137 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 3.9 mm-40 -64.86 -52.88 54.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.66 0.267 . . . . 0.0 110.943 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.625 HD11 HD23 ' A' ' 16' ' ' LEU . 5.2 mt -54.54 -48.02 70.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.052 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -63.46 -30.21 71.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.552 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 m -97.01 3.24 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.268 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.671 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -131.62 -73.46 0.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.397 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.894 ' CD2' HG21 ' A' ' 6' ' ' VAL . 54.8 mt -72.34 149.28 44.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.077 0.465 . . . . 0.0 111.363 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.64 160.09 42.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.538 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -59.22 105.0 0.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.97 37.27 0.62 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.596 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.571 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -132.65 139.3 47.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.784 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.559 HG21 ' OD1' ' A' ' 23' ' ' ASN . 2.5 mt -110.99 117.26 54.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.977 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.971 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 15.2 mt -77.42 100.22 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.995 0.426 . . . . 0.0 110.539 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.1 p -94.63 0.33 55.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.207 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -148.53 142.05 25.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.029 179.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.99 ' HB2' HD11 ' A' ' 58' ' ' LEU . 36.3 t80 -145.68 108.43 4.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.86 0.362 . . . . 0.0 111.061 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 51.88 53.95 11.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.949 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.43 69.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.371 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -123.33 103.25 8.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.802 0.334 . . . . 0.0 110.604 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.28 113.32 1.52 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.332 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.99 HD11 ' HB2' ' A' ' 53' ' ' PHE . 15.1 mt -88.61 9.93 22.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -68.42 145.91 53.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.879 0.371 . . . . 0.0 111.085 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.96 26.11 47.47 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.633 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 58' ' ' LEU . 21.6 mt -116.73 148.12 41.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.686 0.279 . . . . 0.0 110.849 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.64 -167.38 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.551 2.167 . . . . 0.0 112.227 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.9 t80 -97.77 -26.56 14.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.767 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -57.43 -47.93 80.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.968 0.413 . . . . 0.0 110.273 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.528 ' O ' HD23 ' A' ' 69' ' ' LEU . 22.6 m -63.8 -47.03 92.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.087 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.468 ' N ' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -59.27 -53.8 54.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.699 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.553 ' CD1' HG12 ' A' ' 106' ' ' VAL . 21.8 t80 -56.02 -31.14 62.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.692 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.33 -51.08 18.76 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.652 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.74 -34.76 76.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.851 0.358 . . . . 0.0 110.356 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.971 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.8 m-85 -69.06 -34.0 74.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.466 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 7.4 mtpt -81.31 -32.83 32.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.358 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.41 -26.47 57.09 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.51 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.828 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -45.13 139.52 3.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.881 0.372 . . . . 0.0 111.412 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -167.11 99.6 0.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.72 80.12 0.84 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.819 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.19 112.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 110.158 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.828 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.42 107.96 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.752 -178.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 t -98.5 114.43 26.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.45 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.82 122.21 42.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.666 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -83.31 102.93 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.669 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -95.26 142.45 13.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.739 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 53.2 m -108.86 126.06 52.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.014 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -108.71 96.37 19.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.236 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 82' ' ' THR . 41.5 Cg_exo . . . . . 0 C--N 1.345 0.394 0 C-N-CA 122.564 2.176 . . . . 0.0 112.202 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.477 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 6.9 mm-40 . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.086 0.47 . . . . 0.0 111.852 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.525 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.6 t80 -83.18 96.09 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.128 ' CH2' HG23 ' A' ' 33' ' ' ILE . 27.7 m95 -103.39 126.52 50.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.046 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.553 HG12 ' CD1' ' A' ' 67' ' ' TYR . 8.6 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.079 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.822 0.344 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.27 157.13 38.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.699 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 4.5 mttt -151.43 129.68 11.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.973 0.416 . . . . 0.0 110.992 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.798 ' CE2' HG22 ' A' ' 6' ' ' VAL . 26.9 p90 -138.13 170.71 15.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.694 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.56 135.95 48.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.01 0.433 . . . . 0.0 111.349 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.893 HG21 ' CD2' ' A' ' 44' ' ' LEU . 13.3 t -116.77 107.04 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.604 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 38.9 t0 -110.29 127.22 54.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.908 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.708 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.92 157.57 43.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.57 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.02 110.05 5.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.962 0.41 . . . . 0.0 110.889 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.803 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -95.18 150.91 19.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.324 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 20.5 mmtt -138.45 69.28 1.38 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.5 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.4 22.25 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.253 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.29 113.97 1.38 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -162.28 -94.23 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.963 0.411 . . . . 0.0 111.351 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 15.1 mt-10 -69.15 -5.07 20.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.979 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.625 HD21 HD21 ' A' ' 8' ' ' LEU . 2.7 mt -45.09 -40.7 7.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.138 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.521 ' HA2' HD11 ' A' ' 33' ' ' ILE . . . 34.24 53.08 0.73 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 114.485 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.779 HD12 HD11 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -136.88 92.88 2.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.035 0.445 . . . . 0.0 110.232 178.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.529 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 6.0 t -63.92 122.33 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.05 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.779 HD11 HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -100.98 169.33 9.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.438 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.22 167.72 13.82 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.358 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.43 121.63 6.92 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.489 2.126 . . . . 0.0 112.59 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.437 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -133.67 162.52 31.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.03 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.537 ' HG3' HG23 ' A' ' 25' ' ' ILE . 10.7 pt-20 -79.32 -32.84 43.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.537 HG23 ' HG3' ' A' ' 24' ' ' GLU . 3.6 pt -99.81 -7.09 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.867 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.27 -123.57 1.12 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.243 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -140.55 106.2 5.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.93 0.395 . . . . 0.0 111.195 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.6 m -66.63 132.08 47.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.548 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.928 HG21 HD12 ' A' ' 32' ' ' LEU . 43.3 mt -68.58 104.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.903 0.382 . . . . 0.0 110.583 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.529 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -68.19 -23.38 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.223 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 5.5 m-20 -171.83 174.38 4.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.995 0.426 . . . . 0.0 111.13 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.928 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -152.05 127.28 9.85 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.535 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.067 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.0 pt -101.32 100.59 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.212 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -65.91 173.85 2.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.822 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.44 18.93 72.16 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.608 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -111.25 -46.28 3.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.767 0.318 . . . . 0.0 110.289 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -142.75 139.61 17.36 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.368 179.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.5 -49.36 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 113.085 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 43' ' ' LYS . 30.4 mm-40 -61.12 -51.48 68.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.541 HD11 HD23 ' A' ' 16' ' ' LEU . 6.1 mt -54.17 -50.89 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.056 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.41 -30.21 69.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.562 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 m -96.92 2.48 51.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.255 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.606 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.56 -73.58 0.58 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.867 0.365 . . . . 0.0 111.759 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.893 ' CD2' HG21 ' A' ' 6' ' ' VAL . 54.0 mt -72.16 149.52 44.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.006 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -147.4 -175.8 4.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.487 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -87.16 115.04 24.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.09 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.23 31.84 1.78 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.705 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.53 162.63 25.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.649 0.261 . . . . 0.0 110.748 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.437 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.2 mp -133.18 119.21 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.062 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.004 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.7 mt -74.5 100.49 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 110.51 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -93.94 -4.53 49.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.154 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.433 ' CB ' ' HB2' ' A' ' 80' ' ' GLU . 2.0 mttt -144.56 144.29 31.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.968 ' HB2' HD11 ' A' ' 58' ' ' LEU . 51.3 t80 -149.01 110.89 4.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.917 0.389 . . . . 0.0 111.194 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.83 46.05 23.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.75 21.46 76.51 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.47 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -123.62 107.32 11.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.779 0.323 . . . . 0.0 110.758 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.55 118.57 4.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.318 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.968 HD11 ' HB2' ' A' ' 53' ' ' PHE . 12.4 mt -92.6 16.93 11.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.32 144.76 42.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.965 0.412 . . . . 0.0 111.195 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.19 20.53 58.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.695 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 58' ' ' LEU . 81.0 mt -115.4 137.73 23.26 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.54 0.21 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.45 -160.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.421 2.081 . . . . 0.0 112.1 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -103.32 -24.96 13.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -56.01 -47.81 77.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.562 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.505 ' O ' HD23 ' A' ' 69' ' ' LEU . 26.8 m -67.44 -45.63 85.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.817 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.493 ' N ' HG23 ' A' ' 65' ' ' VAL . 15.8 m -56.56 -48.4 77.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.665 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 22.0 t80 -64.75 -30.89 71.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.747 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.45 -50.9 41.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.125 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -68.73 -35.33 76.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.938 0.399 . . . . 0.0 110.444 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 1.004 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 6.3 m-85 -70.31 -27.38 64.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.299 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HG3' HG12 ' A' ' 106' ' ' VAL . 1.5 mtmp? -84.12 -41.68 16.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.14 -22.46 76.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.845 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.803 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . . . -43.26 127.12 4.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.876 0.37 . . . . 0.0 111.698 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -156.05 104.21 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.87 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.44 85.39 1.76 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.271 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.36 115.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 110.357 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.794 HG11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -129.84 107.81 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.648 -179.023 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -99.92 112.86 25.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.314 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.4 124.48 47.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.434 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tt0 -86.87 104.53 16.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.928 0.394 . . . . 0.0 110.047 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.806 HG11 HD22 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -95.17 143.05 12.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.522 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.415 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 98.0 m -108.42 120.17 41.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.638 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -103.5 92.52 4.12 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.505 2.137 . . . . 0.0 112.222 179.77 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.519 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 10.9 mm-40 . . . . . 0 N--CA 1.456 -0.138 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.523 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 2.6 t80 -86.82 96.46 10.21 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.056 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.067 ' CH2' HG23 ' A' ' 33' ' ' ILE . 18.1 m95 -103.34 139.32 38.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.575 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.52 HG23 HD12 ' A' ' 16' ' ' LEU . 11.4 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.111 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 84' ' ' PRO . 10.4 mt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.695 0.283 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -77.54 157.54 30.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.985 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.483 ' HG2' HG23 ' A' ' 82' ' ' THR . 10.2 mttt -154.87 129.71 9.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.666 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.857 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.0 p90 -138.44 171.85 13.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.194 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.57 135.99 48.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.96 0.409 . . . . 0.0 111.256 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.912 HG21 ' CD2' ' A' ' 44' ' ' LEU . 3.5 t -120.19 107.71 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.827 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.581 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 11.9 p30 -108.5 127.18 53.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.718 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.713 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -145.56 154.49 42.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.931 0.395 . . . . 0.0 110.553 179.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.2 111.92 4.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.059 0.457 . . . . 0.0 110.691 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.857 ' HE2' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -97.4 148.47 23.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.675 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.423 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 21.5 mmtt -138.12 69.29 1.39 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.278 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.71 27.69 9.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.184 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.66 111.52 0.56 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' CG ' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.64 -96.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 111.263 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 36' ' ' GLN . 3.6 mt-10 -67.31 -5.73 15.53 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.032 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.857 HD22 ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -46.1 -43.46 14.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.768 0.318 . . . . 0.0 110.445 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.727 ' CA ' HD11 ' A' ' 33' ' ' ILE . . . 33.46 61.82 0.43 Allowed Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 114.611 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.589 HD12 HD21 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -141.96 104.19 4.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.933 0.397 . . . . 0.0 110.375 178.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 t -71.55 119.39 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.148 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.589 HD21 HD12 ' A' ' 18' ' ' LEU . 76.4 mt -108.86 169.17 8.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.551 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -148.16 167.79 12.53 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.529 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.56 135.89 32.09 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.502 2.135 . . . . 0.0 112.747 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.49 162.53 36.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.603 ' HG3' HG23 ' A' ' 25' ' ' ILE . 12.6 pt-20 -79.07 -21.53 46.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.226 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.603 HG23 ' HG3' ' A' ' 24' ' ' GLU . 5.5 pt -114.81 5.38 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.713 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.95 -123.74 1.41 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.129 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 21' ' ' SER . 1.9 p -140.47 109.05 5.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.922 0.392 . . . . 0.0 111.155 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.499 ' N ' HG23 ' A' ' 49' ' ' ILE . 53.2 m -72.04 136.9 46.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.04 HG21 HD12 ' A' ' 32' ' ' LEU . 51.2 mt -73.58 104.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.625 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.83 66.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 3.4 m-20 -161.3 168.37 24.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.04 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -151.28 126.76 10.07 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.244 0.545 . . . . 0.0 111.967 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.101 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -96.4 100.72 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.224 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -73.67 136.67 43.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.037 0.446 . . . . 0.0 111.368 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.65 32.98 4.59 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.743 ' HG3' ' O ' ' A' ' 33' ' ' ILE . 1.1 pp0? -122.72 -21.9 5.5 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -161.19 143.86 9.34 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.106 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.04 -48.42 2.76 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.483 2.122 . . . . 0.0 112.915 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 52.6 mm-40 -67.62 -53.26 29.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 110.838 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.3 mt -54.7 -40.38 51.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.414 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.97 -30.66 65.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.806 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -98.17 3.64 49.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.163 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.577 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.34 -72.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.959 0.409 . . . . 0.0 111.571 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.912 ' CD2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -59.0 149.42 27.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.669 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -153.94 146.81 24.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.58 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -59.54 112.43 1.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.67 38.16 0.93 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.585 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.49 155.01 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 110.821 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 28' ' ' THR . 1.1 mp -124.62 119.42 56.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.983 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.98 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.3 mt -74.57 100.52 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.104 0.478 . . . . 0.0 110.338 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 p -97.36 26.81 4.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.924 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' CB ' ' HB2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -172.71 144.36 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.091 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.899 ' HB2' HD11 ' A' ' 58' ' ' LEU . 64.3 t80 -151.54 108.5 3.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 111.066 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 53.22 52.55 13.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.792 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.93 20.91 71.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.428 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -122.56 103.94 9.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.839 0.352 . . . . 0.0 110.766 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.43 115.58 2.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.276 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 53' ' ' PHE . 13.7 mt -87.64 7.85 27.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -67.74 146.13 54.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.841 0.353 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.73 23.66 55.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.666 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 58' ' ' LEU . 38.9 mt -116.84 149.13 43.49 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.653 0.263 . . . . 0.0 110.896 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.475 ' HG2' HG23 ' A' ' 65' ' ' VAL . 45.3 Cg_endo -68.38 -169.22 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.553 2.169 . . . . 0.0 112.299 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 67' ' ' TYR . 11.3 t80 -96.97 -26.43 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.785 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -57.08 -46.33 82.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.414 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.557 HG12 HD23 ' A' ' 69' ' ' LEU . 28.9 t -68.4 -47.03 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.763 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 88.3 m -56.54 -53.74 54.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.586 ' CE1' HG13 ' A' ' 106' ' ' VAL . 6.2 t80 -60.95 -30.98 70.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.671 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.05 36.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.125 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.722 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -69.55 -33.4 72.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.235 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.98 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.6 m-85 -72.15 -27.26 62.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.299 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HG3' HG12 ' A' ' 106' ' ' VAL . 18.0 mtmt -85.22 -37.74 19.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.701 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.52 -19.39 68.72 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.056 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HB3' ' CE ' ' A' ' 10' ' ' LYS . . . -44.18 131.28 6.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.711 0.291 . . . . 0.0 111.676 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -157.2 102.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.2 82.8 1.3 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.307 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.29 115.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.882 0.373 . . . . 0.0 110.509 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.807 HG11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.78 107.95 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.964 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -98.89 116.02 30.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.195 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.54 128.43 52.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.303 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -88.77 105.46 17.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 0.0 110.252 179.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.676 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -95.14 142.86 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.249 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.483 HG23 ' HG2' ' A' ' 3' ' ' LYS . 95.9 m -108.51 119.61 40.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.608 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.99 89.89 1.76 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.044 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.567 ' HA ' HD22 ' A' ' 1' ' ' LEU . 38.3 Cg_endo . . . . . 0 C--N 1.345 0.357 0 C-N-CA 122.445 2.096 . . . . 0.0 112.075 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.516 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 15.2 mm100 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 121.096 0.474 . . . . 0.0 112.167 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 1.1 t80 -84.74 96.23 9.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.053 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.101 ' CH2' HG23 ' A' ' 33' ' ' ILE . 18.7 m95 -105.94 135.37 47.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.183 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.586 HG13 ' CE1' ' A' ' 67' ' ' TYR . 16.0 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.503 HD23 ' HG3' ' A' ' 84' ' ' PRO . 1.1 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.707 0.289 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.411 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 2.4 tp10 -79.81 159.46 26.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 11.0 mttt -146.18 129.43 16.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.682 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.667 ' CE2' HG22 ' A' ' 6' ' ' VAL . 12.6 p90 -137.07 169.25 18.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.055 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -108.57 135.92 49.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.316 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.699 HG21 ' CD2' ' A' ' 44' ' ' LEU . 17.0 t -115.56 107.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.471 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 12.4 t0 -112.69 127.28 56.08 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.675 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -153.63 157.84 40.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 110.735 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.67 123.62 20.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.118 0.485 . . . . 0.0 111.005 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.936 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -108.02 128.37 54.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.297 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 4.1 mmtp -118.36 68.52 0.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.892 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.76 78.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.262 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.426 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 46.91 99.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.276 -0.42 . . . . 0.0 114.018 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.453 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 6.3 ptpt -157.06 -99.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 16.6 mt-10 -69.15 -5.3 21.57 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.739 HD22 HD21 ' A' ' 18' ' ' LEU . 3.0 mt -45.48 -30.61 1.46 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.063 0.458 . . . . 0.0 109.803 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.567 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 24.79 62.41 0.05 OUTLIER Glycine 0 CA--C 1.519 0.314 0 N-CA-C 115.453 0.941 . . . . 0.0 115.453 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.777 HD22 ' CD1' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -146.33 91.83 2.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.175 0.512 . . . . 0.0 110.252 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 1.7 t -60.17 115.22 3.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.675 HD13 ' SG ' ' A' ' 27' ' ' CYS . 62.7 mt -97.37 163.75 12.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.313 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -141.43 166.85 19.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.488 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.47 130.05 16.69 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.351 2.034 . . . . 0.0 112.682 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.496 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -141.01 162.4 35.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -26.59 37.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.299 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.543 HD11 HD13 ' A' ' 49' ' ' ILE . 3.2 pt -106.84 -7.04 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.826 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.64 -125.14 1.24 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.854 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.675 ' SG ' HD13 ' A' ' 20' ' ' LEU . 25.2 p -140.61 106.07 5.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.906 0.384 . . . . 0.0 111.162 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.408 ' OG1' HG12 ' A' ' 49' ' ' ILE . 87.8 m -66.03 134.44 52.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.458 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.048 HG21 HD12 ' A' ' 32' ' ' LEU . 45.8 mt -75.88 104.88 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.559 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.43 -26.77 63.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.989 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.3 OUTLIER -161.01 169.8 21.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.046 0.451 . . . . 0.0 111.221 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.048 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -154.25 124.68 6.98 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.267 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.09 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.1 pt -96.43 100.49 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.194 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -68.9 153.59 43.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.981 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.37 -23.02 36.78 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.787 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.9 mp0 -67.63 -46.74 71.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.77 0.319 . . . . 0.0 110.811 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -138.24 141.82 33.17 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.477 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.19 -49.04 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.522 2.148 . . . . 0.0 112.96 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 26.9 mm-40 -62.3 -50.95 69.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.338 . . . . 0.0 110.962 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.668 HD13 HD23 ' A' ' 18' ' ' LEU . 4.4 mt -54.47 -50.1 60.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.243 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -60.96 -30.48 70.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.565 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -97.98 3.41 49.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.149 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HD3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.79 -72.99 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.918 0.389 . . . . 0.0 111.625 -178.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.777 ' CD1' HD22 ' A' ' 18' ' ' LEU . 87.3 mt -75.8 145.76 40.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.744 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.67 163.53 38.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.473 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -59.41 110.88 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.92 0.39 . . . . 0.0 110.991 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.67 46.89 0.55 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.682 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.435 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -144.03 139.43 28.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 110.711 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.543 HD13 HD11 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -112.47 117.59 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.23 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.786 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.0 mt -76.85 100.69 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 0.0 110.601 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.52 HG22 HG13 ' A' ' 25' ' ' ILE . 8.7 p -98.18 16.0 22.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.164 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 7.2 mttt -162.42 132.68 4.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.003 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.941 ' HB2' HD11 ' A' ' 58' ' ' LEU . 58.3 t80 -136.78 108.76 7.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 111.067 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 55.27 52.93 10.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.851 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.62 17.51 66.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.358 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -121.01 103.4 9.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 110.634 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . . . -55.49 120.38 7.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.436 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.941 HD11 ' HB2' ' A' ' 53' ' ' PHE . 9.5 mt -92.82 18.11 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.807 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -73.77 142.83 46.22 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.948 0.404 . . . . 0.0 111.312 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.77 18.22 52.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.753 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 58' ' ' LEU . 50.9 mt -109.69 137.85 20.49 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.701 0.251 . . . . 0.0 110.826 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.72 -159.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.302 2.001 . . . . 0.0 112.148 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -106.0 -23.7 12.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.016 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -54.98 -48.8 72.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.3 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.507 ' O ' HD23 ' A' ' 69' ' ' LEU . 30.8 m -68.47 -44.36 83.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.823 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.461 ' N ' HG23 ' A' ' 65' ' ' VAL . 1.5 m -55.95 -54.05 49.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.729 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.548 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 5.1 t80 -62.13 -30.97 71.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.926 0.393 . . . . 0.0 110.437 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.63 -51.13 37.72 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.712 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.37 -42.27 83.72 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.361 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.786 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 11.4 m-85 -63.33 -31.13 72.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 25.9 mtmt -83.03 -31.95 27.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.037 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.407 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -88.83 11.04 70.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.734 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.936 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -76.8 136.93 38.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.663 0.268 . . . . 0.0 110.484 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 2.2 p30 -168.13 100.72 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.144 0.497 . . . . 0.0 110.886 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.91 77.68 0.74 Allowed Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.919 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.08 115.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.141 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.75 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.22 107.66 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.727 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 t -99.5 115.15 28.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.46 120.89 35.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -81.83 111.24 17.87 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.681 HG11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.69 142.28 17.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.95 -178.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.7 m -109.06 118.39 36.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.289 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -107.96 97.23 20.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.139 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HG3' HD23 ' A' ' 1' ' ' LEU . 63.0 Cg_exo . . . . . 0 C--N 1.345 0.343 0 C-N-CA 122.55 2.166 . . . . 0.0 112.383 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.5 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.4 mm-40 . . . . . 0 C--O 1.232 0.132 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.548 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.5 t80 -85.03 96.18 9.32 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.09 ' CH2' HG23 ' A' ' 33' ' ' ILE . 20.0 m95 -104.14 132.05 50.8 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.197 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 70' ' ' PHE . 20.4 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.131 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.844 0.354 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.88 154.07 23.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.636 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -147.75 129.65 15.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.042 0.448 . . . . 0.0 110.929 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.762 ' CE2' HG22 ' A' ' 6' ' ' VAL . 29.6 p90 -138.23 172.09 13.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.666 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.01 136.02 49.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 111.813 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.793 HG21 ' CD2' ' A' ' 44' ' ' LEU . 15.9 t -116.3 107.28 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.124 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.591 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.6 p30 -114.44 127.4 55.81 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.779 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -155.28 160.95 41.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.753 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.49 127.63 33.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.803 ' CE ' HD13 ' A' ' 16' ' ' LEU . 4.2 tmtt? -112.5 136.97 51.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.26 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HB2' ' HG2' ' A' ' 14' ' ' LYS . 13.2 mmtt -131.07 68.92 1.48 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.59 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.405 ' H ' ' HB3' ' A' ' 74' ' ' ASN . . . 34.56 82.94 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.387 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.33 57.66 8.99 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.632 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.464 ' HG2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -98.48 -138.41 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.862 0.363 . . . . 0.0 111.198 -179.033 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.0 mt-10 -69.19 -4.54 18.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.803 HD13 ' CE ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -44.68 -44.2 8.91 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.286 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.649 ' HA3' HD11 ' A' ' 33' ' ' ILE . . . 23.86 68.05 0.03 OUTLIER Glycine 0 CA--C 1.518 0.25 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.592 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.689 HD21 ' HG ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -133.1 92.91 3.09 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.049 0.452 . . . . 0.0 109.895 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.8 t -56.48 113.73 1.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.179 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.431 HD21 HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -94.26 166.82 11.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.259 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.748 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 1.2 m -143.32 157.49 59.72 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.92 127.0 16.86 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.427 2.085 . . . . 0.0 112.574 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.455 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -139.7 162.59 34.75 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.823 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -81.35 -26.58 35.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.392 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.463 HG13 HG22 ' A' ' 51' ' ' THR . 2.9 pt -106.57 -8.41 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.895 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.74 -125.05 1.18 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.125 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -140.6 105.96 5.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.916 0.389 . . . . 0.0 111.189 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.405 ' OG1' HG12 ' A' ' 49' ' ' ILE . 85.0 m -67.33 126.91 30.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.516 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.098 HG21 HD12 ' A' ' 32' ' ' LEU . 24.5 mt -69.02 104.91 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.797 0.332 . . . . 0.0 110.685 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.748 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -68.15 -29.0 67.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.423 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 15.3 m-20 -163.88 167.25 20.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.098 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -149.73 132.74 16.19 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.349 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.124 HG23 ' CH2' ' A' ' 105' ' ' TRP . 4.3 pt -99.03 100.62 10.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.623 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -70.52 166.19 21.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.931 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.73 -0.39 88.28 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.009 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.533 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.32 -44.19 7.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.77 0.319 . . . . 0.0 110.453 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -139.59 139.6 22.74 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.998 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.53 -48.83 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.544 2.163 . . . . 0.0 112.834 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 43' ' ' LYS . 75.6 mm-40 -59.58 -51.23 70.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.654 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.572 HG22 HD21 ' A' ' 32' ' ' LEU . 6.2 mt -57.98 -44.54 87.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.972 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.87 -30.34 71.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.059 0.457 . . . . 0.0 110.218 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 m -99.96 3.41 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.074 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.495 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -126.32 -74.6 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.43 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.849 HD22 HG11 ' A' ' 81' ' ' VAL . 46.9 mt -76.41 151.88 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.582 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.86 -175.88 5.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.391 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -80.98 109.41 15.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.726 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.35 27.29 2.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.689 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.681 ' HB2' HD12 ' A' ' 29' ' ' ILE . 1.7 m-20 -121.2 139.28 53.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 110.681 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.455 HG21 ' OD1' ' A' ' 23' ' ' ASN . 2.0 mt -112.31 117.65 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.16 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.988 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.9 mt -75.6 100.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.398 . . . . 0.0 110.683 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.463 HG22 HG13 ' A' ' 25' ' ' ILE . 8.3 p -97.76 6.33 48.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.376 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -152.67 139.38 18.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.931 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.938 ' HB2' HD11 ' A' ' 58' ' ' LEU . 28.8 t80 -149.08 111.76 4.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.012 0.434 . . . . 0.0 111.217 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 55.62 48.9 17.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.71 23.03 68.69 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.321 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -125.4 98.03 5.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.889 0.376 . . . . 0.0 110.473 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.87 120.27 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.369 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.938 HD11 ' HB2' ' A' ' 53' ' ' PHE . 7.4 mt -92.37 19.87 6.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.977 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -77.02 143.28 39.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.919 0.39 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.33 24.51 61.43 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.732 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 58' ' ' LEU . 26.4 mt -116.21 144.42 32.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.576 0.227 . . . . 0.0 110.906 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.84 -170.62 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.466 2.111 . . . . 0.0 111.902 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -93.43 -26.4 17.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.972 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -43.42 88.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 0.0 110.528 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.543 ' O ' HD23 ' A' ' 69' ' ' LEU . 11.1 p -71.22 -47.13 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.998 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.505 ' N ' HG13 ' A' ' 65' ' ' VAL . 94.4 m -58.59 -53.81 54.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 110.567 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.541 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 73.2 t80 -61.32 -30.7 70.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.679 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.03 -51.25 41.08 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.44 -41.11 85.27 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.259 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.988 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.7 m-85 -61.64 -35.23 77.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.497 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 2.3 mtpt -78.36 -34.06 48.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.065 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.404 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -83.92 8.67 65.57 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.601 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.698 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -74.84 137.76 42.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.768 0.318 . . . . 0.0 110.558 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.405 ' HB3' ' H ' ' A' ' 12' ' ' ALA . 4.8 p30 -176.41 85.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.078 0.466 . . . . 0.0 110.746 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.2 71.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.183 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.43 96.5 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.011 0.434 . . . . 0.0 110.711 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.698 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -101.12 150.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.373 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.2 t -140.68 117.93 11.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.484 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.0 124.77 38.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -88.25 105.2 17.39 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.849 HG11 HD22 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -95.12 142.76 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.15 -178.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 m -108.57 118.98 38.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.414 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -102.82 94.04 4.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.201 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 C--N 1.344 0.308 0 C-N-CA 122.475 2.117 . . . . 0.0 112.107 179.763 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.517 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 7.2 mm-40 . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.541 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.0 t80 -81.03 96.05 7.01 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.124 ' CH2' HG23 ' A' ' 33' ' ' ILE . 47.3 m95 -99.21 143.6 29.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.51 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' A' ' 70' ' ' PHE . 20.4 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.24 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.766 0.317 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.77 159.04 30.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.864 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.407 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 9.7 mttt -153.68 129.57 10.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.811 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.9 p90 -138.17 170.7 15.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.748 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.58 135.78 49.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.977 0.417 . . . . 0.0 111.366 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.811 HG22 ' CE2' ' A' ' 4' ' ' PHE . 14.3 t -116.6 106.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.213 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 9.0 p-10 -113.82 127.07 55.85 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.085 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.695 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -154.05 156.26 37.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 110.742 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.18 117.32 8.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.067 0.46 . . . . 0.0 111.151 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.808 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -101.47 142.0 33.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.132 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HB2' ' NZ ' ' A' ' 14' ' ' LYS . 4.7 mmtp -126.95 69.49 1.27 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.533 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.73 21.49 5.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.34 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.85 113.01 1.45 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.777 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -163.07 -93.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.893 0.378 . . . . 0.0 110.925 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 25.0 mt-10 -69.44 -4.96 20.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.674 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.872 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -44.97 -31.6 1.34 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.114 0.483 . . . . 0.0 109.94 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.543 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 28.39 61.82 0.12 Allowed Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.514 -0.766 . . . . 0.0 114.618 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -142.48 91.96 2.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.898 0.38 . . . . 0.0 110.273 178.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -67.92 109.33 3.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.424 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.607 HD11 HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -84.5 163.18 19.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.773 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.71 160.01 68.14 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.031 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.33 120.66 7.13 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.518 2.145 . . . . 0.0 112.759 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.61 162.7 33.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.002 0.429 . . . . 0.0 111.192 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.592 ' HG3' HG23 ' A' ' 25' ' ' ILE . 16.6 pt-20 -79.8 -39.43 30.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.315 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.592 HG23 ' HG3' ' A' ' 24' ' ' GLU . 1.8 pt -90.24 -12.99 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.863 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.95 -125.23 1.13 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.256 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -140.46 106.08 5.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.916 0.389 . . . . 0.0 110.851 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 94.5 m -63.7 134.68 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.766 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 48' ' ' ASP . 36.3 mt -74.41 104.54 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.916 0.389 . . . . 0.0 110.141 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.29 -33.76 61.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.705 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 19' ' ' SER . 4.1 m-20 -162.24 174.01 13.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.278 0.561 . . . . 0.0 111.495 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.706 HD21 ' CA ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -157.83 136.62 11.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.93 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.137 HG23 ' CH2' ' A' ' 105' ' ' TRP . 4.2 pt -95.63 99.98 10.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 109.673 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -66.91 147.5 53.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.012 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.24 -17.63 56.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.768 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 2.2 mp0 -76.31 -48.45 20.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.733 0.302 . . . . 0.0 110.938 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -134.98 139.74 32.98 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.844 0.354 . . . . 0.0 110.692 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.99 -48.62 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.789 2.326 . . . . 0.0 113.112 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 43' ' ' LYS . 16.3 mm-40 -62.54 -48.42 79.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.0 mt -58.11 -42.71 83.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -30.25 70.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.386 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -99.85 3.55 44.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.351 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -123.36 -70.51 0.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.71 ' CD2' HG21 ' A' ' 6' ' ' VAL . 15.1 mt -72.07 156.99 38.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.398 0.618 . . . . 0.0 112.409 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.706 ' CA ' HD21 ' A' ' 32' ' ' LEU . 1.2 tt0 -153.94 -175.85 5.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.978 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.2 mtp-105 -91.87 99.79 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.47 39.28 0.21 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.586 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.606 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -131.61 174.62 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.6 mt -145.82 118.53 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.992 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 7.1 mt -73.93 100.23 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.142 0.496 . . . . 0.0 110.402 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.467 HG22 HG13 ' A' ' 25' ' ' ILE . 16.9 p -98.73 2.43 47.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.054 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.7 mttt -150.27 139.55 21.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.816 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.952 ' HB2' HD11 ' A' ' 58' ' ' LEU . 41.8 t80 -147.18 113.09 5.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.932 0.396 . . . . 0.0 111.264 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 55.54 48.07 19.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.18 21.7 72.13 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.413 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -127.33 104.95 8.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.371 . . . . 0.0 110.669 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.26 125.42 20.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.251 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.952 HD11 ' HB2' ' A' ' 53' ' ' PHE . 7.4 mt -96.52 27.45 3.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.802 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -82.83 142.42 31.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.04 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.7 21.81 65.5 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.661 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 58' ' ' LEU . 56.8 mt -117.29 136.26 23.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.501 0.191 . . . . 0.0 110.811 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.4 -161.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.419 2.079 . . . . 0.0 112.065 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -98.83 -26.66 14.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.026 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -57.41 -46.02 83.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.406 ' O ' HD23 ' A' ' 69' ' ' LEU . 25.7 t -64.1 -51.93 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.973 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 90.5 m -56.91 -50.2 73.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.584 ' CD1' HG12 ' A' ' 106' ' ' VAL . 29.3 t80 -59.43 -31.12 69.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.991 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.76 -50.85 26.35 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.726 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.76 -32.48 72.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 110.523 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.992 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 4.7 m-85 -73.82 -28.55 61.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.269 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 21.6 mtmt -83.44 -36.68 24.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.802 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.81 -18.0 68.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.102 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.819 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -46.44 130.81 11.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.894 0.378 . . . . 0.0 111.588 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -160.9 102.74 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.736 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.99 85.44 1.64 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.165 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.08 109.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.552 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.819 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -122.91 107.82 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.515 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.6 t -100.72 112.0 24.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.295 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.54 123.44 43.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.444 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.8 104.51 16.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.673 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.7 OUTLIER -95.09 142.54 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.588 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.407 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 51.6 m -108.94 123.45 49.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.369 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -104.24 92.93 5.08 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.159 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 C--N 1.345 0.354 0 C-N-CA 122.622 2.214 . . . . 0.0 112.235 179.87 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.514 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 5.6 mm-40 . . . . . 0 CA--C 1.523 -0.072 0 CA-C-O 121.074 0.464 . . . . 0.0 111.98 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.519 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.1 t80 -83.3 96.44 8.49 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.137 ' CH2' HG23 ' A' ' 33' ' ' ILE . 38.4 m95 -102.96 138.75 39.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.696 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.584 HG12 ' CD1' ' A' ' 67' ' ' TYR . 15.7 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.08 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.753 0.311 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -78.31 157.62 29.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 5.9 mttp -149.57 129.61 13.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.794 ' CE2' HG22 ' A' ' 6' ' ' VAL . 24.6 p90 -137.74 169.6 17.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.616 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.56 135.78 49.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.081 0.467 . . . . 0.0 111.142 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.89 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.4 t -115.8 107.16 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.506 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.0 p30 -110.06 127.19 54.7 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.796 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.715 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.68 155.37 40.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 110.61 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.51 113.86 6.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.94 0.4 . . . . 0.0 110.823 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.866 ' HE2' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -98.87 140.52 32.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.545 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.414 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 6.1 mmtp -127.55 69.34 1.31 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.304 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.18 23.43 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.275 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.27 113.62 1.17 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.612 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -161.78 -94.15 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 36' ' ' GLN . 24.0 mt-10 -69.24 -5.66 24.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.732 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.866 HD22 ' HE2' ' A' ' 10' ' ' LYS . 1.7 tp -45.53 -31.44 1.81 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.008 0.432 . . . . 0.0 109.843 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.568 ' HA2' HD11 ' A' ' 33' ' ' ILE . . . 23.24 59.59 0.04 OUTLIER Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.154 -0.93 . . . . 0.0 114.953 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 18' ' ' LEU . 2.8 pp -138.79 99.34 3.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.073 0.464 . . . . 0.0 110.303 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -68.98 115.86 8.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.598 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.863 HD13 ' SG ' ' A' ' 27' ' ' CYS . 62.2 mt -98.81 161.79 13.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.023 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.79 166.32 28.19 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.425 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.01 98.56 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.711 2.274 . . . . 0.0 113.439 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -107.72 162.83 13.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.916 0.389 . . . . 0.0 111.358 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.773 ' HG3' HG23 ' A' ' 25' ' ' ILE . 12.8 pt-20 -73.76 -42.31 61.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.391 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.773 HG23 ' HG3' ' A' ' 24' ' ' GLU . 3.3 pt -92.68 -7.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.874 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.31 -130.22 1.93 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.858 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.863 ' SG ' HD13 ' A' ' 20' ' ' LEU . 26.0 p -140.64 106.39 5.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.904 0.383 . . . . 0.0 111.357 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.483 ' OG1' HG12 ' A' ' 49' ' ' ILE . 69.0 m -69.52 133.21 47.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.628 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.012 HG21 HD12 ' A' ' 32' ' ' LEU . 39.8 mt -69.08 104.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.282 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.67 -24.41 61.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.963 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.409 ' HB2' ' NE2' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -162.48 163.73 27.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.749 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.012 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -149.31 124.82 10.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.313 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.107 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.0 pt -96.45 100.53 10.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.256 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.28 154.25 42.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.025 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.5 -21.68 43.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.754 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.66 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 6.0 mp0 -68.93 -48.55 63.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.678 0.275 . . . . 0.0 110.829 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -138.08 139.29 25.4 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.55 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.54 -43.72 3.81 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.628 2.218 . . . . 0.0 112.871 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' LYS . 19.0 mp0 -65.3 -51.72 58.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.966 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.589 HG22 HD21 ' A' ' 32' ' ' LEU . 3.8 mt -55.62 -49.36 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.964 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -61.34 -30.22 70.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.2 m -96.76 1.84 51.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.072 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.623 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -127.89 -74.16 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 0.0 111.504 -179.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.89 ' CD2' HG21 ' A' ' 6' ' ' VAL . 76.4 mt -73.53 148.31 43.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.418 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -153.17 158.61 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.635 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -58.89 98.27 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.982 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.91 44.81 0.13 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.604 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.4 146.57 30.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.935 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.483 HG12 ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -116.21 117.78 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.867 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.2 mt -74.7 100.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.005 0.431 . . . . 0.0 110.136 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.44 HG22 HG13 ' A' ' 25' ' ' ILE . 11.5 p -97.7 8.17 45.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.051 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 3.9 mttt -154.11 141.17 19.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.817 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.931 ' HB2' HD11 ' A' ' 58' ' ' LEU . 57.2 t80 -146.51 109.05 4.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.91 0.386 . . . . 0.0 111.229 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.21 49.65 16.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.56 18.79 74.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -124.34 105.9 9.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.661 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.52 124.99 20.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.293 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.931 HD11 ' HB2' ' A' ' 53' ' ' PHE . 8.4 mt -95.97 24.5 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -85.63 125.06 32.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.282 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.75 -20.6 40.99 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.853 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.0 mt -80.07 149.46 69.91 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.684 0.278 . . . . 0.0 111.084 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.84 -167.51 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.625 2.216 . . . . 0.0 112.213 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -96.12 -24.45 16.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.82 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -58.99 -46.49 88.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.984 0.421 . . . . 0.0 110.013 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.536 ' O ' HD23 ' A' ' 69' ' ' LEU . 29.7 m -67.95 -43.4 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.735 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.439 ' N ' HG23 ' A' ' 65' ' ' VAL . 83.5 m -59.13 -53.64 56.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.568 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.541 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 8.6 t80 -59.64 -31.01 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.636 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.93 -51.1 35.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.339 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.72 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -69.78 -34.06 73.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.385 . . . . 0.0 110.184 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.867 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 4.0 m-85 -70.55 -27.68 64.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.031 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.472 ' HG3' HG12 ' A' ' 106' ' ' VAL . 15.5 mtmt -85.18 -39.9 17.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.43 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.37 -21.77 74.63 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.914 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.833 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . . . -42.95 129.44 4.38 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.74 0.305 . . . . 0.0 111.546 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -157.65 102.84 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.017 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.04 83.42 1.37 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.225 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.16 113.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.426 . . . . 0.0 110.395 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.803 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -125.25 107.78 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.724 -179.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.9 t -98.91 114.76 27.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.228 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.19 122.4 40.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.473 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 1.9 tt0 -85.27 104.53 15.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.77 HG11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.24 142.55 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.774 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.408 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 92.1 m -108.82 119.54 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.674 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -103.87 93.3 5.14 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.404 ' HG3' HD11 ' A' ' 49' ' ' ILE . 67.8 Cg_endo . . . . . 0 C--N 1.345 0.384 0 C-N-CA 122.493 2.129 . . . . 0.0 112.281 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.503 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 3.8 mm100 . . . . . 0 C--O 1.231 0.112 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.541 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.2 t80 -84.48 96.34 9.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.209 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.107 ' CH2' HG23 ' A' ' 33' ' ' ILE . 23.5 m95 -104.62 131.14 52.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.215 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.529 ' CG2' HD23 ' A' ' 16' ' ' LEU . 16.1 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.12 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.555 HD22 ' CB ' ' A' ' 84' ' ' PRO . 9.5 mt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.816 0.341 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.58 157.94 19.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.99 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.583 ' HG2' HG23 ' A' ' 82' ' ' THR . 16.1 mttt -153.49 129.54 10.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.816 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.784 ' CE2' HG22 ' A' ' 6' ' ' VAL . 26.1 p90 -136.78 171.23 14.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.451 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.76 135.5 49.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.081 0.467 . . . . 0.0 111.144 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.9 t -114.32 107.27 22.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.928 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.697 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.3 p30 -115.83 127.48 55.08 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.795 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.673 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -153.62 160.91 42.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.637 179.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 128.05 34.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.109 0.48 . . . . 0.0 110.784 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.757 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -114.92 127.89 55.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.319 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.428 ' H ' ' HZ3' ' A' ' 10' ' ' LYS . 6.5 mmtt -121.69 69.13 0.92 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.038 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 43.75 89.91 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.413 ' N ' ' NZ ' ' A' ' 10' ' ' LYS . . . 39.05 96.46 0.01 OUTLIER Glycine 0 C--N 1.337 0.597 0 CA-C-N 116.082 -0.508 . . . . 0.0 114.202 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.5 -106.27 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -69.15 -5.67 23.85 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.113 HD22 HD21 ' A' ' 18' ' ' LEU . 4.5 mt -45.83 -33.44 3.14 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.57 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 24.83 62.97 0.05 OUTLIER Glycine 0 C--N 1.333 0.407 0 CA-C-N 114.979 -1.01 . . . . 0.0 115.159 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.113 HD21 HD22 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -141.13 91.71 2.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.934 0.397 . . . . 0.0 110.173 178.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.414 ' HB3' ' CB ' ' A' ' 31' ' ' ASP . 2.1 t -60.38 113.16 2.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.778 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.962 HD21 HD12 ' A' ' 18' ' ' LEU . 16.8 mt -94.28 160.84 14.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.514 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.48 167.58 21.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.268 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.03 120.52 5.04 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.437 2.091 . . . . 0.0 112.799 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.08 162.62 30.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.209 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.561 ' HG3' HG23 ' A' ' 25' ' ' ILE . 7.8 pt-20 -77.55 -33.09 54.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.1 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.561 HG23 ' HG3' ' A' ' 24' ' ' GLU . 3.6 pt -100.25 -4.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.913 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.17 -126.48 1.47 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.067 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 50' ' ' ILE . 26.2 p -140.51 106.16 5.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.946 0.403 . . . . 0.0 111.162 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.408 ' OG1' HG12 ' A' ' 49' ' ' ILE . 88.7 m -68.74 131.26 44.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.719 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.11 HG21 HD12 ' A' ' 32' ' ' LEU . 10.9 mt -72.03 105.06 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.607 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.27 -24.16 59.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.303 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.414 ' CB ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -157.33 165.67 35.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.014 0.435 . . . . 0.0 111.283 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.11 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -153.66 125.83 7.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.294 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.105 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.4 pt -97.15 100.55 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.652 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -68.31 154.36 41.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.978 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.36 -20.92 47.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.806 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.1 mp0 -71.73 -49.75 36.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.688 0.28 . . . . 0.0 110.887 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -136.95 139.7 29.46 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.867 0.365 . . . . 0.0 110.731 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.97 -48.15 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.653 2.236 . . . . 0.0 112.726 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -60.01 -50.4 73.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.701 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.638 HG22 HD21 ' A' ' 32' ' ' LEU . 6.3 mt -56.85 -47.26 83.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.17 -30.41 71.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.548 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -97.03 1.83 50.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.07 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.32 -73.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.916 0.388 . . . . 0.0 111.458 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.843 HD22 HG11 ' A' ' 81' ' ' VAL . 33.6 mt -75.22 153.28 38.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.522 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.14 -175.83 5.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.572 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -86.82 87.46 7.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.87 0.367 . . . . 0.0 111.014 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.9 43.11 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.697 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.56 156.82 45.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 110.666 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.408 HG12 ' OG1' ' A' ' 28' ' ' THR . 1.1 mp -124.53 117.74 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.359 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.94 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.2 mt -74.59 100.46 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.031 0.443 . . . . 0.0 110.474 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.0 p -93.46 -4.44 51.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.359 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -144.42 144.93 31.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.097 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.967 ' HB2' HD11 ' A' ' 58' ' ' LEU . 41.9 t80 -151.31 108.8 3.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 53.3 52.91 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.31 24.09 67.08 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.332 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -123.91 98.18 5.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.661 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.67 114.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.377 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.967 HD11 ' HB2' ' A' ' 53' ' ' PHE . 12.3 mt -88.5 11.95 15.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.999 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.73 142.98 42.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.862 0.363 . . . . 0.0 111.113 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.1 24.23 64.87 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.775 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 58' ' ' LEU . 59.0 mt -120.07 141.26 31.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.526 0.203 . . . . 0.0 110.766 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.58 -160.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.518 2.145 . . . . 0.0 112.24 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -104.7 -24.54 12.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -55.87 -49.11 74.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 0.0 110.387 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 66' ' ' CYS . 22.2 m -67.13 -45.85 85.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.778 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.467 ' N ' HG23 ' A' ' 65' ' ' VAL . 91.0 m -55.57 -52.86 62.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.022 0.439 . . . . 0.0 110.81 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 26.7 t80 -62.17 -30.88 71.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.739 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.32 -51.37 45.42 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.762 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -65.96 -44.06 86.09 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.668 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.94 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 12.5 m-85 -61.44 -32.41 72.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.133 0.492 . . . . 0.0 109.905 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 6.4 mtpt -80.39 -34.28 36.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.958 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -87.88 10.85 68.7 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.435 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.757 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -73.26 135.22 44.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.58 0.229 . . . . 0.0 110.544 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 4.1 p30 -172.97 92.93 0.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 111.013 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.58 76.24 0.19 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.259 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.02 98.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.023 0.44 . . . . 0.0 110.698 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.712 HG11 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -101.95 152.85 5.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.468 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 t -140.48 119.63 12.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.516 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.12 122.82 30.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.5 106.99 17.89 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.843 HG11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -97.0 143.02 13.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.719 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 3' ' ' LYS . 45.3 m -108.48 119.39 39.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.527 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -103.91 89.33 2.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.112 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.555 ' CB ' HD22 ' A' ' 1' ' ' LEU . 54.4 Cg_endo . . . . . 0 C--N 1.344 0.292 0 C-N-CA 122.581 2.187 . . . . 0.0 112.319 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.493 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.0 mm-40 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 121.167 0.508 . . . . 0.0 112.204 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.52 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 2.1 t80 -84.54 96.4 9.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.105 ' CH2' HG23 ' A' ' 33' ' ' ILE . 28.7 m95 -102.88 137.28 41.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.512 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 70' ' ' PHE . 6.4 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.095 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.738 0.304 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 157.9 31.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.8 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -151.93 129.58 11.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.8 ' CE2' HG22 ' A' ' 6' ' ' VAL . 27.6 p90 -138.54 171.82 13.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.813 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.68 135.94 49.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.955 0.407 . . . . 0.0 111.582 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.849 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.6 t -117.43 107.15 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.381 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.2 p30 -113.47 127.13 55.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.922 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.702 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -152.36 156.39 39.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.393 . . . . 0.0 110.735 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.35 119.66 12.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.647 ' HG3' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -100.96 137.5 39.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.388 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -126.62 69.1 1.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.703 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 33.75 91.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.174 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.6 96.26 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.324 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 33.5 ttmt -156.75 -114.1 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.755 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 9.3 mt-10 -70.88 -5.56 31.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.866 HD22 HD21 ' A' ' 18' ' ' LEU . 1.6 mt -45.43 -34.2 3.0 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.611 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 19.47 64.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 114.8 -1.091 . . . . 0.0 115.454 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.866 HD21 HD22 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -143.46 91.73 2.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.145 0.498 . . . . 0.0 110.107 178.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 2.1 t -59.29 114.58 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.942 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -91.79 163.04 14.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.39 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.14 162.47 53.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.352 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.14 120.54 7.25 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.512 2.142 . . . . 0.0 112.723 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.595 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -133.25 162.46 31.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.721 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -82.65 -29.27 30.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.097 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.533 HG13 HG22 ' A' ' 51' ' ' THR . 2.2 pt -103.49 -6.37 9.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.918 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.66 -125.57 1.29 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.249 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -140.59 106.1 5.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.954 0.407 . . . . 0.0 111.07 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.6 m -68.14 127.71 33.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.389 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.124 HG21 HD12 ' A' ' 32' ' ' LEU . 13.0 mt -70.69 104.92 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.851 0.358 . . . . 0.0 110.622 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.27 -25.64 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.047 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -157.18 166.97 31.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.043 0.449 . . . . 0.0 111.238 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.124 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -155.46 126.88 7.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.006 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.117 HG23 ' CH2' ' A' ' 105' ' ' TRP . 4.1 pt -96.46 100.58 11.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.64 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -72.7 139.67 47.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.842 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.69 -27.91 8.07 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.622 ' OE1' ' HA ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -67.21 -60.81 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.759 0.314 . . . . 0.0 110.712 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -123.77 136.75 27.72 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.129 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.98 -49.12 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.62 2.213 . . . . 0.0 112.903 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -56.82 -49.2 76.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.884 0.373 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.709 HG22 HD21 ' A' ' 32' ' ' LEU . 5.3 mt -57.49 -47.01 85.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.77 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.21 -30.39 71.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.606 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -97.2 1.6 49.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.226 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.515 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.56 -73.67 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 111.388 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.849 ' CD2' HG21 ' A' ' 6' ' ' VAL . 38.8 mt -74.92 145.3 42.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.546 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.36 164.94 36.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.572 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -59.9 108.18 0.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.953 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.24 40.78 0.61 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.603 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.643 ' HB2' HD12 ' A' ' 29' ' ' ILE . 12.0 m-20 -138.17 134.02 34.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.834 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.595 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.9 mt -106.36 117.39 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.908 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.72 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.8 mt -75.68 100.47 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.533 HG22 HG13 ' A' ' 25' ' ' ILE . 4.6 p -102.16 24.52 10.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.879 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 7.1 mttt -169.13 133.76 1.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.178 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.946 ' HB2' HD11 ' A' ' 58' ' ' LEU . 56.9 t80 -141.25 109.22 5.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.238 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 54.98 53.56 10.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.65 16.96 66.38 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -122.52 101.06 7.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.822 0.344 . . . . 0.0 110.608 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.98 123.41 14.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.344 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.946 HD11 ' HB2' ' A' ' 53' ' ' PHE . 3.8 mt -94.96 23.04 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.789 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.82 122.05 33.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.333 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.78 15.08 38.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.048 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.748 HD21 ' HA ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -127.41 159.46 65.44 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.9 0.35 . . . . 0.0 111.136 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.92 -171.77 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.765 2.31 . . . . 0.0 112.44 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -92.91 -33.46 14.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.486 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -48.63 -46.24 39.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.994 0.426 . . . . 0.0 110.649 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' HD23 ' A' ' 69' ' ' LEU . 26.9 m -65.46 -39.0 83.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.783 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 42.2 m -63.86 -53.74 45.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.737 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.693 ' CD1' HG12 ' A' ' 106' ' ' VAL . 26.8 t80 -57.6 -30.78 65.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.01 -51.1 42.8 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.729 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.4 -40.84 81.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.522 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.72 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 16.5 m-85 -64.24 -30.95 71.98 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.419 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -79.64 -33.52 41.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.026 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -90.55 15.53 60.02 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.668 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.638 ' HB1' HG11 ' A' ' 77' ' ' VAL . . . -77.92 133.7 38.03 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 72' ' ' GLY . 2.7 p30 -167.8 89.24 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 111.202 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.92 86.14 0.77 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.58 109.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.075 0.464 . . . . 0.0 110.783 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.647 HG11 ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -122.61 107.77 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.639 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.6 t -99.96 113.99 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.983 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.03 124.53 44.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.638 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.93 104.93 16.72 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.841 HG11 HD22 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -95.13 142.53 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.772 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.9 m -108.86 121.45 45.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.529 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -104.19 92.85 4.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.099 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--N 1.344 0.327 0 C-N-CA 122.528 2.152 . . . . 0.0 112.227 179.891 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.489 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.3 mm-40 . . . . . 0 CA--C 1.523 -0.087 0 CA-C-O 121.303 0.573 . . . . 0.0 112.37 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 4.8 t80 -84.88 96.42 9.32 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.211 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.117 ' CH2' HG23 ' A' ' 33' ' ' ILE . 18.7 m95 -104.59 136.5 44.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.114 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' A' ' 70' ' ' PHE . 30.1 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.069 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.801 0.334 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -78.85 158.76 28.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.707 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 6.6 mttt -150.97 129.54 12.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.777 ' CE1' HG23 ' A' ' 81' ' ' VAL . 9.3 p90 -136.93 170.87 15.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.743 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.57 135.92 49.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.103 0.478 . . . . 0.0 111.253 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.898 HG21 ' CD2' ' A' ' 44' ' ' LEU . 14.8 t -116.42 107.01 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.432 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.1 p30 -110.4 127.05 54.9 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.792 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.697 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.05 153.56 38.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 0.0 110.591 178.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.27 117.43 8.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.066 0.46 . . . . 0.0 110.827 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.948 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -101.93 128.6 48.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.598 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.454 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 7.7 mmtt -119.24 68.56 0.81 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.118 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.02 78.9 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.196 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.99 99.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.463 -0.398 . . . . 0.0 113.822 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 5.6 ptpt -155.79 -103.92 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 7.1 mt-10 -69.13 -5.57 23.17 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.995 HD22 HD21 ' A' ' 18' ' ' LEU . 3.8 mt -45.54 -33.7 2.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.601 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.603 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 26.38 61.98 0.08 OUTLIER Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.024 -0.989 . . . . 0.0 115.201 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.995 HD21 HD22 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -142.82 91.87 2.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.046 0.451 . . . . 0.0 110.003 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 t -62.29 117.75 6.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.773 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.895 HD21 ' CD1' ' A' ' 18' ' ' LEU . 16.2 mt -97.7 167.65 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.462 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.796 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 66.1 m -141.62 156.56 66.34 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.441 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.21 118.63 5.72 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.476 2.117 . . . . 0.0 112.429 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.485 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -128.85 162.75 26.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -24.69 41.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.448 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.425 HG13 HG22 ' A' ' 51' ' ' THR . 4.6 pt -108.71 -9.68 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.941 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 171.41 -122.18 0.94 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.143 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 21' ' ' SER . 8.7 m -140.55 106.46 5.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.812 0.339 . . . . 0.0 111.4 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 49' ' ' ILE . 93.2 m -68.89 125.96 28.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.079 HG21 HD12 ' A' ' 32' ' ' LEU . 40.9 mt -67.81 104.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.628 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.796 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -70.49 -29.0 65.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.967 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.434 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 6.8 m-20 -161.89 170.69 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.061 0.458 . . . . 0.0 111.023 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.079 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -153.28 127.37 9.05 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.429 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.122 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -96.74 100.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.165 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.05 153.2 43.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.047 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.11 -22.34 41.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.751 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 1.5 mp0 -69.94 -45.28 67.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.825 0.345 . . . . 0.0 110.862 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -141.12 139.73 19.79 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.646 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.46 -49.3 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.629 2.22 . . . . 0.0 112.977 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.2 -50.74 72.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.656 HD13 HD23 ' A' ' 18' ' ' LEU . 5.4 mt -55.87 -52.15 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.01 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -59.15 -30.23 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.583 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.2 m -96.46 0.68 50.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.24 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.569 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.98 -73.79 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 111.538 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.898 ' CD2' HG21 ' A' ' 6' ' ' VAL . 45.2 mt -72.87 145.31 46.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.564 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -149.59 159.78 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.621 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -60.94 109.32 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.072 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.46 -17.39 4.76 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.985 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.632 ' HB2' HD12 ' A' ' 29' ' ' ILE . 2.7 m-20 -83.61 148.62 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.991 0.424 . . . . 0.0 111.13 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 28' ' ' THR . 2.9 mt -119.57 117.78 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.599 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.874 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.1 mt -74.53 100.38 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 111.162 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.425 HG22 HG13 ' A' ' 25' ' ' ILE . 9.7 p -102.39 20.84 16.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.1 mttt -167.33 126.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.998 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.958 ' HB2' HD11 ' A' ' 58' ' ' LEU . 44.0 t80 -132.23 109.58 10.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.19 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 50.52 62.96 2.42 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.021 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.74 20.59 48.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.464 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -125.31 98.04 5.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.699 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.71 121.49 8.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.387 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.958 HD11 ' HB2' ' A' ' 53' ' ' PHE . 9.1 mt -93.11 19.48 7.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.813 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.85 143.72 39.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.934 0.397 . . . . 0.0 111.176 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.89 26.61 48.32 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.704 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 58' ' ' LEU . 23.8 mt -118.77 143.58 33.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.635 0.255 . . . . 0.0 110.866 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.26 -164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.548 2.165 . . . . 0.0 112.035 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -110.58 -22.79 11.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.176 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -58.36 -50.99 71.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 110.687 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.517 ' O ' HD23 ' A' ' 69' ' ' LEU . 14.6 m -65.52 -41.44 90.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.94 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 81.4 m -60.47 -52.3 65.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 25.9 t80 -60.34 -30.68 69.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.292 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.46 -51.03 39.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.247 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.734 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.69 -40.72 84.34 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.148 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.874 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.4 m-85 -61.16 -33.25 73.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.422 ' HG3' HG12 ' A' ' 106' ' ' VAL . 26.0 mtmt -83.41 -30.9 26.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.184 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.401 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -90.48 12.35 68.6 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.612 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.948 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -75.59 138.78 41.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.637 0.256 . . . . 0.0 110.379 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 2.6 p30 -169.77 99.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.179 0.514 . . . . 0.0 111.101 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.44 76.35 0.53 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.044 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.82 108.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.938 0.399 . . . . 0.0 110.17 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.788 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -117.13 107.74 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.753 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.0 t -100.01 114.77 28.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.316 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.8 122.16 40.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.679 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 2.7 tt0 -84.17 102.38 12.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.777 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -95.07 142.95 12.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.731 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 54.4 m -108.36 121.97 46.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.4 97.45 22.79 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 82' ' ' THR . 36.6 Cg_exo . . . . . 0 C--N 1.343 0.252 0 C-N-CA 122.533 2.156 . . . . 0.0 112.197 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.528 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 8.5 mm100 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.243 0.544 . . . . 0.0 112.259 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.8 t80 -85.99 96.3 9.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.094 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.122 ' CH2' HG23 ' A' ' 33' ' ' ILE . 13.3 m95 -105.36 136.17 45.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.237 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.673 HG21 ' HB3' ' A' ' 70' ' ' PHE . 11.3 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.122 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.709 HD22 ' HA ' ' A' ' 84' ' ' PRO . 7.1 mt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.8 0.333 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.79 158.8 22.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 11.3 mttt -152.73 129.65 11.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 110.867 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.814 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.0 p90 -137.91 171.18 14.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.784 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.61 135.91 49.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.957 0.408 . . . . 0.0 111.414 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.874 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.0 t -117.63 107.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.452 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 8.6 p-10 -111.02 127.26 55.48 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.972 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.73 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.04 153.68 39.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 110.758 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.19 114.87 6.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.058 0.456 . . . . 0.0 110.51 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.822 ' CE ' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -98.03 145.34 26.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.882 -179.288 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 48.5 mmtt -132.66 69.23 1.48 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.183 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.25 21.89 4.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.493 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.65 115.05 1.52 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.69 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 7.9 ptpt -163.79 -94.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.3 mm-40 -69.21 -4.91 19.57 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.906 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.861 ' CD2' HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -44.95 -38.59 4.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.228 0.537 . . . . 0.0 109.643 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.584 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 33.64 59.06 0.56 Allowed Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.171 -0.922 . . . . 0.0 115.362 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.861 HD21 ' CD2' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -143.06 91.49 2.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.124 0.462 . . . . 0.0 110.059 177.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.6 t -63.32 120.85 12.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.638 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -96.13 167.82 10.98 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.579 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.642 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -142.57 163.13 40.75 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.269 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 21' ' ' SER . 57.6 Cg_endo -71.71 126.11 11.74 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.269 1.979 . . . . 0.0 112.734 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.48 162.74 34.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.076 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.33 -32.71 37.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 51' ' ' THR . 2.4 pt -99.64 -6.94 9.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.87 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.21 -127.49 1.58 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.865 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 75.0 m -140.72 106.41 5.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.855 0.359 . . . . 0.0 111.644 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.7 m -63.64 133.42 53.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.289 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.029 HG21 HD12 ' A' ' 32' ' ' LEU . 47.8 mt -71.65 104.77 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.879 0.371 . . . . 0.0 110.422 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.642 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -68.51 -32.93 73.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.164 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -156.91 174.71 15.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.05 0.452 . . . . 0.0 111.457 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.029 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.74 128.98 7.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.508 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.14 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.2 pt -101.12 100.46 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.088 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -70.58 153.76 42.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.012 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.81 -21.92 43.36 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.682 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.599 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 6.4 mp0 -69.87 -52.57 23.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.672 0.272 . . . . 0.0 110.8 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -133.27 139.33 33.8 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.669 179.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.58 -48.23 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.662 2.241 . . . . 0.0 113.109 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -61.12 -49.32 77.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.761 0.315 . . . . 0.0 110.964 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.3 mt -57.91 -49.93 79.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -60.34 -30.33 69.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.976 0.417 . . . . 0.0 110.452 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -95.3 -1.43 51.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.129 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.587 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -123.93 -73.19 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.462 -178.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.874 ' CD2' HG21 ' A' ' 6' ' ' VAL . 47.8 mt -73.25 147.8 44.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.631 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.03 157.78 43.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.65 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.7 mtp-105 -59.73 96.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.073 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.81 43.38 0.17 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.722 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.18 140.13 35.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.72 0.295 . . . . 0.0 110.686 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.47 ' CD1' HD11 ' A' ' 25' ' ' ILE . 2.0 mt -107.52 117.54 53.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.091 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.9 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 8.8 mt -75.14 100.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.956 0.408 . . . . 0.0 110.461 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.524 HG22 HG13 ' A' ' 25' ' ' ILE . 10.2 p -101.79 23.43 11.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 4.5 mttt -170.21 137.01 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.982 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.98 ' HB2' HD11 ' A' ' 58' ' ' LEU . 35.9 t80 -144.82 115.6 7.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 0.0 111.272 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 53.35 54.42 10.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.75 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.7 22.5 64.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.353 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -128.44 103.16 6.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.935 0.397 . . . . 0.0 110.7 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . . . -54.42 123.52 13.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.399 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.98 HD11 ' HB2' ' A' ' 53' ' ' PHE . 9.3 mt -93.7 22.11 5.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.584 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -77.81 119.58 21.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.888 0.375 . . . . 0.0 111.225 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -16.83 57.21 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.708 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 58' ' ' LEU . 72.1 mt -76.23 135.6 69.55 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.589 0.194 . . . . 0.0 111.041 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -57.69 -160.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.412 2.074 . . . . 0.0 112.213 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 37.4 t80 -101.24 -25.6 13.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.89 -47.69 84.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.792 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HD23 ' A' ' 69' ' ' LEU . 27.9 m -67.58 -46.81 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.502 ' N ' HG23 ' A' ' 65' ' ' VAL . 19.0 m -59.62 -50.08 75.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 110.767 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.722 ' CD1' HG12 ' A' ' 106' ' ' VAL . 50.0 t80 -59.31 -33.3 70.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.982 0.42 . . . . 0.0 110.338 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.61 -50.98 39.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.172 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.711 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.83 -34.92 76.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 110.367 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.9 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 3.8 m-85 -69.52 -27.83 65.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.049 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.422 ' HD3' ' CZ ' ' A' ' 67' ' ' TYR . 19.8 mtmt -85.06 -41.55 15.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.911 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.3 -20.47 77.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.233 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.822 ' HB3' ' CE ' ' A' ' 10' ' ' LYS . . . -42.97 132.88 3.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 111.64 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -162.96 102.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.783 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.39 81.75 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.129 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.81 109.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.905 0.384 . . . . 0.0 110.553 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.786 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -121.46 107.69 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.751 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -98.88 114.76 27.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.404 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.16 123.59 43.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.378 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -87.05 104.69 16.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.964 0.411 . . . . 0.0 109.997 178.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.805 HG11 HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -95.17 142.68 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.655 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.408 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 96.8 m -108.77 123.84 49.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.339 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 -104.61 92.68 5.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.225 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.709 ' HA ' HD22 ' A' ' 1' ' ' LEU . 61.7 Cg_endo . . . . . 0 C--N 1.345 0.367 0 C-N-CA 122.535 2.157 . . . . 0.0 112.133 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.537 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 27.2 mm-40 . . . . . 0 C--O 1.232 0.136 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.517 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.7 t80 -86.58 96.21 10.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.338 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.14 ' CH2' HG23 ' A' ' 33' ' ' ILE . 7.7 m95 -106.16 132.58 52.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.055 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.722 HG12 ' CD1' ' A' ' 67' ' ' TYR . 20.3 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.057 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.791 0.329 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.06 159.3 16.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -151.15 129.62 12.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.799 ' CE2' HG22 ' A' ' 6' ' ' VAL . 30.7 p90 -137.76 172.17 13.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.109 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.71 135.95 49.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 111.544 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.799 HG22 ' CE2' ' A' ' 4' ' ' PHE . 15.7 t -117.05 107.25 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.265 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 5.7 p-10 -113.13 127.2 56.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.884 0.373 . . . . 0.0 111.139 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.704 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.86 156.24 40.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.38 178.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.47 117.6 12.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.9 0.381 . . . . 0.0 110.638 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.903 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -100.03 128.39 46.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.538 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 10.7 mmtt -120.9 68.75 0.88 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.219 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.42 79.73 0.07 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.439 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 44.79 98.63 0.01 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 114.231 0.452 . . . . 0.0 114.231 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 7.5 ptpt -155.85 -102.37 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 1.8 mm-40 -69.23 -5.42 22.68 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.992 HD22 HD21 ' A' ' 18' ' ' LEU . 3.3 mt -45.53 -30.11 1.36 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.996 0.427 . . . . 0.0 110.17 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.549 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 26.76 62.64 0.08 OUTLIER Glycine 0 C--N 1.332 0.337 0 N-CA-C 115.149 0.82 . . . . 0.0 115.149 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.992 HD21 HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -146.18 92.28 2.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.006 0.431 . . . . 0.0 110.331 178.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 26.3 t -66.8 116.69 7.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.277 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -92.87 162.74 13.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.199 0.523 . . . . 0.0 111.961 -179.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.663 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 1.2 m -139.17 148.11 55.95 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.35 124.84 17.24 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.634 2.223 . . . . 0.0 112.816 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.37 162.57 35.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.979 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HG3' HG23 ' A' ' 25' ' ' ILE . 10.0 pt-20 -80.57 -38.89 28.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.086 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.562 HG23 ' HG3' ' A' ' 24' ' ' GLU . 1.9 pt -91.33 -9.24 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.959 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 168.87 -123.2 1.07 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.452 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -140.51 106.19 5.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.771 0.32 . . . . 0.0 110.939 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.413 ' N ' HG23 ' A' ' 49' ' ' ILE . 86.5 m -67.07 119.37 11.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.532 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.692 HD12 ' HB2' ' A' ' 48' ' ' ASP . 7.6 mt -66.51 104.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.52 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.663 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -68.89 -28.58 66.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.342 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -165.63 178.72 6.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.342 0.591 . . . . 0.0 111.336 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -163.9 136.1 4.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.747 178.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.189 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.5 pt -95.9 100.32 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.244 0.545 . . . . 0.0 110.572 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -65.07 154.04 39.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.869 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.04 -27.46 16.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.522 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 3.5 mp0 -65.76 -49.56 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 110.461 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.663 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -133.98 140.21 35.64 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.475 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.31 -49.28 0.95 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.644 2.229 . . . . 0.0 113.169 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 43' ' ' LYS . 13.5 mm-40 -60.94 -50.48 73.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 111.036 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.615 HD13 HD23 ' A' ' 18' ' ' LEU . 3.3 mt -55.98 -51.2 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.257 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -59.37 -30.14 68.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.028 0.442 . . . . 0.0 110.632 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -99.42 3.45 45.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.425 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.518 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -122.94 -70.18 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.701 ' CD2' HG21 ' A' ' 6' ' ' VAL . 15.0 mt -70.9 153.72 42.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.266 0.555 . . . . 0.0 112.259 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.476 ' HA ' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -153.94 137.34 15.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.26 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HG3' HD11 ' A' ' 32' ' ' LEU . 13.7 mtp-105 -48.18 114.07 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 111.435 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.93 7.1 6.16 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.18 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.692 ' HB2' HD12 ' A' ' 29' ' ' ILE . 54.0 m-20 -106.61 163.96 12.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.913 0.357 . . . . 0.0 111.099 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 25' ' ' ILE . 1.2 mp -131.48 120.14 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.027 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.004 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.9 mt -74.61 100.28 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.496 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.43 HG22 HG13 ' A' ' 25' ' ' ILE . 15.7 p -93.55 -9.58 37.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.238 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -139.18 145.97 39.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.963 ' HB2' HD11 ' A' ' 58' ' ' LEU . 31.1 t80 -152.55 112.54 3.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.865 0.364 . . . . 0.0 111.109 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 56.81 42.86 25.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.851 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.22 22.74 77.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.427 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -121.82 108.15 13.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.343 . . . . 0.0 110.75 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.66 107.95 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.308 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.963 HD11 ' HB2' ' A' ' 53' ' ' PHE . 20.6 mt -80.72 0.65 33.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.54 145.2 52.8 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.932 0.396 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.66 19.13 66.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.736 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.0 mt -120.15 141.51 31.81 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.575 0.226 . . . . 0.0 110.924 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.92 -158.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.507 2.138 . . . . 0.0 112.259 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -105.39 -23.91 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.929 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -56.32 -49.0 75.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 110.544 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.48 ' O ' HD23 ' A' ' 69' ' ' LEU . 19.0 m -67.02 -45.36 87.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.996 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.445 ' N ' HG23 ' A' ' 65' ' ' VAL . 57.0 m -56.97 -49.7 74.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.701 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.529 ' CD1' HG12 ' A' ' 106' ' ' VAL . 25.3 t80 -63.74 -31.01 72.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.835 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.99 33.09 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.749 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -65.83 -42.21 90.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.814 0.34 . . . . 0.0 110.519 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 1.004 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.7 m-85 -63.74 -32.62 74.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.919 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -82.65 -30.37 29.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.324 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.12 17.26 58.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.542 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.903 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -79.23 136.21 37.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.764 0.316 . . . . 0.0 110.626 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -170.12 98.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.126 0.489 . . . . 0.0 110.728 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.56 77.25 0.52 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.887 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.54 110.39 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.857 0.36 . . . . 0.0 110.412 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.725 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -119.41 107.96 22.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.629 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.8 t -105.49 106.25 16.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.303 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.27 127.79 56.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.938 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -89.06 107.62 19.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.919 0.39 . . . . 0.0 109.985 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.669 HG23 ' CE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -98.23 143.05 13.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.875 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.9 m -108.49 124.49 50.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.188 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -105.64 93.57 7.44 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.372 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.445 ' HG3' HD11 ' A' ' 49' ' ' ILE . 73.7 Cg_endo . . . . . 0 C--N 1.345 0.353 0 C-N-CA 122.555 2.17 . . . . 0.0 112.199 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.492 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 4.5 mm100 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 121.053 0.454 . . . . 0.0 111.952 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.504 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 3.3 t80 -79.4 95.9 5.88 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.189 ' CH2' HG23 ' A' ' 33' ' ' ILE . 53.2 m95 -100.86 145.61 28.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.036 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.529 HG12 ' CD1' ' A' ' 67' ' ' TYR . 8.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.22 160.53 19.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.949 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HG2' HG23 ' A' ' 82' ' ' THR . 9.6 mttt -155.37 129.61 8.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.706 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.81 ' CE2' HG22 ' A' ' 6' ' ' VAL . 33.0 p90 -136.26 173.29 11.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.272 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.65 137.61 46.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 111.258 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.881 HG21 ' CD2' ' A' ' 44' ' ' LEU . 6.9 t -122.76 107.28 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.84 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 25.7 t0 -110.14 127.18 54.76 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.78 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.723 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.54 159.17 44.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.674 179.044 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.38 114.24 9.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.794 ' HG2' HD21 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -95.39 140.83 29.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.347 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 3.8 mmtp -132.57 69.27 1.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.36 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.36 22.09 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.336 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.92 114.27 0.96 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.536 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -162.08 -96.42 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.959 0.409 . . . . 0.0 111.367 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 16.7 mt-10 -68.23 -4.39 13.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.122 0.569 . . . . 0.0 112.156 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.987 HD12 HD21 ' A' ' 18' ' ' LEU . 2.8 mm? -44.48 -32.71 1.47 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.136 0.493 . . . . 0.0 110.03 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.556 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 32.93 51.24 0.47 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.333 -0.849 . . . . 0.0 114.65 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.987 HD21 HD12 ' A' ' 16' ' ' LEU . 1.3 pp -141.27 91.62 2.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.019 0.438 . . . . 0.0 110.323 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 6.0 t -68.63 119.52 13.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.812 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.861 HD21 HD12 ' A' ' 50' ' ' ILE . 5.5 mp -94.23 167.89 11.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.52 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -143.88 164.69 28.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.074 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.56 128.68 15.62 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.347 2.032 . . . . 0.0 112.672 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.591 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -140.02 162.66 34.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.039 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.04 -16.74 45.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.52 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.535 HD11 HD13 ' A' ' 49' ' ' ILE . 6.8 pt -118.1 -7.14 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.787 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 169.75 -124.98 1.2 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.839 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.495 ' CB ' HD23 ' A' ' 20' ' ' LEU . 21.0 m -140.81 106.16 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.905 0.383 . . . . 0.0 111.413 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 98.3 m -65.79 128.89 37.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.212 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.02 HG21 HD12 ' A' ' 32' ' ' LEU . 56.2 mt -68.8 104.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.953 0.406 . . . . 0.0 110.534 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -67.42 -31.45 71.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.11 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.6 172.25 16.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 111.268 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.02 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -153.5 125.36 7.8 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.335 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.135 HG23 ' CH2' ' A' ' 105' ' ' TRP . 9.0 pt -97.09 100.49 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.967 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.88 160.4 31.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.93 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.16 3.39 88.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.93 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.91 -41.88 8.58 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.897 0.38 . . . . 0.0 110.734 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -143.5 140.95 18.1 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.428 179.177 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.09 -48.75 0.42 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.61 2.207 . . . . 0.0 113.241 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.7 mp0 -62.85 -45.58 91.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 111.065 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.586 HD13 HD23 ' A' ' 18' ' ' LEU . 3.9 mt -61.48 -49.84 82.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.962 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.23 -30.15 68.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.722 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -94.53 -12.87 26.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.234 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.601 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -111.75 -75.08 0.62 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.844 -178.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.881 ' CD2' HG21 ' A' ' 6' ' ' VAL . 32.8 mt -70.54 151.6 44.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.858 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -153.11 172.91 16.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.458 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -73.57 113.31 10.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.81 0.338 . . . . 0.0 111.052 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.98 27.34 2.99 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.812 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.842 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -122.09 136.45 54.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.731 0.301 . . . . 0.0 110.91 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.591 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.2 mt -105.96 118.09 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.861 HD12 HD21 ' A' ' 20' ' ' LEU . 2.9 mt -75.24 100.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 p -104.42 27.8 7.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.181 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.1 mttt -172.76 138.3 0.82 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.166 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.915 ' HB2' HD11 ' A' ' 58' ' ' LEU . 25.7 t80 -150.07 112.28 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.393 . . . . 0.0 111.237 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 55.66 51.0 13.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.69 21.51 65.15 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.367 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -124.03 101.27 7.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.575 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.4 120.93 6.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.369 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.915 HD11 ' HB2' ' A' ' 53' ' ' PHE . 14.6 mt -92.36 18.78 7.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.07 126.12 32.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.974 0.416 . . . . 0.0 111.429 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -19.67 43.5 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.069 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.6 mt -81.2 140.63 49.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.542 0.211 . . . . 0.0 111.171 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.51 -157.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.633 2.222 . . . . 0.0 112.16 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -104.45 -23.56 13.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.021 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -56.69 -49.06 76.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.06 0.457 . . . . 0.0 110.377 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.505 ' O ' HD23 ' A' ' 69' ' ' LEU . 30.7 m -71.46 -45.44 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.856 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.469 ' N ' HG23 ' A' ' 65' ' ' VAL . 91.2 m -55.0 -51.98 64.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.757 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 13.8 t80 -66.74 -30.65 70.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.656 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.73 -51.06 60.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.233 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.753 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.12 -41.44 86.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.856 0.36 . . . . 0.0 110.192 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.615 ' HB3' HG21 ' A' ' 106' ' ' VAL . 3.4 m-85 -62.58 -33.7 75.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.672 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.407 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 13.0 mtmt -79.73 -35.73 38.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.373 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.71 7.66 72.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.566 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.659 ' HB1' HG11 ' A' ' 77' ' ' VAL . . . -71.4 141.44 50.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 0.0 110.808 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -175.25 99.17 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.681 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.42 74.68 0.51 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.819 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.26 120.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 110.081 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.701 HG11 ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -132.0 107.91 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.84 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -99.75 111.88 24.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.473 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.93 128.81 55.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.397 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.87 104.74 17.29 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.782 HG11 HD22 ' A' ' 44' ' ' LEU . 1.7 m -95.05 143.16 12.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.781 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 62.0 m -108.22 127.91 54.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.205 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.11 95.44 15.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 82' ' ' THR . 52.7 Cg_exo . . . . . 0 C--N 1.343 0.265 0 C-N-CA 122.496 2.13 . . . . 0.0 112.147 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.538 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 5.2 mm100 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 121.119 0.485 . . . . 0.0 112.153 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.53 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -86.83 96.28 10.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.135 ' CH2' HG23 ' A' ' 33' ' ' ILE . 14.7 m95 -104.22 138.64 40.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 111.783 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 70' ' ' PHE . 18.6 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.113 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.748 0.309 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.23 158.23 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.804 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HG2' HG23 ' A' ' 82' ' ' THR . 16.0 mttp -151.62 129.67 11.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.746 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.774 ' CE2' HG22 ' A' ' 6' ' ' VAL . 30.1 p90 -138.29 170.87 15.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.69 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.62 136.02 48.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.043 0.449 . . . . 0.0 111.431 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.878 HG21 ' CD2' ' A' ' 44' ' ' LEU . 19.6 t -114.93 106.93 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.681 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 15.4 p-10 -110.65 127.01 55.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.894 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.687 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.87 159.27 44.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.377 . . . . 0.0 110.39 178.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.67 113.62 11.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.998 0.428 . . . . 0.0 110.941 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.837 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -97.66 151.63 19.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.431 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 8.0 mmtt -138.34 69.43 1.38 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.637 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.55 23.2 5.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.282 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.7 113.64 1.45 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.558 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -161.88 -96.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 0.0 110.985 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 19.4 mt-10 -69.41 -5.56 24.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.659 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.786 HD22 ' CD2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.6 -36.02 4.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.267 0.556 . . . . 0.0 109.583 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.553 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 25.32 62.6 0.06 OUTLIER Glycine 0 CA--C 1.52 0.352 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.999 HD12 HD21 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -138.56 91.69 2.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.166 0.508 . . . . 0.0 109.992 177.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.452 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.4 t -59.51 112.35 1.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.824 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.999 HD21 HD12 ' A' ' 18' ' ' LEU . 7.0 mt -96.21 168.3 10.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.613 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -146.6 158.33 46.66 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.335 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.35 125.07 13.37 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.475 2.117 . . . . 0.0 112.488 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.531 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -132.71 162.52 31.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.002 0.429 . . . . 0.0 111.105 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -81.63 -18.01 46.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.425 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 49' ' ' ILE . 6.5 pt -117.8 -4.61 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.706 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.83 -123.51 1.14 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.183 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 1.3 m -140.76 106.47 5.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.825 0.345 . . . . 0.0 111.575 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.4 ' OG1' HG12 ' A' ' 49' ' ' ILE . 97.0 m -69.64 137.56 52.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.039 HG21 HD12 ' A' ' 32' ' ' LEU . 22.5 mt -79.46 104.92 8.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.865 0.364 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -71.59 -28.08 63.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -160.54 169.36 23.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 111.205 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.039 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -152.42 127.24 9.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.349 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.086 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -98.19 100.47 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.296 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.53 154.37 42.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.024 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.05 -20.72 47.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.903 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 11.9 mp0 -70.74 -48.03 56.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.71 142.2 33.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.787 0.327 . . . . 0.0 110.703 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.56 -48.85 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.545 2.163 . . . . 0.0 112.901 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' LYS . 23.1 mm-40 -61.41 -50.14 74.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 111.027 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.734 HD11 HD23 ' A' ' 16' ' ' LEU . 4.1 mt -56.44 -51.45 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.142 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -59.89 -30.31 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.819 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -97.79 1.98 48.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.427 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -125.6 -72.23 0.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.779 0.323 . . . . 0.0 111.552 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.878 ' CD2' HG21 ' A' ' 6' ' ' VAL . 49.1 mt -77.51 152.91 33.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.089 0.471 . . . . 0.0 111.61 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -150.35 -175.91 5.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.503 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -81.62 95.0 7.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.048 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.34 43.09 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.799 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.579 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -138.78 145.38 40.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 110.877 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.531 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.0 OUTLIER -116.55 118.13 57.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -179.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.971 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.4 mt -74.62 100.46 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 110.83 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -100.45 26.5 6.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.724 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.8 mttt -172.61 136.16 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.905 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB2' HD11 ' A' ' 58' ' ' LEU . 61.3 t80 -142.62 109.98 5.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.219 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.57 48.71 19.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.914 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.78 76.98 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.396 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -124.71 105.61 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 0.0 110.712 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.92 121.81 10.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.316 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.918 HD11 ' HB2' ' A' ' 53' ' ' PHE . 11.4 mt -92.72 16.87 11.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.965 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.39 141.46 52.17 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.868 0.366 . . . . 0.0 111.081 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.79 29.65 55.12 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.667 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 58' ' ' LEU . 10.8 mt -115.36 135.32 22.56 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.5 0.19 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 61' ' ' LEU . 53.2 Cg_exo -54.69 -169.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.404 2.069 . . . . 0.0 112.167 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -98.39 -26.38 14.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.038 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -58.53 -46.84 85.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.032 0.444 . . . . 0.0 110.584 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.507 ' O ' HD23 ' A' ' 69' ' ' LEU . 20.3 t -66.45 -48.97 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.897 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 1.3 m -57.5 -53.75 54.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.769 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.549 ' CD1' HG12 ' A' ' 106' ' ' VAL . 38.3 t80 -58.07 -31.25 66.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.81 -51.04 24.52 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.714 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.99 -32.71 72.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 110.26 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.971 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 4.8 m-85 -72.42 -29.01 63.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.04 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 7.2 mtpt -85.15 -35.88 21.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.581 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.12 -22.7 65.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.874 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.837 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . . . -42.98 128.14 4.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.563 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -155.25 103.26 2.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 110.945 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.04 86.62 1.88 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.265 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.27 114.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 110.622 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.829 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.51 107.78 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.227 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 4.3 t -102.64 108.45 19.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.488 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.53 125.31 52.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.522 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -86.47 112.04 21.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.874 0.369 . . . . 0.0 110.216 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.847 HG11 HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -101.28 142.39 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.616 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.431 HG23 ' HG2' ' A' ' 3' ' ' LYS . 94.2 m -108.85 124.61 50.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.392 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -107.07 90.34 5.36 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.104 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--N 1.344 0.293 0 C-N-CA 122.656 2.238 . . . . 0.0 112.502 179.866 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.515 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 18.1 mm-40 . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 121.093 0.473 . . . . 0.0 112.243 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 1.8 t80 -84.8 96.13 9.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.086 ' CH2' HG23 ' A' ' 33' ' ' ILE . 25.6 m95 -102.55 132.21 48.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.316 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.549 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.4 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.178 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.797 0.332 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.01 162.44 14.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.428 ' HG2' HG23 ' A' ' 82' ' ' THR . 10.6 mttt -155.77 129.62 8.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.759 ' CE2' HG22 ' A' ' 6' ' ' VAL . 30.0 p90 -140.04 175.38 9.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.785 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.49 139.27 47.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.159 0.504 . . . . 0.0 111.84 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.889 HG21 ' CD2' ' A' ' 44' ' ' LEU . 17.5 t -120.91 107.02 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.239 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 25.8 p-10 -112.24 127.24 55.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.714 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.06 156.14 42.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.008 0.432 . . . . 0.0 110.47 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.06 114.82 9.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.014 0.435 . . . . 0.0 110.539 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.925 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -96.4 145.01 26.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.739 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 23.8 mmtt -134.99 69.32 1.45 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.32 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.43 26.58 9.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.182 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.01 112.98 0.51 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.304 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.422 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -157.11 -94.46 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.027 0.442 . . . . 0.0 111.296 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 15.3 mt-10 -68.25 -4.45 14.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.154 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.075 HD13 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -44.58 -30.12 0.85 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.548 0.213 . . . . 0.0 110.552 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 19.47 53.22 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 114.62 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.075 HD21 HD13 ' A' ' 16' ' ' LEU . 2.0 pp -135.57 103.15 5.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.945 0.402 . . . . 0.0 110.066 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.2 t -69.06 122.08 17.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.138 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.743 HD22 HD12 ' A' ' 50' ' ' ILE . 10.6 mt -105.0 159.75 15.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.63 167.72 20.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.479 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.74 135.15 21.2 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.556 2.171 . . . . 0.0 112.585 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.444 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -147.4 162.64 38.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.088 179.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -32.89 38.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.154 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.574 HG13 HG22 ' A' ' 51' ' ' THR . 2.3 pt -99.12 -7.95 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.82 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.78 -122.81 1.04 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.416 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 m -140.52 106.45 5.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.75 0.309 . . . . 0.0 111.246 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.519 ' N ' HG23 ' A' ' 49' ' ' ILE . 93.6 m -66.95 127.33 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.399 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.547 HD11 HD13 ' A' ' 44' ' ' LEU . 30.7 mt -68.93 104.75 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.683 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -71.1 -23.38 62.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.945 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -171.68 172.45 4.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.825 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.745 HD22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -163.48 131.76 3.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.986 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.173 HG23 ' CH2' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -95.53 144.14 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.597 -179.112 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -94.0 169.39 10.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.937 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.87 21.38 71.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.764 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -111.77 -33.51 6.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 110.891 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -156.25 144.91 14.69 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.15 -47.91 4.12 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.469 2.112 . . . . 0.0 112.779 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 43' ' ' LYS . 14.2 mp0 -65.77 -52.27 52.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.221 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.888 HD13 HD23 ' A' ' 18' ' ' LEU . 2.6 mt -54.91 -40.95 55.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.558 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -71.23 -30.09 65.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.153 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.56 3.71 32.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.062 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -127.47 -73.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.889 ' CD2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -60.12 148.88 34.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.884 -178.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -153.85 -175.71 5.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.539 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -92.93 116.8 29.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.51 -14.86 8.13 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.074 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.516 ' HB2' HD12 ' A' ' 29' ' ' ILE . 14.6 m-20 -85.87 158.8 19.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 111.267 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 28' ' ' THR . 1.1 mp -130.4 121.84 51.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.736 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.755 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 14.6 mt -74.26 100.63 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.034 0.445 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.574 HG22 HG13 ' A' ' 25' ' ' ILE . 7.5 p -102.4 26.88 7.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.906 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 2.8 mttt -172.7 135.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.982 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB2' HD11 ' A' ' 58' ' ' LEU . 68.0 t80 -139.34 120.83 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.93 0.395 . . . . 0.0 111.37 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.63 39.88 22.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.985 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.17 17.52 78.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.498 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -124.23 106.5 10.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 0.0 110.714 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.62 124.57 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.431 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.918 HD11 ' HB2' ' A' ' 53' ' ' PHE . 10.4 mt -94.91 23.34 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.81 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.95 144.28 38.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.091 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.89 24.01 57.29 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.695 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.703 HD12 ' HA ' ' A' ' 58' ' ' LEU . 83.3 mt -116.46 139.03 24.89 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.539 0.209 . . . . 0.0 110.803 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.95 -161.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.408 2.072 . . . . 0.0 112.17 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -106.73 -24.27 12.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -56.8 -50.65 71.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.063 0.459 . . . . 0.0 110.599 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.51 ' O ' HD23 ' A' ' 69' ' ' LEU . 16.4 m -63.21 -47.45 92.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.067 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.454 ' N ' HG23 ' A' ' 65' ' ' VAL . 63.5 m -57.5 -53.79 54.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 110.895 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.607 ' CE1' HG12 ' A' ' 106' ' ' VAL . 18.6 t80 -57.37 -31.0 65.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.715 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.23 -51.11 18.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.233 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.739 HD13 ' CD2' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.31 -32.29 72.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 110.331 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.755 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.5 m-85 -73.1 -31.32 64.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.976 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.448 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -85.11 -29.87 24.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.577 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.27 -22.45 44.5 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.855 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.925 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . . . -43.46 131.52 4.92 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.809 0.338 . . . . 0.0 111.519 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -157.06 101.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.05 85.27 1.49 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.623 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 110.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.824 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.749 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.6 108.0 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.685 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -99.25 111.29 23.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.479 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.23 124.03 46.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -88.31 107.29 18.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 110.289 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.64 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -95.29 142.94 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.443 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 92.8 m -108.45 128.4 54.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.079 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -110.54 93.43 16.37 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.208 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 82' ' ' THR . 38.8 Cg_exo . . . . . 0 C--N 1.344 0.293 0 C-N-CA 122.584 2.189 . . . . 0.0 112.218 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.502 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 29.3 mm-40 . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.906 0.384 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.518 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -80.88 96.0 6.89 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.173 ' CH2' HG23 ' A' ' 33' ' ' ILE . 54.7 m95 -100.71 138.05 38.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.698 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.607 HG12 ' CE1' ' A' ' 67' ' ' TYR . 34.4 m . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.211 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 84' ' ' PRO . 5.6 mp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.794 0.331 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 82' ' ' THR . 1.2 tp10 -60.09 162.51 5.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.824 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.9 mttt -156.19 129.52 8.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.61 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.829 ' CE2' HG22 ' A' ' 6' ' ' VAL . 35.0 p90 -136.92 173.94 11.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.791 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.8 135.87 49.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.955 0.407 . . . . 0.0 111.389 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.855 HG21 HD21 ' A' ' 44' ' ' LEU . 12.6 t -117.58 107.34 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.142 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -109.98 127.94 55.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.07 0.462 . . . . 0.0 110.9 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.66 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -159.52 153.07 22.61 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.928 179.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.94 127.14 31.67 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.529 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.959 ' HG2' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -103.79 136.58 43.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.79 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -115.45 69.6 0.73 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.94 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.93 27.61 0.74 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.398 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.77 73.07 1.13 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.281 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.591 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 29.6 ttmt -120.26 -102.82 0.41 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.571 0.224 . . . . 0.0 111.023 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 7.7 mt-10 -70.95 -6.35 37.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.959 HD13 ' HG2' ' A' ' 10' ' ' LYS . 7.7 tp -46.16 -39.13 9.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 12.33 62.99 0.01 OUTLIER Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.434 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -127.88 91.77 3.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.135 0.493 . . . . 0.0 109.798 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.821 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -52.8 119.35 4.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.844 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.642 HD21 HD13 ' A' ' 18' ' ' LEU . 53.3 mt -107.39 165.26 11.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.542 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 0.9 OUTLIER -145.19 167.68 13.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.361 179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 21' ' ' SER . 70.1 Cg_endo -75.2 135.81 19.19 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.494 2.129 . . . . 0.0 112.82 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.64 162.56 38.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.013 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.45 -28.85 41.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.183 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 pt -103.82 -2.01 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.919 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.8 -124.9 1.33 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.135 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.557 ' SG ' HD12 ' A' ' 50' ' ' ILE . 22.9 p -140.22 106.39 5.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.822 0.344 . . . . 0.0 111.078 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 84.8 m -65.45 128.85 37.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.69 104.74 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.618 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.821 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -67.11 -27.58 67.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.588 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -171.66 179.94 2.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.779 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.86 134.92 3.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.003 178.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.178 HG23 ' CH2' ' A' ' 105' ' ' TRP . 2.8 pt -95.99 119.39 43.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.79 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -72.22 175.24 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.308 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.41 -51.58 4.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.635 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -46.26 -74.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.672 0.272 . . . . 0.0 110.723 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -117.74 131.4 24.13 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.691 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.64 -42.74 8.68 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.457 2.105 . . . . 0.0 112.502 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.97 -48.45 81.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.677 HD13 HD23 ' A' ' 18' ' ' LEU . 6.0 mt -59.43 -42.33 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.567 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.27 -30.12 69.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.679 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -99.67 3.36 45.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.505 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HD3' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -125.08 -71.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.819 -179.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.855 HD21 HG21 ' A' ' 6' ' ' VAL . 10.1 mt -72.17 150.33 43.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.248 0.547 . . . . 0.0 112.156 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -153.84 149.6 27.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.248 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 -55.64 107.97 0.39 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.186 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.24 41.0 0.42 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.624 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -142.06 164.07 31.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.573 0.225 . . . . 0.0 110.619 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.6 mp -133.32 120.29 38.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.238 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.834 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.1 mt -74.59 100.65 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.045 0.45 . . . . 0.0 110.471 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 p -99.84 18.63 17.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.948 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -162.27 142.52 9.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.138 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.896 ' HB2' HD11 ' A' ' 58' ' ' LEU . 60.2 t80 -151.67 109.85 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.911 0.386 . . . . 0.0 111.1 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 51.94 55.31 9.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.01 23.35 65.79 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.358 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.91 99.72 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.804 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.46 120.57 7.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.285 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.896 HD11 ' HB2' ' A' ' 53' ' ' PHE . 5.1 mt -92.81 16.97 11.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.45 127.34 32.04 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.827 0.346 . . . . 0.0 111.142 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.65 -23.26 31.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.777 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.5 mt -79.6 148.34 69.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 111.096 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.661 ' HG2' HG23 ' A' ' 65' ' ' VAL . 40.6 Cg_endo -67.21 -168.37 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.499 2.132 . . . . 0.0 112.205 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -87.76 -28.45 21.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.618 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.73 -42.33 83.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.406 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.661 HG23 ' HG2' ' A' ' 62' ' ' PRO . 41.4 t -66.2 -53.94 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.744 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.423 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 89.4 m -56.07 -53.82 52.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.056 0.455 . . . . 0.0 110.781 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CD1' HG12 ' A' ' 106' ' ' VAL . 28.3 t80 -56.89 -30.88 64.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.18 -51.16 22.48 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.731 HD13 ' CD2' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.88 -37.18 81.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.351 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.834 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 10.1 m-85 -68.34 -32.04 71.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.955 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 2.9 mtpt -81.34 -34.4 31.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.17 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.36 -23.77 55.87 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.458 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.017 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -45.99 138.92 4.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.658 0.266 . . . . 0.0 111.301 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -170.87 97.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.038 0.447 . . . . 0.0 111.571 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.46 96.36 2.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.93 87.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.128 0.489 . . . . 0.0 110.442 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.017 HG21 ' HB1' ' A' ' 73' ' ' ALA . 3.5 t -114.4 130.72 68.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.147 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.7 t -122.82 139.62 53.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.449 ' HG2' ' CE1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -142.66 129.23 20.25 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.825 0.345 . . . . 0.0 111.675 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -91.21 108.12 19.66 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.719 HG11 HD22 ' A' ' 44' ' ' LEU . 1.9 m -95.16 142.64 13.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.837 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.414 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 45.3 m -108.65 125.33 51.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.196 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -107.68 97.63 21.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.097 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 82' ' ' THR . 50.9 Cg_exo . . . . . 0 C--N 1.345 0.346 0 C-N-CA 122.532 2.155 . . . . 0.0 112.286 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 17.9 mm-40 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.96 0.409 . . . . 0.0 112.083 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.6 t80 -76.81 95.98 4.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.178 ' CH2' HG23 ' A' ' 33' ' ' ILE . 68.4 m95 -101.71 138.14 39.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.352 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.832 ' CG2' HD23 ' A' ' 16' ' ' LEU . 16.0 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.196 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.796 0.331 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.405 ' HB3' ' CG ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -91.14 155.43 18.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.918 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 8.9 mttp -144.86 129.57 18.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.848 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.773 ' CE2' HG22 ' A' ' 6' ' ' VAL . 26.5 p90 -137.03 171.49 14.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.818 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.72 136.03 48.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.057 0.456 . . . . 0.0 111.394 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.856 HG21 ' CD2' ' A' ' 44' ' ' LEU . 16.0 t -116.26 107.33 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.551 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 12.3 t0 -110.66 127.21 55.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.027 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.714 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.53 157.72 43.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 110.481 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.31 110.21 5.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.987 0.422 . . . . 0.0 111.037 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.79 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -94.56 144.39 25.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.093 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 6.6 mmtp -130.05 69.33 1.44 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.436 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.5 20.92 6.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.274 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' CA ' ' HZ3' ' A' ' 10' ' ' LYS . . . 91.31 114.56 1.88 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -164.56 -94.29 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 111.444 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.633 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 29.1 mt-10 -69.2 -4.49 17.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.126 0.57 . . . . 0.0 112.359 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.137 HD22 HD21 ' A' ' 18' ' ' LEU . 2.5 mt -44.65 -32.13 1.38 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.482 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 30.34 59.61 0.22 Allowed Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 115.13 177.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.137 HD21 HD22 ' A' ' 16' ' ' LEU . 1.3 pp -148.11 91.83 1.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.034 0.445 . . . . 0.0 110.202 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 30' ' ' ALA . 3.0 t -65.75 117.28 7.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.549 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.583 HD11 ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -88.0 170.35 11.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.603 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.81 159.39 56.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.11 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.76 111.52 2.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.427 2.085 . . . . 0.0 112.727 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.57 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -124.24 162.51 23.54 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.718 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 25' ' ' ILE . 7.0 pt-20 -83.46 -29.06 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.349 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.57 HG13 HG22 ' A' ' 51' ' ' THR . 1.6 pt -102.09 -8.66 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.763 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.43 -123.81 1.06 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.136 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.53 105.86 5.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.906 0.384 . . . . 0.0 111.046 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.449 ' N ' HG23 ' A' ' 49' ' ' ILE . 92.3 m -68.64 128.95 38.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.179 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.041 HG21 HD12 ' A' ' 32' ' ' LEU . 40.8 mt -70.25 104.8 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.858 0.361 . . . . 0.0 110.639 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 19' ' ' SER . . . -69.86 -30.66 68.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.959 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.442 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.8 OUTLIER -158.34 173.65 16.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.413 . . . . 0.0 111.299 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.041 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -155.8 126.89 7.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.397 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.114 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.6 pt -96.9 100.38 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.972 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -69.16 155.4 40.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.075 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.0 -14.66 64.72 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.859 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.561 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 4.1 mp0 -76.83 -47.61 20.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.711 0.291 . . . . 0.0 110.717 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.633 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.4 138.96 23.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.653 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.22 -51.02 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.662 2.241 . . . . 0.0 113.012 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -58.54 -48.78 79.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.769 0.318 . . . . 0.0 111.044 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.574 HD13 HD23 ' A' ' 18' ' ' LEU . 4.6 mt -57.32 -50.44 76.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.133 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.39 -30.26 68.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.562 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -97.48 0.65 47.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.173 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.466 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.21 -73.74 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.838 0.351 . . . . 0.0 111.697 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.879 HD12 HD22 ' A' ' 18' ' ' LEU . 34.1 mt -73.29 157.29 37.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.045 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -153.94 -175.9 5.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.221 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -90.56 104.96 17.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 111.127 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.49 -8.7 3.72 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.21 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.18 160.43 15.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 111.182 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.57 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.0 OUTLIER -126.9 119.69 53.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.849 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 4.3 mt -74.57 100.6 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 110.997 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.57 HG22 HG13 ' A' ' 25' ' ' ILE . 7.7 p -101.07 22.6 12.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.735 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.2 mttt -167.54 136.54 2.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.887 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.929 ' HB2' HD11 ' A' ' 58' ' ' LEU . 56.7 t80 -142.73 111.02 6.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.93 0.395 . . . . 0.0 111.265 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 54.17 46.84 24.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.26 22.15 78.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.431 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -126.16 106.41 9.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 110.737 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.68 121.49 9.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.324 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.929 HD11 ' HB2' ' A' ' 53' ' ' PHE . 7.9 mt -94.36 21.37 7.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.752 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -78.4 143.34 36.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.955 0.407 . . . . 0.0 111.097 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.23 24.02 60.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.792 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.51 ' HB3' HG21 ' A' ' 65' ' ' VAL . 34.6 mt -116.42 138.54 24.45 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.56 0.219 . . . . 0.0 110.841 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.36 -159.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.466 2.111 . . . . 0.0 112.182 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 67' ' ' TYR . 30.4 t80 -103.06 -24.44 13.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.984 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -57.73 -48.79 78.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.46 . . . . 0.0 110.515 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 61' ' ' LEU . 18.3 m -63.96 -46.92 92.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.084 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.458 ' N ' HG23 ' A' ' 65' ' ' VAL . 1.5 m -58.8 -51.86 68.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.85 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.514 ' CZ ' ' CE2' ' A' ' 104' ' ' TYR . 10.8 t80 -58.55 -31.22 67.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.23 -51.08 22.7 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.657 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -69.06 -32.24 71.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 110.268 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.849 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 8.9 m-85 -73.76 -28.69 61.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.283 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.433 ' HG3' HG12 ' A' ' 106' ' ' VAL . 29.2 mtmt -85.02 -38.99 18.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.7 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.16 -22.27 74.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.855 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.798 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -44.16 127.87 5.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.832 0.348 . . . . 0.0 111.691 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -159.45 104.02 1.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.089 0.471 . . . . 0.0 110.756 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.96 84.35 1.64 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.072 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 114.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 0.0 110.366 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.798 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -127.38 107.61 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.406 -179.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 t -99.57 114.96 28.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.062 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.83 123.49 41.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.574 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -85.84 105.78 16.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.189 179.107 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.824 HG11 HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -96.61 142.68 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.893 -179.079 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.41 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 91.7 m -108.85 117.78 35.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.603 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.405 ' CG ' ' HB3' ' A' ' 2' ' ' GLU . 22.1 ptt180 -104.53 93.78 6.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.04 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--N 1.344 0.317 0 C-N-CA 122.512 2.141 . . . . 0.0 112.337 179.861 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.538 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 5.1 mm100 . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.122 0.487 . . . . 0.0 112.224 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.514 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -86.87 96.03 10.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.114 ' CH2' HG23 ' A' ' 33' ' ' ILE . 8.5 m95 -104.67 134.54 47.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.254 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 70' ' ' PHE . 11.7 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.139 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.61 156.34 29.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.772 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 8.9 mttt -150.93 129.58 12.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.812 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.8 p90 -137.66 170.14 16.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.68 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.65 135.87 49.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.057 0.456 . . . . 0.0 111.305 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.873 HG21 ' CD2' ' A' ' 44' ' ' LEU . 11.5 t -116.37 107.01 21.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.289 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 1.6 p30 -110.44 127.28 55.04 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.053 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.1 156.35 42.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.95 0.405 . . . . 0.0 110.663 178.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 113.45 7.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.026 0.441 . . . . 0.0 110.586 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.782 ' CE ' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -96.33 151.26 19.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.434 0.635 . . . . 0.0 111.896 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 20.2 mmtt -138.0 69.27 1.39 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.246 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 53.84 24.06 4.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.3 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.43 113.94 1.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.551 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.426 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -159.28 -97.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.765 0.317 . . . . 0.0 111.312 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.0 mm-40 -69.14 -5.78 24.5 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.161 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.809 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -45.23 -33.97 2.59 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.885 0.374 . . . . 0.0 110.497 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.568 ' HA3' HD11 ' A' ' 33' ' ' ILE . . . 26.17 62.22 0.07 OUTLIER Glycine 0 CA--C 1.522 0.483 0 N-CA-C 115.379 0.912 . . . . 0.0 115.379 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.974 HD12 HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -139.62 91.81 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.023 0.439 . . . . 0.0 110.244 177.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 1.9 t -61.74 114.28 3.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.023 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.974 HD11 HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -93.78 161.59 14.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.36 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 30' ' ' ALA . 19.3 p -136.3 164.77 40.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.577 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.56 122.0 8.48 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.773 2.316 . . . . 0.0 112.841 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.14 162.44 34.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 25' ' ' ILE . 4.8 pt-20 -80.09 -36.83 34.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.115 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.554 HD11 HD13 ' A' ' 49' ' ' ILE . 2.1 pt -94.93 -7.65 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.02 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.76 -125.18 1.27 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.366 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -140.69 106.28 5.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.882 0.372 . . . . 0.0 111.522 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' HG12 ' A' ' 49' ' ' ILE . 98.7 m -69.76 128.37 36.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.197 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.011 HG21 HD12 ' A' ' 32' ' ' LEU . 49.6 mt -64.41 104.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.855 0.359 . . . . 0.0 110.446 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.567 ' HB2' ' HB3' ' A' ' 21' ' ' SER . . . -71.96 -26.84 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.496 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 1.8 m-20 -159.47 163.96 34.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.739 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.011 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -153.68 129.14 9.9 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.113 0.482 . . . . 0.0 111.971 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.173 HG23 ' CH2' ' A' ' 105' ' ' TRP . 3.0 pt -96.17 108.92 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.083 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -82.38 128.61 34.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.079 0.466 . . . . 0.0 111.294 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.2 30.37 3.17 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.814 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -117.49 -29.89 5.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.708 0.29 . . . . 0.0 111.279 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -151.31 143.11 15.86 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.79 -47.18 2.83 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.453 2.102 . . . . 0.0 112.894 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 7.2 mm-40 -66.02 -51.53 57.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.2 mt -55.47 -46.6 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.229 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.65 -30.37 71.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.991 0.424 . . . . 0.0 110.524 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -97.46 3.52 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.229 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.66 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -128.71 -72.67 0.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.944 0.402 . . . . 0.0 111.821 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.873 ' CD2' HG21 ' A' ' 6' ' ' VAL . 26.8 mt -73.7 149.11 42.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.119 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -153.96 155.8 36.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.357 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -57.81 104.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.151 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.03 45.2 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.899 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -144.77 145.05 31.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.366 . . . . 0.0 110.888 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.554 HD13 HD11 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -112.58 117.57 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.351 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.01 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 7.0 mt -74.89 100.23 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.264 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 25' ' ' ILE . 13.9 p -93.68 -3.93 51.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.278 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -144.89 147.28 32.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.979 ' HB2' HD11 ' A' ' 58' ' ' LEU . 22.8 t80 -153.32 114.05 4.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.884 0.373 . . . . 0.0 111.323 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.42 46.36 25.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.002 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.54 24.73 76.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.353 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -124.98 102.98 7.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 110.654 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.97 114.95 1.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.457 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.979 HD11 ' HB2' ' A' ' 53' ' ' PHE . 13.2 mt -91.12 15.78 11.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.59 125.36 35.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.72 15.62 51.94 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.373 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -128.64 159.74 66.43 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.976 0.388 . . . . 0.0 111.131 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.3 -171.7 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.695 2.264 . . . . 0.0 112.524 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 12.4 t80 -94.05 -32.11 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.594 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.72 -46.6 50.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.999 0.428 . . . . 0.0 110.449 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' O ' HD23 ' A' ' 69' ' ' LEU . 24.4 m -64.26 -41.05 91.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.86 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 17.1 m -62.77 -51.77 65.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.919 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.698 ' CD1' HG12 ' A' ' 106' ' ' VAL . 37.2 t80 -58.49 -30.96 67.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.713 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.67 -50.96 31.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.665 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -70.07 -31.49 69.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.411 . . . . 0.0 110.239 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 1.01 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 3.4 m-85 -72.86 -27.61 62.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.138 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 1.8 mtpt -85.2 -43.84 13.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.794 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.28 -23.41 78.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.016 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.782 ' HB3' ' CE ' ' A' ' 10' ' ' LYS . . . -42.16 128.89 3.73 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 111.735 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -157.32 103.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.09 83.6 1.44 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.267 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.08 114.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.469 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.781 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.31 107.83 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.687 -179.056 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 t -100.35 111.98 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.501 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.9 124.02 49.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.323 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -87.13 104.66 16.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.066 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.682 HG11 HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.94 142.52 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.421 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.409 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 83.9 m -108.92 119.95 41.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.636 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -102.77 91.33 2.77 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo . . . . . 0 C--N 1.345 0.379 0 C-N-CA 122.531 2.154 . . . . 0.0 112.544 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.534 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 26.5 mm100 . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 5.7 t80 -86.85 96.47 10.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.243 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.173 ' CH2' HG23 ' A' ' 33' ' ' ILE . 9.0 m95 -106.48 137.16 44.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.698 HG12 ' CD1' ' A' ' 67' ' ' TYR . 27.5 m . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.207 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.858 0.361 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.66 156.07 25.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.532 ' HG2' HG23 ' A' ' 82' ' ' THR . 25.1 mttp -150.74 129.59 12.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.962 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.806 ' CE2' HG22 ' A' ' 6' ' ' VAL . 25.5 p90 -136.85 171.58 14.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.801 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.62 135.65 49.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.031 0.443 . . . . 0.0 111.223 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.837 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.3 t -116.11 107.28 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.361 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 14.5 p-10 -110.0 127.23 54.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.7 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.36 158.6 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.527 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.02 113.32 8.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.103 0.478 . . . . 0.0 110.913 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.887 ' HE2' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -97.51 145.59 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.425 -179.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 12.4 mmtt -131.46 69.43 1.47 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.225 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.14 23.19 5.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.3 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.12 113.48 1.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.59 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 6.6 ptpt -161.5 -94.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 9.5 mt-10 -69.47 -5.9 26.95 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.669 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.887 HD22 ' HE2' ' A' ' 10' ' ' LYS . 2.1 tp -45.8 -34.36 3.67 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.538 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 22.74 62.16 0.03 OUTLIER Glycine 0 C--N 1.331 0.262 0 CA-C-N 114.933 -1.031 . . . . 0.0 115.008 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.786 HD22 HD12 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.43 91.7 2.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 110.097 178.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 5.0 t -61.59 118.94 7.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.021 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.582 HD21 ' CD1' ' A' ' 50' ' ' ILE . 7.8 mp -100.25 159.12 15.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.359 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.905 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 56.0 m -130.41 156.71 79.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.629 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.91 111.4 2.18 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.531 2.154 . . . . 0.0 112.474 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.492 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -122.85 162.57 21.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.064 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.621 ' HG3' HG23 ' A' ' 25' ' ' ILE . 11.1 pt-20 -79.09 -31.66 44.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.189 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.621 HG23 ' HG3' ' A' ' 24' ' ' GLU . 2.8 pt -101.12 -8.3 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.969 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 170.26 -121.19 0.9 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.484 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' SER . 3.0 m -140.47 106.48 5.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 111.224 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.555 ' N ' HG23 ' A' ' 49' ' ' ILE . 97.5 m -69.69 119.96 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.561 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.94 HG21 HD12 ' A' ' 32' ' ' LEU . 52.7 mt -61.35 104.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.741 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.905 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -73.72 -29.58 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.5 OUTLIER -158.67 171.45 20.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.064 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.94 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -159.31 128.2 5.26 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.454 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.166 HG23 ' CH2' ' A' ' 105' ' ' TRP . 2.4 pt -96.47 100.69 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.274 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -69.79 145.32 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.085 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.13 -25.34 23.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.915 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.574 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 1.8 mp0 -66.71 -47.52 72.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.722 0.296 . . . . 0.0 110.858 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -136.65 140.21 31.44 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.68 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.43 -50.15 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.635 2.223 . . . . 0.0 112.924 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -59.37 -49.71 76.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 110.997 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.701 HD13 HD23 ' A' ' 18' ' ' LEU . 5.2 mt -55.85 -53.01 42.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -58.43 -30.17 66.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.6 m -97.17 0.99 49.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.338 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.37 -73.41 0.62 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 0.0 111.566 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.84 HD22 HG11 ' A' ' 81' ' ' VAL . 21.3 mt -72.81 155.59 39.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.908 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.5 -175.77 5.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.474 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -90.57 98.0 11.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.035 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.43 -18.53 1.68 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.046 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.79 162.44 21.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 111.236 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 28' ' ' THR . 1.1 mp -128.9 120.36 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.918 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.884 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.9 mt -74.48 100.22 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 110.644 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.512 HG22 HG13 ' A' ' 25' ' ' ILE . 7.5 p -94.71 -7.4 40.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -141.43 147.95 38.77 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.972 ' HB2' HD11 ' A' ' 58' ' ' LEU . 26.8 t80 -152.58 110.38 3.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 0.0 111.256 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 54.14 47.44 23.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.858 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.35 24.81 73.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.231 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -123.88 102.41 7.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 0.0 110.584 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.11 114.01 1.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.427 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.972 HD11 ' HB2' ' A' ' 53' ' ' PHE . 15.3 mt -89.83 14.39 12.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.927 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -78.39 142.97 37.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.046 0.45 . . . . 0.0 111.232 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.05 26.52 61.15 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.744 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 58' ' ' LEU . 63.0 mt -120.24 140.79 30.61 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.607 0.242 . . . . 0.0 110.96 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.67 -166.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.507 2.138 . . . . 0.0 112.168 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -101.6 -24.97 14.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.105 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -45.84 84.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.686 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' HD23 ' A' ' 69' ' ' LEU . 25.7 t -68.08 -50.48 58.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.499 ' SG ' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -55.91 -48.36 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.566 ' CD1' HG12 ' A' ' 106' ' ' VAL . 15.7 t80 -64.3 -30.98 72.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.13 -50.9 35.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.958 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.685 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.5 -35.51 79.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 110.396 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.884 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 2.6 m-85 -69.77 -28.85 66.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.217 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.405 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 21.1 mtmt -84.98 -36.52 21.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.739 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.61 -20.0 67.15 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.976 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.824 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -45.34 126.93 6.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.752 0.311 . . . . 0.0 111.532 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -154.78 103.73 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.28 85.78 1.8 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.063 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.93 116.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.456 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.824 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -131.19 107.72 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.632 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.6 t -99.41 114.3 27.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.33 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.79 125.34 48.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.478 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -86.76 103.8 15.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.928 0.394 . . . . 0.0 110.091 178.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.84 HG11 HD22 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -95.17 143.1 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.521 -179.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.532 HG23 ' HG2' ' A' ' 3' ' ' LYS . 77.7 m -108.32 116.77 32.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -102.69 89.8 1.97 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.062 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.344 0.322 0 C-N-CA 122.525 2.15 . . . . 0.0 112.213 179.904 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.507 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 14.5 mm100 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.932 0.396 . . . . 0.0 111.715 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.519 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 1.3 t80 -81.49 96.07 7.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 1.166 ' CH2' HG23 ' A' ' 33' ' ' ILE . 33.4 m95 -100.91 136.98 39.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.113 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.739 ' CG2' HD23 ' A' ' 16' ' ' LEU . 25.6 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.171 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.8 155.65 27.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HG2' HG23 ' A' ' 82' ' ' THR . 9.4 mttt -149.39 129.72 13.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.069 0.462 . . . . 0.0 110.708 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.775 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.1 p90 -138.49 169.58 17.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.688 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.58 135.88 49.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.158 0.504 . . . . 0.0 111.382 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.822 HG21 ' CD2' ' A' ' 44' ' ' LEU . 19.2 t -114.42 107.06 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.157 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 1.5 p30 -111.74 127.27 55.74 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.016 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.698 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -151.68 157.8 42.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.55 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.401 ' HB3' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -71.33 118.33 14.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 110.696 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.933 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -101.14 129.13 47.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.812 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 3.5 mmtp -119.61 68.61 0.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.166 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.9 77.33 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 48.95 100.78 0.01 OUTLIER Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.329 -0.462 . . . . 0.0 114.167 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -159.4 -101.58 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 22.3 mt-10 -69.22 -5.41 22.57 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.785 HD22 HD21 ' A' ' 18' ' ' LEU . 2.7 mt -45.5 -30.32 1.39 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.963 0.411 . . . . 0.0 109.906 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.551 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 24.81 63.05 0.05 OUTLIER Glycine 0 C--N 1.331 0.284 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.785 HD21 HD22 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -145.85 92.02 2.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.108 0.48 . . . . 0.0 110.098 178.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.5 t -63.42 120.73 12.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.175 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.461 HD21 HD12 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -100.0 158.07 16.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.585 -179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.41 163.33 51.28 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.348 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.33 117.56 5.22 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.492 2.128 . . . . 0.0 112.77 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.469 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -130.9 162.61 29.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG3' HG23 ' A' ' 25' ' ' ILE . 17.1 pt-20 -79.66 -37.26 36.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.643 HG23 ' HG3' ' A' ' 24' ' ' GLU . 2.3 pt -94.34 -6.03 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.888 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.27 -122.65 1.08 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.619 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -138.99 106.23 5.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.727 0.298 . . . . 0.0 110.924 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.439 ' N ' HG23 ' A' ' 49' ' ' ILE . 88.6 m -66.82 121.04 14.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.246 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.685 HD12 ' HB2' ' A' ' 48' ' ' ASP . 32.0 mt -62.85 104.59 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.561 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.568 ' HA ' HD22 ' A' ' 94' ' ' LEU . . . -72.1 -25.5 61.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -172.54 -178.02 1.87 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.386 0.612 . . . . 0.0 111.38 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -164.36 136.73 4.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.553 178.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.145 HG23 ' CH2' ' A' ' 105' ' ' TRP . 3.1 pt -96.0 100.32 10.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.303 0.573 . . . . 0.0 110.334 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -63.6 153.24 36.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.86 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.8 -16.15 61.46 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.703 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.2 mp0 -77.77 -50.08 13.09 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.712 0.291 . . . . 0.0 110.727 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -135.07 139.69 32.68 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.766 0.317 . . . . 0.0 110.829 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.15 -50.27 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.693 2.262 . . . . 0.0 113.05 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.7 mp0 -59.56 -49.25 78.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 110.838 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.66 HD13 HD23 ' A' ' 18' ' ' LEU . 4.2 mt -56.04 -48.22 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.92 -30.3 70.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.511 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 m -99.16 3.37 46.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.367 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -125.32 -71.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.822 ' CD2' HG21 ' A' ' 6' ' ' VAL . 14.4 mt -71.13 156.24 39.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.466 0.65 . . . . 0.0 112.498 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.71 ' HA ' HD21 ' A' ' 32' ' ' LEU . 5.2 mt-30 -153.95 -175.78 5.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.857 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -92.83 117.55 30.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.888 0.375 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.35 17.53 4.38 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.896 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.685 ' HB2' HD12 ' A' ' 29' ' ' ILE . 6.1 m-20 -115.32 167.35 10.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.783 0.291 . . . . 0.0 110.82 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.469 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.5 mp -137.01 120.61 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.014 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 9.8 mt -74.21 100.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.07 0.462 . . . . 0.0 110.567 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 25' ' ' ILE . 11.2 p -95.71 -3.71 45.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.245 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -144.52 143.96 31.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.984 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.95 ' HB2' HD11 ' A' ' 58' ' ' LEU . 32.0 t80 -150.1 111.74 4.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.954 0.407 . . . . 0.0 111.369 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.68 46.17 26.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.132 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.95 24.26 76.55 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.391 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -126.68 104.47 8.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.693 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.3 117.28 3.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.223 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.95 HD11 ' HB2' ' A' ' 53' ' ' PHE . 8.5 mt -92.8 17.67 10.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.968 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -87.21 127.72 35.15 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.891 0.376 . . . . 0.0 111.226 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.4 -23.84 28.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.791 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.24 153.81 66.25 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.998 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.01 -172.57 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.578 2.186 . . . . 0.0 112.244 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 67' ' ' TYR . 55.0 t80 -91.95 -29.18 16.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.713 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -53.96 -43.43 69.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.58 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.509 ' O ' HD23 ' A' ' 69' ' ' LEU . 10.1 p -65.28 -46.22 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.5 ' N ' HG13 ' A' ' 65' ' ' VAL . 89.4 m -60.21 -49.62 76.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.661 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.59 ' CD1' HG12 ' A' ' 106' ' ' VAL . 16.1 t80 -58.52 -31.97 68.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.599 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.01 -50.85 20.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.213 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.732 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.46 -37.02 82.29 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.473 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 1.014 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.0 m-85 -67.49 -34.02 76.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 34.9 mtmt -82.18 -29.76 31.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.28 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.85 15.93 61.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.637 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.933 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -78.12 138.14 38.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.709 0.29 . . . . 0.0 110.591 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 2.2 p30 -169.52 100.07 0.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.989 0.424 . . . . 0.0 110.785 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.17 78.32 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.961 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.36 114.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.962 0.411 . . . . 0.0 110.27 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.73 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.82 107.85 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.614 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.7 t -102.71 109.81 21.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.303 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.63 123.77 48.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.57 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tt0 -86.66 106.24 17.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 110.307 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.686 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -95.95 142.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.626 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.439 HG23 ' HG2' ' A' ' 3' ' ' LYS . 94.2 m -108.78 120.81 43.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -103.9 91.43 3.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.405 ' HD3' HD12 ' A' ' 49' ' ' ILE . 56.6 Cg_endo -70.74 -175.22 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.45 2.1 . . . . 0.0 112.325 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -67.27 158.88 80.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.36 169.14 17.65 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.521 2.147 . . . . 0.0 112.22 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 146.5 -54.73 0.54 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.571 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.3 m -96.59 125.3 40.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.995 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.08 70.71 0.8 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.477 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.04 -44.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.551 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -99.06 -44.05 6.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.74 -32.35 4.18 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.501 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.17 155.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.309 . . . . 0.0 110.923 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 30' ' ' ALA . 10.2 mp -73.28 -30.6 63.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.745 HG23 ' NE2' ' A' ' 103' ' ' GLN . 13.4 p -99.34 113.63 64.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.777 ' HG2' HD13 ' A' ' 98' ' ' LEU . 59.1 Cg_endo -72.83 -167.94 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.625 2.217 . . . . 0.0 112.198 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.63 62.84 7.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.781 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.777 HD13 ' HG2' ' A' ' 96' ' ' PRO . 1.6 mp -89.28 -71.73 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.001 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.33 -163.74 1.75 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.854 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -54.55 -55.3 30.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.821 0.343 . . . . 0.0 110.746 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -142.13 26.22 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -52.36 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.979 0.418 . . . . 0.0 110.441 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.745 ' NE2' HG23 ' A' ' 95' ' ' VAL . 17.1 mm-40 -139.13 170.66 15.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.155 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.508 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.0 t80 -79.44 96.1 5.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.145 ' CH2' HG23 ' A' ' 33' ' ' ILE . 54.3 m95 -99.3 139.83 34.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.095 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.59 HG12 ' CD1' ' A' ' 67' ' ' TYR . 10.8 m . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.125 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.736 0.303 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.15 162.21 22.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.912 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.9 mttp -154.43 129.64 9.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.816 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.714 ' CE2' HG22 ' A' ' 6' ' ' VAL . 12.7 p90 -137.71 169.73 17.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.882 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.46 135.82 49.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.002 0.429 . . . . 0.0 111.069 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.894 HG21 ' CD2' ' A' ' 44' ' ' LEU . 11.3 t -117.07 107.27 21.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.574 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 6.8 p-10 -108.56 127.15 53.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.805 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.96 155.05 40.27 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.955 0.407 . . . . 0.0 110.481 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.94 119.04 11.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.246 0.546 . . . . 0.0 110.459 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.744 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -101.89 149.79 23.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.092 -178.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 16.7 mmtt -138.55 68.94 1.38 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.182 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.09 27.16 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.425 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 96.18 116.9 3.25 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.099 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -169.75 -99.09 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 111.533 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.683 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 26.6 mt-10 -69.37 -4.77 19.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.692 HD22 ' CD2' ' A' ' 18' ' ' LEU . 4.2 mt -44.16 -37.96 3.43 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.832 0.348 . . . . 0.0 110.33 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.551 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 33.37 55.43 0.58 Allowed Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.802 -0.635 . . . . 0.0 114.146 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.731 ' CD1' HD21 ' A' ' 20' ' ' LEU . 1.1 pp -138.33 91.94 2.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.822 0.344 . . . . 0.0 110.365 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -63.07 110.37 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.577 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.731 HD21 ' CD1' ' A' ' 18' ' ' LEU . 3.3 mt -91.62 161.11 15.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.736 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.828 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 7.0 m -142.94 152.2 58.13 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.68 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.69 135.87 70.14 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.661 2.241 . . . . 0.0 112.706 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.559 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -145.3 162.68 36.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.141 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 25' ' ' ILE . 8.0 pt-20 -81.56 -19.76 41.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' A' ' 24' ' ' GLU . 5.8 pt -115.34 -4.61 11.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.753 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.79 -123.39 1.15 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.166 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' SER . 0.9 OUTLIER -140.68 106.05 5.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.774 0.321 . . . . 0.0 111.265 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.4 ' OG1' HG12 ' A' ' 49' ' ' ILE . 88.4 m -70.82 128.61 36.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.598 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.086 HG21 HD12 ' A' ' 32' ' ' LEU . 16.6 mt -71.65 104.92 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.712 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.828 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -69.84 -29.34 66.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.174 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.51 164.34 38.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.086 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -150.87 128.79 11.71 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.262 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.128 HG23 ' CH2' ' A' ' 105' ' ' TRP . 11.5 pt -104.78 100.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.347 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -72.16 159.98 33.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.086 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.56 64.72 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.125 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.555 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -81.54 -41.67 21.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.941 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.683 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -139.29 136.28 17.86 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.197 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.9 -44.46 5.4 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.622 2.214 . . . . 0.0 113.137 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 3.9 mm-40 -64.86 -52.88 54.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.66 0.267 . . . . 0.0 110.943 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.625 HD11 HD23 ' A' ' 16' ' ' LEU . 5.2 mt -54.54 -48.02 70.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.052 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -63.46 -30.21 71.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.552 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 m -97.01 3.24 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.268 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.671 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -131.62 -73.46 0.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.397 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.894 ' CD2' HG21 ' A' ' 6' ' ' VAL . 54.8 mt -72.34 149.28 44.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.077 0.465 . . . . 0.0 111.363 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.64 160.09 42.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.538 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -59.22 105.0 0.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.97 37.27 0.62 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.596 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.571 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -132.65 139.3 47.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.784 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.559 HG21 ' OD1' ' A' ' 23' ' ' ASN . 2.5 mt -110.99 117.26 54.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.977 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.971 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 15.2 mt -77.42 100.22 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.995 0.426 . . . . 0.0 110.539 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.1 p -94.63 0.33 55.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.207 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -148.53 142.05 25.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.029 179.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.99 ' HB2' HD11 ' A' ' 58' ' ' LEU . 36.3 t80 -145.68 108.43 4.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.86 0.362 . . . . 0.0 111.061 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 51.88 53.95 11.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.949 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.43 69.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.371 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -123.33 103.25 8.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.802 0.334 . . . . 0.0 110.604 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.28 113.32 1.52 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.332 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.99 HD11 ' HB2' ' A' ' 53' ' ' PHE . 15.1 mt -88.61 9.93 22.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -68.42 145.91 53.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.879 0.371 . . . . 0.0 111.085 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.96 26.11 47.47 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.633 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 58' ' ' LEU . 21.6 mt -116.73 148.12 41.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.686 0.279 . . . . 0.0 110.849 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.64 -167.38 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.551 2.167 . . . . 0.0 112.227 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.9 t80 -97.77 -26.56 14.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.767 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -57.43 -47.93 80.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.968 0.413 . . . . 0.0 110.273 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.528 ' O ' HD23 ' A' ' 69' ' ' LEU . 22.6 m -63.8 -47.03 92.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.087 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.468 ' N ' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -59.27 -53.8 54.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.699 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.553 ' CD1' HG12 ' A' ' 106' ' ' VAL . 21.8 t80 -56.02 -31.14 62.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.692 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.33 -51.08 18.76 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.652 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.74 -34.76 76.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.851 0.358 . . . . 0.0 110.356 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.971 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.8 m-85 -69.06 -34.0 74.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.466 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 7.4 mtpt -81.31 -32.83 32.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.358 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.41 -26.47 57.09 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.51 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.828 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -45.13 139.52 3.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.881 0.372 . . . . 0.0 111.412 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -167.11 99.6 0.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.741 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.72 80.12 0.84 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.819 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.19 112.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 110.158 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.828 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.42 107.96 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.752 -178.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 t -98.5 114.43 26.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.45 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.82 122.21 42.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.666 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -83.31 102.93 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.669 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -95.26 142.45 13.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.739 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 53.2 m -108.86 126.06 52.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.014 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -108.71 96.37 19.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.236 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 82' ' ' THR . 41.5 Cg_exo -56.03 -175.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.564 2.176 . . . . 0.0 112.202 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -110.76 161.25 25.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.771 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.76 169.23 18.05 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.556 2.17 . . . . 0.0 112.285 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.49 -52.91 0.29 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -91.07 -176.01 4.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.63 -28.79 7.3 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.64 28.24 16.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.591 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -91.02 -40.85 11.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.12 117.29 5.57 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.419 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.33 154.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.963 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 30' ' ' ALA . 45.9 mt -121.04 20.8 11.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.25 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.533 HG22 ' H ' ' A' ' 97' ' ' ARG . 10.4 p -146.55 128.57 7.63 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.41 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.647 ' HD2' HD21 ' A' ' 98' ' ' LEU . 89.8 Cg_endo -80.74 13.4 2.32 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.707 2.272 . . . . 0.0 112.978 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.533 ' H ' HG22 ' A' ' 95' ' ' VAL . 1.2 mpt_? 66.64 79.69 0.23 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.858 0.361 . . . . 0.0 111.146 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.647 HD21 ' HD2' ' A' ' 96' ' ' PRO . 1.6 mm? -93.23 -64.97 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.117 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.28 -163.24 1.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.237 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.46 ' O ' ' CD ' ' A' ' 101' ' ' ARG . 0.1 OUTLIER -66.88 72.73 0.09 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.288 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.599 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER 62.7 -49.32 0.19 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.599 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 1.5 p30 20.16 86.89 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.901 0.48 . . . . 0.0 112.164 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 101' ' ' ARG . 6.9 mm-40 -145.36 179.1 7.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.086 0.47 . . . . 0.0 111.852 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.525 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.6 t80 -83.18 96.09 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.128 ' CH2' HG23 ' A' ' 33' ' ' ILE . 27.7 m95 -103.39 126.52 50.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.046 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.553 HG12 ' CD1' ' A' ' 67' ' ' TYR . 8.6 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.079 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.822 0.344 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.27 157.13 38.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.699 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 4.5 mttt -151.43 129.68 11.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.973 0.416 . . . . 0.0 110.992 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.798 ' CE2' HG22 ' A' ' 6' ' ' VAL . 26.9 p90 -138.13 170.71 15.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.694 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.56 135.95 48.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.01 0.433 . . . . 0.0 111.349 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.893 HG21 ' CD2' ' A' ' 44' ' ' LEU . 13.3 t -116.77 107.04 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.604 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 38.9 t0 -110.29 127.22 54.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.908 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.708 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.92 157.57 43.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.57 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.02 110.05 5.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.962 0.41 . . . . 0.0 110.889 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.803 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -95.18 150.91 19.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.324 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 20.5 mmtt -138.45 69.28 1.38 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.5 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.4 22.25 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.253 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.29 113.97 1.38 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -162.28 -94.23 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.963 0.411 . . . . 0.0 111.351 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 15.1 mt-10 -69.15 -5.07 20.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.979 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.625 HD21 HD21 ' A' ' 8' ' ' LEU . 2.7 mt -45.09 -40.7 7.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.138 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.521 ' HA2' HD11 ' A' ' 33' ' ' ILE . . . 34.24 53.08 0.73 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 114.485 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.779 HD12 HD11 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -136.88 92.88 2.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.035 0.445 . . . . 0.0 110.232 178.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.529 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 6.0 t -63.92 122.33 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.05 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.779 HD11 HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -100.98 169.33 9.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.438 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.22 167.72 13.82 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.358 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.43 121.63 6.92 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.489 2.126 . . . . 0.0 112.59 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.437 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -133.67 162.52 31.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.03 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.537 ' HG3' HG23 ' A' ' 25' ' ' ILE . 10.7 pt-20 -79.32 -32.84 43.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.537 HG23 ' HG3' ' A' ' 24' ' ' GLU . 3.6 pt -99.81 -7.09 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.867 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.27 -123.57 1.12 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.243 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -140.55 106.2 5.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.93 0.395 . . . . 0.0 111.195 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.6 m -66.63 132.08 47.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.548 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.928 HG21 HD12 ' A' ' 32' ' ' LEU . 43.3 mt -68.58 104.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.903 0.382 . . . . 0.0 110.583 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.529 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -68.19 -23.38 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.223 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 5.5 m-20 -171.83 174.38 4.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.995 0.426 . . . . 0.0 111.13 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.928 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -152.05 127.28 9.85 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.535 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.067 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.0 pt -101.32 100.59 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.212 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -65.91 173.85 2.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.822 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.44 18.93 72.16 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.608 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -111.25 -46.28 3.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.767 0.318 . . . . 0.0 110.289 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -142.75 139.61 17.36 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.368 179.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.5 -49.36 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 113.085 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 43' ' ' LYS . 30.4 mm-40 -61.12 -51.48 68.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.541 HD11 HD23 ' A' ' 16' ' ' LEU . 6.1 mt -54.17 -50.89 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.056 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.41 -30.21 69.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.562 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 m -96.92 2.48 51.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.255 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.606 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.56 -73.58 0.58 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.867 0.365 . . . . 0.0 111.759 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.893 ' CD2' HG21 ' A' ' 6' ' ' VAL . 54.0 mt -72.16 149.52 44.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.006 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -147.4 -175.8 4.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.487 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -87.16 115.04 24.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.09 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.23 31.84 1.78 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.705 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.53 162.63 25.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.649 0.261 . . . . 0.0 110.748 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.437 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.2 mp -133.18 119.21 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.062 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.004 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.7 mt -74.5 100.49 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 110.51 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -93.94 -4.53 49.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.154 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.433 ' CB ' ' HB2' ' A' ' 80' ' ' GLU . 2.0 mttt -144.56 144.29 31.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.968 ' HB2' HD11 ' A' ' 58' ' ' LEU . 51.3 t80 -149.01 110.89 4.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.917 0.389 . . . . 0.0 111.194 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.83 46.05 23.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.75 21.46 76.51 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.47 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -123.62 107.32 11.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.779 0.323 . . . . 0.0 110.758 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.55 118.57 4.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.318 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.968 HD11 ' HB2' ' A' ' 53' ' ' PHE . 12.4 mt -92.6 16.93 11.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.32 144.76 42.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.965 0.412 . . . . 0.0 111.195 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.19 20.53 58.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.695 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 58' ' ' LEU . 81.0 mt -115.4 137.73 23.26 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.54 0.21 . . . . 0.0 110.85 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.45 -160.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.421 2.081 . . . . 0.0 112.1 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -103.32 -24.96 13.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -56.01 -47.81 77.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.562 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.505 ' O ' HD23 ' A' ' 69' ' ' LEU . 26.8 m -67.44 -45.63 85.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.817 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.493 ' N ' HG23 ' A' ' 65' ' ' VAL . 15.8 m -56.56 -48.4 77.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.665 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 22.0 t80 -64.75 -30.89 71.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.747 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.45 -50.9 41.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.125 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -68.73 -35.33 76.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.938 0.399 . . . . 0.0 110.444 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 1.004 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 6.3 m-85 -70.31 -27.38 64.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.299 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HG3' HG12 ' A' ' 106' ' ' VAL . 1.5 mtmp? -84.12 -41.68 16.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.14 -22.46 76.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.845 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.803 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . . . -43.26 127.12 4.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.876 0.37 . . . . 0.0 111.698 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -156.05 104.21 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.87 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.44 85.39 1.76 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.271 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.36 115.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 110.357 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.794 HG11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -129.84 107.81 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.648 -179.023 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -99.92 112.86 25.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.314 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.4 124.48 47.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.434 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tt0 -86.87 104.53 16.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.928 0.394 . . . . 0.0 110.047 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.806 HG11 HD22 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -95.17 143.05 12.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.522 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.415 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 98.0 m -108.42 120.17 41.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.638 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -103.5 92.52 4.12 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.39 -176.17 1.83 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.505 2.137 . . . . 0.0 112.222 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.0 pttt -126.01 153.42 73.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.26 160.46 49.74 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.529 2.153 . . . . 0.0 112.409 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.99 -55.01 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.531 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 t -88.79 -41.98 12.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.345 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.97 162.15 11.04 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.43 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.43 57.54 1.27 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.504 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.1 t -102.43 26.25 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.92 -166.2 19.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.415 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.02 169.82 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 110.83 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.38 -34.55 18.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.949 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.407 HG23 ' HD2' ' A' ' 96' ' ' PRO . 10.3 p -72.19 138.94 81.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.833 ' HG2' HD13 ' A' ' 98' ' ' LEU . 69.1 Cg_endo -85.32 28.43 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.701 2.268 . . . . 0.0 113.142 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 57.84 56.22 4.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.899 0.38 . . . . 0.0 111.313 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.833 HD13 ' HG2' ' A' ' 96' ' ' PRO . 3.0 mp -93.21 -58.56 2.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.21 -165.0 2.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -52.88 -79.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.275 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.418 ' CB ' HG22 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -162.08 80.22 0.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.1 0.476 . . . . 0.0 111.345 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -100.77 29.4 4.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.146 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.519 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 10.9 mm-40 -68.59 -177.51 0.96 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.449 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.523 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 2.6 t80 -86.82 96.46 10.21 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.056 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.067 ' CH2' HG23 ' A' ' 33' ' ' ILE . 18.1 m95 -103.34 139.32 38.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.575 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.52 HG23 HD12 ' A' ' 16' ' ' LEU . 11.4 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.111 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 84' ' ' PRO . 10.4 mt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.695 0.283 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -77.54 157.54 30.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.985 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' HG2' HG23 ' A' ' 82' ' ' THR . 10.2 mttt -154.87 129.71 9.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.666 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.857 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.0 p90 -138.44 171.85 13.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.194 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.57 135.99 48.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.96 0.409 . . . . 0.0 111.256 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.912 HG21 ' CD2' ' A' ' 44' ' ' LEU . 3.5 t -120.19 107.71 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.827 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.581 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 11.9 p30 -108.5 127.18 53.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.718 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.713 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -145.56 154.49 42.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.931 0.395 . . . . 0.0 110.553 179.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.2 111.92 4.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.059 0.457 . . . . 0.0 110.691 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.857 ' HE2' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -97.4 148.47 23.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.675 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.423 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 21.5 mmtt -138.12 69.29 1.39 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.278 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.71 27.69 9.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.184 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.66 111.52 0.56 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' CG ' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.64 -96.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 111.263 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 36' ' ' GLN . 3.6 mt-10 -67.31 -5.73 15.53 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.032 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.857 HD22 ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -46.1 -43.46 14.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.768 0.318 . . . . 0.0 110.445 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.727 ' CA ' HD11 ' A' ' 33' ' ' ILE . . . 33.46 61.82 0.43 Allowed Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 114.611 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.589 HD12 HD21 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -141.96 104.19 4.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.933 0.397 . . . . 0.0 110.375 178.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 t -71.55 119.39 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.148 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.589 HD21 HD12 ' A' ' 18' ' ' LEU . 76.4 mt -108.86 169.17 8.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.551 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -148.16 167.79 12.53 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.529 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.56 135.89 32.09 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.502 2.135 . . . . 0.0 112.747 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.49 162.53 36.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.603 ' HG3' HG23 ' A' ' 25' ' ' ILE . 12.6 pt-20 -79.07 -21.53 46.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.226 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.603 HG23 ' HG3' ' A' ' 24' ' ' GLU . 5.5 pt -114.81 5.38 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.713 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.95 -123.74 1.41 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.129 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 21' ' ' SER . 1.9 p -140.47 109.05 5.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.922 0.392 . . . . 0.0 111.155 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.499 ' N ' HG23 ' A' ' 49' ' ' ILE . 53.2 m -72.04 136.9 46.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.04 HG21 HD12 ' A' ' 32' ' ' LEU . 51.2 mt -73.58 104.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.625 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.676 ' HA ' HD13 ' A' ' 94' ' ' LEU . . . -69.1 -28.83 66.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 3.4 m-20 -161.3 168.37 24.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.04 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -151.28 126.76 10.07 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.244 0.545 . . . . 0.0 111.967 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.101 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -96.4 100.72 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.224 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -73.67 136.67 43.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.037 0.446 . . . . 0.0 111.368 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.65 32.98 4.59 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.743 ' HG3' ' O ' ' A' ' 33' ' ' ILE . 1.1 pp0? -122.72 -21.9 5.5 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -161.19 143.86 9.34 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.106 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.04 -48.42 2.76 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.483 2.122 . . . . 0.0 112.915 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 52.6 mm-40 -67.62 -53.26 29.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 110.838 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.3 mt -54.7 -40.38 51.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.414 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.97 -30.66 65.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.806 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -98.17 3.64 49.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.163 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.577 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.34 -72.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.959 0.409 . . . . 0.0 111.571 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.912 ' CD2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -59.0 149.42 27.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.669 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -153.94 146.81 24.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.58 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -59.54 112.43 1.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.67 38.16 0.93 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.585 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.49 155.01 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 110.821 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 28' ' ' THR . 1.1 mp -124.62 119.42 56.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.983 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.98 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.3 mt -74.57 100.52 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.104 0.478 . . . . 0.0 110.338 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 p -97.36 26.81 4.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.924 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' CB ' ' HB2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -172.71 144.36 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.091 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.899 ' HB2' HD11 ' A' ' 58' ' ' LEU . 64.3 t80 -151.54 108.5 3.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 111.066 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 53.22 52.55 13.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.792 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.93 20.91 71.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.428 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -122.56 103.94 9.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.839 0.352 . . . . 0.0 110.766 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.43 115.58 2.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.276 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 53' ' ' PHE . 13.7 mt -87.64 7.85 27.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -67.74 146.13 54.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.841 0.353 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.73 23.66 55.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.666 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 58' ' ' LEU . 38.9 mt -116.84 149.13 43.49 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.653 0.263 . . . . 0.0 110.896 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.475 ' HG2' HG23 ' A' ' 65' ' ' VAL . 45.3 Cg_endo -68.38 -169.22 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.553 2.169 . . . . 0.0 112.299 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 67' ' ' TYR . 11.3 t80 -96.97 -26.43 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.785 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -57.08 -46.33 82.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.414 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.557 HG12 HD23 ' A' ' 69' ' ' LEU . 28.9 t -68.4 -47.03 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.763 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 88.3 m -56.54 -53.74 54.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.586 ' CE1' HG13 ' A' ' 106' ' ' VAL . 6.2 t80 -60.95 -30.98 70.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.671 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.05 36.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.125 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.722 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -69.55 -33.4 72.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.235 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.98 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.6 m-85 -72.15 -27.26 62.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.299 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HG3' HG12 ' A' ' 106' ' ' VAL . 18.0 mtmt -85.22 -37.74 19.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.701 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.52 -19.39 68.72 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.056 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HB3' ' CE ' ' A' ' 10' ' ' LYS . . . -44.18 131.28 6.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.711 0.291 . . . . 0.0 111.676 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -157.2 102.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.2 82.8 1.3 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.307 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.29 115.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.882 0.373 . . . . 0.0 110.509 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.807 HG11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.78 107.95 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.964 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -98.89 116.02 30.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.195 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.54 128.43 52.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.303 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -88.77 105.46 17.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 0.0 110.252 179.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.676 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -95.14 142.86 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.249 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.483 HG23 ' HG2' ' A' ' 3' ' ' LYS . 95.9 m -108.51 119.61 40.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.608 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.99 89.89 1.76 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.044 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.567 ' HA ' HD22 ' A' ' 1' ' ' LEU . 38.3 Cg_endo -66.55 -175.71 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.445 2.096 . . . . 0.0 112.075 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -106.19 157.65 34.39 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.025 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.85 -174.02 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.561 2.174 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.32 -36.81 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.534 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.9 t -107.09 -174.14 2.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 0.0 110.902 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.5 76.85 1.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.454 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.12 93.57 1.55 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.485 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.5 p -100.03 26.21 6.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.51 -126.45 0.87 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.496 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.38 -174.58 4.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.322 . . . . 0.0 110.85 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.676 HD13 ' HA ' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -70.66 -11.27 60.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.428 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 95' ' ' VAL . 14.5 p -98.48 120.56 59.0 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.107 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.824 ' HG2' HD13 ' A' ' 98' ' ' LEU . 56.3 Cg_endo -71.63 -168.37 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.439 2.093 . . . . 0.0 112.221 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -80.68 60.29 3.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.1 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.824 HD13 ' HG2' ' A' ' 96' ' ' PRO . 3.5 mp -93.11 -71.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.971 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.43 -164.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.568 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -64.25 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 110.581 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.796 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.5 mpt_? -140.38 -79.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.82 28.04 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 110.838 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.516 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 15.2 mm100 -82.64 -177.33 6.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.167 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 1.1 t80 -84.74 96.23 9.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.053 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.101 ' CH2' HG23 ' A' ' 33' ' ' ILE . 18.7 m95 -105.94 135.37 47.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.183 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.586 HG13 ' CE1' ' A' ' 67' ' ' TYR . 16.0 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.503 HD23 ' HG3' ' A' ' 84' ' ' PRO . 1.1 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.707 0.289 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.411 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 2.4 tp10 -79.81 159.46 26.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 11.0 mttt -146.18 129.43 16.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.682 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.667 ' CE2' HG22 ' A' ' 6' ' ' VAL . 12.6 p90 -137.07 169.25 18.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.055 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -108.57 135.92 49.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.316 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.699 HG21 ' CD2' ' A' ' 44' ' ' LEU . 17.0 t -115.56 107.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.471 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 12.4 t0 -112.69 127.28 56.08 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.675 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -153.63 157.84 40.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 110.735 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.67 123.62 20.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.118 0.485 . . . . 0.0 111.005 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.936 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -108.02 128.37 54.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.297 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 4.1 mmtp -118.36 68.52 0.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.892 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.76 78.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.262 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.426 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 46.91 99.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.276 -0.42 . . . . 0.0 114.018 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.453 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 6.3 ptpt -157.06 -99.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 16.6 mt-10 -69.15 -5.3 21.57 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.739 HD22 HD21 ' A' ' 18' ' ' LEU . 3.0 mt -45.48 -30.61 1.46 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.063 0.458 . . . . 0.0 109.803 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.567 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 24.79 62.41 0.05 OUTLIER Glycine 0 CA--C 1.519 0.314 0 N-CA-C 115.453 0.941 . . . . 0.0 115.453 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.777 HD22 ' CD1' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -146.33 91.83 2.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.175 0.512 . . . . 0.0 110.252 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 1.7 t -60.17 115.22 3.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.675 HD13 ' SG ' ' A' ' 27' ' ' CYS . 62.7 mt -97.37 163.75 12.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.313 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -141.43 166.85 19.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.488 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.47 130.05 16.69 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.351 2.034 . . . . 0.0 112.682 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.496 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -141.01 162.4 35.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -26.59 37.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.299 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.543 HD11 HD13 ' A' ' 49' ' ' ILE . 3.2 pt -106.84 -7.04 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.826 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.64 -125.14 1.24 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.854 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.675 ' SG ' HD13 ' A' ' 20' ' ' LEU . 25.2 p -140.61 106.07 5.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.906 0.384 . . . . 0.0 111.162 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.408 ' OG1' HG12 ' A' ' 49' ' ' ILE . 87.8 m -66.03 134.44 52.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.458 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.048 HG21 HD12 ' A' ' 32' ' ' LEU . 45.8 mt -75.88 104.88 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.559 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.43 -26.77 63.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.989 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.786 ' OD1' HG22 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -161.01 169.8 21.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.046 0.451 . . . . 0.0 111.221 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.048 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -154.25 124.68 6.98 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.267 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.09 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.1 pt -96.43 100.49 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.194 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -68.9 153.59 43.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.981 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.37 -23.02 36.78 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.787 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.9 mp0 -67.63 -46.74 71.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.77 0.319 . . . . 0.0 110.811 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -138.24 141.82 33.17 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.477 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.19 -49.04 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.522 2.148 . . . . 0.0 112.96 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 26.9 mm-40 -62.3 -50.95 69.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.338 . . . . 0.0 110.962 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.668 HD13 HD23 ' A' ' 18' ' ' LEU . 4.4 mt -54.47 -50.1 60.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.243 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -60.96 -30.48 70.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.565 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -97.98 3.41 49.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.149 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HD3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.79 -72.99 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.918 0.389 . . . . 0.0 111.625 -178.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.777 ' CD1' HD22 ' A' ' 18' ' ' LEU . 87.3 mt -75.8 145.76 40.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.744 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.67 163.53 38.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.473 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -59.41 110.88 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.92 0.39 . . . . 0.0 110.991 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.67 46.89 0.55 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.682 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.435 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -144.03 139.43 28.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 110.711 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.543 HD13 HD11 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -112.47 117.59 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.23 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.786 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.0 mt -76.85 100.69 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 0.0 110.601 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.52 HG22 HG13 ' A' ' 25' ' ' ILE . 8.7 p -98.18 16.0 22.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.164 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 7.2 mttt -162.42 132.68 4.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.003 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.941 ' HB2' HD11 ' A' ' 58' ' ' LEU . 58.3 t80 -136.78 108.76 7.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 111.067 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 55.27 52.93 10.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.851 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.62 17.51 66.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.358 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -121.01 103.4 9.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 110.634 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . . . -55.49 120.38 7.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.436 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.941 HD11 ' HB2' ' A' ' 53' ' ' PHE . 9.5 mt -92.82 18.11 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.807 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -73.77 142.83 46.22 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.948 0.404 . . . . 0.0 111.312 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.77 18.22 52.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.753 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 58' ' ' LEU . 50.9 mt -109.69 137.85 20.49 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.701 0.251 . . . . 0.0 110.826 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.72 -159.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.302 2.001 . . . . 0.0 112.148 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -106.0 -23.7 12.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.016 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -54.98 -48.8 72.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.3 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.507 ' O ' HD23 ' A' ' 69' ' ' LEU . 30.8 m -68.47 -44.36 83.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.823 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.461 ' N ' HG23 ' A' ' 65' ' ' VAL . 1.5 m -55.95 -54.05 49.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.729 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.548 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 5.1 t80 -62.13 -30.97 71.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.926 0.393 . . . . 0.0 110.437 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.63 -51.13 37.72 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.712 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.37 -42.27 83.72 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.361 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.786 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 11.4 m-85 -63.33 -31.13 72.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 25.9 mtmt -83.03 -31.95 27.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.037 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.407 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -88.83 11.04 70.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.734 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.936 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -76.8 136.93 38.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.663 0.268 . . . . 0.0 110.484 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 2.2 p30 -168.13 100.72 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.144 0.497 . . . . 0.0 110.886 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.91 77.68 0.74 Allowed Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.919 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.08 115.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.141 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.75 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.22 107.66 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.727 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 t -99.5 115.15 28.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.46 120.89 35.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -81.83 111.24 17.87 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.681 HG11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.69 142.28 17.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.95 -178.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.7 m -109.06 118.39 36.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.289 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -107.96 97.23 20.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.139 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HG3' HD23 ' A' ' 1' ' ' LEU . 63.0 Cg_exo -50.8 162.1 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.55 2.166 . . . . 0.0 112.383 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 154.49 93.7 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.905 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.75 -175.65 0.79 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.564 2.176 . . . . 0.0 112.255 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.44 -69.89 2.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.445 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.46 143.37 34.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.37 . . . . 0.0 110.861 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.91 -67.4 0.55 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.564 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -138.75 100.12 0.28 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.431 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.0 t -74.94 -39.38 61.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 110.961 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.35 -174.68 19.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.9 p -88.18 177.84 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.755 0.312 . . . . 0.0 110.838 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.65 23.96 13.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.786 HG22 ' OD1' ' A' ' 31' ' ' ASP . 10.7 t -123.99 135.66 26.59 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.906 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.767 ' HG2' HD13 ' A' ' 98' ' ' LEU . 61.9 Cg_endo -88.33 25.66 0.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.831 2.354 . . . . 0.0 113.0 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.64 53.22 13.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.184 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.767 HD13 ' HG2' ' A' ' 96' ' ' PRO . 5.6 mp -93.22 -71.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.229 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 mt -138.91 -169.56 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.061 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -71.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.349 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.508 ' HD3' HG22 ' A' ' 33' ' ' ILE . 2.2 mpt_? -164.3 78.19 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.155 0.503 . . . . 0.0 111.326 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -101.22 27.41 6.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.096 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.5 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.4 mm-40 -66.22 -177.66 0.55 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.432 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.548 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.5 t80 -85.03 96.18 9.32 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.09 ' CH2' HG23 ' A' ' 33' ' ' ILE . 20.0 m95 -104.14 132.05 50.8 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.197 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 70' ' ' PHE . 20.4 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.131 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.844 0.354 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.88 154.07 23.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.636 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -147.75 129.65 15.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.042 0.448 . . . . 0.0 110.929 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.762 ' CE2' HG22 ' A' ' 6' ' ' VAL . 29.6 p90 -138.23 172.09 13.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.666 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.01 136.02 49.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.011 0.434 . . . . 0.0 111.813 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.793 HG21 ' CD2' ' A' ' 44' ' ' LEU . 15.9 t -116.3 107.28 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.124 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.591 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.6 p30 -114.44 127.4 55.81 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.779 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -155.28 160.95 41.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.753 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.49 127.63 33.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.171 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.803 ' CE ' HD13 ' A' ' 16' ' ' LEU . 4.2 tmtt? -112.5 136.97 51.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.26 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HB2' ' HG2' ' A' ' 14' ' ' LYS . 13.2 mmtt -131.07 68.92 1.48 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.59 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.405 ' H ' ' HB3' ' A' ' 74' ' ' ASN . . . 34.56 82.94 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.387 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.33 57.66 8.99 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.632 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.464 ' HG2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -98.48 -138.41 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.862 0.363 . . . . 0.0 111.198 -179.033 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.0 mt-10 -69.19 -4.54 18.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.803 HD13 ' CE ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -44.68 -44.2 8.91 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.286 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.649 ' HA3' HD11 ' A' ' 33' ' ' ILE . . . 23.86 68.05 0.03 OUTLIER Glycine 0 CA--C 1.518 0.25 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.592 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.689 HD21 ' HG ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -133.1 92.91 3.09 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.049 0.452 . . . . 0.0 109.895 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.8 t -56.48 113.73 1.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.179 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.431 HD21 HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -94.26 166.82 11.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.259 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.748 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 1.2 m -143.32 157.49 59.72 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.92 127.0 16.86 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.427 2.085 . . . . 0.0 112.574 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.455 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -139.7 162.59 34.75 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.823 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -81.35 -26.58 35.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.392 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.463 HG13 HG22 ' A' ' 51' ' ' THR . 2.9 pt -106.57 -8.41 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.895 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.74 -125.05 1.18 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.125 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -140.6 105.96 5.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.916 0.389 . . . . 0.0 111.189 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.405 ' OG1' HG12 ' A' ' 49' ' ' ILE . 85.0 m -67.33 126.91 30.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.516 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.098 HG21 HD12 ' A' ' 32' ' ' LEU . 24.5 mt -69.02 104.91 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.797 0.332 . . . . 0.0 110.685 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.748 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -68.15 -29.0 67.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.423 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 15.3 m-20 -163.88 167.25 20.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.015 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.098 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -149.73 132.74 16.19 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.349 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.124 HG23 ' CH2' ' A' ' 105' ' ' TRP . 4.3 pt -99.03 100.62 10.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.623 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -70.52 166.19 21.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.931 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.73 -0.39 88.28 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.009 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.533 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.32 -44.19 7.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.77 0.319 . . . . 0.0 110.453 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -139.59 139.6 22.74 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.998 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.53 -48.83 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.544 2.163 . . . . 0.0 112.834 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 43' ' ' LYS . 75.6 mm-40 -59.58 -51.23 70.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.654 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.572 HG22 HD21 ' A' ' 32' ' ' LEU . 6.2 mt -57.98 -44.54 87.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.972 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.87 -30.34 71.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.059 0.457 . . . . 0.0 110.218 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 m -99.96 3.41 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.074 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.495 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -126.32 -74.6 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.43 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.849 HD22 HG11 ' A' ' 81' ' ' VAL . 46.9 mt -76.41 151.88 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.582 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.86 -175.88 5.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.391 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -80.98 109.41 15.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.726 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.35 27.29 2.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.689 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.681 ' HB2' HD12 ' A' ' 29' ' ' ILE . 1.7 m-20 -121.2 139.28 53.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 110.681 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.455 HG21 ' OD1' ' A' ' 23' ' ' ASN . 2.0 mt -112.31 117.65 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.16 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.988 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.9 mt -75.6 100.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.398 . . . . 0.0 110.683 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.463 HG22 HG13 ' A' ' 25' ' ' ILE . 8.3 p -97.76 6.33 48.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.376 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -152.67 139.38 18.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.931 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.938 ' HB2' HD11 ' A' ' 58' ' ' LEU . 28.8 t80 -149.08 111.76 4.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.012 0.434 . . . . 0.0 111.217 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 55.62 48.9 17.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.71 23.03 68.69 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.321 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -125.4 98.03 5.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.889 0.376 . . . . 0.0 110.473 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.87 120.27 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.369 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.938 HD11 ' HB2' ' A' ' 53' ' ' PHE . 7.4 mt -92.37 19.87 6.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.977 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -77.02 143.28 39.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.919 0.39 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.33 24.51 61.43 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.732 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 58' ' ' LEU . 26.4 mt -116.21 144.42 32.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.576 0.227 . . . . 0.0 110.906 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.84 -170.62 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.466 2.111 . . . . 0.0 111.902 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -93.43 -26.4 17.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.972 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -43.42 88.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 0.0 110.528 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.543 ' O ' HD23 ' A' ' 69' ' ' LEU . 11.1 p -71.22 -47.13 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.998 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.505 ' N ' HG13 ' A' ' 65' ' ' VAL . 94.4 m -58.59 -53.81 54.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 110.567 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.541 ' CZ ' ' CZ ' ' A' ' 104' ' ' TYR . 73.2 t80 -61.32 -30.7 70.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.679 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.03 -51.25 41.08 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.44 -41.11 85.27 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.259 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.988 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.7 m-85 -61.64 -35.23 77.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.497 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 2.3 mtpt -78.36 -34.06 48.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.065 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.404 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -83.92 8.67 65.57 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.601 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.698 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -74.84 137.76 42.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.768 0.318 . . . . 0.0 110.558 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.405 ' HB3' ' H ' ' A' ' 12' ' ' ALA . 4.8 p30 -176.41 85.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.078 0.466 . . . . 0.0 110.746 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.2 71.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.183 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.43 96.5 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.011 0.434 . . . . 0.0 110.711 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.698 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -101.12 150.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.373 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.2 t -140.68 117.93 11.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.484 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.0 124.77 38.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -88.25 105.2 17.39 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.849 HG11 HD22 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -95.12 142.76 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.15 -178.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 m -108.57 118.98 38.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.414 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -102.82 94.04 4.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.201 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.45 -175.08 1.64 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.475 2.117 . . . . 0.0 112.107 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -75.77 155.73 84.93 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.98 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.79 168.92 17.27 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.601 2.2 . . . . 0.0 112.322 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.12 -136.2 3.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.507 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.2 m -62.59 97.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 0.0 110.943 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.07 -178.74 21.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.515 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.85 -101.54 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -64.11 -32.83 74.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.834 0.349 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.09 52.89 10.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.511 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 m -59.32 165.74 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 30' ' ' ALA . 1.1 mp -98.18 -32.72 11.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.9 t -109.27 130.61 22.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.328 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.876 ' HG2' HD13 ' A' ' 98' ' ' LEU . 53.1 Cg_endo -68.33 -162.45 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.457 2.105 . . . . 0.0 111.443 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.53 55.09 3.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.015 0.436 . . . . 0.0 110.557 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.876 HD13 ' HG2' ' A' ' 96' ' ' PRO . 1.9 mp -81.46 -71.56 0.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.01 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.488 HD23 ' HD3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -118.73 -166.95 1.3 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.691 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.488 ' HD3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -72.13 -47.38 51.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.903 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.593 ' HG3' ' CG2' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -177.59 27.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.402 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.438 ' OD1' HD22 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -53.24 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.29 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.517 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 7.2 mm-40 -137.43 171.35 14.59 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.541 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.0 t80 -81.03 96.05 7.01 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.124 ' CH2' HG23 ' A' ' 33' ' ' ILE . 47.3 m95 -99.21 143.6 29.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.51 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' A' ' 70' ' ' PHE . 20.4 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.24 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.766 0.317 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.77 159.04 30.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.864 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.407 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 9.7 mttt -153.68 129.57 10.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.811 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.9 p90 -138.17 170.7 15.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.748 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.58 135.78 49.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.977 0.417 . . . . 0.0 111.366 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.811 HG22 ' CE2' ' A' ' 4' ' ' PHE . 14.3 t -116.6 106.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.213 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 9.0 p-10 -113.82 127.07 55.85 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.085 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.695 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -154.05 156.26 37.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 110.742 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.18 117.32 8.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.067 0.46 . . . . 0.0 111.151 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.808 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -101.47 142.0 33.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.132 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HB2' ' NZ ' ' A' ' 14' ' ' LYS . 4.7 mmtp -126.95 69.49 1.27 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.533 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.73 21.49 5.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.34 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.85 113.01 1.45 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.777 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -163.07 -93.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.893 0.378 . . . . 0.0 110.925 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 25.0 mt-10 -69.44 -4.96 20.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.674 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.872 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -44.97 -31.6 1.34 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.114 0.483 . . . . 0.0 109.94 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.543 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 28.39 61.82 0.12 Allowed Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.514 -0.766 . . . . 0.0 114.618 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -142.48 91.96 2.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.898 0.38 . . . . 0.0 110.273 178.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -67.92 109.33 3.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.424 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.607 HD11 HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -84.5 163.18 19.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.773 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.71 160.01 68.14 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.031 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.33 120.66 7.13 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.518 2.145 . . . . 0.0 112.759 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.61 162.7 33.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.002 0.429 . . . . 0.0 111.192 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.592 ' HG3' HG23 ' A' ' 25' ' ' ILE . 16.6 pt-20 -79.8 -39.43 30.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.315 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.592 HG23 ' HG3' ' A' ' 24' ' ' GLU . 1.8 pt -90.24 -12.99 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.863 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.95 -125.23 1.13 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.256 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -140.46 106.08 5.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.916 0.389 . . . . 0.0 110.851 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 94.5 m -63.7 134.68 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.766 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 48' ' ' ASP . 36.3 mt -74.41 104.54 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.916 0.389 . . . . 0.0 110.141 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.539 ' HA ' HD12 ' A' ' 94' ' ' LEU . . . -75.29 -33.76 61.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.705 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 19' ' ' SER . 4.1 m-20 -162.24 174.01 13.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.278 0.561 . . . . 0.0 111.495 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.706 HD21 ' CA ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -157.83 136.62 11.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.93 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.137 HG23 ' CH2' ' A' ' 105' ' ' TRP . 4.2 pt -95.63 99.98 10.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 109.673 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -66.91 147.5 53.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.012 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.24 -17.63 56.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.768 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 2.2 mp0 -76.31 -48.45 20.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.733 0.302 . . . . 0.0 110.938 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -134.98 139.74 32.98 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.844 0.354 . . . . 0.0 110.692 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.99 -48.62 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.789 2.326 . . . . 0.0 113.112 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 43' ' ' LYS . 16.3 mm-40 -62.54 -48.42 79.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.0 mt -58.11 -42.71 83.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -30.25 70.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.386 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -99.85 3.55 44.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.351 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -123.36 -70.51 0.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.71 ' CD2' HG21 ' A' ' 6' ' ' VAL . 15.1 mt -72.07 156.99 38.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.398 0.618 . . . . 0.0 112.409 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.706 ' CA ' HD21 ' A' ' 32' ' ' LEU . 1.2 tt0 -153.94 -175.85 5.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.978 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.2 mtp-105 -91.87 99.79 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.47 39.28 0.21 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.586 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.606 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -131.61 174.62 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.6 mt -145.82 118.53 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.951 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.992 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 7.1 mt -73.93 100.23 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.142 0.496 . . . . 0.0 110.402 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.467 HG22 HG13 ' A' ' 25' ' ' ILE . 16.9 p -98.73 2.43 47.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.054 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.7 mttt -150.27 139.55 21.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.816 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.952 ' HB2' HD11 ' A' ' 58' ' ' LEU . 41.8 t80 -147.18 113.09 5.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.932 0.396 . . . . 0.0 111.264 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 55.54 48.07 19.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.18 21.7 72.13 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.413 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -127.33 104.95 8.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.371 . . . . 0.0 110.669 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.26 125.42 20.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.251 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.952 HD11 ' HB2' ' A' ' 53' ' ' PHE . 7.4 mt -96.52 27.45 3.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.802 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -82.83 142.42 31.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.04 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.7 21.81 65.5 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.661 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 58' ' ' LEU . 56.8 mt -117.29 136.26 23.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.501 0.191 . . . . 0.0 110.811 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.4 -161.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.419 2.079 . . . . 0.0 112.065 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -98.83 -26.66 14.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.026 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -57.41 -46.02 83.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.406 ' O ' HD23 ' A' ' 69' ' ' LEU . 25.7 t -64.1 -51.93 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.973 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 90.5 m -56.91 -50.2 73.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.584 ' CD1' HG12 ' A' ' 106' ' ' VAL . 29.3 t80 -59.43 -31.12 69.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.991 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.76 -50.85 26.35 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.726 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.76 -32.48 72.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 110.523 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.992 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 4.7 m-85 -73.82 -28.55 61.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.269 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 21.6 mtmt -83.44 -36.68 24.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.802 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.81 -18.0 68.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.102 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.819 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -46.44 130.81 11.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.894 0.378 . . . . 0.0 111.588 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -160.9 102.74 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.736 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.99 85.44 1.64 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.165 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.08 109.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.552 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.819 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -122.91 107.82 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.515 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.6 t -100.72 112.0 24.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.295 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.54 123.44 43.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.444 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.8 104.51 16.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.673 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.7 OUTLIER -95.09 142.54 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.588 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.407 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 51.6 m -108.94 123.45 49.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.369 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -104.24 92.93 5.08 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.159 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.17 -174.66 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.622 2.214 . . . . 0.0 112.235 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 157.2 34.17 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.798 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.49 162.74 32.63 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.578 2.186 . . . . 0.0 112.411 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.94 -87.06 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.8 t -169.23 152.05 4.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.59 179.18 16.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.409 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.7 130.23 1.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m -96.89 -30.96 12.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.851 0.358 . . . . 0.0 110.996 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -151.94 -94.75 0.11 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.444 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.857 ' C ' HD13 ' A' ' 94' ' ' LEU . 1.1 m -161.77 142.79 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.857 HD13 ' C ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -132.26 73.23 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.446 0.641 . . . . 0.0 110.528 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.625 HG12 ' NE2' ' A' ' 103' ' ' GLN . 14.6 p -44.96 137.7 4.43 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.651 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.626 ' HD2' HD21 ' A' ' 98' ' ' LEU . 88.6 Cg_endo -78.74 20.13 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.664 2.243 . . . . 0.0 113.314 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.81 76.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.802 0.334 . . . . 0.0 111.688 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.626 HD21 ' HD2' ' A' ' 96' ' ' PRO . 1.4 mm? -93.27 -33.64 13.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.105 0.479 . . . . 0.0 110.133 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.33 -156.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.059 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.17 -75.64 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.419 0.152 . . . . 0.0 111.254 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.556 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -176.97 -50.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.855 -0.157 . . . . 0.0 111.185 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.556 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 5.9 p30 30.19 81.9 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.689 0.395 . . . . 0.0 111.809 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.625 ' NE2' HG12 ' A' ' 95' ' ' VAL . 5.6 mm-40 -145.9 178.27 8.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.074 0.464 . . . . 0.0 111.98 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.519 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.1 t80 -83.3 96.44 8.49 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.137 ' CH2' HG23 ' A' ' 33' ' ' ILE . 38.4 m95 -102.96 138.75 39.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.696 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.584 HG12 ' CD1' ' A' ' 67' ' ' TYR . 15.7 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.08 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.753 0.311 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -78.31 157.62 29.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 5.9 mttp -149.57 129.61 13.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.794 ' CE2' HG22 ' A' ' 6' ' ' VAL . 24.6 p90 -137.74 169.6 17.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.616 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.56 135.78 49.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.081 0.467 . . . . 0.0 111.142 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.89 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.4 t -115.8 107.16 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.506 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.0 p30 -110.06 127.19 54.7 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.796 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.715 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.68 155.37 40.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 110.61 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.51 113.86 6.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.94 0.4 . . . . 0.0 110.823 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.866 ' HE2' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -98.87 140.52 32.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.545 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.414 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 6.1 mmtp -127.55 69.34 1.31 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.304 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.18 23.43 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.275 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.27 113.62 1.17 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.612 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -161.78 -94.15 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 36' ' ' GLN . 24.0 mt-10 -69.24 -5.66 24.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.732 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.866 HD22 ' HE2' ' A' ' 10' ' ' LYS . 1.7 tp -45.53 -31.44 1.81 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.008 0.432 . . . . 0.0 109.843 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.568 ' HA2' HD11 ' A' ' 33' ' ' ILE . . . 23.24 59.59 0.04 OUTLIER Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.154 -0.93 . . . . 0.0 114.953 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 18' ' ' LEU . 2.8 pp -138.79 99.34 3.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.073 0.464 . . . . 0.0 110.303 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -68.98 115.86 8.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.598 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.863 HD13 ' SG ' ' A' ' 27' ' ' CYS . 62.2 mt -98.81 161.79 13.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.023 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.79 166.32 28.19 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.425 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.01 98.56 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.711 2.274 . . . . 0.0 113.439 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -107.72 162.83 13.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.916 0.389 . . . . 0.0 111.358 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.773 ' HG3' HG23 ' A' ' 25' ' ' ILE . 12.8 pt-20 -73.76 -42.31 61.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.391 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.773 HG23 ' HG3' ' A' ' 24' ' ' GLU . 3.3 pt -92.68 -7.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.874 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.31 -130.22 1.93 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.858 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.863 ' SG ' HD13 ' A' ' 20' ' ' LEU . 26.0 p -140.64 106.39 5.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.904 0.383 . . . . 0.0 111.357 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.483 ' OG1' HG12 ' A' ' 49' ' ' ILE . 69.0 m -69.52 133.21 47.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.628 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.012 HG21 HD12 ' A' ' 32' ' ' LEU . 39.8 mt -69.08 104.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.282 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.826 ' HA ' HD22 ' A' ' 94' ' ' LEU . . . -71.67 -24.41 61.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.963 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.409 ' HB2' ' NE2' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -162.48 163.73 27.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.749 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.012 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -149.31 124.82 10.33 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.313 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.107 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.0 pt -96.45 100.53 10.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.256 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.28 154.25 42.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.025 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.5 -21.68 43.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.754 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.66 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 6.0 mp0 -68.93 -48.55 63.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.678 0.275 . . . . 0.0 110.829 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -138.08 139.29 25.4 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.55 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.54 -43.72 3.81 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.628 2.218 . . . . 0.0 112.871 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' LYS . 19.0 mp0 -65.3 -51.72 58.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.966 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.589 HG22 HD21 ' A' ' 32' ' ' LEU . 3.8 mt -55.62 -49.36 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.964 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -61.34 -30.22 70.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.2 m -96.76 1.84 51.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.072 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.623 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -127.89 -74.16 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 0.0 111.504 -179.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.89 ' CD2' HG21 ' A' ' 6' ' ' VAL . 76.4 mt -73.53 148.31 43.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.418 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -153.17 158.61 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.635 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -58.89 98.27 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.982 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.91 44.81 0.13 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.604 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.4 146.57 30.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.935 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.483 HG12 ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -116.21 117.78 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.867 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.2 mt -74.7 100.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.005 0.431 . . . . 0.0 110.136 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.44 HG22 HG13 ' A' ' 25' ' ' ILE . 11.5 p -97.7 8.17 45.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.051 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 3.9 mttt -154.11 141.17 19.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.817 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.931 ' HB2' HD11 ' A' ' 58' ' ' LEU . 57.2 t80 -146.51 109.05 4.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.91 0.386 . . . . 0.0 111.229 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.21 49.65 16.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.56 18.79 74.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -124.34 105.9 9.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.661 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.52 124.99 20.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.293 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.931 HD11 ' HB2' ' A' ' 53' ' ' PHE . 8.4 mt -95.97 24.5 5.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -85.63 125.06 32.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.282 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.75 -20.6 40.99 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.853 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.0 mt -80.07 149.46 69.91 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.684 0.278 . . . . 0.0 111.084 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.84 -167.51 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.625 2.216 . . . . 0.0 112.213 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -96.12 -24.45 16.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.82 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -58.99 -46.49 88.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.984 0.421 . . . . 0.0 110.013 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.536 ' O ' HD23 ' A' ' 69' ' ' LEU . 29.7 m -67.95 -43.4 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.735 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.439 ' N ' HG23 ' A' ' 65' ' ' VAL . 83.5 m -59.13 -53.64 56.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.568 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.541 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 8.6 t80 -59.64 -31.01 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.636 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.93 -51.1 35.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.339 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.72 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -69.78 -34.06 73.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.385 . . . . 0.0 110.184 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.867 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 4.0 m-85 -70.55 -27.68 64.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.031 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.472 ' HG3' HG12 ' A' ' 106' ' ' VAL . 15.5 mtmt -85.18 -39.9 17.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.43 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.37 -21.77 74.63 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.914 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.833 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . . . -42.95 129.44 4.38 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.74 0.305 . . . . 0.0 111.546 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -157.65 102.84 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.017 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.04 83.42 1.37 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.225 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.16 113.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.426 . . . . 0.0 110.395 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.803 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -125.25 107.78 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.724 -179.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.9 t -98.91 114.76 27.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.228 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.19 122.4 40.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.473 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 1.9 tt0 -85.27 104.53 15.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.77 HG11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.24 142.55 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.774 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.408 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 92.1 m -108.82 119.54 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.674 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -103.87 93.3 5.14 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.404 ' HG3' HD11 ' A' ' 49' ' ' ILE . 67.8 Cg_endo -74.09 -174.05 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.493 2.129 . . . . 0.0 112.281 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.83 157.45 38.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.84 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.02 177.1 5.39 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.563 2.176 . . . . 0.0 112.313 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.36 37.29 1.8 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.556 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -165.07 168.37 17.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.22 -137.41 29.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.527 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.99 -120.37 3.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.417 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.97 -35.48 15.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.847 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.88 178.21 15.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.443 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.2 155.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.899 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.826 HD22 ' HA ' ' A' ' 30' ' ' ALA . 4.9 mp -110.23 -28.21 8.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 97' ' ' ARG . 13.2 p -119.8 129.23 25.46 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.647 ' HD2' HD21 ' A' ' 98' ' ' LEU . 92.7 Cg_endo -80.61 15.27 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.569 2.179 . . . . 0.0 113.136 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.591 ' H ' HG22 ' A' ' 95' ' ' VAL . 1.3 mmm180 65.44 78.44 0.27 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.794 0.33 . . . . 0.0 111.369 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.647 HD21 ' HD2' ' A' ' 96' ' ' PRO . 1.4 mm? -93.24 -65.25 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.797 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.57 -158.49 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.701 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -46.29 -53.51 10.62 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.81 0.338 . . . . 0.0 111.152 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.575 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -164.53 -51.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.575 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 0.3 OUTLIER 36.05 77.25 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.888 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 101' ' ' ARG . 3.8 mm100 -143.13 179.0 7.32 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.541 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.2 t80 -84.48 96.34 9.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.209 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.107 ' CH2' HG23 ' A' ' 33' ' ' ILE . 23.5 m95 -104.62 131.14 52.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.215 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.529 ' CG2' HD23 ' A' ' 16' ' ' LEU . 16.1 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.12 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.555 HD22 ' CB ' ' A' ' 84' ' ' PRO . 9.5 mt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.816 0.341 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.58 157.94 19.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.99 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.583 ' HG2' HG23 ' A' ' 82' ' ' THR . 16.1 mttt -153.49 129.54 10.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.816 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.784 ' CE2' HG22 ' A' ' 6' ' ' VAL . 26.1 p90 -136.78 171.23 14.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.451 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.76 135.5 49.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.081 0.467 . . . . 0.0 111.144 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.9 t -114.32 107.27 22.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.928 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.697 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.3 p30 -115.83 127.48 55.08 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.795 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.673 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -153.62 160.91 42.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.637 179.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 128.05 34.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.109 0.48 . . . . 0.0 110.784 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.757 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -114.92 127.89 55.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.319 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' H ' ' HZ3' ' A' ' 10' ' ' LYS . 6.5 mmtt -121.69 69.13 0.92 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.038 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 43.75 89.91 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.413 ' N ' ' NZ ' ' A' ' 10' ' ' LYS . . . 39.05 96.46 0.01 OUTLIER Glycine 0 C--N 1.337 0.597 0 CA-C-N 116.082 -0.508 . . . . 0.0 114.202 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.5 -106.27 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -69.15 -5.67 23.85 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.113 HD22 HD21 ' A' ' 18' ' ' LEU . 4.5 mt -45.83 -33.44 3.14 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.57 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 24.83 62.97 0.05 OUTLIER Glycine 0 C--N 1.333 0.407 0 CA-C-N 114.979 -1.01 . . . . 0.0 115.159 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.113 HD21 HD22 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -141.13 91.71 2.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.934 0.397 . . . . 0.0 110.173 178.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.414 ' HB3' ' CB ' ' A' ' 31' ' ' ASP . 2.1 t -60.38 113.16 2.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.778 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.962 HD21 HD12 ' A' ' 18' ' ' LEU . 16.8 mt -94.28 160.84 14.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.514 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.48 167.58 21.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.268 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.03 120.52 5.04 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.437 2.091 . . . . 0.0 112.799 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.08 162.62 30.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.209 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.561 ' HG3' HG23 ' A' ' 25' ' ' ILE . 7.8 pt-20 -77.55 -33.09 54.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.1 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.561 HG23 ' HG3' ' A' ' 24' ' ' GLU . 3.6 pt -100.25 -4.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.913 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.17 -126.48 1.47 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.067 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 50' ' ' ILE . 26.2 p -140.51 106.16 5.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.946 0.403 . . . . 0.0 111.162 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.408 ' OG1' HG12 ' A' ' 49' ' ' ILE . 88.7 m -68.74 131.26 44.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.719 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.11 HG21 HD12 ' A' ' 32' ' ' LEU . 10.9 mt -72.03 105.06 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.607 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.27 -24.16 59.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.303 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.414 ' CB ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -157.33 165.67 35.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.014 0.435 . . . . 0.0 111.283 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.11 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -153.66 125.83 7.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.294 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.105 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.4 pt -97.15 100.55 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.652 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -68.31 154.36 41.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.978 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.36 -20.92 47.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.806 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 7.1 mp0 -71.73 -49.75 36.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.688 0.28 . . . . 0.0 110.887 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -136.95 139.7 29.46 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.867 0.365 . . . . 0.0 110.731 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.97 -48.15 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.653 2.236 . . . . 0.0 112.726 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -60.01 -50.4 73.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.701 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.638 HG22 HD21 ' A' ' 32' ' ' LEU . 6.3 mt -56.85 -47.26 83.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.17 -30.41 71.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.548 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -97.03 1.83 50.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.07 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.32 -73.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.916 0.388 . . . . 0.0 111.458 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.843 HD22 HG11 ' A' ' 81' ' ' VAL . 33.6 mt -75.22 153.28 38.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.522 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.14 -175.83 5.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.572 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -86.82 87.46 7.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.87 0.367 . . . . 0.0 111.014 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.9 43.11 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.697 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.56 156.82 45.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 110.666 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.408 HG12 ' OG1' ' A' ' 28' ' ' THR . 1.1 mp -124.53 117.74 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.359 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.94 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.2 mt -74.59 100.46 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.031 0.443 . . . . 0.0 110.474 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.0 p -93.46 -4.44 51.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.359 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -144.42 144.93 31.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.097 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.967 ' HB2' HD11 ' A' ' 58' ' ' LEU . 41.9 t80 -151.31 108.8 3.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 53.3 52.91 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.31 24.09 67.08 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.332 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -123.91 98.18 5.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.661 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.67 114.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.377 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.967 HD11 ' HB2' ' A' ' 53' ' ' PHE . 12.3 mt -88.5 11.95 15.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.999 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -75.73 142.98 42.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.862 0.363 . . . . 0.0 111.113 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.1 24.23 64.87 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.775 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 58' ' ' LEU . 59.0 mt -120.07 141.26 31.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.526 0.203 . . . . 0.0 110.766 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.58 -160.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.518 2.145 . . . . 0.0 112.24 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -104.7 -24.54 12.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -55.87 -49.11 74.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 0.0 110.387 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 66' ' ' CYS . 22.2 m -67.13 -45.85 85.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.778 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.467 ' N ' HG23 ' A' ' 65' ' ' VAL . 91.0 m -55.57 -52.86 62.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.022 0.439 . . . . 0.0 110.81 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 26.7 t80 -62.17 -30.88 71.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.739 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.32 -51.37 45.42 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.762 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -65.96 -44.06 86.09 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.668 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.94 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 12.5 m-85 -61.44 -32.41 72.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.133 0.492 . . . . 0.0 109.905 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 6.4 mtpt -80.39 -34.28 36.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.958 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -87.88 10.85 68.7 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.435 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.757 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -73.26 135.22 44.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.58 0.229 . . . . 0.0 110.544 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 4.1 p30 -172.97 92.93 0.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 111.013 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.58 76.24 0.19 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.259 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.02 98.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.023 0.44 . . . . 0.0 110.698 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.712 HG11 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -101.95 152.85 5.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.468 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 t -140.48 119.63 12.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.516 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.12 122.82 30.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.5 106.99 17.89 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.843 HG11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -97.0 143.02 13.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.719 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 3' ' ' LYS . 45.3 m -108.48 119.39 39.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.527 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -103.91 89.33 2.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.112 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.555 ' CB ' HD22 ' A' ' 1' ' ' LEU . 54.4 Cg_endo -69.61 -175.2 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.581 2.187 . . . . 0.0 112.319 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 162.47 50.11 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.18 165.75 29.22 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.564 2.176 . . . . 0.0 112.211 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.3 83.69 0.9 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.443 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.54 -51.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.357 . . . . 0.0 110.806 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.28 -58.16 15.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.443 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.27 -107.07 0.23 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.593 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.2 m -101.3 -31.06 11.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.984 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.7 -59.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.35 177.89 8.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -26.13 68.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.033 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.413 HG11 ' OD1' ' A' ' 31' ' ' ASP . 14.9 p -138.31 136.02 18.87 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.363 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.573 ' HD2' HD11 ' A' ' 98' ' ' LEU . 57.9 Cg_endo -74.61 -164.78 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.402 2.068 . . . . 0.0 112.293 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.05 70.01 2.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.903 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.639 ' H ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -89.86 -67.37 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.992 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.667 HD22 ' HD3' ' A' ' 100' ' ' ARG . 1.8 mt -135.11 -170.97 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.75 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.667 ' HD3' HD22 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -45.6 -71.47 0.07 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.57 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -149.83 -51.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.097 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.57 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 0.4 OUTLIER 33.35 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.483 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.493 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.0 mm-40 -143.88 178.04 8.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.167 0.508 . . . . 0.0 112.204 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.52 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 2.1 t80 -84.54 96.4 9.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.105 ' CH2' HG23 ' A' ' 33' ' ' ILE . 28.7 m95 -102.88 137.28 41.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.512 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 70' ' ' PHE . 6.4 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.095 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.738 0.304 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 157.9 31.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.8 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -151.93 129.58 11.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.8 ' CE2' HG22 ' A' ' 6' ' ' VAL . 27.6 p90 -138.54 171.82 13.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.813 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.68 135.94 49.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.955 0.407 . . . . 0.0 111.582 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.849 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.6 t -117.43 107.15 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.381 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.2 p30 -113.47 127.13 55.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.922 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.702 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -152.36 156.39 39.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.393 . . . . 0.0 110.735 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.35 119.66 12.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.647 ' HG3' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -100.96 137.5 39.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.388 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -126.62 69.1 1.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.703 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 33.75 91.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.174 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.6 96.26 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.324 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 33.5 ttmt -156.75 -114.1 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.755 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 9.3 mt-10 -70.88 -5.56 31.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.866 HD22 HD21 ' A' ' 18' ' ' LEU . 1.6 mt -45.43 -34.2 3.0 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.611 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 19.47 64.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 114.8 -1.091 . . . . 0.0 115.454 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.866 HD21 HD22 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -143.46 91.73 2.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.145 0.498 . . . . 0.0 110.107 178.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 2.1 t -59.29 114.58 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.942 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -91.79 163.04 14.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.39 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.14 162.47 53.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.352 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.14 120.54 7.25 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.512 2.142 . . . . 0.0 112.723 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.595 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -133.25 162.46 31.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.721 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -82.65 -29.27 30.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.097 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.533 HG13 HG22 ' A' ' 51' ' ' THR . 2.2 pt -103.49 -6.37 9.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.918 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.66 -125.57 1.29 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.249 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -140.59 106.1 5.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.954 0.407 . . . . 0.0 111.07 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.6 m -68.14 127.71 33.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.389 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.124 HG21 HD12 ' A' ' 32' ' ' LEU . 13.0 mt -70.69 104.92 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.851 0.358 . . . . 0.0 110.622 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.27 -25.64 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.047 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -157.18 166.97 31.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.043 0.449 . . . . 0.0 111.238 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.124 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -155.46 126.88 7.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.006 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.117 HG23 ' CH2' ' A' ' 105' ' ' TRP . 4.1 pt -96.46 100.58 11.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.64 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -72.7 139.67 47.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.842 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.69 -27.91 8.07 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.622 ' OE1' ' HA ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -67.21 -60.81 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.759 0.314 . . . . 0.0 110.712 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -123.77 136.75 27.72 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.129 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.98 -49.12 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.62 2.213 . . . . 0.0 112.903 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -56.82 -49.2 76.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.884 0.373 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.709 HG22 HD21 ' A' ' 32' ' ' LEU . 5.3 mt -57.49 -47.01 85.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.77 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.21 -30.39 71.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.606 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -97.2 1.6 49.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.226 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.515 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -128.56 -73.67 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 111.388 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.849 ' CD2' HG21 ' A' ' 6' ' ' VAL . 38.8 mt -74.92 145.3 42.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.546 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.36 164.94 36.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.572 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -59.9 108.18 0.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.953 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.24 40.78 0.61 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.603 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.643 ' HB2' HD12 ' A' ' 29' ' ' ILE . 12.0 m-20 -138.17 134.02 34.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.834 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.595 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.9 mt -106.36 117.39 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.908 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.72 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.8 mt -75.68 100.47 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.533 HG22 HG13 ' A' ' 25' ' ' ILE . 4.6 p -102.16 24.52 10.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.879 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 7.1 mttt -169.13 133.76 1.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.178 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.946 ' HB2' HD11 ' A' ' 58' ' ' LEU . 56.9 t80 -141.25 109.22 5.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.238 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 54.98 53.56 10.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.65 16.96 66.38 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -122.52 101.06 7.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.822 0.344 . . . . 0.0 110.608 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.98 123.41 14.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.344 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.946 HD11 ' HB2' ' A' ' 53' ' ' PHE . 3.8 mt -94.96 23.04 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.789 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.82 122.05 33.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.333 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.78 15.08 38.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.048 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.748 HD21 ' HA ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -127.41 159.46 65.44 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.9 0.35 . . . . 0.0 111.136 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.92 -171.77 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.765 2.31 . . . . 0.0 112.44 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -92.91 -33.46 14.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.486 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -48.63 -46.24 39.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.994 0.426 . . . . 0.0 110.649 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' HD23 ' A' ' 69' ' ' LEU . 26.9 m -65.46 -39.0 83.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.783 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 42.2 m -63.86 -53.74 45.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.737 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.693 ' CD1' HG12 ' A' ' 106' ' ' VAL . 26.8 t80 -57.6 -30.78 65.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.01 -51.1 42.8 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.729 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.4 -40.84 81.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.522 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.72 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 16.5 m-85 -64.24 -30.95 71.98 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.419 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -79.64 -33.52 41.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.026 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -90.55 15.53 60.02 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.668 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.638 ' HB1' HG11 ' A' ' 77' ' ' VAL . . . -77.92 133.7 38.03 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 72' ' ' GLY . 2.7 p30 -167.8 89.24 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 111.202 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.92 86.14 0.77 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.58 109.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.075 0.464 . . . . 0.0 110.783 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.647 HG11 ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -122.61 107.77 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.639 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.6 t -99.96 113.99 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.983 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.03 124.53 44.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.638 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -86.93 104.93 16.72 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.841 HG11 HD22 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -95.13 142.53 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.772 -179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.9 m -108.86 121.45 45.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.529 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -104.19 92.85 4.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.099 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.48 -175.17 1.69 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.528 2.152 . . . . 0.0 112.227 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 158.7 62.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.04 173.81 6.67 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.602 2.201 . . . . 0.0 112.248 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.89 -91.96 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.581 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 t -77.1 -41.48 41.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.75 155.46 10.48 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.87 -178.69 26.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.485 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.95 -33.02 34.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.773 0.32 . . . . 0.0 110.94 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.21 -105.66 1.11 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.477 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.4 m -103.47 179.61 4.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 0.0 110.805 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.42 -31.56 7.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.025 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 95' ' ' VAL . 14.0 p -140.71 114.45 7.24 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.65 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.872 ' HG2' HD13 ' A' ' 98' ' ' LEU . 73.6 Cg_endo -75.85 -166.6 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.598 2.198 . . . . 0.0 112.036 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -88.68 64.66 7.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.437 . . . . 0.0 110.644 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.872 HD13 ' HG2' ' A' ' 96' ' ' PRO . 1.5 mp -88.07 -71.69 0.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.442 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.54 -163.85 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.159 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.63 -78.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.008 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.577 ' HG2' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -147.42 -51.84 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.318 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.577 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 6.5 m-80 32.92 79.76 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.637 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.489 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 11.3 mm-40 -143.37 177.99 8.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.303 0.573 . . . . 0.0 112.37 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 4.8 t80 -84.88 96.42 9.32 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.211 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.117 ' CH2' HG23 ' A' ' 33' ' ' ILE . 18.7 m95 -104.59 136.5 44.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.114 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' A' ' 70' ' ' PHE . 30.1 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.069 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.801 0.334 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -78.85 158.76 28.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.707 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 6.6 mttt -150.97 129.54 12.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.777 ' CE1' HG23 ' A' ' 81' ' ' VAL . 9.3 p90 -136.93 170.87 15.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.743 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.57 135.92 49.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.103 0.478 . . . . 0.0 111.253 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.898 HG21 ' CD2' ' A' ' 44' ' ' LEU . 14.8 t -116.42 107.01 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.432 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 2.1 p30 -110.4 127.05 54.9 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.792 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.697 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.05 153.56 38.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 0.0 110.591 178.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.27 117.43 8.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.066 0.46 . . . . 0.0 110.827 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.948 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -101.93 128.6 48.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.598 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.454 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 7.7 mmtt -119.24 68.56 0.81 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.118 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.02 78.9 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.196 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.99 99.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.463 -0.398 . . . . 0.0 113.822 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 5.6 ptpt -155.79 -103.92 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 7.1 mt-10 -69.13 -5.57 23.17 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.995 HD22 HD21 ' A' ' 18' ' ' LEU . 3.8 mt -45.54 -33.7 2.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.601 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.603 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 26.38 61.98 0.08 OUTLIER Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.024 -0.989 . . . . 0.0 115.201 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.995 HD21 HD22 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -142.82 91.87 2.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.046 0.451 . . . . 0.0 110.003 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 t -62.29 117.75 6.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.773 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.895 HD21 ' CD1' ' A' ' 18' ' ' LEU . 16.2 mt -97.7 167.65 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.462 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.796 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 66.1 m -141.62 156.56 66.34 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.441 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.21 118.63 5.72 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.476 2.117 . . . . 0.0 112.429 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.485 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -128.85 162.75 26.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -24.69 41.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.448 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.425 HG13 HG22 ' A' ' 51' ' ' THR . 4.6 pt -108.71 -9.68 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.941 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 171.41 -122.18 0.94 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.143 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 21' ' ' SER . 8.7 m -140.55 106.46 5.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.812 0.339 . . . . 0.0 111.4 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 49' ' ' ILE . 93.2 m -68.89 125.96 28.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.079 HG21 HD12 ' A' ' 32' ' ' LEU . 40.9 mt -67.81 104.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.628 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.796 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -70.49 -29.0 65.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.967 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.434 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 6.8 m-20 -161.89 170.69 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.061 0.458 . . . . 0.0 111.023 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.079 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -153.28 127.37 9.05 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.429 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.122 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -96.74 100.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.165 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.05 153.2 43.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.047 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.11 -22.34 41.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.751 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 1.5 mp0 -69.94 -45.28 67.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.825 0.345 . . . . 0.0 110.862 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -141.12 139.73 19.79 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.646 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.46 -49.3 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.629 2.22 . . . . 0.0 112.977 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.2 -50.74 72.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.656 HD13 HD23 ' A' ' 18' ' ' LEU . 5.4 mt -55.87 -52.15 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.01 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -59.15 -30.23 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.583 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.2 m -96.46 0.68 50.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.24 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.98 -73.79 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 111.538 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.898 ' CD2' HG21 ' A' ' 6' ' ' VAL . 45.2 mt -72.87 145.31 46.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.564 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -149.59 159.78 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.621 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -60.94 109.32 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.072 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.46 -17.39 4.76 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.985 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.632 ' HB2' HD12 ' A' ' 29' ' ' ILE . 2.7 m-20 -83.61 148.62 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.991 0.424 . . . . 0.0 111.13 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 28' ' ' THR . 2.9 mt -119.57 117.78 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.599 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.874 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.1 mt -74.53 100.38 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 111.162 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.425 HG22 HG13 ' A' ' 25' ' ' ILE . 9.7 p -102.39 20.84 16.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.1 mttt -167.33 126.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.998 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.958 ' HB2' HD11 ' A' ' 58' ' ' LEU . 44.0 t80 -132.23 109.58 10.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.19 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 50.52 62.96 2.42 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.021 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.74 20.59 48.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.464 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -125.31 98.04 5.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.699 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.71 121.49 8.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.387 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.958 HD11 ' HB2' ' A' ' 53' ' ' PHE . 9.1 mt -93.11 19.48 7.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.813 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.85 143.72 39.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.934 0.397 . . . . 0.0 111.176 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.89 26.61 48.32 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.704 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 58' ' ' LEU . 23.8 mt -118.77 143.58 33.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.635 0.255 . . . . 0.0 110.866 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.26 -164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.548 2.165 . . . . 0.0 112.035 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -110.58 -22.79 11.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.176 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -58.36 -50.99 71.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 110.687 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.517 ' O ' HD23 ' A' ' 69' ' ' LEU . 14.6 m -65.52 -41.44 90.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.94 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 81.4 m -60.47 -52.3 65.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 104' ' ' TYR . 25.9 t80 -60.34 -30.68 69.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.292 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.46 -51.03 39.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.247 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.734 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.69 -40.72 84.34 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.148 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.874 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.4 m-85 -61.16 -33.25 73.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.422 ' HG3' HG12 ' A' ' 106' ' ' VAL . 26.0 mtmt -83.41 -30.9 26.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.184 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.401 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -90.48 12.35 68.6 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.612 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.948 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -75.59 138.78 41.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.637 0.256 . . . . 0.0 110.379 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 2.6 p30 -169.77 99.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.179 0.514 . . . . 0.0 111.101 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.44 76.35 0.53 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.044 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.82 108.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.938 0.399 . . . . 0.0 110.17 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.788 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -117.13 107.74 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.753 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.0 t -100.01 114.77 28.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.316 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.8 122.16 40.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.679 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 2.7 tt0 -84.17 102.38 12.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.777 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -95.07 142.95 12.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.731 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 54.4 m -108.36 121.97 46.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.4 97.45 22.79 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 82' ' ' THR . 36.6 Cg_exo -57.24 167.06 3.72 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.533 2.156 . . . . 0.0 112.197 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -115.48 156.48 45.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.972 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.28 172.13 9.34 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.702 2.268 . . . . 0.0 112.181 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.12 80.09 0.31 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.533 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.5 m 61.45 98.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.869 0.366 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.47 75.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.501 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.57 96.42 1.06 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.514 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.23 26.29 9.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.731 0.301 . . . . 0.0 110.969 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.17 -120.06 8.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.531 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -151.54 169.91 20.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 30' ' ' ALA . 6.6 mp -86.51 -64.86 1.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.522 HG21 ' OE1' ' A' ' 103' ' ' GLN . 11.7 p -113.43 122.89 34.34 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.547 ' HD2' HD11 ' A' ' 98' ' ' LEU . 45.2 Cg_endo -70.58 -167.02 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.337 2.025 . . . . 0.0 112.366 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.63 67.31 4.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.023 0.44 . . . . 0.0 110.961 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.646 ' H ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -88.17 -65.91 0.97 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.819 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.79 179.05 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.653 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.411 ' HB3' ' HD2' ' A' ' 101' ' ' ARG . 0.1 OUTLIER -47.76 -71.57 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.115 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.791 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.6 mpt_? -139.48 -80.53 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.021 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.2 t30 48.85 28.0 1.78 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.135 0.493 . . . . 0.0 110.939 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.528 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 8.5 mm100 -81.86 -177.52 6.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.259 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 2.8 t80 -85.99 96.3 9.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.094 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.122 ' CH2' HG23 ' A' ' 33' ' ' ILE . 13.3 m95 -105.36 136.17 45.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.237 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.673 HG21 ' HB3' ' A' ' 70' ' ' PHE . 11.3 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.122 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.709 HD22 ' HA ' ' A' ' 84' ' ' PRO . 7.1 mt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.8 0.333 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.79 158.8 22.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 11.3 mttt -152.73 129.65 11.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 110.867 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.814 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.0 p90 -137.91 171.18 14.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.784 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.61 135.91 49.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.957 0.408 . . . . 0.0 111.414 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.874 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.0 t -117.63 107.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.452 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 8.6 p-10 -111.02 127.26 55.48 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.972 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.73 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.04 153.68 39.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 110.758 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.19 114.87 6.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.058 0.456 . . . . 0.0 110.51 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.822 ' CE ' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -98.03 145.34 26.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.882 -179.288 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 48.5 mmtt -132.66 69.23 1.48 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.183 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.25 21.89 4.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.493 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.65 115.05 1.52 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.69 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 7.9 ptpt -163.79 -94.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.3 mm-40 -69.21 -4.91 19.57 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.906 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.861 ' CD2' HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -44.95 -38.59 4.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.228 0.537 . . . . 0.0 109.643 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.584 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 33.64 59.06 0.56 Allowed Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.171 -0.922 . . . . 0.0 115.362 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.861 HD21 ' CD2' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -143.06 91.49 2.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.124 0.462 . . . . 0.0 110.059 177.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.6 t -63.32 120.85 12.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.638 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -96.13 167.82 10.98 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.579 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.642 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -142.57 163.13 40.75 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.269 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 21' ' ' SER . 57.6 Cg_endo -71.71 126.11 11.74 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.269 1.979 . . . . 0.0 112.734 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.48 162.74 34.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.076 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.33 -32.71 37.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 51' ' ' THR . 2.4 pt -99.64 -6.94 9.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.87 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.21 -127.49 1.58 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.865 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 75.0 m -140.72 106.41 5.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.855 0.359 . . . . 0.0 111.644 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.7 m -63.64 133.42 53.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.289 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.029 HG21 HD12 ' A' ' 32' ' ' LEU . 47.8 mt -71.65 104.77 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.879 0.371 . . . . 0.0 110.422 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.642 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -68.51 -32.93 73.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.164 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -156.91 174.71 15.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.05 0.452 . . . . 0.0 111.457 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.029 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.74 128.98 7.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.508 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.14 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.2 pt -101.12 100.46 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.088 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -70.58 153.76 42.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.012 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.81 -21.92 43.36 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.682 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.599 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 6.4 mp0 -69.87 -52.57 23.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.672 0.272 . . . . 0.0 110.8 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -133.27 139.33 33.8 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.669 179.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.58 -48.23 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.662 2.241 . . . . 0.0 113.109 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -61.12 -49.32 77.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.761 0.315 . . . . 0.0 110.964 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 4.3 mt -57.91 -49.93 79.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -60.34 -30.33 69.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.976 0.417 . . . . 0.0 110.452 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -95.3 -1.43 51.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.129 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.587 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -123.93 -73.19 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.462 -178.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.874 ' CD2' HG21 ' A' ' 6' ' ' VAL . 47.8 mt -73.25 147.8 44.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.631 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.03 157.78 43.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.65 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.7 mtp-105 -59.73 96.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.073 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.81 43.38 0.17 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.722 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.18 140.13 35.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.72 0.295 . . . . 0.0 110.686 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.47 ' CD1' HD11 ' A' ' 25' ' ' ILE . 2.0 mt -107.52 117.54 53.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.091 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.9 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 8.8 mt -75.14 100.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.956 0.408 . . . . 0.0 110.461 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.524 HG22 HG13 ' A' ' 25' ' ' ILE . 10.2 p -101.79 23.43 11.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 4.5 mttt -170.21 137.01 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.982 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.98 ' HB2' HD11 ' A' ' 58' ' ' LEU . 35.9 t80 -144.82 115.6 7.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 0.0 111.272 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 53.35 54.42 10.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.75 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.7 22.5 64.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.353 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -128.44 103.16 6.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.935 0.397 . . . . 0.0 110.7 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . . . -54.42 123.52 13.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.399 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.98 HD11 ' HB2' ' A' ' 53' ' ' PHE . 9.3 mt -93.7 22.11 5.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.584 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -77.81 119.58 21.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.888 0.375 . . . . 0.0 111.225 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -16.83 57.21 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.708 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 58' ' ' LEU . 72.1 mt -76.23 135.6 69.55 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.589 0.194 . . . . 0.0 111.041 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -57.69 -160.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.412 2.074 . . . . 0.0 112.213 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 37.4 t80 -101.24 -25.6 13.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.89 -47.69 84.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.792 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HD23 ' A' ' 69' ' ' LEU . 27.9 m -67.58 -46.81 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.502 ' N ' HG23 ' A' ' 65' ' ' VAL . 19.0 m -59.62 -50.08 75.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 110.767 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.722 ' CD1' HG12 ' A' ' 106' ' ' VAL . 50.0 t80 -59.31 -33.3 70.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.982 0.42 . . . . 0.0 110.338 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.61 -50.98 39.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.172 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.711 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.83 -34.92 76.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 110.367 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.9 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 3.8 m-85 -69.52 -27.83 65.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.049 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.422 ' HD3' ' CZ ' ' A' ' 67' ' ' TYR . 19.8 mtmt -85.06 -41.55 15.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.911 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.3 -20.47 77.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.233 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.822 ' HB3' ' CE ' ' A' ' 10' ' ' LYS . . . -42.97 132.88 3.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 111.64 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -162.96 102.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.783 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.39 81.75 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.129 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.81 109.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.905 0.384 . . . . 0.0 110.553 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.786 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -121.46 107.69 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.751 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -98.88 114.76 27.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.404 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.16 123.59 43.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.378 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -87.05 104.69 16.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.964 0.411 . . . . 0.0 109.997 178.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.805 HG11 HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -95.17 142.68 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.655 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.408 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 96.8 m -108.77 123.84 49.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.339 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 -104.61 92.68 5.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.225 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.709 ' HA ' HD22 ' A' ' 1' ' ' LEU . 61.7 Cg_endo -73.62 -175.07 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.535 2.157 . . . . 0.0 112.133 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.18 159.58 30.13 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.13 -173.77 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.565 2.176 . . . . 0.0 112.195 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 138.13 46.51 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.579 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.3 t -163.35 179.41 7.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.99 160.51 26.15 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.14 -37.91 3.32 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.85 -31.48 18.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.351 . . . . 0.0 110.909 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.45 -146.76 33.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.539 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.6 158.05 31.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.775 0.321 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.96 -21.1 64.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.224 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 95' ' ' VAL . 11.3 p -127.86 114.32 20.58 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.126 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.784 ' HG2' HD13 ' A' ' 98' ' ' LEU . 59.4 Cg_endo -72.81 -167.93 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.593 2.196 . . . . 0.0 112.317 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.51 61.52 4.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.859 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.784 HD13 ' HG2' ' A' ' 96' ' ' PRO . 2.9 mp -93.09 -71.45 0.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.01 -168.64 3.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.692 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -58.57 -63.52 1.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.796 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.801 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -140.25 -80.21 0.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.083 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.6 m120 49.81 27.31 2.25 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.114 0.483 . . . . 0.0 110.93 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.537 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 27.2 mm-40 -81.89 -178.38 6.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.312 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.517 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.7 t80 -86.58 96.21 10.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.338 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.14 ' CH2' HG23 ' A' ' 33' ' ' ILE . 7.7 m95 -106.16 132.58 52.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.055 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.722 HG12 ' CD1' ' A' ' 67' ' ' TYR . 20.3 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.057 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.791 0.329 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.06 159.3 16.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -151.15 129.62 12.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.799 ' CE2' HG22 ' A' ' 6' ' ' VAL . 30.7 p90 -137.76 172.17 13.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.109 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.71 135.95 49.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 111.544 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.799 HG22 ' CE2' ' A' ' 4' ' ' PHE . 15.7 t -117.05 107.25 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.265 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 5.7 p-10 -113.13 127.2 56.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.884 0.373 . . . . 0.0 111.139 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.704 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.86 156.24 40.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.38 178.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.47 117.6 12.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.9 0.381 . . . . 0.0 110.638 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.903 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -100.03 128.39 46.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.538 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 10.7 mmtt -120.9 68.75 0.88 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.219 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.42 79.73 0.07 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.439 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . 44.79 98.63 0.01 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 114.231 0.452 . . . . 0.0 114.231 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 7.5 ptpt -155.85 -102.37 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 1.8 mm-40 -69.23 -5.42 22.68 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.992 HD22 HD21 ' A' ' 18' ' ' LEU . 3.3 mt -45.53 -30.11 1.36 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.996 0.427 . . . . 0.0 110.17 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.549 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 26.76 62.64 0.08 OUTLIER Glycine 0 C--N 1.332 0.337 0 N-CA-C 115.149 0.82 . . . . 0.0 115.149 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.992 HD21 HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -146.18 92.28 2.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.006 0.431 . . . . 0.0 110.331 178.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 26.3 t -66.8 116.69 7.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.277 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -92.87 162.74 13.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.199 0.523 . . . . 0.0 111.961 -179.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.663 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 1.2 m -139.17 148.11 55.95 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.35 124.84 17.24 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.634 2.223 . . . . 0.0 112.816 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.37 162.57 35.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.979 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HG3' HG23 ' A' ' 25' ' ' ILE . 10.0 pt-20 -80.57 -38.89 28.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.086 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.562 HG23 ' HG3' ' A' ' 24' ' ' GLU . 1.9 pt -91.33 -9.24 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.959 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 168.87 -123.2 1.07 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.452 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -140.51 106.19 5.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.771 0.32 . . . . 0.0 110.939 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.413 ' N ' HG23 ' A' ' 49' ' ' ILE . 86.5 m -67.07 119.37 11.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.532 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.692 HD12 ' HB2' ' A' ' 48' ' ' ASP . 7.6 mt -66.51 104.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.52 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.663 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -68.89 -28.58 66.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.342 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -165.63 178.72 6.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.342 0.591 . . . . 0.0 111.336 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -163.9 136.1 4.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.747 178.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.189 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.5 pt -95.9 100.32 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.244 0.545 . . . . 0.0 110.572 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -65.07 154.04 39.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.869 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.04 -27.46 16.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.522 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 3.5 mp0 -65.76 -49.56 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 110.461 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.663 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -133.98 140.21 35.64 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.475 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.31 -49.28 0.95 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.644 2.229 . . . . 0.0 113.169 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 43' ' ' LYS . 13.5 mm-40 -60.94 -50.48 73.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 111.036 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.615 HD13 HD23 ' A' ' 18' ' ' LEU . 3.3 mt -55.98 -51.2 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.257 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -59.37 -30.14 68.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.028 0.442 . . . . 0.0 110.632 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -99.42 3.45 45.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.425 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.518 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -122.94 -70.18 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.701 ' CD2' HG21 ' A' ' 6' ' ' VAL . 15.0 mt -70.9 153.72 42.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.266 0.555 . . . . 0.0 112.259 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.476 ' HA ' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -153.94 137.34 15.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.26 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HG3' HD11 ' A' ' 32' ' ' LEU . 13.7 mtp-105 -48.18 114.07 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 111.435 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.93 7.1 6.16 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.18 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.692 ' HB2' HD12 ' A' ' 29' ' ' ILE . 54.0 m-20 -106.61 163.96 12.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.913 0.357 . . . . 0.0 111.099 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 25' ' ' ILE . 1.2 mp -131.48 120.14 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.027 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.004 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.9 mt -74.61 100.28 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.496 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.43 HG22 HG13 ' A' ' 25' ' ' ILE . 15.7 p -93.55 -9.58 37.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.238 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -139.18 145.97 39.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.963 ' HB2' HD11 ' A' ' 58' ' ' LEU . 31.1 t80 -152.55 112.54 3.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.865 0.364 . . . . 0.0 111.109 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 56.81 42.86 25.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.851 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.22 22.74 77.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.427 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -121.82 108.15 13.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.343 . . . . 0.0 110.75 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.66 107.95 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.308 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.963 HD11 ' HB2' ' A' ' 53' ' ' PHE . 20.6 mt -80.72 0.65 33.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.54 145.2 52.8 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.932 0.396 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.66 19.13 66.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.736 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.0 mt -120.15 141.51 31.81 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.575 0.226 . . . . 0.0 110.924 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.92 -158.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.507 2.138 . . . . 0.0 112.259 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -105.39 -23.91 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.929 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -56.32 -49.0 75.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 110.544 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.48 ' O ' HD23 ' A' ' 69' ' ' LEU . 19.0 m -67.02 -45.36 87.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.996 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.445 ' N ' HG23 ' A' ' 65' ' ' VAL . 57.0 m -56.97 -49.7 74.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.701 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.529 ' CD1' HG12 ' A' ' 106' ' ' VAL . 25.3 t80 -63.74 -31.01 72.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.835 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.37 -50.99 33.09 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.749 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -65.83 -42.21 90.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.814 0.34 . . . . 0.0 110.519 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 1.004 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.7 m-85 -63.74 -32.62 74.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.919 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -82.65 -30.37 29.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.324 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -93.12 17.26 58.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.542 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.903 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . . . -79.23 136.21 37.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.764 0.316 . . . . 0.0 110.626 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -170.12 98.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.126 0.489 . . . . 0.0 110.728 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.56 77.25 0.52 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.887 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.54 110.39 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.857 0.36 . . . . 0.0 110.412 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.725 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -119.41 107.96 22.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.629 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.8 t -105.49 106.25 16.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.303 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.27 127.79 56.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.938 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -89.06 107.62 19.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.919 0.39 . . . . 0.0 109.985 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.669 HG23 ' CE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -98.23 143.05 13.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.875 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.9 m -108.49 124.49 50.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.188 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -105.64 93.57 7.44 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.372 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.445 ' HG3' HD11 ' A' ' 49' ' ' ILE . 73.7 Cg_endo -77.3 -174.12 2.07 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.555 2.17 . . . . 0.0 112.199 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -105.47 154.18 39.26 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.812 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.08 162.44 35.56 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.539 2.159 . . . . 0.0 112.272 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.1 107.85 1.11 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.546 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.3 t 61.13 164.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.94 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.51 51.62 57.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.45 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.72 109.61 0.97 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.44 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.9 m -97.79 -35.17 10.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.23 -170.8 38.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.569 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.3 m -59.52 161.2 6.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.839 0.352 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 30' ' ' ALA . 1.1 mp -83.04 -30.53 28.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.99 137.18 21.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.848 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.802 ' HD2' HD11 ' A' ' 98' ' ' LEU . 96.1 Cg_endo -81.87 21.73 0.92 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.661 2.24 . . . . 0.0 113.483 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.09 69.28 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 0.0 111.29 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.802 HD11 ' HD2' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -93.3 -62.5 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.774 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.488 HD22 HD22 ' A' ' 102' ' ' ASN . 1.0 OUTLIER -123.21 -163.29 1.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.511 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.71 -77.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.63 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.498 ' HG3' HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -134.29 24.26 3.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.655 179.149 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.488 HD22 HD22 ' A' ' 99' ' ' LEU . 1.5 t-20 -51.06 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.896 0.379 . . . . 0.0 110.549 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.492 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 4.5 mm100 -141.54 173.55 11.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.952 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.504 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 3.3 t80 -79.4 95.9 5.88 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.189 ' CH2' HG23 ' A' ' 33' ' ' ILE . 53.2 m95 -100.86 145.61 28.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.036 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.529 HG12 ' CD1' ' A' ' 67' ' ' TYR . 8.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.22 160.53 19.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.949 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HG2' HG23 ' A' ' 82' ' ' THR . 9.6 mttt -155.37 129.61 8.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.706 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.81 ' CE2' HG22 ' A' ' 6' ' ' VAL . 33.0 p90 -136.26 173.29 11.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.272 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.65 137.61 46.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 111.258 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.881 HG21 ' CD2' ' A' ' 44' ' ' LEU . 6.9 t -122.76 107.28 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.84 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 25.7 t0 -110.14 127.18 54.76 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.78 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.723 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.54 159.17 44.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.674 179.044 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.38 114.24 9.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.794 ' HG2' HD21 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -95.39 140.83 29.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.347 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 3.8 mmtp -132.57 69.27 1.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.36 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.36 22.09 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.336 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.92 114.27 0.96 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.536 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -162.08 -96.42 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.959 0.409 . . . . 0.0 111.367 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 16.7 mt-10 -68.23 -4.39 13.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.122 0.569 . . . . 0.0 112.156 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.987 HD12 HD21 ' A' ' 18' ' ' LEU . 2.8 mm? -44.48 -32.71 1.47 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.136 0.493 . . . . 0.0 110.03 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.556 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 32.93 51.24 0.47 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.333 -0.849 . . . . 0.0 114.65 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.987 HD21 HD12 ' A' ' 16' ' ' LEU . 1.3 pp -141.27 91.62 2.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.019 0.438 . . . . 0.0 110.323 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 6.0 t -68.63 119.52 13.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.812 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.861 HD21 HD12 ' A' ' 50' ' ' ILE . 5.5 mp -94.23 167.89 11.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.52 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -143.88 164.69 28.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.074 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.56 128.68 15.62 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.347 2.032 . . . . 0.0 112.672 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.591 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -140.02 162.66 34.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.039 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.04 -16.74 45.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.52 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.535 HD11 HD13 ' A' ' 49' ' ' ILE . 6.8 pt -118.1 -7.14 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.787 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 169.75 -124.98 1.2 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.839 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' CB ' HD23 ' A' ' 20' ' ' LEU . 21.0 m -140.81 106.16 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.905 0.383 . . . . 0.0 111.413 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 98.3 m -65.79 128.89 37.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.212 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.02 HG21 HD12 ' A' ' 32' ' ' LEU . 56.2 mt -68.8 104.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.953 0.406 . . . . 0.0 110.534 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HA ' HD22 ' A' ' 94' ' ' LEU . . . -67.42 -31.45 71.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.11 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.6 172.25 16.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 111.268 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.02 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -153.5 125.36 7.8 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.335 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.135 HG23 ' CH2' ' A' ' 105' ' ' TRP . 9.0 pt -97.09 100.49 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.967 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.88 160.4 31.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.93 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.16 3.39 88.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.93 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.91 -41.88 8.58 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.897 0.38 . . . . 0.0 110.734 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -143.5 140.95 18.1 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.428 179.177 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.09 -48.75 0.42 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.61 2.207 . . . . 0.0 113.241 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.7 mp0 -62.85 -45.58 91.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 111.065 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.586 HD13 HD23 ' A' ' 18' ' ' LEU . 3.9 mt -61.48 -49.84 82.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.962 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.23 -30.15 68.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.722 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -94.53 -12.87 26.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.234 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.601 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -111.75 -75.08 0.62 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.844 -178.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.881 ' CD2' HG21 ' A' ' 6' ' ' VAL . 32.8 mt -70.54 151.6 44.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.858 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -153.11 172.91 16.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.458 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -73.57 113.31 10.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.81 0.338 . . . . 0.0 111.052 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.98 27.34 2.99 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.812 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.842 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -122.09 136.45 54.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.731 0.301 . . . . 0.0 110.91 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.591 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.2 mt -105.96 118.09 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.861 HD12 HD21 ' A' ' 20' ' ' LEU . 2.9 mt -75.24 100.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 p -104.42 27.8 7.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.181 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.1 mttt -172.76 138.3 0.82 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.166 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.915 ' HB2' HD11 ' A' ' 58' ' ' LEU . 25.7 t80 -150.07 112.28 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.393 . . . . 0.0 111.237 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 55.66 51.0 13.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.69 21.51 65.15 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.367 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -124.03 101.27 7.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.575 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.4 120.93 6.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.369 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.915 HD11 ' HB2' ' A' ' 53' ' ' PHE . 14.6 mt -92.36 18.78 7.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.07 126.12 32.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.974 0.416 . . . . 0.0 111.429 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.72 -19.67 43.5 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.069 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.6 mt -81.2 140.63 49.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.542 0.211 . . . . 0.0 111.171 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.51 -157.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.633 2.222 . . . . 0.0 112.16 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -104.45 -23.56 13.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.021 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -56.69 -49.06 76.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.06 0.457 . . . . 0.0 110.377 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.505 ' O ' HD23 ' A' ' 69' ' ' LEU . 30.7 m -71.46 -45.44 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.856 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.469 ' N ' HG23 ' A' ' 65' ' ' VAL . 91.2 m -55.0 -51.98 64.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.757 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CE1' ' CD2' ' A' ' 104' ' ' TYR . 13.8 t80 -66.74 -30.65 70.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.656 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.73 -51.06 60.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.233 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.753 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -67.12 -41.44 86.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.856 0.36 . . . . 0.0 110.192 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.615 ' HB3' HG21 ' A' ' 106' ' ' VAL . 3.4 m-85 -62.58 -33.7 75.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.672 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.407 ' HD3' ' CE2' ' A' ' 67' ' ' TYR . 13.0 mtmt -79.73 -35.73 38.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.373 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.71 7.66 72.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.566 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.659 ' HB1' HG11 ' A' ' 77' ' ' VAL . . . -71.4 141.44 50.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 0.0 110.808 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -175.25 99.17 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.681 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.42 74.68 0.51 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.819 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.26 120.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 110.081 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.701 HG11 ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -132.0 107.91 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.84 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -99.75 111.88 24.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.473 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.93 128.81 55.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.397 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.87 104.74 17.29 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.782 HG11 HD22 ' A' ' 44' ' ' LEU . 1.7 m -95.05 143.16 12.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.781 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 62.0 m -108.22 127.91 54.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.205 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.11 95.44 15.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 82' ' ' THR . 52.7 Cg_exo -53.93 -174.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.496 2.13 . . . . 0.0 112.147 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -84.53 158.97 59.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.36 -179.75 2.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.623 2.215 . . . . 0.0 112.288 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 146.79 -133.57 4.88 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.551 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.86 173.09 17.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.714 0.293 . . . . 0.0 110.892 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.11 -46.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.64 -89.59 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.2 p -100.01 -31.25 11.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.942 0.401 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.38 140.73 6.48 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.533 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 m 60.67 171.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 30' ' ' ALA . 2.2 mp -90.76 -29.04 17.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 p -84.66 138.94 37.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.081 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.79 ' HG2' HD13 ' A' ' 98' ' ' LEU . 59.3 Cg_endo -87.96 29.22 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.757 2.304 . . . . 0.0 113.066 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 53.09 51.09 16.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 111.319 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.79 HD13 ' HG2' ' A' ' 96' ' ' PRO . 5.9 mp -93.28 -39.45 10.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.674 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 99' ' ' LEU . 6.8 tp -153.05 175.56 12.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.21 -69.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.963 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.779 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.4 mpt_? -140.86 -79.34 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.058 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 t30 48.63 27.54 1.53 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 111.076 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.538 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 5.2 mm100 -81.18 -177.91 6.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.153 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.53 ' CD2' ' CE1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -86.83 96.28 10.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.135 ' CH2' HG23 ' A' ' 33' ' ' ILE . 14.7 m95 -104.22 138.64 40.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 111.783 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 70' ' ' PHE . 18.6 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.113 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.748 0.309 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.23 158.23 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.804 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HG2' HG23 ' A' ' 82' ' ' THR . 16.0 mttp -151.62 129.67 11.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.746 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.774 ' CE2' HG22 ' A' ' 6' ' ' VAL . 30.1 p90 -138.29 170.87 15.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.69 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.62 136.02 48.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.043 0.449 . . . . 0.0 111.431 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.878 HG21 ' CD2' ' A' ' 44' ' ' LEU . 19.6 t -114.93 106.93 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.681 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 15.4 p-10 -110.65 127.01 55.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.894 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.687 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.87 159.27 44.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.377 . . . . 0.0 110.39 178.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.67 113.62 11.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.998 0.428 . . . . 0.0 110.941 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.837 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -97.66 151.63 19.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.431 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 8.0 mmtt -138.34 69.43 1.38 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.637 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.55 23.2 5.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.282 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.7 113.64 1.45 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.558 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -161.88 -96.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 0.0 110.985 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 19.4 mt-10 -69.41 -5.56 24.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.659 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.786 HD22 ' CD2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.6 -36.02 4.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.267 0.556 . . . . 0.0 109.583 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.553 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 25.32 62.6 0.06 OUTLIER Glycine 0 CA--C 1.52 0.352 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.999 HD12 HD21 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -138.56 91.69 2.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.166 0.508 . . . . 0.0 109.992 177.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.452 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.4 t -59.51 112.35 1.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.824 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.999 HD21 HD12 ' A' ' 18' ' ' LEU . 7.0 mt -96.21 168.3 10.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.613 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -146.6 158.33 46.66 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.335 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.35 125.07 13.37 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.475 2.117 . . . . 0.0 112.488 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.531 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -132.71 162.52 31.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.002 0.429 . . . . 0.0 111.105 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -81.63 -18.01 46.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.425 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 49' ' ' ILE . 6.5 pt -117.8 -4.61 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.706 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.83 -123.51 1.14 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.183 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 1.3 m -140.76 106.47 5.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.825 0.345 . . . . 0.0 111.575 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.4 ' OG1' HG12 ' A' ' 49' ' ' ILE . 97.0 m -69.64 137.56 52.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.039 HG21 HD12 ' A' ' 32' ' ' LEU . 22.5 mt -79.46 104.92 8.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.865 0.364 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.779 ' HA ' HD22 ' A' ' 94' ' ' LEU . . . -71.59 -28.08 63.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -160.54 169.36 23.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 111.205 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.039 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -152.42 127.24 9.57 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.349 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.086 HG23 ' CH2' ' A' ' 105' ' ' TRP . 5.3 pt -98.19 100.47 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.296 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.53 154.37 42.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.024 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.05 -20.72 47.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.903 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 11.9 mp0 -70.74 -48.03 56.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.71 142.2 33.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.787 0.327 . . . . 0.0 110.703 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.56 -48.85 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.545 2.163 . . . . 0.0 112.901 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' LYS . 23.1 mm-40 -61.41 -50.14 74.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 111.027 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.734 HD11 HD23 ' A' ' 16' ' ' LEU . 4.1 mt -56.44 -51.45 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.142 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -59.89 -30.31 68.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.819 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 m -97.79 1.98 48.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.427 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -125.6 -72.23 0.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.779 0.323 . . . . 0.0 111.552 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.878 ' CD2' HG21 ' A' ' 6' ' ' VAL . 49.1 mt -77.51 152.91 33.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.089 0.471 . . . . 0.0 111.61 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -150.35 -175.91 5.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.503 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -81.62 95.0 7.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.048 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.34 43.09 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.799 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.579 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -138.78 145.38 40.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 110.877 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.531 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.0 OUTLIER -116.55 118.13 57.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -179.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.971 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.4 mt -74.62 100.46 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 110.83 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -100.45 26.5 6.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.724 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.8 mttt -172.61 136.16 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.905 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB2' HD11 ' A' ' 58' ' ' LEU . 61.3 t80 -142.62 109.98 5.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.219 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.57 48.71 19.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.914 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.78 76.98 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.396 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -124.71 105.61 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 0.0 110.712 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.92 121.81 10.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.316 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.918 HD11 ' HB2' ' A' ' 53' ' ' PHE . 11.4 mt -92.72 16.87 11.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.965 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.39 141.46 52.17 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.868 0.366 . . . . 0.0 111.081 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.79 29.65 55.12 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.667 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 58' ' ' LEU . 10.8 mt -115.36 135.32 22.56 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.5 0.19 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 61' ' ' LEU . 53.2 Cg_exo -54.69 -169.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.404 2.069 . . . . 0.0 112.167 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -98.39 -26.38 14.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.038 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -58.53 -46.84 85.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.032 0.444 . . . . 0.0 110.584 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.507 ' O ' HD23 ' A' ' 69' ' ' LEU . 20.3 t -66.45 -48.97 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.897 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 1.3 m -57.5 -53.75 54.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.769 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.549 ' CD1' HG12 ' A' ' 106' ' ' VAL . 38.3 t80 -58.07 -31.25 66.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.81 -51.04 24.52 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.714 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.99 -32.71 72.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 110.26 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.971 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 4.8 m-85 -72.42 -29.01 63.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.04 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 7.2 mtpt -85.15 -35.88 21.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.581 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.12 -22.7 65.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.874 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.837 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . . . -42.98 128.14 4.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.563 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -155.25 103.26 2.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 110.945 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.04 86.62 1.88 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.265 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.27 114.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 110.622 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.829 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.51 107.78 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.227 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 4.3 t -102.64 108.45 19.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.488 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.53 125.31 52.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.522 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -86.47 112.04 21.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.874 0.369 . . . . 0.0 110.216 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.847 HG11 HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -101.28 142.39 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.616 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.431 HG23 ' HG2' ' A' ' 3' ' ' LYS . 94.2 m -108.85 124.61 50.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.392 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -107.07 90.34 5.36 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.104 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.33 -173.12 1.66 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.656 2.238 . . . . 0.0 112.502 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -123.19 156.02 63.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.777 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.19 161.8 41.29 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.564 2.176 . . . . 0.0 112.249 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.99 -65.63 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.513 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.1 p -75.56 -39.46 58.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.388 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.73 -104.15 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.44 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.77 -117.14 0.95 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.69 26.14 6.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.51 154.54 21.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -132.37 166.53 21.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.294 . . . . 0.0 110.952 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.779 HD22 ' HA ' ' A' ' 30' ' ' ALA . 1.7 mp -79.93 -49.6 11.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.796 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 95' ' ' VAL . 11.0 p -136.98 113.83 9.85 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.693 ' HG2' HD13 ' A' ' 98' ' ' LEU . 57.8 Cg_endo -72.41 -175.52 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.527 2.152 . . . . 0.0 112.165 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.73 61.18 3.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.081 0.467 . . . . 0.0 110.783 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.693 HD13 ' HG2' ' A' ' 96' ' ' PRO . 2.0 mp -93.07 -71.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.04 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.73 169.29 9.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -79.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.953 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.812 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -141.7 -79.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.917 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.33 28.39 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.096 0.475 . . . . 0.0 111.062 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.515 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 18.1 mm-40 -82.05 -178.94 7.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.243 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 1.8 t80 -84.8 96.13 9.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.086 ' CH2' HG23 ' A' ' 33' ' ' ILE . 25.6 m95 -102.55 132.21 48.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.316 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.549 HG12 ' CD1' ' A' ' 67' ' ' TYR . 11.4 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.178 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.797 0.332 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.01 162.44 14.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' HG2' HG23 ' A' ' 82' ' ' THR . 10.6 mttt -155.77 129.62 8.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.759 ' CE2' HG22 ' A' ' 6' ' ' VAL . 30.0 p90 -140.04 175.38 9.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.785 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.49 139.27 47.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.159 0.504 . . . . 0.0 111.84 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.889 HG21 ' CD2' ' A' ' 44' ' ' LEU . 17.5 t -120.91 107.02 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.239 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 25.8 p-10 -112.24 127.24 55.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.714 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.06 156.14 42.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.008 0.432 . . . . 0.0 110.47 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.06 114.82 9.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.014 0.435 . . . . 0.0 110.539 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.925 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -96.4 145.01 26.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.739 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 23.8 mmtt -134.99 69.32 1.45 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.32 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.43 26.58 9.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.182 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.01 112.98 0.51 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.304 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.422 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -157.11 -94.46 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.027 0.442 . . . . 0.0 111.296 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 15.3 mt-10 -68.25 -4.45 14.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.154 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.075 HD13 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -44.58 -30.12 0.85 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.548 0.213 . . . . 0.0 110.552 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 19.47 53.22 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 114.62 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.075 HD21 HD13 ' A' ' 16' ' ' LEU . 2.0 pp -135.57 103.15 5.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.945 0.402 . . . . 0.0 110.066 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 1.2 t -69.06 122.08 17.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.138 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.743 HD22 HD12 ' A' ' 50' ' ' ILE . 10.6 mt -105.0 159.75 15.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.63 167.72 20.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.479 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.74 135.15 21.2 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.556 2.171 . . . . 0.0 112.585 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.444 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -147.4 162.64 38.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.088 179.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -32.89 38.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.154 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.574 HG13 HG22 ' A' ' 51' ' ' THR . 2.3 pt -99.12 -7.95 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.82 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.78 -122.81 1.04 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.416 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 m -140.52 106.45 5.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.75 0.309 . . . . 0.0 111.246 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.519 ' N ' HG23 ' A' ' 49' ' ' ILE . 93.6 m -66.95 127.33 32.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.399 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.547 HD11 HD13 ' A' ' 44' ' ' LEU . 30.7 mt -68.93 104.75 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.683 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -71.1 -23.38 62.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.945 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -171.68 172.45 4.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.825 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.745 HD22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -163.48 131.76 3.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.986 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.173 HG23 ' CH2' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -95.53 144.14 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.597 -179.112 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -94.0 169.39 10.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.937 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.87 21.38 71.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.764 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -111.77 -33.51 6.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 110.891 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -156.25 144.91 14.69 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.15 -47.91 4.12 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.469 2.112 . . . . 0.0 112.779 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 43' ' ' LYS . 14.2 mp0 -65.77 -52.27 52.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.221 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.888 HD13 HD23 ' A' ' 18' ' ' LEU . 2.6 mt -54.91 -40.95 55.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.558 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -71.23 -30.09 65.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.153 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.56 3.71 32.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.062 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -127.47 -73.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.889 ' CD2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -60.12 148.88 34.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.884 -178.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -153.85 -175.71 5.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.539 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -92.93 116.8 29.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.51 -14.86 8.13 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.074 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.516 ' HB2' HD12 ' A' ' 29' ' ' ILE . 14.6 m-20 -85.87 158.8 19.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 111.267 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 28' ' ' THR . 1.1 mp -130.4 121.84 51.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.736 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.755 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 14.6 mt -74.26 100.63 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.034 0.445 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.574 HG22 HG13 ' A' ' 25' ' ' ILE . 7.5 p -102.4 26.88 7.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.906 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 2.8 mttt -172.7 135.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.982 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB2' HD11 ' A' ' 58' ' ' LEU . 68.0 t80 -139.34 120.83 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.93 0.395 . . . . 0.0 111.37 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.63 39.88 22.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.985 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.17 17.52 78.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.498 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -124.23 106.5 10.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 0.0 110.714 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.62 124.57 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.431 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.918 HD11 ' HB2' ' A' ' 53' ' ' PHE . 10.4 mt -94.91 23.34 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.81 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.95 144.28 38.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.091 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.89 24.01 57.29 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.695 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.703 HD12 ' HA ' ' A' ' 58' ' ' LEU . 83.3 mt -116.46 139.03 24.89 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.539 0.209 . . . . 0.0 110.803 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.95 -161.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.408 2.072 . . . . 0.0 112.17 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -106.73 -24.27 12.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -56.8 -50.65 71.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.063 0.459 . . . . 0.0 110.599 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.51 ' O ' HD23 ' A' ' 69' ' ' LEU . 16.4 m -63.21 -47.45 92.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.067 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.454 ' N ' HG23 ' A' ' 65' ' ' VAL . 63.5 m -57.5 -53.79 54.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 110.895 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.607 ' CE1' HG12 ' A' ' 106' ' ' VAL . 18.6 t80 -57.37 -31.0 65.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.715 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.23 -51.11 18.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.233 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.739 HD13 ' CD2' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -68.31 -32.29 72.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 110.331 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.755 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 5.5 m-85 -73.1 -31.32 64.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.976 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.448 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -85.11 -29.87 24.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.577 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.27 -22.45 44.5 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.855 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.925 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . . . -43.46 131.52 4.92 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.809 0.338 . . . . 0.0 111.519 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -157.06 101.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.05 85.27 1.49 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.623 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 110.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.824 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.749 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -124.6 108.0 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.685 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -99.25 111.29 23.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.479 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.23 124.03 46.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -88.31 107.29 18.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 110.289 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.64 HG23 ' CE1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -95.29 142.94 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.443 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 92.8 m -108.45 128.4 54.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.079 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -110.54 93.43 16.37 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.208 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 82' ' ' THR . 38.8 Cg_exo -60.07 -174.17 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.584 2.189 . . . . 0.0 112.218 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -109.38 160.98 25.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.59 167.03 23.88 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.491 2.127 . . . . 0.0 112.297 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.1 -104.97 0.27 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.477 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.3 m -102.83 -176.8 3.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.63 -173.38 30.25 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.448 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.08 66.1 3.47 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.496 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.44 -30.85 64.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.963 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.09 65.98 3.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.7 m 60.72 -179.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 0.0 110.94 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 94' ' ' LEU . 3.8 mm? -112.4 -44.34 3.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.948 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 10.1 p -135.08 141.44 38.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.029 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.552 ' HG2' HD13 ' A' ' 98' ' ' LEU . 19.1 Cg_endo -84.8 169.12 10.65 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.627 2.218 . . . . 0.0 112.387 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.53 61.52 3.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.12 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.552 HD13 ' HG2' ' A' ' 96' ' ' PRO . 6.0 mp -80.73 -68.97 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.081 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.28 -170.76 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.021 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.29 64.34 4.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.98 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.781 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER 64.5 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.178 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.7 m120 50.03 26.59 2.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 110.745 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.502 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 29.3 mm-40 -85.9 176.64 7.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.807 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.518 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -80.88 96.0 6.89 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.173 ' CH2' HG23 ' A' ' 33' ' ' ILE . 54.7 m95 -100.71 138.05 38.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.698 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.607 HG12 ' CE1' ' A' ' 67' ' ' TYR . 34.4 m . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.211 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 84' ' ' PRO . 5.6 mp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.794 0.331 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 82' ' ' THR . 1.2 tp10 -60.09 162.51 5.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.824 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.9 mttt -156.19 129.52 8.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.61 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.829 ' CE2' HG22 ' A' ' 6' ' ' VAL . 35.0 p90 -136.92 173.94 11.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.791 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.8 135.87 49.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.955 0.407 . . . . 0.0 111.389 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.855 HG21 HD21 ' A' ' 44' ' ' LEU . 12.6 t -117.58 107.34 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.142 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -109.98 127.94 55.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.07 0.462 . . . . 0.0 110.9 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.66 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -159.52 153.07 22.61 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.928 179.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.94 127.14 31.67 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.529 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.959 ' HG2' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -103.79 136.58 43.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.79 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -115.45 69.6 0.73 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.94 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.93 27.61 0.74 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.398 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.77 73.07 1.13 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.281 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.591 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 29.6 ttmt -120.26 -102.82 0.41 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.571 0.224 . . . . 0.0 111.023 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 7.7 mt-10 -70.95 -6.35 37.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.959 HD13 ' HG2' ' A' ' 10' ' ' LYS . 7.7 tp -46.16 -39.13 9.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 16' ' ' LEU . . . 12.33 62.99 0.01 OUTLIER Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.434 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -127.88 91.77 3.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.135 0.493 . . . . 0.0 109.798 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.821 ' OG ' ' HB3' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -52.8 119.35 4.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.844 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.642 HD21 HD13 ' A' ' 18' ' ' LEU . 53.3 mt -107.39 165.26 11.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.542 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 0.9 OUTLIER -145.19 167.68 13.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.361 179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 21' ' ' SER . 70.1 Cg_endo -75.2 135.81 19.19 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.494 2.129 . . . . 0.0 112.82 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.64 162.56 38.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.013 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.45 -28.85 41.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.183 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 pt -103.82 -2.01 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.919 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.8 -124.9 1.33 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.135 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.557 ' SG ' HD12 ' A' ' 50' ' ' ILE . 22.9 p -140.22 106.39 5.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.822 0.344 . . . . 0.0 111.078 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 84.8 m -65.45 128.85 37.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.69 104.74 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.618 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.821 ' HB3' ' OG ' ' A' ' 19' ' ' SER . . . -67.11 -27.58 67.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.588 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -171.66 179.94 2.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.779 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.86 134.92 3.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.003 178.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.178 HG23 ' CH2' ' A' ' 105' ' ' TRP . 2.8 pt -95.99 119.39 43.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.79 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -72.22 175.24 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.308 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.41 -51.58 4.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.635 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -46.26 -74.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.672 0.272 . . . . 0.0 110.723 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -117.74 131.4 24.13 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.691 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.64 -42.74 8.68 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.457 2.105 . . . . 0.0 112.502 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.97 -48.45 81.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.677 HD13 HD23 ' A' ' 18' ' ' LEU . 6.0 mt -59.43 -42.33 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.567 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.27 -30.12 69.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.679 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -99.67 3.36 45.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.505 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HD3' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -125.08 -71.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.819 -179.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.855 HD21 HG21 ' A' ' 6' ' ' VAL . 10.1 mt -72.17 150.33 43.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.248 0.547 . . . . 0.0 112.156 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -153.84 149.6 27.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.248 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 -55.64 107.97 0.39 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.186 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.24 41.0 0.42 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.624 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -142.06 164.07 31.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.573 0.225 . . . . 0.0 110.619 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.6 mp -133.32 120.29 38.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.238 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.834 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 6.1 mt -74.59 100.65 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.045 0.45 . . . . 0.0 110.471 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 p -99.84 18.63 17.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.948 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -162.27 142.52 9.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.138 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.896 ' HB2' HD11 ' A' ' 58' ' ' LEU . 60.2 t80 -151.67 109.85 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.911 0.386 . . . . 0.0 111.1 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 51.94 55.31 9.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.01 23.35 65.79 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.358 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.91 99.72 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.804 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.46 120.57 7.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.285 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.896 HD11 ' HB2' ' A' ' 53' ' ' PHE . 5.1 mt -92.81 16.97 11.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.45 127.34 32.04 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.827 0.346 . . . . 0.0 111.142 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.65 -23.26 31.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.777 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.5 mt -79.6 148.34 69.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 111.096 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.661 ' HG2' HG23 ' A' ' 65' ' ' VAL . 40.6 Cg_endo -67.21 -168.37 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.499 2.132 . . . . 0.0 112.205 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -87.76 -28.45 21.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.618 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.73 -42.33 83.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.406 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.661 HG23 ' HG2' ' A' ' 62' ' ' PRO . 41.4 t -66.2 -53.94 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.744 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.423 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 89.4 m -56.07 -53.82 52.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.056 0.455 . . . . 0.0 110.781 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CD1' HG12 ' A' ' 106' ' ' VAL . 28.3 t80 -56.89 -30.88 64.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.18 -51.16 22.48 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.731 HD13 ' CD2' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.88 -37.18 81.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.351 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.834 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 10.1 m-85 -68.34 -32.04 71.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.955 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 2.9 mtpt -81.34 -34.4 31.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.17 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.36 -23.77 55.87 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.458 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.017 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -45.99 138.92 4.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.658 0.266 . . . . 0.0 111.301 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -170.87 97.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.038 0.447 . . . . 0.0 111.571 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.46 96.36 2.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.93 87.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.128 0.489 . . . . 0.0 110.442 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.017 HG21 ' HB1' ' A' ' 73' ' ' ALA . 3.5 t -114.4 130.72 68.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.147 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.7 t -122.82 139.62 53.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.449 ' HG2' ' CE1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -142.66 129.23 20.25 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.825 0.345 . . . . 0.0 111.675 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -91.21 108.12 19.66 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.719 HG11 HD22 ' A' ' 44' ' ' LEU . 1.9 m -95.16 142.64 13.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.837 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.414 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 45.3 m -108.65 125.33 51.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.196 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -107.68 97.63 21.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.097 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 82' ' ' THR . 50.9 Cg_exo -53.5 -176.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.532 2.155 . . . . 0.0 112.286 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.04 161.44 23.31 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.884 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.16 176.4 4.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.579 2.186 . . . . 0.0 112.309 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.98 -73.35 0.2 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.5 t -135.2 98.14 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 0.0 110.852 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.77 -71.26 0.18 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.554 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -108.08 91.66 0.69 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.595 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 p -73.86 -39.73 63.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.854 0.359 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -157.12 -70.84 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.51 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.4 p -160.08 170.5 21.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.4 -29.43 14.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 97' ' ' ARG . 13.7 p -95.28 132.88 26.95 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.674 ' HD2' HD21 ' A' ' 98' ' ' LEU . 95.8 Cg_endo -80.05 16.54 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.708 2.272 . . . . 0.0 113.109 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.457 ' H ' HG22 ' A' ' 95' ' ' VAL . 6.8 mmm-85 64.61 78.28 0.29 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.796 0.331 . . . . 0.0 111.314 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.674 HD21 ' HD2' ' A' ' 96' ' ' PRO . 1.4 mm? -93.28 -57.73 2.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.78 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mt -134.34 -167.26 1.93 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.637 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.66 -63.97 0.84 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.502 ' HG3' HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -151.74 25.53 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -51.93 91.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.955 0.407 . . . . 0.0 110.361 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 17.9 mm-40 -142.53 174.37 10.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.083 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 2.6 t80 -76.81 95.98 4.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.178 ' CH2' HG23 ' A' ' 33' ' ' ILE . 68.4 m95 -101.71 138.14 39.09 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.352 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.832 ' CG2' HD23 ' A' ' 16' ' ' LEU . 16.0 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.196 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.796 0.331 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.405 ' HB3' ' CG ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -91.14 155.43 18.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.918 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 8.9 mttp -144.86 129.57 18.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.848 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.773 ' CE2' HG22 ' A' ' 6' ' ' VAL . 26.5 p90 -137.03 171.49 14.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.818 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.72 136.03 48.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.057 0.456 . . . . 0.0 111.394 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.856 HG21 ' CD2' ' A' ' 44' ' ' LEU . 16.0 t -116.26 107.33 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.551 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 12.3 t0 -110.66 127.21 55.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.027 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.714 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.53 157.72 43.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 110.481 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.31 110.21 5.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.987 0.422 . . . . 0.0 111.037 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.79 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -94.56 144.39 25.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.093 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HB2' ' CD ' ' A' ' 14' ' ' LYS . 6.6 mmtp -130.05 69.33 1.44 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.436 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.5 20.92 6.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.274 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' CA ' ' HZ3' ' A' ' 10' ' ' LYS . . . 91.31 114.56 1.88 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' CD ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -164.56 -94.29 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 111.444 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.633 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 29.1 mt-10 -69.2 -4.49 17.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.126 0.57 . . . . 0.0 112.359 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.137 HD22 HD21 ' A' ' 18' ' ' LEU . 2.5 mt -44.65 -32.13 1.38 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.482 ' CA ' HG12 ' A' ' 33' ' ' ILE . . . 30.34 59.61 0.22 Allowed Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 115.13 177.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.137 HD21 HD22 ' A' ' 16' ' ' LEU . 1.3 pp -148.11 91.83 1.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.034 0.445 . . . . 0.0 110.202 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 30' ' ' ALA . 3.0 t -65.75 117.28 7.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.549 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.583 HD11 ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -88.0 170.35 11.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.603 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.81 159.39 56.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.11 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.76 111.52 2.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.427 2.085 . . . . 0.0 112.727 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.57 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -124.24 162.51 23.54 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.718 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 25' ' ' ILE . 7.0 pt-20 -83.46 -29.06 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.349 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.57 HG13 HG22 ' A' ' 51' ' ' THR . 1.6 pt -102.09 -8.66 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.763 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.43 -123.81 1.06 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.136 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.53 105.86 5.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.906 0.384 . . . . 0.0 111.046 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.449 ' N ' HG23 ' A' ' 49' ' ' ILE . 92.3 m -68.64 128.95 38.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.179 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.041 HG21 HD12 ' A' ' 32' ' ' LEU . 40.8 mt -70.25 104.8 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.858 0.361 . . . . 0.0 110.639 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HA ' HD22 ' A' ' 94' ' ' LEU . . . -69.86 -30.66 68.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.959 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.442 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.8 OUTLIER -158.34 173.65 16.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.413 . . . . 0.0 111.299 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.041 HD12 HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -155.8 126.89 7.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.397 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.114 HG23 ' CH2' ' A' ' 105' ' ' TRP . 6.6 pt -96.9 100.38 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.972 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -69.16 155.4 40.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.075 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.0 -14.66 64.72 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.859 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.561 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 4.1 mp0 -76.83 -47.61 20.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.711 0.291 . . . . 0.0 110.717 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.633 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.4 138.96 23.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.653 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.22 -51.02 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.662 2.241 . . . . 0.0 113.012 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -58.54 -48.78 79.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.769 0.318 . . . . 0.0 111.044 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.574 HD13 HD23 ' A' ' 18' ' ' LEU . 4.6 mt -57.32 -50.44 76.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.133 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.39 -30.26 68.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.562 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 m -97.48 0.65 47.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.173 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.21 -73.74 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.838 0.351 . . . . 0.0 111.697 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.879 HD12 HD22 ' A' ' 18' ' ' LEU . 34.1 mt -73.29 157.29 37.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.045 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -153.94 -175.9 5.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.221 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -90.56 104.96 17.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 111.127 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.49 -8.7 3.72 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.21 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.18 160.43 15.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 111.182 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.57 HG21 ' OD1' ' A' ' 23' ' ' ASN . 1.0 OUTLIER -126.9 119.69 53.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.849 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 4.3 mt -74.57 100.6 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 110.997 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.57 HG22 HG13 ' A' ' 25' ' ' ILE . 7.7 p -101.07 22.6 12.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.735 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 1.2 mttt -167.54 136.54 2.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.887 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.929 ' HB2' HD11 ' A' ' 58' ' ' LEU . 56.7 t80 -142.73 111.02 6.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.93 0.395 . . . . 0.0 111.265 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 54.17 46.84 24.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.26 22.15 78.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.431 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -126.16 106.41 9.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 110.737 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.68 121.49 9.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.324 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.929 HD11 ' HB2' ' A' ' 53' ' ' PHE . 7.9 mt -94.36 21.37 7.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.752 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -78.4 143.34 36.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.955 0.407 . . . . 0.0 111.097 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.23 24.02 60.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.792 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.51 ' HB3' HG21 ' A' ' 65' ' ' VAL . 34.6 mt -116.42 138.54 24.45 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.56 0.219 . . . . 0.0 110.841 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.36 -159.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.466 2.111 . . . . 0.0 112.182 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 67' ' ' TYR . 30.4 t80 -103.06 -24.44 13.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.984 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -57.73 -48.79 78.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.46 . . . . 0.0 110.515 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 61' ' ' LEU . 18.3 m -63.96 -46.92 92.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.084 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.458 ' N ' HG23 ' A' ' 65' ' ' VAL . 1.5 m -58.8 -51.86 68.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.85 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.514 ' CZ ' ' CE2' ' A' ' 104' ' ' TYR . 10.8 t80 -58.55 -31.22 67.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.23 -51.08 22.7 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.657 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -69.06 -32.24 71.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 110.268 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.849 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 8.9 m-85 -73.76 -28.69 61.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.283 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.433 ' HG3' HG12 ' A' ' 106' ' ' VAL . 29.2 mtmt -85.02 -38.99 18.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.7 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.16 -22.27 74.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.855 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.798 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -44.16 127.87 5.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.832 0.348 . . . . 0.0 111.691 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -159.45 104.02 1.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.089 0.471 . . . . 0.0 110.756 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.96 84.35 1.64 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.072 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 114.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 0.0 110.366 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.798 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -127.38 107.61 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.406 -179.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 t -99.57 114.96 28.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.062 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.83 123.49 41.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.574 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -85.84 105.78 16.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.189 179.107 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.824 HG11 HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -96.61 142.68 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.893 -179.079 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.41 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 91.7 m -108.85 117.78 35.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.603 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.405 ' CG ' ' HB3' ' A' ' 2' ' ' GLU . 22.1 ptt180 -104.53 93.78 6.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.04 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.79 -176.86 2.22 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.512 2.141 . . . . 0.0 112.337 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.3 157.02 41.22 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.939 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.75 163.44 27.79 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.587 2.192 . . . . 0.0 112.289 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.36 -142.65 3.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.564 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.57 106.9 18.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.805 0.336 . . . . 0.0 110.952 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.89 -85.37 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.451 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -179.36 -117.75 0.55 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.468 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 p -69.85 -27.09 64.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.747 0.308 . . . . 0.0 110.942 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.66 -53.59 0.76 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.392 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.32 171.88 9.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.728 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 30' ' ' ALA . 7.5 mp -96.83 22.45 8.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.097 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.575 HG22 ' H ' ' A' ' 97' ' ' ARG . 12.1 p -139.55 125.52 12.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.827 ' HG2' HD13 ' A' ' 98' ' ' LEU . 98.9 Cg_endo -85.31 22.12 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.831 2.354 . . . . 0.0 113.012 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.575 ' H ' HG22 ' A' ' 95' ' ' VAL . 19.7 mmt85 59.67 61.45 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.926 0.393 . . . . 0.0 110.959 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.827 HD13 ' HG2' ' A' ' 96' ' ' PRO . 1.4 mp -93.24 -65.91 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.046 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -126.14 176.9 6.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -65.01 78.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.186 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.797 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER 62.14 -79.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.272 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 46.21 28.57 0.69 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.083 0.468 . . . . 0.0 111.115 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.538 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 5.1 mm100 -79.43 -177.47 5.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.224 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.514 ' CE2' ' CZ ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -86.87 96.03 10.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.114 ' CH2' HG23 ' A' ' 33' ' ' ILE . 8.5 m95 -104.67 134.54 47.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.254 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 70' ' ' PHE . 11.7 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.139 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.61 156.34 29.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.772 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HE3' ' CG2' ' A' ' 82' ' ' THR . 8.9 mttt -150.93 129.58 12.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.812 ' CE2' HG22 ' A' ' 6' ' ' VAL . 28.8 p90 -137.66 170.14 16.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.68 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.65 135.87 49.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.057 0.456 . . . . 0.0 111.305 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.873 HG21 ' CD2' ' A' ' 44' ' ' LEU . 11.5 t -116.37 107.01 21.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.289 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 1.6 p30 -110.44 127.28 55.04 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.053 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -148.1 156.35 42.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.95 0.405 . . . . 0.0 110.663 178.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 113.45 7.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.026 0.441 . . . . 0.0 110.586 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.782 ' CE ' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -96.33 151.26 19.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.434 0.635 . . . . 0.0 111.896 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 20.2 mmtt -138.0 69.27 1.39 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.246 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 53.84 24.06 4.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.3 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.43 113.94 1.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.551 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' CE ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -159.28 -97.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.765 0.317 . . . . 0.0 111.312 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 3.0 mm-40 -69.14 -5.78 24.5 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.161 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.809 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -45.23 -33.97 2.59 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.885 0.374 . . . . 0.0 110.497 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.568 ' HA3' HD11 ' A' ' 33' ' ' ILE . . . 26.17 62.22 0.07 OUTLIER Glycine 0 CA--C 1.522 0.483 0 N-CA-C 115.379 0.912 . . . . 0.0 115.379 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.974 HD12 HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -139.62 91.81 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.023 0.439 . . . . 0.0 110.244 177.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 1.9 t -61.74 114.28 3.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.023 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.974 HD11 HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -93.78 161.59 14.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.36 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 30' ' ' ALA . 19.3 p -136.3 164.77 40.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.577 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.56 122.0 8.48 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.773 2.316 . . . . 0.0 112.841 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.14 162.44 34.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 25' ' ' ILE . 4.8 pt-20 -80.09 -36.83 34.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.115 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.554 HD11 HD13 ' A' ' 49' ' ' ILE . 2.1 pt -94.93 -7.65 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.02 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.76 -125.18 1.27 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.366 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -140.69 106.28 5.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.882 0.372 . . . . 0.0 111.522 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' HG12 ' A' ' 49' ' ' ILE . 98.7 m -69.76 128.37 36.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.197 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.011 HG21 HD12 ' A' ' 32' ' ' LEU . 49.6 mt -64.41 104.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.855 0.359 . . . . 0.0 110.446 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.589 ' HA ' HD13 ' A' ' 94' ' ' LEU . . . -71.96 -26.84 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.611 ' OD1' HG11 ' A' ' 95' ' ' VAL . 1.8 m-20 -159.47 163.96 34.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.739 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.011 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -153.68 129.14 9.9 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.113 0.482 . . . . 0.0 111.971 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.173 HG23 ' CH2' ' A' ' 105' ' ' TRP . 3.0 pt -96.17 108.92 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.083 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -82.38 128.61 34.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.079 0.466 . . . . 0.0 111.294 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.2 30.37 3.17 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.814 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -117.49 -29.89 5.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.708 0.29 . . . . 0.0 111.279 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -151.31 143.11 15.86 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.028 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.79 -47.18 2.83 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.453 2.102 . . . . 0.0 112.894 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 7.2 mm-40 -66.02 -51.53 57.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.2 mt -55.47 -46.6 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.229 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.65 -30.37 71.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.991 0.424 . . . . 0.0 110.524 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 m -97.46 3.52 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.229 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.66 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -128.71 -72.67 0.6 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.944 0.402 . . . . 0.0 111.821 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.873 ' CD2' HG21 ' A' ' 6' ' ' VAL . 26.8 mt -73.7 149.11 42.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.119 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -153.96 155.8 36.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.357 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -57.81 104.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.151 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.03 45.2 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.899 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -144.77 145.05 31.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.366 . . . . 0.0 110.888 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.554 HD13 HD11 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -112.58 117.57 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.351 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.01 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 7.0 mt -74.89 100.23 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.264 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 25' ' ' ILE . 13.9 p -93.68 -3.93 51.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.278 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -144.89 147.28 32.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.979 ' HB2' HD11 ' A' ' 58' ' ' LEU . 22.8 t80 -153.32 114.05 4.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.884 0.373 . . . . 0.0 111.323 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.42 46.36 25.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.002 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.54 24.73 76.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.353 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -124.98 102.98 7.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 110.654 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.97 114.95 1.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.457 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.979 HD11 ' HB2' ' A' ' 53' ' ' PHE . 13.2 mt -91.12 15.78 11.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.59 125.36 35.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.72 15.62 51.94 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.373 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -128.64 159.74 66.43 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.976 0.388 . . . . 0.0 111.131 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.3 -171.7 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.695 2.264 . . . . 0.0 112.524 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 12.4 t80 -94.05 -32.11 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.594 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.72 -46.6 50.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.999 0.428 . . . . 0.0 110.449 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' O ' HD23 ' A' ' 69' ' ' LEU . 24.4 m -64.26 -41.05 91.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.86 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 17.1 m -62.77 -51.77 65.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.919 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.698 ' CD1' HG12 ' A' ' 106' ' ' VAL . 37.2 t80 -58.49 -30.96 67.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.713 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.67 -50.96 31.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.665 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -70.07 -31.49 69.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.411 . . . . 0.0 110.239 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 1.01 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 3.4 m-85 -72.86 -27.61 62.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.138 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 67' ' ' TYR . 1.8 mtpt -85.2 -43.84 13.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.794 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.28 -23.41 78.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.016 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.782 ' HB3' ' CE ' ' A' ' 10' ' ' LYS . . . -42.16 128.89 3.73 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 111.735 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -157.32 103.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.09 83.6 1.44 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.267 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.08 114.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.469 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.781 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.31 107.83 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.687 -179.056 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 t -100.35 111.98 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.501 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.9 124.02 49.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.323 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -87.13 104.66 16.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.066 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.682 HG11 HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.94 142.52 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.421 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.409 ' CG2' ' HE3' ' A' ' 3' ' ' LYS . 83.9 m -108.92 119.95 41.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.636 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -102.77 91.33 2.77 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.69 -174.2 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.531 2.154 . . . . 0.0 112.544 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -105.47 157.76 33.76 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.38 174.4 3.47 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.569 2.179 . . . . 0.0 112.297 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.46 27.88 46.07 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.526 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.85 101.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.957 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.73 -147.42 14.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.545 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.12 179.56 14.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.526 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.9 m -61.14 -31.12 70.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.765 0.316 . . . . 0.0 110.92 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.27 -40.81 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.61 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.0 m -143.23 -174.24 4.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.589 HD13 ' HA ' ' A' ' 30' ' ' ALA . 1.1 mp -107.75 -33.84 7.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.009 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.611 HG11 ' OD1' ' A' ' 31' ' ' ASP . 7.7 p -128.5 129.19 23.57 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.636 ' HG2' HD11 ' A' ' 98' ' ' LEU . 33.5 Cg_endo -68.63 -162.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.2 1.933 . . . . 0.0 112.097 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.7 mmt-85 -93.71 66.35 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 111.527 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.636 HD11 ' HG2' ' A' ' 96' ' ' PRO . 0.7 OUTLIER -80.15 -71.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.677 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.866 HD12 ' HG2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -153.55 -166.48 2.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.566 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.866 ' HG2' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -46.22 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.226 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.799 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 1.5 mpt_? -140.23 -79.01 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.649 0.261 . . . . 0.0 110.916 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.623 ' CB ' HD11 ' A' ' 99' ' ' LEU . 56.9 t30 46.65 29.09 0.88 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.244 0.545 . . . . 0.0 110.88 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.534 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 26.5 mm100 -81.51 -176.36 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.448 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 5.7 t80 -86.85 96.47 10.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.243 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.173 ' CH2' HG23 ' A' ' 33' ' ' ILE . 9.0 m95 -106.48 137.16 44.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.698 HG12 ' CD1' ' A' ' 67' ' ' TYR . 27.5 m . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.207 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.858 0.361 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.66 156.07 25.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.532 ' HG2' HG23 ' A' ' 82' ' ' THR . 25.1 mttp -150.74 129.59 12.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.962 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.806 ' CE2' HG22 ' A' ' 6' ' ' VAL . 25.5 p90 -136.85 171.58 14.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.801 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.62 135.65 49.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.031 0.443 . . . . 0.0 111.223 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.837 HG21 ' CD2' ' A' ' 44' ' ' LEU . 12.3 t -116.11 107.28 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.361 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 14.5 p-10 -110.0 127.23 54.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.7 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -149.36 158.6 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.527 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.02 113.32 8.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.103 0.478 . . . . 0.0 110.913 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.887 ' HE2' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -97.51 145.59 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.425 -179.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 12.4 mmtt -131.46 69.43 1.47 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.225 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.14 23.19 5.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.3 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.12 113.48 1.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.59 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HD2' ' CG ' ' A' ' 11' ' ' LYS . 6.6 ptpt -161.5 -94.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 37' ' ' TYR . 9.5 mt-10 -69.47 -5.9 26.95 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.669 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.887 HD22 ' HE2' ' A' ' 10' ' ' LYS . 2.1 tp -45.8 -34.36 3.67 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.538 ' HA3' ' CG1' ' A' ' 33' ' ' ILE . . . 22.74 62.16 0.03 OUTLIER Glycine 0 C--N 1.331 0.262 0 CA-C-N 114.933 -1.031 . . . . 0.0 115.008 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.786 HD22 HD12 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.43 91.7 2.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 110.097 178.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 5.0 t -61.59 118.94 7.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.021 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.582 HD21 ' CD1' ' A' ' 50' ' ' ILE . 7.8 mp -100.25 159.12 15.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.359 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.905 ' OG ' ' HB2' ' A' ' 30' ' ' ALA . 56.0 m -130.41 156.71 79.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.629 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.91 111.4 2.18 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.531 2.154 . . . . 0.0 112.474 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.492 ' OD1' HG21 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -122.85 162.57 21.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.064 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.621 ' HG3' HG23 ' A' ' 25' ' ' ILE . 11.1 pt-20 -79.09 -31.66 44.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.189 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.621 HG23 ' HG3' ' A' ' 24' ' ' GLU . 2.8 pt -101.12 -8.3 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.969 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 50' ' ' ILE . . . 170.26 -121.19 0.9 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.484 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' SER . 3.0 m -140.47 106.48 5.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 0.0 111.224 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.555 ' N ' HG23 ' A' ' 49' ' ' ILE . 97.5 m -69.69 119.96 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.561 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.94 HG21 HD12 ' A' ' 32' ' ' LEU . 52.7 mt -61.35 104.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.741 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.905 ' HB2' ' OG ' ' A' ' 21' ' ' SER . . . -73.72 -29.58 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' CB ' ' HG3' ' A' ' 103' ' ' GLN . 0.5 OUTLIER -158.67 171.45 20.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.064 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.94 HD12 HG21 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -159.31 128.2 5.26 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.454 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.166 HG23 ' CH2' ' A' ' 105' ' ' TRP . 2.4 pt -96.47 100.69 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.274 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -69.79 145.32 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.085 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.13 -25.34 23.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.915 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.574 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 1.8 mp0 -66.71 -47.52 72.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.722 0.296 . . . . 0.0 110.858 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 15' ' ' GLU . 1.3 m-85 -136.65 140.21 31.44 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.68 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.43 -50.15 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.635 2.223 . . . . 0.0 112.924 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -59.37 -49.71 76.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 110.997 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.701 HD13 HD23 ' A' ' 18' ' ' LEU . 5.2 mt -55.85 -53.01 42.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -58.43 -30.17 66.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.6 m -97.17 0.99 49.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.338 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' CB ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -126.37 -73.41 0.62 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 0.0 111.566 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.84 HD22 HG11 ' A' ' 81' ' ' VAL . 21.3 mt -72.81 155.59 39.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.908 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -151.5 -175.77 5.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.474 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -90.57 98.0 11.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.035 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.43 -18.53 1.68 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.046 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.79 162.44 21.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 111.236 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 28' ' ' THR . 1.1 mp -128.9 120.36 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.918 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.884 HD13 ' CZ ' ' A' ' 70' ' ' PHE . 5.9 mt -74.48 100.22 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 110.644 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.512 HG22 HG13 ' A' ' 25' ' ' ILE . 7.5 p -94.71 -7.4 40.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -141.43 147.95 38.77 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.972 ' HB2' HD11 ' A' ' 58' ' ' LEU . 26.8 t80 -152.58 110.38 3.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 0.0 111.256 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 54.14 47.44 23.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.858 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.35 24.81 73.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.231 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -123.88 102.41 7.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 0.0 110.584 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.11 114.01 1.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.427 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.972 HD11 ' HB2' ' A' ' 53' ' ' PHE . 15.3 mt -89.83 14.39 12.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.927 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -78.39 142.97 37.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.046 0.45 . . . . 0.0 111.232 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.05 26.52 61.15 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.744 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 58' ' ' LEU . 63.0 mt -120.24 140.79 30.61 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.607 0.242 . . . . 0.0 110.96 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.67 -166.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.507 2.138 . . . . 0.0 112.168 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -101.6 -24.97 14.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.105 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -45.84 84.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.686 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' HD23 ' A' ' 69' ' ' LEU . 25.7 t -68.08 -50.48 58.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.499 ' SG ' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -55.91 -48.36 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.566 ' CD1' HG12 ' A' ' 106' ' ' VAL . 15.7 t80 -64.3 -30.98 72.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.13 -50.9 35.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.958 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.685 HD13 ' CD1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -67.5 -35.51 79.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 110.396 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.884 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 2.6 m-85 -69.77 -28.85 66.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.217 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.405 ' HE2' ' CD2' ' A' ' 67' ' ' TYR . 21.1 mtmt -84.98 -36.52 21.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.739 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.61 -20.0 67.15 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.976 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.824 ' HB1' ' CG1' ' A' ' 77' ' ' VAL . . . -45.34 126.93 6.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.752 0.311 . . . . 0.0 111.532 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -154.78 103.73 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.28 85.78 1.8 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.063 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.93 116.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.456 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.824 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -131.19 107.72 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.632 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.6 t -99.41 114.3 27.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.33 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.79 125.34 48.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.478 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -86.76 103.8 15.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.928 0.394 . . . . 0.0 110.091 178.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.84 HG11 HD22 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -95.17 143.1 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.521 -179.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.532 HG23 ' HG2' ' A' ' 3' ' ' LYS . 77.7 m -108.32 116.77 32.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -102.69 89.8 1.97 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.062 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.83 -178.86 1.41 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.525 2.15 . . . . 0.0 112.213 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.4 mtmm -75.58 157.41 84.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.986 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.4 166.56 28.0 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.658 2.239 . . . . 0.0 112.328 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.42 168.86 39.71 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.528 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.35 106.34 9.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.803 0.335 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -130.14 65.59 0.59 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.395 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.46 -88.39 0.38 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.471 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.58 -34.53 6.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.76 -51.42 0.73 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.413 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -104.96 171.61 7.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.769 0.318 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.1 -41.27 18.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.905 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 97' ' ' ARG . 14.9 p -117.44 124.23 29.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.603 ' HD2' HD21 ' A' ' 98' ' ' LEU . 73.0 Cg_endo -76.8 12.85 1.57 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.561 2.174 . . . . 0.0 113.252 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.578 ' H ' HG22 ' A' ' 95' ' ' VAL . 1.8 mtt180 68.47 74.52 0.27 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.887 0.375 . . . . 0.0 111.412 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.603 HD21 ' HD2' ' A' ' 96' ' ' PRO . 1.4 mm? -93.14 -35.76 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.301 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.3 -163.19 1.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.204 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.86 -74.58 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.801 ' HB3' ' HZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -141.88 -72.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.628 179.515 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.25 27.24 3.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 110.671 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.507 ' HB2' ' CE2' ' A' ' 105' ' ' TRP . 14.5 mm100 -89.87 171.84 9.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.715 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.519 ' CZ ' ' CE2' ' A' ' 67' ' ' TYR . 1.3 t80 -81.49 96.07 7.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.166 ' CH2' HG23 ' A' ' 33' ' ' ILE . 33.4 m95 -100.91 136.98 39.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.113 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.739 ' CG2' HD23 ' A' ' 16' ' ' LEU . 25.6 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.171 179.992 . . . . . . . . 1 1 . 1 stop_ save_